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Summary 
_____________________________________________________________________ 
 
Glutaredoxins are nearly ubiquitious small enzymes which protect the thiol 
groups of cellular proteins from oxidative stress, contribute to iron-sulfur 
cluster biogenesis or regulate protein activities via redox modification. Three 
different classes of glutatreoxins are distinguished by their active site motif: 
CPYC-type glutaredoxins catalyze the reduction and oxidation of thiol groups 
and mediate defense against oxidative stress; CGFS-type glutaredoxins are 
weak catalysts but associate with iron-sulfur clusters, possibly transferring them 
to target proteins. Whereas CPYC- and CGFS-type glutaredoxins are found in 
all types of organisms, CC-type glutaredoxins, which are called ROXYs in 
Arabidopsis thaliana, are restricted to land plants. In contrast to their relatively 
well characterized relatives, CC-type glutaredoxins are biochemically poorly 
understood. Information about these glutaredoxins is only available from in vivo 
studies. Mutant analysis and studies with plants ectopically expressing ROXYs 
have shown that they modulate TGACG binding (TGA) factor activity. As an 
example, the CC-type glutaredoxin ROXY9 was shown to repress TGA1-
mediated hyponastic growth when overexpressed. Since TGA1 was shown to 
be redox-regulated in plants treated with the defense hormone salicylic acid, it 
was speculated that ROXY9 represses TGA1 via catalytic activity. Therefore, 
this study was set up to analyze whether recombinant ROXY9 exhibits 
oxidoreductase and/or iron-sulfur cluster binding activity. Up to now, 
difficulties in the purification of CC-type glutaredoxins has been the bottleneck 
for their biochemical characterization. Similarly, ROXY9 could not be purified 
in a soluble, non-aggregated state when using Escherichia coli as an expression 
host. Strikingly, expression in insect cells resulted in large amounts of 
monomeric and soluble ROXY9 fused to a strep-MBP-tag. However, the 
protein turned out to oxidize quickly under aerobic conditions. Reduction of 
the oxidized protein by glutathione might be inefficient, which could explain 
the inactivity of ROXY9 towards the typical glutaredoxin substrates bis(2-
hydroxyethyl)disulphide (HEDS), insulin, and the redox-sensitive green 
fluorescent protein (roGFP). Still, a weak reductase activity of ROXY9 towards 
glutathionylated glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
observed, suggesting that ROXY9 in principle can reduce target proteins. In 
contrast to its weak reductase activity, ROXY9 turned out to glutathionylate 
roGFP efficiently with the help of glutathione disulfide, suggesting that 
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ROXY9 might repress TGA1 in vivo via glutathionylation. However, because 
all these observations might have been influenced by the oxidation of the 
protein, the catalytic activity of ROXY9 has to be reproduced with fully 
reduced protein. Aside from catalysis, ROXY9 appeared to bind an iron-sulfur 
cluster under anaerobic conditions. This raises the alternative hypothesis that 
it could repress TGA1 via recruitment of an iron-sulfur cluster-dependent 
repression complex. In vivo analysis of the repression capacity of overexpressed 
mutated ROXY9 versions suggested that ROXY9 requires the second cysteine 
and the tyrosine of its extended active site motif CCLCY for its activity. Future 
experiments under anaerobic conditions will have to clarify whether ROXY9 
requires these amino acids for catalysis or for iron-sulfur cluster binding. In an 
initial experiment to address the repression mechanism of TGA1 by ROXY9 
in vivo, a TGA1 version with mutated cysteine residues was constructed and 
expressed in the tga1 tga4 mutant. This mutant protein is resistant to oxidation 
and was as active in vivo as wildtype TGA1 regarding hyponastic growth and 
flowering. However, the experimental setup might not allow the detection of a 
weak contribution of the TGA1 redox state to hyponastic growth and 
flowering; thus, this experiment does currently not allow to conclude whether 
TGA1 is redox-controlled. To test this hypothesis in the future, ROXY9 will 
have to be overexpressed in tga1 tga4 mutants complemented with wildtype 
TGA1 and the TGA1 cysteine mutant to find out, whether ROXY9 can still 
repress the TGA1 cysteine mutant. 
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Redox signaling via thiol groups 
_____________________________________________________________________ 
 
With the evolution of photosynthesis and oxygen-based cellular respiration, 
organisms became exposed to the byproducts of these two processes, namely 
reactive oxygen and reactive nitrogen species (ROS and RNS). On the one 
hand, both, ROS and RNS can damage biological macromolecules by 
oxidation, such as proteins, lipids and DNA and thereby interfere with normal 
metabolism. On the other hand, controlled redox modification of proteins 
allows changes in their activity, which serves as a means of signal transduction 
in many fundamental processes, such as development or stress responses [1–
13]. 
During redox signaling, protein cysteine residues are of particular importance: 
Cysteines exhibit a thiol group which can undergo a variety of redox 
modifications (Figure I1). These modifications range from inter- or 
intramolecular disulfide bridges to nitrosylation and the oxidation to sulfenic 
acid. In addition, cysteine residues can react with the ubiquitous antioxidant 
glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) (Figure I2A) leading to the 
formation of a glutathione-mixed disulfide (Figure I1). Moreover, sulfenic acid 
groups can be converted into sulfinic acid groups. While all aforementioned 
redox modifications are usually reversible, sulfinic acid groups can be converted 
irreversibly into sulfonic acid groups by further oxidation (Figure I1) 
[5,7,8,11,12]. Importantly, not every cysteine residue allows these 
modifications. Whether and which modifications occur at a specific cysteine 
residue is currently not fully understood. The ability of the thiol group to 
deprotonate contributes to its reactivity. The pKa value of free cysteine is ca. 
8.3; thus the equilibrium of the thiol form and the thiolate form of free cysteine 
is shifted to the protonated state at cellular pH [1]. The extent of deprotonation 
of a cysteine in a protein depends on the steric and electrostatic environment 
of this specific cysteine residue. In addition, enzymes specific for certain 
cysteine residues can catalyze redox modifications [1,5,6,11,14–16]. 
Several redox modifications have been implied in signaling. Prominent 
examples are the transcription factors OxyR in Escherichia coli (E. coli) [17–23], 
Yap1 in yeast [24–26], and NF-κB in mammals [27,28]. In plants, the DNA 
binding of TCP transcription factors and certain homeodomain transcription 
Redox signaling via thiol groups 
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Figure I1. Redox modifications on protein cysteine residues. The different modifications 
which can occur on protein cysteine residues are shown as structural formulas; the names of 
the different modifications are shown below the schemes. Double arrows indicate reversible 
reactions, single arrows indicate irreversible reactions. The thiol group is at equilibrium with ist 
thiolate, the more reactive species (A). It can react with another thiol group from a different 
protein (B) or another thiol from the same protein (C). Reaction with glutathione (D) or 
nitrosylating species (E) is possible, as well. In addition, different states of reversible or 
irreversible oxidation can occur (F, G, and H). The figure was taken from Zaffagnini et al. 2012 
[7] and modified. 
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factors depends on redox sensitive cysteine residues [29,30] and the 
transcriptional co- activator NPR1 has been proposed to be redox-regulated by 
disulfide bridge formation and nitrosylation [31–34]. In addition, metabolic 
processes such as glycolysis, gluconeogenesis, the Calvin-Benson and the 
tricarboxylic acid cycle, as well as mitochondrial respiration and photosynthetic 
electron transport are redox-regulated [35–43]. The dehydrogenase activity of 
plant glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was shown to be 
inactivated by glutathionylation and nitrosylation [37,44–46]; still, these redox 
modifications are thought to initiate moonlighting activities of this enzyme 
[37,46–48]. 
Certain redox modifications on cysteine residues, such as glutathionylation, can 
occur spontaneously [2,5,7,15]. However, a controlled way of redox signaling 
also requires the action of specific enzymes [5,6,8,11,15,49]. Two important 
types of enzymes involved in redox signaling are thioredoxins and 
glutaredoxins. Originally, both types of enzymes were described to transfer 
electrons to ribonucleotide reductase and to reduce different disulfide 
containing molecules [50–61]. Later, both, thioredoxins and glutaredoxins, 
were found to regulate the activity of target proteins specifically to transmit 
signals. For instance, the plant homedomain transcription factors Hahb-10 and 
HAHR1 and the transcriptional co-activator NPR1 can be reduced by 
thioredoxins [30,33], while plastidial GAPDH is reduced by thioredoxins and 
glutaredoxins [47,48,62,63]. 
Introduction 
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Thioredoxins and glutaredoxins 
_____________________________________________________________________ 
 
Thioredoxins and glutaredoxins are widely distributed members of the 
thioredoxin superfamily, a group of proteins sharing the so-called thioredoxin 
fold (Figure I2B and C). The thioredoxin fold consists of four β -strands 
assembled into a mixed β -sheet. This β -sheet is sandwiched by three α -helices. 
The beginning of helix α1 and the loop between helix α1 and strand β1 comprise 
the active site, a four amino-acid motif. This basic structure of the thioredoxin 
fold can be extended by additional α -helices and β-strands [1,2,7,9,64–68]. 
The active site motif of thioredoxins and glutaredoxins contains cysteine 
residues important for enzyme activity. In both, thioredoxins and 
glutaredoxins, a conserved cysteine residue is present at the N-terminal end of 
the active site motif. Many reasons for its reactivity have been considered, such 
as stabilization of the thiolate by the dipole of helix α1 [69–72]. In case of 
human Grx1 and pig liver thioltransferase, the positively charged environment 
of the N-terminal active site cysteine residue was found to stabilize its thiolate 
form [73,74]. This effect was recently confirmed for other glutaredoxins by 
Begas et al. (2017) and attributed to a specific positively charged amino acid 
(frequently a lysine) preceeding the active site (K28 in poplar GRXC1, Figure 
I2C, [75]). 
Despite having the same fold and a similar active site, thioredoxins and 
glutaredoxins differ in their redox potential and thus, the electron donors they 
use. While thioredoxins usually exhibit a redox potential of around -300 mV, 
glutaredoxins frequently show redox potentials ranging from -170 to -270 mV. 
[1,76–78]. Thus, thioredoxins are directly reduced by reduced nicotineamide 
adenine dinucleotide phosphate (NADPH, redox potential ca. -315 mV), 
whereas glutaredoxins use the weaker reductant glutathione. The oxidized form 
of glutathione is called glutathione disulfide (GSSG, Figure I2A). The redox 
potential of GSH and GSSG was measured to be ca. -240 mV at pH 7.0 
[1,66,76]. 
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Figure I2. Glutathione and the thioredoxin fold. (A) Structural formula of glutathione 
(GSH) and glutathione disulfide (GSSG). In case of GSH, the pKa value of the cysteine thiol 
is indicated and the pseudo-peptide bond between the γ-carboxyl group of glutamate and the 
α-amino group of cysteine is highlighted [1]. Images were taken from www.wikipedia.org. (B) 
Schematic representation of the core thioredoxin fold found in bacteria. Please note, that the 
number of α-helices is higher in plant glutaredoxins. The location of the active site is marked 
by a yellow dot. Sites important for glutathione binding are highlighted in red [1,79,80]. (C) 
The solution structure solved by nuclear magnetic resonance (NMR) spectroscopy of the 
poplar CPYC-type glutaredoxin GRXC1 (CGYC acitve site) was determined by Feng et al. 
(2006) (PDB accession: 1Z7P [81]). The PDB data file was used to prepare the picture of the 
ribbon structure in PyMOL. The first and the last active site cysteine (CysA and CysB, 
respectively) are shown as yellow stick representations. A red coloring marks the sites of 
residues important for glutathione binding [1,79]. The figure was in parts taken from Lillig et 
al. (2008) and Gutsche et al. (2015) and modified [79,80]. 
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Thioredoxins 
 
In thioredoxins, the consensus sequence of the active site motif is CGPC [66]. 
Using both active site cysteine residues, they reduce protein disulfide bonds 
[50] and possibly glutathionylated proteins [82]. They can also reduce 
nitrosylated thiol groups [33,34,83]. Disulfide bridge reduction follows the so-
called dithiol mechanism or disulfide exchange reaction: It is initiated by the N-
terminal active site cysteine residue attacking the disulfide bridge of the target 
protein(s). The target disulfide bridge is resolved, and a new disulfide bridge 
formed between the N-terminal active site cysteine residue of the thioredoxin 
and one of the target cysteines. This intermolecular disulfide is then resolved 
by the C-terminal active site cysteine of the thioredoxin, releasing a reduced 
target protein and leading to a disulfide bridge between the two active site 
cysteines of the thioredoxin [69]. This intramolecular disulfide is reduced by 
thioredoxin reductase (TR), transferring electrons from NADPH to the 
thioredoxin active site cysteines [51,54]. Still, some plastidial thioredoxins have 
been shown to receive electrons from Ferredoxin thioredoxin reductase (FTR) 
[78,84,85]. 
 
 
Glutaredoxins 
 
Glutathione binding and reaction mechanisms of glutaredoxins 
In contrast to thioredoxins, glutaredoxins bind glutathione using it as an 
electron donor [74,86]. They harbor at least one cysteine at the N-terminal end 
of the active site; sometimes, another cysteine is present at the C-terminal end 
of the active site [1]. Glutaredoxins reduce disulfide bridges as well as 
glutathione-mixed disulfides [52,61]. In addition, they are able to 
glutathionylate protein cysteinyl residues [87,88]. Some glutaredoxins were 
even shown to associate with iron-sulfur clusters [89,90]. Importantly, not 
every glutaredoxin shows all these activities; still, they depend on glutathione-
binding to fulfill their specific functions [1,2,7,9]. Starting in 1991 [86], a 
multitude of structural studies on glutaredoxins from different organisms   
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Figure I3, part I. Glutathione binding by the CPYC-type glutaredoxin Grx2 from 
human. The crystal structure of human Grx2 bound non-covalently to glutathione was solved 
by Johansson et al. (2006) to a resolution of 2.05 Å (PDB accession: 2FLS). The structure 
pictures were produced from the PDB file using PyMOL. (A) Surface representation visualizing 
the glutathione binding groove, (B) Secondary and tertiary structure with selected residues 
depicted as sticks to show the glutathione binding mode. The active site cysteines are shown 
in yellow, glutathione binding motifs and residues are coloured in red. Glutathione is shown as 
stick model in orange.
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Figure I3, part II. Glutathione binding residues of the CGFS-type glutaredoxin Grx4 
from E. coli. The NMR structure of E. coli Grx4 was solved by Fladvad et al. (2005) [91]. The 
structure pictures were produced from the PDB file (accession: 1YKA) using PyMOL. (C and 
D) Surface representation visualizing the glutathione binding groove from two different angles; 
(D) shows the glutaredoxin from approximately the same view as human Grx2 in Figure I3A 
and B. (E) Secondary and tertiary structure with selected residues depicted as sticks to show 
the putative glutathione binding mode. The active site cysteines are shown in yellow. Please 
note that the glutathione binding mode presented here derives from alignments and steric 
analysis. Potential glutathione binding residues inferred from comparisons with E. coli Grx3 are 
coloured in red. W68 and P69 (dark and light cyan) of the WP motif were speculated to determine 
the binding of glutathione in place of the buried GG motif. All other residues belonging to 
glutathione binding motifs are shown in light blue. Lys22, Arg59, Phe71, Cys84 and Asp85 were 
found to bind glutathione in holo Grx4 (Figure I6C) [92].  
Thioredoxins and glutaredoxins 
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Figure I3, part III. Glutathione binding by the CC-type glutaredoxin ROXY19 from 
Arabidopsis thaliana. The structure was modeled using Chimera by Gutsche et al. (2015) [80]. 
(F and G) Surface representation visualizing the glutathione binding groove from two different 
angles; (F) shows the glutaredoxin from approximately the same view as human Grx2 in Figure 
I3A and B. (H) Secondary and tertiary structure with selected residues depicted as sticks to 
show the putative glutathione binding mode. The active site cysteines are shown in yellow, 
glutathione binding motifs and residues are coloured in magenta. The conserved histidine 
residue following the active site motif is shown in purple. Glutathione is depicted as a stick 
model in orange. Residues K99 and D114 seem to block the glutathione binding groove in 
contrast to the CPYC-type glutaredoxin Grx2 from human (Figure I3A and B). 
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revealed that glutathione associates with a groove on the protein surface (Figure 
I2B and C and I3A, C and D) [79–81,93–100]. Together, these studies show 
that the glutathione-binding groove is lined by several polar residues. The 
glycine of glutathione is located at the end of the groove pointing upwards in 
the structural representations in Figures I3A and B. This part of the groove is 
formed by amino acids surrounding the active site motif in the primary 
structure. The glycine moiety is often bound by hydrogen bonds and salt 
bridges from polar and/or positively charged amino acids. In contrast, the 
glutamyl moiety binds in the region of the so-called GG motif and its following 
amino acids located at the opposite end of the groove. The region of the GG 
motif contains neutral and/or polar or charged amino acids. The center of the 
groove harbors a highly conserved TV/FP motif. The backbone of the protein 
in the region of the TV/FP motif and its surrounding residues interacts with 
the backbone of glutathione. They also associate with the glutamate and/or the 
cysteine of glutathione. The cysteine moiety of glutathione is located close to 
the active site of the glutaredoxin, next to the TV/FP motif [9,80,93]. In some 
glutaredoxin structures, the cysteine of glutathione is covalently bound to an 
invariant cysteine of the active site (Figure SIC) [94,96]. Only few structures 
show glutathione bound non-covalently to the groove of the glutaredoxin 
(Figure I3A) [Johansson et al., 2006; published in PDB] [9]. 
The glutathione binding mode described above represents a prototype model. 
Glutathione is a rather flexible molecule, and some glutaredoxins might use a 
slightly altered way to bind glutathione (Figure I3C to H) [9]. For instance, E. 
coli Grx4 and related glutaredoxins were speculated to employ a conserved WP 
motif shortly before the TFP motif for glutathione binding, since the GG motif 
is buried beneath the tryptophane and thus, not accessible for an interaction 
with glutathione (Figure I3C to E, [75,91]). Likewise, a structural model of the 
glutaredoxin ROXY19 suggests that glutathione binding in the same mode as 
shown in Figure I3A and B would cause steric conflicts (Figure I3F to H, [80]). 
The covalently bound glutathione molecule represents an intermediate during 
the catalysis of disulfide reduction. To reduce protein disulfide bridges or 
glutathione-mixed disulfides, glutaredoxins either employ the monothiol or the 
dithiol mechanism. Dithiol and monothiol mechanism are distinguished by the 
number of cysteines used for catalysis (Figure I4A and B) [1,9,74,79,93,94,101–
103]. The reaction sequence of both mechanisms starts with the oxidative half 
reaction, during which the substrate becomes reduced and the glutaredoxin 
oxidized. Afterwards, the glutaredoxin is recycled during the reductive half 
reaction [9]. 
Thioredoxins and glutaredoxins 
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The monothiol mechanism (Figure I4A) relies only on the N-terminal active 
site cysteine, which attacks the glutathione-mixed disulfide or the protein 
disulfide (Figure I4A and B, step A). When a glutathione-mixed disulfide is used 
as a substrate, the glutaredoxin N-terminal active site cysteine takes over the 
glutathione moiety from the substrate in a disulfide exchange reaction. As a 
result, the N-terminal active site cysteine residue of the glutaredoxin becomes 
covalently linked to the cysteine of glutathione (Figure SIC) and a free thiol on 
the target protein is formed (Figure I4A, step A). In case a protein disulfide 
bridge serves as a substrate, the glutaredoxin first resolves the disulfide by 
forming an intermolecular disulfide bridge with one of the target cysteines. The 
intermolecular disulfide bridge is then reduced by a molecule of glutathione. 
This leads to a glutathionylated glutaredoxin and thiol groups on the target 
protein (Figure I4B, step B). Independent of the initial substrate, the 
glutathionylated glutaredoxin is regenerated by another molecule of 
glutathione: Its thiol group attacks the disulfide bond between the first 
glutathione molecule and the cysteine of the glutaredoxin. This results in 
formation of GSSG and a reduced glutaredoxin (Figure SIA, Figure I4A, steps 
B and C, Figure I4B, steps C and D). GSSG is converted into two molecules of 
GSH by glutathione reductase using the reducing power of NADPH. 
The dithiol mechanism of glutaredoxins (Figure I4A and B) involves additional 
cysteine residues, either located at the C-terminal end of the active site motif, 
or sometimes outside the active site. Disulfide reduction via the dithiol 
mechanism shares the first step with the monothiol mechansim (Figure I4A 
and B, step A). However, the release of the reduced target and the regeneration 
of the glutaredoxin proceed differently and depend on the type of disulfide 
substrate used. As described above, during reduction of a glutathione-mixed 
disulfide (Figure I4A, step A) or a protein disulfide by the glutaredoxin with the 
help of glutathione (Figure I4B, step B), the glutaredoxin becomes covalently 
bound to glutathione. In the dithiol mechanism, this glutathione-mixed 
disulfide bond on the glutaredoxin is either resolved by the second active site 
cysteine or an external cysteine residue of the glutaredoxin. This gives rise to 
an intramolecular disulfide bridge within the glutaredoxin (Figure SIB, Figure 
I4A, step D). In most cases, such an intramolecular disulfide bridge is reduced 
by two molecules of glutathione, the first one binding to the N-terminal active 
site cysteine because of a disulfide exchange (Figure I4A, step E). The second 
glutathione molecule reacts with the newly formed glutathione-mixed disulfide 
according to the monothiol mechanism (Figure I4A, steps B and C). 
Alternatively, the intramolecular disulfide bonds resulting from the dithiol 
mechanism are reduced by ferredoxin thioredoxin reductase in the chloroplast 
Introduction 
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or thioredoxin reductase (Figure I4A step F). In case a protein disulfide bridge 
is reduced by the glutaredoxin, the glutaredoxin can immediately reduce the 
disulfide bridge by a disulfide exchange reaction using the N-terminal active 
site cysteine and an additional cysteine. Glutathione is not used as an electron 
donor during this step (Figure I4B, step E). The resulting intramolecular 
disulfide bridge of the glutaredoxin is subsequently reduced by two molecules 
of glutathione (Figure I4B, steps G, C, and D) or by TR or FTR (Figure I4B, step 
H) [1,9,74,78,79,93,94,101–106]. 
Whether the dithiol or the monothiol mechanism or both are used for catalysis, 
is specific for a given glutaredoxin. Recently, Ukuwela et al. (2018) 
demonstrated that E. coli Grx1 and human Grx1 are able to catalyze disulfide 
reduction employing the monothiol and the dithiol mechanism in parallel [102]. 
In contrast, the plant glutaredoxin AtGRXC5 was shown to operate only via 
the monothiol mechanism though it contains a second active site cysteine as 
well as external cysteines [94]. The role of the second active site or external 
cysteine residues represent still confusing aspects of glutaredoxin catalysis. In 
some cases, the second active site cysteine lowers the deglutathionylation 
activity [77,94], whereas in other glutaredoxins, it enhances catalysis [107]. 
Various potential explanations, such as influencing the reactivity of the N-
terminal active site cysteine residue, protecting it under oxidative conditions or 
allowing a distracting reaction via the dithiol mechanism have been discussed. 
[9,77,94]. The cysteine resolving model represents a logical explanation for the 
function of this second active site cysteine residue (or addional external 
cysteines) in agreement with the evolution of glutaredoxin catalysis [9]. 
However, further studies are necessary to substantiate this hypothesis. As for 
the second active site cysteine, the functions of external cysteines are not fully 
understood. External cysteine residues can fulfill functions other than catalysis. 
With respect to GRXC1 and GRXC2 from poplar, an external cysteine enables 
dimerization of two glutaredoxin subunits via an intermolecular disulfide bridge 
[77,98]. Couturier et al. (2011) showed that the external cysteine of AtGRXC5 
can be glutathionylated [94]. Thus, external cysteines were suggested to regulate 
some glutaredoxins or to play a role in signaling [77,98]. 
The example of the additional cysteine residues within glutaredoxins indicates 
that the details of glutaredoxin catalysis are currently not well understood. 
Interestingly, there are different classes of glutaredoxins with differential 
catalytic activity. Whereas glutaredoxins with an active site of the consensus 
CPYC are usually catalytically active, glutaredoxins with a CGFS active site 
motif are almost inactive. In an attempt to explain these differences, the role   
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Figure I4, part I. Reaction mechanisms used by glutaredoxins. Glutaredoxins 
deglutathionylate other proteins via the monothiol or the dithiol mechanism (A). During 
deglutathionylation via the monothiol mechansim, a reduced glutaredoxin takes over the 
glutathione moiety (-SG) from the glutathionylated target protein (step A) and then 
deglutathionylates itself with the help of another glutathione molecule (GSH), releasing 
glutathione disulfide (GSSG, steps B and C). When using the dithiol mechanism for 
degluathionylation, the glutaredoxin is deglutathionylated forming an intramolecular disulfide 
(step D), which is subsequently resolved by two molecules of glutathione (steps E, B, and C) or 
thioredoxins (TR) or ferredoxin thioredoxin reductase (FTR, step F). (B) shows the reduction 
of disulfide bridges in target proteins via the mono- or dithiol mechanism. During the dithiol 
mechanism, an intramolecular disulfide is formed within the glutaredoxin in the course of a 
disulfide exchange (steps A and E), whereas in the monothiol mechanism, the glutaredoxin 
undergoes glutathionylation and deglutathionylation only (steps A to D). However, after step B 
of the monothiol mechanism, the glutaredoxin can also enter the dithiol mechanism (steps F, G 
and H). During the dithiol mechanism, the disulfide bridge is either resolved by TR or FTR 
(step H) or via two molecules of GSH, releasing GSSG (steps G, C and D). When viewed in terms 
of the reaction sequence steps A, B, F, H or A, B, F, G, C, D, the reaction product of step F 
belongs to the reductive half-reaction. When viewed from the reaction sequence beginning 
with steps A and E, it belongs to the oxidative half reaction. The schemes were taken from 
Rouhier et al. (2008) [1], Deponte (2013) [9], and Ukuwela et al. (2018) [102] and modified.  
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Figure I4, part II. The glutathione scaffold and acitvation site of glutaredoxins. The 
glutathione binding groove is divided in a scaffold (blue) and an activation site (red). In (C), 
the basic functions of the activation and the scaffold site of glutaredoxins during catalysis are 
illustrated. The glutaredoxin is shown in grey. The scaffold site containing a glutamate residue 
(E197 in ScGrx6) binds the glutathione moiety of the substrate (blue), which is attacked by the 
thiolate of the active site cysteine (-S-) (C136 in ScGrx6). After release of the deglutathionylated 
substrate, the thiolate from the glutathione molecule bound by the activation site (containing a 
conserved lysine, K133 in ScGrx6, shown in red) reacts with the disulphide between the active 
site cysteine and glutathione from the substrate. For simplicity, the figure does not show the 
actual transition states occuring during catalysis. Therefore, it should be noted that glutaredoxin 
catalysis probably occurs via an SN2 reaction [9]. For details, the reader is referred to reference 
[75]. (D) shows the glutathione binding groove in the crystal structure of Saccharomyces cerevisiae 
Grx6. Residues belonging to the potential glutathione scaffold site associating with the 
glutathionylated substrate are highlighted in blue. The putative glutathione activation site is 
depicted in red. The N-terminal acitve site cysteine is shown in yellow and active site serine 
residues in orange. The structure was solved by Luo et al. (2010) [108] to a resolution of 1.5 Å. 
The representation was prepared according to the findings by Begas et al. (2017) in PyMOL 
using the PDB file (accession: 3L4N). K133, Y138, and E197 are homologous to the residues in 
ScGrx7 characterized by Begas et al. (2017) [75]. 
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of two distinct residues of the glutathione binding groove during catalysis was 
discovered [9,75,109]. By analysing the reaction kinetics of mutant Saccharomyces 
cerevisiae (S. cerevisiae) Grx7 in comparison to the wildtype enzyme, Begas et al 
(2017) could show that the conserved lysine preceding the active site binds the 
recycling glutathione and activates the cysteine of glutathione, as well as the N-
terminal active site cysteine residue of the glutaredoxin. In contrast, a glutamate 
in the region of the GG motif was found to support the binding of the 
glutathionylated substrate. Homologous residues in a Plasmodium falciparum 
(P. falciparum) glutaredoxin (PfGrx) were found to play the same role [75]. This 
suggested that the glutathione binding groove revealed by structural studies 
might rather consist of two glutathione binding sites: a scaffold site associating 
with the glutamyl moiety of the glutathione moiety of the glutathionylated 
substrate and an activation site binding the recycling glutathione molecule via 
the glycine and cysteine part of glutathione. In addition, the activation site 
might deprotonate the thiol groups of the enzyme and glutathione (Figure I4C 
and D). Already a few years before, Li et al. (2010) noticed that replacement of 
the aspartate homologous to the scaffold glutamate by a serine in yeast Grx1 
(Figure SIA and B) results in a lower Km for glutathione but higher turnover 
number and a higher specific activity [110]. Aside from the conserved lysine 
and the glutamate residue, initial data indicated that the tyrosine found in the 
active site of active glutaredoxins (CPYC active site) also belongs to the 
activation site, but might fulfill other functions, as well [75]. Interestingly, this 
residue adopts different rotamers in the structures of glutaredoxins with 
different oxidation states (Figures I3B and SIA to C). Because the structures 
represent intermediates during catalysis, it was already speculated that this 
residue might change its conformation during catalysis, thereby contributing to 
the displacement of GSSG from the active site [91,110,111]. However, Begas 
et al. (2017) did not discover a change in the concentrations of glutathionylated 
and non-glutathionylated enzyme during catalysis, when the active site tyrosine 
was mutated. Based on further sequence comparisons, Begas et al. (2017) 
assigned additional amino acids to the activation and the scaffold region of the 
glutathione binding groove. In summary, the glutathione activation site could 
be located at the end of the groove harboring the active site cysteine and the 
conserved lysine residue. The other part of the groove composed of the GG 
and the TV/FP motif could form the scaffold site (Figure I4D) [75]. 
 
 
 
Introduction 
25 
 
Association of glutaredoxins with iron-sulfur clusters 
Aside from disulfide reduction, some glutaredoxins were found to bind iron-
sulfur clusters [81,95,112–117]. These cofactors are composed of iron and 
sulfide ions, forming either a rhombic [2Fe-2S] or a cubic [4Fe-4S] cluster 
(Figure I5B and C). [3Fe-4S] clusters exhibit either a linear or a cuboidal 
structure and can even include other metal ions than those of iron (Figure I5D, 
E, and F). Iron-sulfur clusters are frequently bound to the cysteines of proteins. 
Apart from the basic forms of iron-sulfur clusters shown in Figure I5, iron-
sulfur clusters are part of complex cofactor assemblies, such as siroheme 
cofactors or the FeMo cofactor and the [8Fe-7S] cluster found in nitrogenase 
(Figure I5G, H, and I) [118–120]. Single iron ions ligated by cysteine residues 
are referred to as mononuclear iron sulfur clusters (Figure I5A) [121]. The 
biogenesis of iron sulfur clusters is accomplished by a set of enzymes. First, 
iron ions and sulfide ions – the latter derived from free cysteine and provided 
by cysteine desulfurases – are assembled on a scaffold protein. Finally, a carrier 
protein takes over the assembled cluster and donates it to the apo-form of the 
target protein. Within their target proteins, iron sulfur clusters serve for 
electron transport or for catalysis [118]. 
Initially, all glutaredoxins were found to coordinate [2Fe-2S] clusters. However, 
in 2013, Zhang et al. proposed that glutaredoxins previously thought to bind 
solely [2Fe-2S] clusters might also coordinate [3Fe-4S]+ and mixtures of [2Fe-
2S] and [3Fe-4S]+ clusters [90]. In case of the well-studied [2Fe-2S] glutaredoxin 
complexes, the cluster bridges two glutaredoxin subunits and is ligated by the 
N-terminal active site cysteine residues and the thiol group of two glutathione 
molecules, one bound to each subunit (Figure I6A to C) [81,92,94,95,97,113–
115,122–125]. As for the catalytic activity, differences in the structure of iron-
sulfur cluster-bound glutaredoxins depend on the active site motif: In 
glutaredoxins with a CPYC active site motif, these subunits are – with respect 
to the central β-sheet – either assembled in a perpendicular (Figure I6A and B) 
[94,113,124], whereas they are arranged in a co-planar way for glutaredoxins 
with a CGFS active site (Figure I6C and D) [92,95,124,125]. In some cases, two 
of these dimers might further assemble into tetramers. This was, among others, 
described for human Grx5 (Figure I6D); however, later, contradicting results 
were published [122,124,125]. An exception from this concept represents the 
zebrafish glutaredoxin Grx2. Albeit Grx2 closely resembles other glutaredoxins 
in its structure, it coordinates a [2Fe-2S] cluster as a monomer via cysteine 
residues outside the active site [126]. 
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Figure I5. Different types of iron sulfur clusters. The figure shows different types of iron-
sulfur clusters and their coordination. (A) Mononuclear clusters, (B) [2Fe-2S] clusters, (C) [4Fe-
4S] clusters, and (D) linear [3Fe-4S] clusters need four ligands, which are frequently cysteines 
(RS). Cuboidal [3Fe-4S] clusters (E) are complexed by three ligands, but can incorporate other 
metal ions (M) bound by a fourth ligand (L), as shown in (F). Iron sulfur clusters can form 
complex cofactor structures: (G) Siroheme cluster composed of a [4Fe-4S] cluster bridged to a 
heme found e.g. in E. coli sulfite reductase; [8Fe-7S] P cluster (H) and FeMo cofactor with a 
part of the coordinating homocitrate (I) found in nitrogenase. The iron-coordinating cysteine 
residues are indicated by Cys-S. The carboxyl groups of heme are indicated by COOH. Colour 
code: red – iron ions (Fe), yellow – sulphide ions (S), black – carbon, blue – nitrogen (N), pink 
– hydrogen (H), purple – molybdenum (Mo), green – oxygen (O). The figure was taken from 
Beinert et al. (1997) [119] and modified. 
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Interestingly, there are only minor changes in the conformation of the 
glutaredoxin and the mode of glutathione binding upon iron-sulfur cluster 
incorporation [124]. While the overall thioredoxin fold of glutaredoxins 
remains after incorporation of an iron-sulfur cluster, E. coli Grx4 and human 
Grx5 adopt a more “extended” conformation (Figure 6C and D) [92,125]. 
Similarly, certain loops and the N-terminal part of helix α4 of AtGRXC5 are 
bent backward in comparison to the apo-form and, thus, point away from the 
subunit interface upon cluster binding (Figure 6A and B) [94]. As for the 
conformation of the glutaredoxin, the way of glutathione binding upon 
assembly into the cluster-bridged oligomers only changes weakly. Which 
changes in the glutathione binding mode occur depends again on the active site 
of the glutaredoxin. These differences were worked out by Couturier et al. 
(2015) using Arabidopsis thaliana (A. thaliana) GRXC5 and E. coli Grx4 as 
examples: In glutaredoxins with a CPYC active site, such as A. thaliana GRXC5, 
the side chains of the active site residues change their orientations (Figure I6E) 
[124]. The last active site residue associates with the conserved lysine residue 
before the active site, thereby stabilizing the loop containing the active site for 
cluster binding [94,124]. Active site residues in addition to the N-terminal 
cysteine were found to stabilize the position of glutathione [81,94,124] (Figure 
I6A, B and E). In addition, cross-contacts between glutathione of one 
glutaredoxin subunit and the active site residues of the other subunit were 
described [81,94,124] (Figures I3 and I6). In contrast, in glutaredoxins with a 
CGFS-active site, the conformation of some active site residues does not 
change strongly upon cluster binding (Figure I6F). Still, the last active site serine 
interacts with the conserved lysine residue before the active site, as observed 
for CPYC glutaredoxins [124]. In addition, loop regions including the loop 
containing the N-terminal active site cysteine change their conformation upon 
cluster binding in E. coli Grx4 (Figures I3E and I6C and F) [92]. Moreover, 
several contacts between the two glutaredoxin subunits independent of 
glutathione are established (Figure I6C and F) [92,124,125]. 
Consequently, the active site composition and additional residues outside the 
active site determine the ability to bind iron-sulfur clusters. To date, the precise 
requirements allowing iron-sulfur cluster binding are still not fully understood 
[94,97,112,113,124]. The function of cluster binding might vary among 
glutaredoxins, ranging from putative sensory and regulatory functions to the 
assembly and the transfer or the storage of these cofactors 
[81,94,97,113,114,116,117,124,127–131]. 
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Figure I6, part I. Iron sulfur cluster binding by CPYC glutaredoxins. The crystal structure 
of holo GRXC5 from A. thaliana, a CPYC-type glutaredoxin, was solved by Couturier et al. 
(2011) [94] to a resolution of 2.4 Å. The structure pictures were produced from the PDB file 
(accession: 3RHC) using PyMOL according to the findings by Couturier et al. (2011) [94] and 
Couturier et al. (2015) [124]. The two glutaredoxin subunits of the dimer are shown in blue and 
grey, respectively. The first active site cysteines of both subunits are depicted in yellow and 
residues important for glutathione binding are shown in red and purple, respectively. Residues 
forming contacts to the glutathione molecule of the other subunit are coloured in light and 
dark cyan, respectively. The glutathione molecule bound to each subunit is presented as a stick 
model in orange. The [2Fe-2S] cluster is shown as spheres (yellow: sulfur, orange: iron). (A) 
and (B) show the same structure from different angles.  
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Figure I6, part II. Iron sulfur cluster binding by CGFS glutaredoxins. The crystal 
structure of holo Grx4 from E. coli, a CGFS glutaredoxin, was solved by Iwema et al. (2009) 
[92] to a resolution of 1.9 Å. The structure picture was produced from the PDB file (accession: 
2WCI) according to the results of Iwema et al. (2009) [92] using PyMOL. The two glutaredoxin 
subunits of the dimer are shown in blue and grey, respectively. The first active site cysteines of 
both subunits are depicted in yellow and residues important for glutathione binding are shown 
in light red and dark red, respectively. Residues establishing contacts to the other subunit are 
shown in light and dark cyan, respectively. Residues binding to both, glutathione and the other 
subunit are depicted in purple and pink, respectively. The glutathione molecule bound to each 
subunit is presented as a stick model in orange. The [2Fe-2S] cluster is shown as spheres 
(yellow: sulfur, orange: iron). 
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Figure I6, part III. Iron sulfur cluster binding by CGFS glutaredoxins. The crystal 
structure of human holo Grx5, a CGFS glutaredoxin, was solved by Johansson et al. (2011) 
[125] to a resolution of 2.4 Å. The structure picture was produced from the PDB file (accession: 
2WUL) using PyMOL. The four glutaredoxin subunits of the dimer are shown in different 
shades of blue and grey, respectively. The first active site cysteine of each subunit is depicted 
in yellow. The glutathione molecule bound to each subunit is presented as a stick model in 
orange. The two [2Fe-2S] cluster are shown as spheres (yellow: sulfur, orange: iron). For 
reasons of simplicity, neither glutathione binding residues nor intersubunit contacts were 
highlighted. 
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Figure I6, part IV. Rearrangements in the active site of CPYC and CGFS-type 
glutaredoxins upon iron-sulfur cluster binding. (E) Overlay of the crystal structures of 
AtGRXC5 apo-protein bound to glutathione and one subunit of the AtGRXC5 holo-protein; 
AtGRXC5 is a CPYC-glutaredoxin. (F) Overlay of the crystal structures of EcGrx4 apo-protein 
and one subunit of the EcGrx4 holo-protein; EcGrx4 belongs to the CGFS-type glutaredoxins. 
The iron and sulfur ions of the iron-sulfur cluster are shown as orange and yellow spheres, 
respectively. The apo-protein is shown in dark blue, the holo-protein in light blue. Amino acids 
of the active site region are highlighted in light cyan for the holo-protein and in dark cyan for 
the apo-protein and represented as stick models. Glutathione is shown as an orange (belonging 
to holo-protein) or red (belonging to apo-protein) stick model. The N-terminal active site 
cysteine of the holo-protein is shown in yellow, whereas the one of the apo-protein is depicted 
in light orange. The loop containing the active site cysteine is indicated by an arrow in (F). The 
figures were created from the PDB files (accessions: 3RHB, 3RHC, 1YKA, 2WCI) in PyMOL 
and are based on the articles by Couturier et al. (2015) [124], Couturier et al. (2011) [94], and 
Iwema et al. (2009) [92].  
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Different classes of glutaredoxins in plants and their functions 
Compared to other organisms, plants harbor an extraordinarily large number 
of glutaredoxins [132–134]. Thus, while E. coli, S. cerevisiae and humans contain 
only about a handful of glutaredoxin genes, 31 glutaredoxin genes have been 
identified in A. thaliana. Similar numbers have been described for poplar (36) 
and rice (27) [134]. Phylogenetic analysis of the numerous plant glutaredoxins 
revealed three major groups. As mentioned before, each group is characterized 
by a conserved active site motif. According to the predominant amino acids in 
this motif, the three major glutaredoxin classes are termed “CPYC-“, “CGFS-
“ and “CC-type glutaredoxins”. While CPYC- and CGFS-type glutaredoxins 
are found in most prokaryotes and eukaryotes, CC-type glutaredoxins only 
evolved in land plants [132–135]. Within land plants, the number of CPYC- 
and CGFS-type glutaredoxins remained relatively constant from mosses to 
angiosperms and does not differ strongly from the number of glutaredoxins in 
other organisms. However, the class of CC-type glutaredoxins underwent 
multiple events of gene duplication during the evolution of higher land plants. 
Thus, the large number of glutaredoxins in plants results from the increase in 
the number of the CC-type glutaredoxins [134–136]. 
 
CPYC-type glutaredoxins 
Plant CPYC glutaredoxins (Figures I2C, I3A and B, I6A and B, and SI1C) 
exhibit active site motifs of the consensus sequence C(P/G/S)(Y/F)(C/S) 
[135] and efficiently catalyze the reduction of protein disulfides and 
glutathione-mixed disulfides [77,88,94,96,137]. A few studies indicate, that 
CPYC glutaredoxins are also able to transfer glutathione to the cysteines of 
target proteins [87,88] and can catalyze the oxidation of redox-sensitiv GFP 
(roGFP) [97]. 
Higher plants contain four cytosolic CPYC glutaredoxins: GRXC1, GRXC2, 
GRXC3 and GRXC4, and at least one chloroplastic CPYC glutaredoxin named 
GRXS12. In Brassicacea, an additional CPYC glutaredoxin, GRXC5, is located 
in the chloroplast [77,94,96,113,137]. GRXC1 and GRXC2 differ in their 
properties slightly from GRXC3 and GRXC4, forming two subclasses of 
CPYC glutaredoxins. While GRXC1 and GRXC2 might dimerize via a disulfide 
bridge, the other glutaredoxins do not. This might result in different reaction 
mechanisms [77]. GRXC1 and GRXC2 have been studied extensively at the 
biochemical level and by mutant analysis. They are indispensable for plant 
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viability [77,81,112,113]. They contribute strongly to the cellular glutaredoxin 
activity and might be involved in the protection of the cell from oxidative 
damage [112]. Besides, GRX370 was found to modulate the activity of the 
kinase BAK1 via glutathionylation, implicating a function of this glutaredoxin 
in brassinosteroid signaling [88]. Interestingly, GRXC1 was shown to dimerize 
via an iron-sulfur cluster coordinated by the N-terminal active site cysteine 
residues and the cysteine moiety of glutathione [112,113]. Later, the same mode 
of iron-sulfur cluster coordination was also described for chloroplastic GRXC5 
[94]. Because GRXC1 is catalytically active only in its apoform and because 
GRXC5 cannot transfer clusters to other proteins, the binding to the iron-
sulfur cluster observed for both proteins was proposed to play a regulatory role: 
During oxidative stress, the cluster might be destroyed, releasing catalytically 
active glutaredoxins, which help to protect the cell from oxidative damage 
[94,112,138]. 
 
CGFS-type glutaredoxins 
In contrast to CPYC-type glutaredoxins, the active site of CGFS glutaredoxins 
(Figures I3C, D, and E, I6C and D) is perfectly conserved [135]. Interestlingly, 
all these glutaredoxins exhibit only weak activity in the classical biochemical 
assays to assess the catalytic activity of glutaredoxins: They are less efficient in 
the reduction of the artificial compound bis(2-hydroxyethyl)disulfide (HEDS) 
and the reduction of dehydroascorbate (DHA) than CPYC glutaredoxins. They 
show an equally low activity towards protein substrates such as glutathionylated 
GAPDH, insulin or roGFP [75,97,116,117]. Moreover, for GRXS15 from A. 
thaliana, a weak activity regarding roGFP oxidation was observed [75,97]. Thus, 
catalysis of redox reactions appears not to be their main function in the cell. A 
possible role of these glutaredoxins emerged in 2002. In this year, Rodríguez-
Manzaneque et al. showed that the mitochondrial glutaredoxin Grx5 in S. 
cerevisiae contributes to the assembly of iron-sulfur clusters [89]. Subsequently, 
the CGFS-type glutaredoxins from plants, namely GRXS14, GRX15, GRXS16, 
and GRXS17, were found to complement the S. cerevisiae grx5 mutant at least 
partially. This suggested a contribution of plant CGFS-type glutaredoxins to 
iron-sulfur cluster assembly. All of them were shown to bind [2Fe-2S] clusters 
as dimers with the help of glutathione [94,95,97,114,116,117,123,129,139], but 
– as mentionend before – the possibility to associate with [3Fe-4S]+ clusters 
should not be excluded [90]. 
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In plants, the cytoplasm, plastids and mitochondria harbor their own iron-
sulfur cluster assembly machinery which are partly interconnected [118]. 
Similarly, plant CGFS-type glutaredoxin localize specifically to the three 
compartments. GRXS15 represents the only mitochondrial glutaredoxin in 
plants and is therefore essential. It possibly contributes to the maturation of 
mitochondrial iron-sulfur cluster proteins [97]. The plastidial glutaredoxins 
GRXS14 and GRXS16 are non-essential; they mediate chlorophyll 
maintenance in chloroplasts [131,140]. At least GRXS16 can take over iron-
sulfur clusters from another assembly protein [129]. The cytosolic CGFS 
glutaredoxin GRXS17 is a diverging representative of the CGFS-type 
glutaredoxins: It contains three glutaredoxin domains and dimerizes via [2Fe-
2S] clusters bound to each of the glutaredoxin modules, presumably using 
glutathione for coordination. Though the second glutaredoxin domain was 
shown to complement the yeast grx5 mutant, the influence of GRXS17 on 
cytosolic iron-sulfur proteins in planta is at best weak [123,128]. In contrast, 
GRXS17 was linked with plant development and stress responses 
[123,128,141–144]. The protein is localized in the cytosol and in the nucleus, 
despite its molecular weight above the exclusion limit of the nuclear pore 
complex and the lack of an import signal. As it interacts with the transcription 
factor NF-YC11/NC2α, it was speculated to regulate gene expression via redox 
modulation of NF-YC11/NC2α in response to environmental stimuli [123]. 
 
CC-type glutaredoxins 
In contrast to the well-studied CPYC- and CGFS-type glutaredoxins, the CC-
type glutaredoxins (Figures I3 F, G and H) are poorly understood. A. thaliana 
has 21 CC-type glutaredoxins, also named ROXYs [135,145]. Their active site 
motif is characterized by a conserved cysteine directly following the N-terminal 
active site cysteine (CC motif; consensus: CC(M/C)(C/S/G), Figure SI2) 
[135,136]. In 2005, the first CC-type glutaredoxin, ROXY1, was described as a 
regulator of flower development [146]. Later, it was shown that it interacts 
physically with the TGA transcription factor PERIANTHIA (PAN) in the 
nucleus to restrict the number of petals in the flower of A. thaliana [145]. About 
the same time, ROXY19, together with the TGA transcription factors TGA2, 
5 and 6, was proposed to mediate the crosstalk between the signaling pathways 
of the plant hormones salicylic acid (SA) and jasmonic acid (JA)/ethylene (ET) 
[147]. Since then, many studies described CC-type glutaredoxins as regulators 
of various developmental processes and stress responses in different plant 
species [146–167]. A subset of these studies also linked their function with 
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TGA transcription factors [145–148,151,152,155–157,159,160,162–164,168–
172]. Though the interaction specificity of CC-type glutaredoxins with TGA 
transcription factors is broad [145,147,168,170] [M. Willmer, unpublished], 
there are specific pairs of the two types of proteins regarding the regulation of 
certain processes [145–148,151,152,155–157,159,162–164,168–171]. For some 
parts of the plant, such as flowers, specificity might rely on tissue- and/or 
organ-specific expression patterns which overlap for certain TGA factors and 
certain CC-type glutaredoxins [145,162,164,169,170]. However, the 
mechanisms conferring specificity to those pairs of ROXYs and TGA 
transcription factors expressed in parallel in leaves are unknown [152]. TGA 
transcription factors seem to be repressed by CC-type glutaredoxins in their 
capacity to regulate transcription [145,147,151,160,162,164,169,173]. 
Interestingly, CC-type glutaredoxins require their active site for regulation of 
TGA factors. ROXY19 has a CCMC active site. Using ROXY19-
overexpressing plants, it could be shown that only the first active site cysteine 
residue might be necessary for its function, but the highly conserved second 
cysteine of the CC motif and the last active site cysteine might be dispensable 
[152,174]. ROXY1 has the same active site as ROXY19. However, 
contradicting results regarding the requirement of its cysteine residues have 
been published: While Xing et al. (2005) showed, that ROXY1 requires the first 
cysteine residue for its activity, Ziemann (2010) noticed that an SSMS mutant 
of ROXY1 is active. However, these discrepancies could be attributed to 
different experimental conditions, such as the different expression constructs 
used in these studies: Whereas Xing et al. (2005) employed the CaMV35S 
promoter, Ziemann (2010) used the ROXY1 promoter which more likely 
reflects the natural expression intensities of ROXY1 [146,175]. Since some 
glutaredoxins contribute to the regulation of transcription factors and since 
TGA transcription factors contain conserved cysteine residues (Figure I8 and 
SI3), CC-type glutaredoxins were speculated repeatedly to redox-modulate 
TGA transcription factor, thereby controlling their activity [145–
149,151,153,155,160,163,164,166,168–173]. However, biochemical studies 
characterizing the catalytic abilities of CC-type glutaredoxins are scarce. The 
biochemical characterization of these glutaredoxins has been hampered by the 
inability to purify them after expression in E. coli. Only low amounts of poplar 
GrxS7.2 deleted for its hydrophobic C-terminus harboring a motif mediating 
transcriptional repression could be obtained. Interestingly, the purified protein 
showed a brownish colour, indicative of iron-sulfur cluster binding. Because of 
the difficulties to express and purify CC-type glutaredoxins for biochemical 
analyses, Couturier et al., (2010) constructed chimeric proteins to mimick CC-
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type glutaredoxins. For this, they exchanged the active site of CPYC 
glutaredoxins with the active site of a CC-type glutaredoxin. Though these 
chimeric proteins were catalytically only weakly active, they were able to 
associate with an [2Fe-2S] cluster, forming a dimer. Because other 
glutaredoxins bind iron-sulfur clusters frequently with the help of glutathione, 
it was speculated that CC-type glutaredoxins might also require glutathione for 
cluster incorporation [176]. The glutathione binding site is only partially 
conserved in CC-type glutaredoxins, as indicated by structural modelling 
approaches (Figure I3 and SI2) [80,158,176]. The glutathione scaffold site 
appears to be blocked in the structural model of ROXY19 (Figure I3F to H). 
In addition, the activation site contains a negatively charged glutamate (residue 
87) where CPYC- and CGFS-type glutaredoxins harbor a positively charged 
residue (Figure I3A to E) [80]. However, ROXY19 was shown to bind 
glutathione with a dissociation constant comparable to a CPYC glutaredoxin 
and both, ROXY19 and ROXY1, require an intact GG motif for their activity, 
suggesting that glutathione binding is possible [158,168,174]. 
Aside from the lack of evidence for a catalytic activity in vitro, in vivo data argues 
against a redox modulation in the case of ROXY19. The single cysteine found 
in the ROXY19-interacting TGA5 (Figure I8 and SI3) could be mutated into a 
serine without noticeable effect on the activity of the transcription factor [152]. 
Instead, a hydrophobic ALWL motif at the very C-terminal end of ROXY19 
and many other CC-type glutaredoxins (Figure SI2) was shown to mediate 
repression [145,168,170]. When present, this motif enables the interaction with 
the transcriptional co-repressor TOPLESS (TPL). TPL recruits chromatin 
modifiers leading to gene silencing [177]. Thus, the recruitment of co-
repressors might provide a better explanation for a repressive mechanism. 
Instead of acting as a redox modulator, CC-type glutaredoxins might represent 
targets of redox control [152]. In support of this idea, the interaction of the 
Marchantia polymorpha TGA transcription factor MpTGA with the CC-type 
glutaredoxins MpROXY1 and MpROXY2 appears to be rather stable, as it 
could be visualized in EMSA experiments. Interestingly, the interaction 
depends on a reduced ROXY protein and a reduced TGA factor [160]. 
Still, the ALWL motif is not conserved in all CC-type glutaredoxins found in 
A. thaliana. ROXY6, 7, 8, 9 and 20 lack this motif, and are not able to repress 
TGA2 and PAN. Interestingly, ROXY9 and ROXY8 were shown to repress 
the activity of TGA1 and TGA4 [145,155–157,168,170]. In this context, 
Willmer (2014) could show that several CC-type glutaredoxins from A. thaliana 
are able to interact with so-called TIFY proteins [178]. TIFY-proteins are 
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characterized by a protein-interaction domain containing a conserved motif of 
the amino acids TIFY. The transcriptional repressors from jasmonate signaling, 
the JAZ proteins, are part of the TIFY family [179,180]. Several JAZ proteins 
could interact with CC-type glutaredoxins [178]. JAZ proteins were shown to 
interact directly or indirectly via NINJA with the corepressor TPL [179,181]. 
This raised the hypothesis of whether CC-type glutaredoxins could recruit TPL 
via the JAZ proteins to the TGA transcription factors, thereby mediating the 
repression [178].
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TGA transcription factors 
_____________________________________________________________________ 
 
 
The TGA transcription factor family in Arabidopsis thaliana 
 
TGA transcription factors constitute a group of plant-specific basic leucine 
zipper (bZIP) transcription factors. In bZIP transcription factors, an α-helical 
domain containing basic amino acids mediates binding to the DNA, whereas 
the leucine zipper allows dimerization of these transcription factors (Figure 
I7A). The leucine zipper consists of an α-helix in which every seventh amino 
acid is a leucine. Usually, such a heptad is repeated about nine times. The 
leucine heptad repeats result in a hydrophobic side of the helix. Contacts 
between these hydrophobic regions of two monomers leads to dimerization of 
these transcription factors. Homodimerization, but sometimes also 
heterodimer formation is possible. Since bZIP transcription factors act as 
dimers, they usually recognize specifically palindromic DNA sequences [182]. 
TGA transcription factors, for instance, associate with the palindromic 
sequence TGACGTCA. The first five basepairs of this sequence are sufficient 
for binding [183–185]. The bZIP domain in TGA transcription factors is rather 
short since they harbor only three of the leucine heptad repeats (Figure I7B 
and SI3). In addition, TGA factors contain an N-terminal extension (N) of 
variable length. The N-terminal domain of TGA transcription factors mediates 
at least partially transcriptional regulation [186–189]. C-terminally of the bZIP 
domain are two glutamine-rich regions (Q1 and Q2) [182,184,190]. Glutamine-
rich regions usually mediate transcriptional activation [191]. Regarding TGA 
factors, the precise function of these domains is not yet understood. However, 
the regions C-terminally of the bZIP domain might contribute to the 
interaction with transcriptional regulators [170,189,190,192–194]. 
In A. thaliana, there are ten TGA transcription factors (Figure I7C). Based on 
their sequence homology, they are divided into five different clades. Clade I 
consists of TGA1 and TGA4, clade II contains TGA2, TGA5 and TGA6. 
TGA3 and TGA7 form clade III. Clade IV is composed of TGA9 and TGA10, 
while clade V has only one member called PAN ("TGA8") [190]. Each clade   
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Figure I7. TGA transcription factors are bZIP transcription factors. (A) Structure of a 
basic leucine zipper (bZIP) transcription factor exemplified by the crystal structure of yeast 
Pap1 shown as a dimer (blue) bound to DNA (orange and red). The leucine zipper and the 
DNA binding region of each monomer are shown in different shades of blue. The leucine 
residues within the leucine zipper domain are pictured as sticks whereas the sticks in the basic 
DNA binding region represent lysines and arginines. The structure was solved by Fujii et al. 
(2000) [195] to a resolution of 2 Å, and the image created from the PDB file (accession: 1GD2) 
in PyMOL. (B) Overview of the domain structure of TGA transcription factors. Q1 and Q2 
represent the two glutamine-rich regions. (C) Unrooted cladogramm of the TGA transcription 
factors from A. thaliana. The icons behind the names of the TGA factors represent the function 
of the corresponding class: rosette leaves with lightning – environmental stress response, white 
flower – flowering. The figure was taken from Gutsche et al. (2015) [80] and modified. 
 
 
has a different function within the plant. Clade II TGA factors were extensively 
studied with respect to their function in the plant defense response “systemic 
acquired resistance”. To regulate the defense program against biotrophic 
pathogens, clade II TGA factors interact with the SA-binding transcriptional 
regulators NPR1, NPR3 and NPR4 [192,193,196–201]. NPR1 and TGA2 were 
found to bind constitutively to the promoter of the defense gene PR-1. 
However, under non-inducing conditions, TGA2 is bound in high-order 
complexes to the DNA. These complexes are formed via its N-terminal domain 
and do not interact with NPR1, thereby preventing PR-1 transcription 
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[189,202,203]. In parallel, clade II TGA factors interact with the corepressors 
of defense gene expression, NPR3 and NPR4 [201]. Upon infection by a 
biotrophic pathogen, salicylic acid is produced by the plant [204] which binds 
to NPR1, NPR3 and NPR4 [199,200]. On the one hand, SA-binding inhibits 
the corepressors NPR3 and NPR4 [201]. On the other hand, SA-binding by 
NPR1 enables the protein to interact with TGA2 to repress the TGA2 N-
terminus via its BTB/POZ domain, thereby resolving the high-order TGA2 
complexes. An enhanceosome consisting probably of a TGA2 and an NPR1 
dimer is formed on the DNA. This enhanceosome activates PR-1 transcription 
via a C-terminal transactivation domain in NPR1 [189,200,203]. Interestingly, 
this domain contains two oxidized cysteine residues [203]. 
The response towards biotrophic pathogens has to be balanced with the 
defense against necrotrophic pathogens which is controlled by the plant 
hormones jasmonic acid (JA) and ethylene (ET) [205]. Clade II TGA factors 
not only activate SA-dependent genes, but also JA/ET-dependent genes. This 
activation can be repressed by overexpressing the CC-type glutaredoxin 
ROXY19. Further experiments showed a protein-protein interaction between 
ROXY19 and clade II TGA factors, as well as activation of ROXY19 
transcription by SA. Thus, it was concluded that ROXY19 might mediate the 
repression of clade II TGA factors during JA/ET signaling. However, loss-of-
function evidence for this assumption is still missing [147,168]. Aside from 
defense responses against pathogens, TGA2, 5 and 6 also mediate the 
detoxification of xenobiotics. This response is controlled by interaction with a 
coactivator protein called SCL14 [206]. In addition, ectopically expressed 
ROXY19 acts again as an inhibitor of clade II TGA factors in the induction of 
the detoxification program [152]. 
The clade IV and V TGA factors – TGA9, TGA10, and PAN – have been 
associated with flower development. PAN restricts the number of petals in the 
flower of A. thaliana to four [207]. Since mutation of ROXY1 leads to less than 
four petals and since ROXY1 interacts with PAN, it might repress PAN during 
petal development. Interestingly, a cysteine in the C-terminus of PAN is 
required for PAN function and its N-terminus contains several cysteines 
sensitive to oxidative modifications. Thus, it was speculated about a potential 
redox control of PAN by ROXY1. However, as outlined before, functional 
analysis of ROXY1 active site mutants provided conflicting results regarding 
this assumption [145,146,172,175]. TGA9 and 10 control anther development 
and are therefore indespensable for male fertility. Interestingly, they are not 
only regulated by ROXY1, but also by ROXY2 [169]. Recently, TGA9 and 
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TGA10 were linked with defense responses against pathogens; however, 
coregulators have not yet been identified [208]. 
Knowledge about clade III TGA factors is relatively scarce. TGA3 interacts 
strongly with NPR1 and participates with clade II TGA factors in pathogen 
defense [193,209]. Its role in immunity has repeatedly been observed [210–214]. 
In addition, it plays a role in heavy metal tolerance [215,216]. TGA3 interacts 
with some CC-type glutaredoxins [145,170]; [M. Willmer, unpublished]. 
Moreover, it is constitutively bound to the ROXY19 promoter and, in addition 
to clade II transcription factors, contributes to the activation of ROXY19 
transcription after SA treatment [151]. Like TGA3, TGA7 interacts with NPR1 
and CC-type glutaredoxins [145,217,218] [M. Willmer, unpublished]. The 
interaction with NPR1 enhances the DNA-binding activity of TGA7 in vitro, 
The DNA fragments used for this study included elements of the PR-1 
promoter. However, a function of TGA7 in defense gene expression remains 
to be demonstrated [218]. 
For clade I TGA transcription factors, first, a function in basal resistance was 
observed. Basal resistance includes the sensing of and initial defense responses 
to a pathogen in order to prevent its spread. Examples for such initial defense 
responses are cell wall reinforcement and the production of ROS and toxic 
proteins [219,220]. Both, TGA1 and TGA4, control this process redundantly 
[221]. The tga1 tga4 double mutant is defective in callose deposition and the 
production of PR genes, though these processes could not be linked to 
transcriptional events [222]. TGA1 and TGA4 regulate only a small number of 
genes involved in defense and operate mainly independently of NPR1 [223]. 
Still, the interaction between clade I TGA factors and NPR1 was proposed to 
depend on the redox state of the TGA factors [224]. TGA1 contains four 
conserved cysteine residues located in or around the glutatmine-rich regions 
(C172, C260, C266 and C287, Figure I8 and SI3). Després et al. showed in 2003 
that the pool of TGA1 and TGA4 in A. thaliana cells is partly reduced and   
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Figure I8. Conserved cysteine residues in TGA transcription factors from A. thaliana. 
All cysteine residues found in the 10 TGA factors from A. thaliana are indicated by thiol groups 
(-SH) along the domain structure of the proteins. Cysteine residues conserved among different 
TGA factors are indicated by the same colours. Residues for which a redox modification or a 
function in regulating the activity of the TGA factors has been speculated or investigated, are 
marked by asterisks. The schemes of the TGA factors were grouped according to their clades 
and numbering. A detailed alignment highlighting all cysteine residues in theTGA transcription 
factors is shown in Figure SI3. For TGA1, the positions of the cysteine residues are indicated 
above the thiol groups. The scheme was taken from Gatz (2012) [190] and modified. 
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partly oxidized. Upon treatment with salicylic acid, the pool shifts completely 
to the reduced state. Further experiments involving in vitro translated TGA1 
treated with the reducing agent β-mercaptoethanol or left in its oxidized state 
suggested the formation of a disulfide bridge between C260 and C266. This 
disulfide bridge might be present under non-inducing conditions, preventing 
the interaction with NPR1. According to the model, reduction of the disulfide 
bridge leads to the interaction with NPR1 and subsequent enhancement of the 
TGA1 DNA-binding activity [224]. However, because the overlap between SA-
induced genes regulated by TGA1 and NPR1 is rather small, this redox 
regulation was speculated to affect the transcription of only a small subset of 
genes [223]. A few years later, Lindermayr et al. (2010) examined the reactivity 
of the TGA1 cysteine residues towards nitrosoglutathione (GSNO). GSNO 
occurs naturally in cells, as it arises from the reaction of glutathione with NO. 
It can act as both, a nitrosyl donor and as a glutathionyl donor [225,226]. In 
contrast to the study by Després et al., recombinant TGA1 was found to contain 
a disulfide bridge between cysteines 172 and 287 after purification and when 
treated with hydrogen peroxide in vitro. In both cases, this disulfide bridge was 
broken by reaction with GSNO. While C172 can be glutathionylated, C260 and 
C266 can be glutathionylated and nitrosylated. C287 was only modified when 
high concentrations of GSNO were used. The reaction with GSNO enhanced 
the DNA binding of TGA1 even in the absence of NPR1 [32]. However, 
phenotypic evidence for a redox-based regulation of TGA1 and/or TGA4 in 
innate immunity is still lacking [32]. Despite this and the discrepancies 
regarding the location of the disulfide bridge in TGA1 between the mentioned 
studies, Després et al. (2003) and Lindermayr et al. (2010) show that the redox 
state of the cysteine residues in TGA1 changes in vivo, as well as in vitro. 
 
 
Connections between clade I TGA transcription factors 
and CC-type glutaredoxins 
 
Beside their function in response to biotic stress [157,159,221], TGA1 and 
TGA4 also regulate hyponastic growth [155,156], a response towards low light 
conditions, flooding or heat. Normally, the rosette leaves of A. thaliana are 
spread flat on the soil. Since in this state, A. thaliana is sensitive to the 
aforementioned environmental stresses, it raises its leaves in order to reach 
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regions of stronger light or to allow aeration of the rosette leaves [227]. The 
increase in the petiole angle during hyponastic growth is caused by an 
asymmetric cell growth: Since cells at the abaxial side expand more strongly 
than at the adaxial side of the petiole, the petiole bends upwards [228]. 
So far, the control of hyponastic growth by TGA1 and TGA4 has not yet been 
correlated with co-activators regulating clade I TGA factors directly, but recent 
work established a connection to the CC-type glutaredoxin ROXY9 [155,156]. 
ROXY9 interacts directly with TGA1 and TGA4 [156,157]. As mentioned 
before, it belongs to the CC-type glutaredoxins lacking the ALWL motif 
[145,168,170]. ROXY9 can repress low light-induced hyponastic growth. So 
far, its function in hyponastic growth has only been confirmed by analyzing 
overexpression lines of this glutaredoxin. A roxy9 knock-out mutant does not 
differ from the wildtype regarding hyponastic growth [155,156]. However, this 
effect might be caused by the existence of redundant proteins. ROXY9 is most 
closely related to ROXY8, 7 and 6, all of them lacking the ALWL motif. In 
ROXY20, the ALWL motif is replaced by a non-functional ALWA sequence 
[145,168,170]. In addition, ROXY8 exerts the same repressive effect on 
hyponasty when overexpressed. Thus, some or all these CC-type glutaredoxins 
might be redundant with ROXY9. This assumption is further supported by the 
observation, that all these ROXYs as well as ROXY20 undergo changes in 
expression similar to that of ROXY9 during hyponastic growth [155,156]: 
Under control light conditions of 100 to 120 µmol s-1 m-2, ROXY9 transcript 
levels are low. They decrease even further when A. thaliana encouters low light 
conditions. Interestingly, upon backshift of low light-treated plants to control 
light conditions, ROXY9 transcription is strongly induced. This induction is 
mediated by TGA1 and TGA4. 
In support of the connection between clade I TGA factors and ROXY9, an 
overlap between the genes repressed by ROXY9 and activated by TGA1 and 
TGA4 during hyponastic growth has been observed. These genes included 
auxin-dependent genes and genes for cell growth. Altogether, these results 
suggested, that TGA1 and TGA4 activate hyponastic growth during low light 
by inducing cell growth at the abaxial side of the petiole. When normal light 
conditions return, TGA1 and TGA4 induce strongly ROXY9 transcription, 
thereby producing their own repressor in a negative feedback loop. Repression 
of TGA1 and TGA4-regulated genes by ROXY9 causes the leaves to resume 
their usual horizontal position [155,156]. 
To repress hyponastic growth, ROXY9 requires its active center composed of 
the amino acid sequence CCLC. The CC motif, but not the C-terminal active 
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site cysteine, are indispensable for repression by ROXY9. The C-terminal end 
of the protein comprising the amino acids SILY does not influence its 
repressive mechanism [155]. Since ROXY9 cannot interact with TPL [168,177] 
and since TGA1 might be redox-regulated [32,224], the assumption that 
ROXY9 might change the redox state of the TGA1 cysteines was investigated. 
However, complementation analysis of the tga1 tga4 mutant suggested that the 
two central cysteines in TGA1 (C260 and C266) were not necessary for 
controlling hyponastic growth [155]. 
Motivated by the finding of the interaction of clade I TGA factors and ROXY9, 
the involvement of TGA1 and TGA4 in innate immunity was revisited 
regarding a functional correlation to ROXY9 [159]: TGA1 and TGA4 have 
been shown to control the expression of defense genes early after infection or 
induction by SA, but not at later timepoints [159,223]. Interestingly, a similar 
observation was also made for plants overexpressing ROXY9, further 
supporting the functional relationship between both proteins [159]. 
In addition to their function in biotic and abiotic stresses, TGA1 and TGA4 
are involved in plant development: Flowering is delayed in the tga1 tga4 double 
mutant and its leaves are curled and arranged in a windmill-like fashion [223]. 
Both phenotypes also occur in ROXY9 overexpression lines. Although the 
delay in flowering of the tga1 tga4 mutant could not be observed by Muthreich 
(2014), a cross between the tga1 tga4 mutant and ROXY9 overexpression plants 
showed that the delay in flowering seen for ROXY9 overexpression depends 
on clade I TGA factors [157]. 
Analysis of hyponastic growth and flowering provides direct links between 
ROXY9 and clade I TGA factors. However, an additional function of clade I 
transcription factors in nitrate-dependent root growth is reminiscent of 
functions reported for CC-type glutaredoxins [154,166,229,230]: 
Transcription of TGA1 and TGA4 is induced in roots by nitrate [229]. Both 
transcription factors regulate the expression of almost all nitrate-responsive 
genes. The nitrate uptake systems NRT2.1 and NRT2.2, however, are only 
weakly induced by TGA1 and TGA4. Consistent with this, nitrate uptake is not 
affected in the tga1 tga4 double mutant. Instead, clade I TGA factors activate 
primary and lateral root growth in response to nitrate [229]. In addition, they 
control root hair development [230]. Interestingly, ROXY9 was recently 
identified as a mobile protein involved in controlling the root growth on soil 
with unevenly distributed nitrogen sources: Roots growing in soil containing 
too low amounts of nitrogen produce a peptide hormone traveling to the shoot. 
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This peptide hormone induces the transcription of ROXY9 and its paralogue 
ROXY6 in the leaves. Both, ROXY9 and ROXY6, are transported via the 
phloem to the roots in those regions of the soil rich in nitrogen. This serves to 
activate NRT2.1 [154]. This activation of NRT2.1 is, however, in contrast to 
the repressive effect of ROXY9 on clade I TGA factors observed for other 
functions of the two proteins [155–157,159]. Aside from ROXY9, the CC-type 
glutaredoxins ROXY11, 12, 13 and 15 have been associated with root growth 
in response to nitrate [166,231]. These four CC-type glutaredoxins contain an 
ALWL motif [145,168,170] and are encoded in a cluster on chromosome 4 
[136,166,231]. Their transcription is induced by nitrate [166]. In soil rich in 
nitrate, they enhance lateral root growth but limit primary root growth, in order 
to increase the surface needed for the uptake of nitrate [166,231]. Interestingly, 
ROXY11, 12, 13 and 15 were shown to be transcriptionally regulated under 
basal conditions by clade I TGA factors and ROXY9. While the four cluster 
ROXYs are repressed by TGA1 and TGA4, their transcription is activated by 
ROXY9 [155,156].
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Aim of this thesis 
_____________________________________________________________________ 
 
The aim of this study was to find out whether the peculiar CCLCY active site 
of the CC-type glutaredoxin ROXY9 allows the catalysis of redox reactions or 
enables the binding of an iron-sulfur cluster for the formation of iron-sulfur 
cluster-dependent protein complexes. For this, the following experiments were 
set up: 
• The function of overexpressed mutant variants of ROXY9 carrying a 
CCLCA or CPYC active site should be examined in planta. 
 
• Recombinant ROXY9 should be produced to analyze its catalytic 
activity in standard glutaredoxin activity assays and its ability to bind 
iron-sulfur clusters by in vitro reconstitution experiments. 
 
• The ROXY9 interaction partner TGA1 should be mutated in its four 
cysteine residues and the functionality of such a protein in vivo should 
be analyzed. 
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Work with organisms 
_____________________________________________________________________ 
 
 
Cultivation of Escherichia coli 
 
E. coli was grown on Luria-Bertani (LB) plates or in LB or dYT broth. If 
applicable, the medium was supplied with the required antibiotic. For liquid 
cultures, flasks or test tubes were used. The cultures were incubated at 37°C, 
shaking at 220 rpm. Plates were incubated over night (ON) at 37°C and stored 
at 4°C. 
Cryo-cultures of E. coli were prepared by either mixing 100 µl DMSO with 
900 µl of an overnight culture, or by mixing an aliquot of an overnight culture 
with glycerol to a final concentration of 15 % glycerol. Alternatively, cells were 
scraped off from a plate and transferred to 15 % glycerol in LB. Both, DMSO 
and glycerol stocks were thoroughly mixed, frozen in N2(l) and stored at -70°C. 
 
LB medium 
 
Component Concentration 
Tryptone/peptone from casein 1 %(w/v) 
Yeast extract 0.5 %(w/v) 
NaCl 1 %(w/v) 
 
For plates, 1.2 %(w/v) agar was added. 
The medium was autoclaved. 
 
dYT medium 
 
Component Concentration 
Tryptone/peptone from caseine 1.6 %(w/v) 
Yeast extract 1 %(w/v) 
NaCl 0.5 %(w/v) 
 
The pH was adjusted to 7.0 to 7.2 using 1 M NaOH. 
The medium was autoclaved. 
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Antibiotic concentrations used to select for E. coli transformants 
Antibiotic Solvent Stock 
concentration 
Selective 
concentration 
Ampicillin dH2O 100 mg/ml 100 to 200 µg/ml 
Spectinomycin dH2O 50 mg/ml 100 µg/ml 
Gentamicin dH2O 25 mg/ml 25 µg/ml 
 
 
 
Preparation of chemically competent E. coli cells 
 
To prepare chemically competent E. coli cells, a modified version of the 
protocol by Inoue et al. (1990) [232] was applied. 
First, a single colony was inoculated in 5 ml SOC+ and incubated over day at 
37°C. 2 ml of this preculture were used to inoculate 300 ml SOC+ medium. 
The cells were grown at 18°C over night until an optical densitiy at 600 nm 
(OD600nm) of 0.5 was reached. The culture flask was placed in an ice-waterbath 
for 10 min prior to distributing the culture to six sterile 50 ml falcon tubes. The 
cells were harvested by centrifugation at 4000 rpm at 4°C for 10 min. The 
supernatant was poured off and 15 ml ice-cold Inoue transformation buffer 
were added to each tube. The cells were resuspended gently in the buffer. The 
suspensions from three tubes each were pooled, resulting in two tubes with 
45 ml suspension. The cells were spun down at 4000 rpm for 10 min at 4°C. 
The supernatant was decanted, and the remaining buffer was removed by 
placing the tubes top-down on paper towels. Each pellet was carefully 
resuspended in 15 ml ice-cold Inoue transformation buffer. 1050 µl DMSO 
were added and mixed with the suspension by swirling. The suspension was 
stored on ice for 10 min. 200 µl aliquots of the suspensions were distributed to 
pre-cooled sterile reaction tubes. The aliquots were immediately frozen in liquid 
nitrogen and stored at -70°C until transformation.
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SOC medium 
 
Component Concentration 
Trypton/Peptone from caseine 2 %(w/v) 
Yeast extract 0.5 %(w/v) 
NaCl 10 mM 
KCl 2.5 mM 
 
The solution was filled up with dH2O to the final volume and autoclaved for 
10 min at 121°C. After cooling down, SOC medium was completed to obtain 
SOC+. For this, MgCl2 and MgSO4 were added to a final concentration of 
10 mM each. Additionally, the medium was supplied with glucose to a final 
concentration of 20 mM. To avoid large changes in the volume, 1000x stock 
solutions of MgCl2, MgSO4, and glucose were used. 
 
Transformation buffer 
 
Component Concentration 
PIPES pH 6.7 10 mM 
KCl 250 mM 
CaCl2 × 2 H2O 15 mM 
MnCl2 × 4 H2O 55 mM 
 
CaCl2, KCl and PIPES were dissolved in H2O to 96 % of the final volume. 
The pH was adjusted with 1 M KOH. Afterwards, MnCl2 was added from a 
2 M stock solution and the solution filled up to the final volume. The buffer 
was filtered through a wetted bottle top filter (0.45 µm pore size) into sterile 
bottles. 
 
 
 
Preparation of fresh chemically competent E. coli cells 
using CaCl2 
 
To prepare fresh competent cells, the desired E. coli strain was inoculated in LB 
media and incubated over night at 37°C, shaking at 220 rpm. The next day, the 
OD600nm was measured and 10 ml LB inoculated to an OD600nm of 0.1. This main 
culture was incubated at 37°C and 220 rpm until it reached an OD600nm of 0.3. 
The cells were harvested by centrifugation at 4000 rpm at 4°C for 5 min in 
sterile tubes. The media was discarded, and the pellet resuspended in 10 ml 
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sterile 50 mM CaCl2. The cells were incubated on ice for ca. 30 min and then 
spun down again (4000 rpm, 4°C, 5 min). The supernatant was removed, and 
the cells resuspended in ca. 1 ml 50 mM CaCl2. 100 µl aliquots of this 
suspension were used for transformation following the usual protocol. 
 
 
Reactivation of chemically competent E. coli using CaCl2 
 
When chemically competent BL21 cells started to lose their competence, the 
cells were made competent again by incubating them in CaCl2. The cell aliquot 
was first thawed on ice. Once thawed, it was spun down briefly, the supernatant 
was removed, and the cell pellet was resuspended in 1 ml sterile 50 mM CaCl2 
solution. The cells were incubated for ca. 30 to 60 min on ice. After brief 
centrifugation, the supernatant was removed. The cells were resuspended in 
200 µl fresh sterile 50 mM CaCl2 solution and used for transformation 
according to the standard protocol. 
 
 
Transformation of chemically competent E. coli cells 
 
Aliquots of chemically competent E. coli cells were thawed on ice. For 
transformation, an aliquot was mixed with a small amount of the desired 
plasmid, ligation mix or ligation-indepenendet cloning (LIC) mix. As a negative 
control, another aliquot of the competent E. coli cells was left untreated. Next, 
the samples were incubated on ice for ca. 30 min. Then, the cells were heat-
shocked at 42°C for ca. 1.5 min and cooled down on ice for ca. 5 min. 800 µl 
LB or dYT medium were added and the cells incubated for at least 45 min at 
37°C, shaking. Afterwards, the cells were spun down briefly and the 
supernatant was decanted. The remaining drop of supernatant was used to 
resuspend the cell pellet. The suspension was plated on LB plates supplied with 
the required antibiotic. The plates were incubated overnight at 37°C. 
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Cultivation of Agrobacterium tumefaciens 
 
Agrobacterium tumefaciens (A. tumefaciens) was cultivated in YEB medium or 
streaked out on YEB plates. Broth culures were incubated at 29°C for one or 
two days, shaking them at 220 rpm. Plates were incubated at 29°C for one or 
two days. If necessary, the YEB medium was supplemented with antibiotics. 
 
YEB medium 
 
Component Concentration 
Meat extract 1 %(w/v) 
Yeast extract 0.2 %(w/v) 
Tryptone/Peptone from caseine 0.5 %(w/v) 
Sucrose 0.5 %(w/v) 
 
The pH was adjusted to 7.0 using 1 M NaOH. For plates, 1.2 %(w/v) agar 
was added. 
The medium was autoclaved. After autoclaving, sterile MgSO4 was added to 
a final concentration of 2 mM. 
 
Antibiotic concentrations used to select for A. tumefaciens 
transformants 
Antibiotic Solvent Stock 
concentration 
Selective 
concentration 
Rifampicin dH2O 
acidified 
with HCl 
10 mg/ml 50 µg/ml 
Spectinomycin dH2O 50 mg/ml 100 µg/ml 
Gentamicin dH2O 25 mg/ml 25 µg/ml 
 
 
 
Preparation of electro-competent A. tumefaciens cells 
 
To prepare electrocompetent A. tumefaciens GV3101 cells, the strain was grown 
in 400 ml YEB+ in a 2 l flask for two days at 29°C, shaking at 220 rpm. The 
culture was distributed to 50 ml falcon tubes. The tubes were centrifuged at 
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4000 rpm to harvest the cells. The supernatant was discarded, and each pellet 
was washed three times with dH2O and finally with 15 % glycerol. After the 
last wash step, the cell pellet was resuspended in 1 to 3 ml 15 % glycerol. The 
cell suspensions were pooled. Finally, 300 µl aliquots were distributed to 
reaction tubes and frozen in liquid nitrogen. The cell aliquots were stored at -
70°C until transformation. 
 
 
Transformation of A. tumefaciens 
 
Aliquots of electro-competent A. tumefaciens cells were thawed on ice and mixed 
with 100 ng plasmid DNA. To include a negative control, one cell aliquot 
underwent the transformation procedure without addition of DNA. The cells 
were incubated on ice for at least 30 min. Subsequently, the cells were 
transferred to sterilized cuvettes and subjected to an electric pulse (2.5 kV, 
200 Ω, 25 µF). Imediately after the electroshock, the cells were mixed with 1 ml 
YEB medium and transferred back to the reaction tubes. The samples were 
incubated for 2 h at 29°C on a shaker. Finally, the cells were centrifuged. After 
decanting the supernatant, the cells were resuspended in the remaining drop of 
liquid and plated on selective plates. The plates were incubated for two days at 
29°C. 
 
 
Cultivation of Arabidopsis thaliana 
 
A. thaliana seeds were surface-sterilized in a chlorine gas atmosphere in a 
dessicator. For this, 50 ml of a 12 % sodium hypochlorite solution were mixed 
with 2.5 ml 32 % HCl in a jar placed in the dessicator together with reaction 
tubes containing the seeds for sterilization. For storage of surface-sterilized 
seeds, the chlorine gas was allowed to evaporate from the tubes for 
approximately 30 to 60 min. 
A. thaliana was grown on soil (Fruhstorpfer Topferde Typ T Struktur 1 fein) in 
round pots (diameter: 6 cm) or square pots (9 cm × 9 cm). For this, seeds were 
surface-sterilized for at least 2 h using chlorine gas, placed on the soil surface 
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and moistened with tab water. Subsequently, the sown seeds were stratified in 
the cold room over night or up to a week. After stratification, the pots were 
transferred to climate chambers or Percival incubators and cultivated under the 
indicated fluence rate, day length, temperature and humidity. 
To grow A. thaliana on Murashige-Skoog (MS) plates, seeds were sterilized for 
at least 5 h using chlorine gas. The clorine gas was allowed to evaporate under 
a clean bench. The seeds were placed on the plate surface using a sterile tooth 
pick. Alternatively, the sterizlized seeds were resuspended in 0.1 %(w/v) plant 
agar in dH2O and transferred to the plate with the help of a 200 µl pipette using 
autoclaved cut tips. 
 
 
Transformation of A. thaliana and generation of stably 
transformed plants 
 
Transformation 
A. thaliana was transformed using the flower dip method [233]. Per T-DNA to 
be transformed, approximatley ten square pots with nine A. thaliana plants each 
were grown under long day conditions (16 h light with 60 % humidity at 
22°C/8 h dark with 60 % humidiy at 18°C, fluence rate: 100 to 
120 µmol∙m-2∙s-1) until flowering. Alternatively, approximately four seeds were 
sown on round pots. In this case, approximately 15 pots were needed for the 
transformation of a single T-DNA. Optionally, once the plants started to 
flower, the first flowers were cut off to allow the formation of more floral 
stems. 
When the A. thaliana plants were flowering, cultures of A. tumefaciens GV3101 
transformed with the desired T-DNA vector were prepared. First, a preculture 
was prepared. For this, 10 to 20 ml YEB medium with antibiotics in 100 ml 
flasks were inoculated from plates and grown at 29°C, shaking them at 220 rpm 
for one to two days. 8 to 10 ml of these pre-cultures were used to inoculate 300 
to 400 ml main cultures in 2 l-flasks. After one or two days at 29°C and 
220 rpm, the cells were harvested by centrifugation at 5000 rpm for 10 min at 
room temperature (RT), using a Sorvall RC6+ centrifuge (Rotor SLA-3000). 
The supernatant was discarded, and the cell pellet resuspended in ca. 40 ml 
sucrose solution. Next, the OD600nm of these cell suspensions was determined, 
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and 500 ml cell suspensions of an OD600nm = 0.8 were prepared in beakers. The 
flowers of the A. thaliana plants were dipped into the cell suspension for 
approximately 10 to 20 sec. Finally, the dipped plants were covered with a 
plastic hood and incubated overnight under long day conditions. Afterwards, 
the hoods were removed, and the plants cultivated until seed formation was 
finished. 
 
T1 genereation 
The seeds of the dipped plants were collected and an appropriate number of 
them was sown on soil. The plants (T1 generation) were grown for 
approximately one week under long day conditions in a climate chamber. 
During the second week, the plants were sprayed two to three times with Basta 
solution to select for transformants. Transformants were then transferred to 
individual pots and cultivated further in a long day climate chamber. Optionally, 
before or during the onset of flowering, leaf material for a pre-characterization 
of the plants by Western Blot or qPCR was taken. With this pre-
characterization, the expression of the transgene was checked. As soon as they 
started to form floral stems, the plants were covered with ARACONs 
(Betatech) to allow self-fertilization only. The seeds of the individual plants 
were harvested. 
 
T2 generation 
Seeds of T1 plants (T2 generation) expressing the transgene were used to test 
whether the mother plant had obtained only a single T-DNA or more T-DNAs 
during transformation. For this, seeds of the T1 generation were subjected to 
selection via the Basta-active substance phosphinotricine (PTT). About 100 
plants were sown on 2MS plates containing PTT. The plates were incubated in 
a 14 h light/10 h dark regime in a climate chamber without control of air 
humidity. The fluence rate was 120 µmol∙m-2∙s-1. As a negative control, a PTT-
sensitive plant was included. A PTT-resistant plant was used as a positive 
control. After 10 to 14 days, the percentage of PTT surviving T2 plants and the 
rate of PTT-sensitive T2 plants was determined by counting. Roughly 75 % of 
surviving T2 plants indicated a single T-DNA insertion, whereas roughly 93 % 
of survivors suggested the insertion of two T-DNAs. 
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Optionally, if not done in the T1 genration, a mixture of T2 plants was used 
for a pre-characterization regarding expression of the transgene. For this, 
approximately 30 seeds of a single T1 plant were sown on a single pot on soil 
and harvested after 3 weeks for a pre-characterization by qRT-PCR or Western 
Blot to detect expression of the transgene. Those plants expressing the 
transgene were selected for addressing the question of the number of T-DNAs 
present in the mother plant, following the procedure described above. 
All plants showing expression of the transgene from a single T-DNA were 
selected for propagation. For this, 20 to 40 seeds were sown on individual pots 
and the plants grown under long day conditions. Once floral stems were visible, 
the plants were covered with ARACONs for self-fertilization. Finally, the ripe 
seeds were harvested. 
 
T3 generation 
The T2 generation contains homozygous plants. To identify homozygous 
plants, the seeds of the T2 generation (T3 generation) were harvested. 
Approximately 100 seeds per plant were sown on 2MS plates for PTT selection 
as described for the T2 generation. In case of a T2 plant homozygous for the 
transgene, all decendants of this plant should be resistant to PTT. A T2 plant 
heterozygous for the transgene should only produce 75 % resistant decendants. 
Loss of the transgene in a T2 plant would result only in plants sensitive to PTT. 
Seeds from homozygous transgenic plants were sown on soil for futher 
propagation and/or directly used for experiments. Seeds from plants in which 
the transgene was lost during segregation after self-fertilization were kept as a 
control for experiments. 
 
 
Sucrose solution 
 
Component Concentration 
Sucrose 5 %(w/v) 
Silwet L77 0.02 %(v/v) 
 
Sucrose solution was always prepared freshly. 
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Basta solution 
 
Component Concentration 
Silwet L77 0.02 %(v/v) 
Basta 0.2 %(v/v) 
 
Basta solution was pepared using tab water and stored at 4°C. 
 
2MS plates 
 
Component Concentration 
MS 0.44 % (w/v) 
Sucrose 2 % (w/v) 
 
The pH of the solution was adjusted to 5.7 using KOH. Then, 0.68 %(w/v) 
plant agar were added and the mixture autoclaved. After autoclaving, the 
solution was allowed to cool down and PTT was added to a final 
concentration of 6 mg/l using a stock solution of 10 mg PTT per ml dH2O. 
 
 
 
Hyponastic growth experiment 
 
Hyponastic growth experiments were carried out as described previously 
[155,156]. Briefly, plants were grown on individual pots at 12 h light/12 h dark 
cycle at a fluence rate of 100 to 120 µmol∙m-2∙s-1and 60 % humidity during both, 
day and night. After approximately 28 days, the plants were subjected to low 
light (LL) treatment to induce hyponasty. For this, the plants were splitted into 
three groups with ca. 10 plants per genotype: One group served as a control 
and was therefore incubated under control light (CL) conditions (fluence rate: 
100 – 120 µmol∙m-2∙s-1) throughout the entire experiment. The second group 
was used to analyze the onset of hyponasty; these plants were placed in low 
light (fluence rate: 10 to 20 µmol∙m-2∙s-1) 1.5 hours after beginning of the 
photoperiod. They were kept under these conditions until 7.5 hours after onset 
of the photoperiod on the next day had passed. Using the third group, the 
reversal of the hyponastic response was assessed. For this, the third group of 
plants was first treated with low light, starting 1.5 hours after beginning of the 
photoperiod until the onset of night. Shortly after the onset of the next 
photoperiod, the plants were placed again in control light conditions for 7.5 h. 
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Finally, the plants were photographed in the side view using a Canon 
PowerShot G11 camera and the angle of the petiole of the seventh or eighth 
leaf measured using the angle tool in ImageJ 1.x [234]. 
 
 
Analysis of the leaf morphology 
 
To analyze the overall leaf morphology and the petiole length, individual plants 
were grown in a climate chamber with a 12 h day and a 12 h night rhythm at 
22°C and 60 % relative humidity. The fluence rate was 100 – 120 µmol∙m-2∙s-1. 
After 28 days, leaf 7 and leaf 8 were detached at the petiole base and 
photographed in the top view using a Canon PowerShot G11 camera. Using 
these pictures, the length of the petiole and the leaf blade of either leaf 7 or leaf 
8 were measured using the line tool in image J 1.x [234]. The total leaf length 
was obtained by adding the petiole length to the length of the leaf blade. The 
ratio of petiole length to total leaf length was computed and plotted in a bar 
chart. For this experiment, ca. 9 replicates for each plant line were examined. 
A replicate corresponds to one plant from which either leaf 7 or leaf 8 was used 
for the measurement. 
 
 
Flowering experiment 
 
To analyze the duration until flowering, ca. 6 plants were cultivated on 
individual pots under long day conditions in a climate chamber (16 h day at 
22°C, 8 h night at 18°C, relative humididy at day and night: 60 %, fluence rate: 
100 - 120 µmol∙m-2∙s-1). As soon as a floral stem of about 1 cm in length could 
be observed, the number of days from the start of incubation in the climate 
chamber to this day was determined. In addition, the leaves of the plant were 
counted to find out whether the plant is generally delayed in development or 
shows a delay particularly in flowering. 
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Work with DNA 
_____________________________________________________________________ 
 
 
Polymerase chain reaction (PCR) 
 
To prepare a PCR, the following components were mixed in a PCR tube: 
Component Volume Final concentration 
Primer fwd (10 µM) 2.5 µl 0.5 µM 
Primer rev (10 µM) 2.5 µl 0.5 µM 
dNTPs (10 mM) 1 µl 0.2 mM 
5x Phusion HF Buffer containing 
7.5 mM MgCl2 
10 µl 1x 
Template DNA Depending on template 
Phusion High-Fidelity DNA 
Polymerase (2 U/µl) 
0.5 µl 0.02 U/µl 
Total volume Ad 50 µl dH2O  
 
The standard PCR programm used was: 
Step Temperature 
[°C] 
Duration [min] Number of 
cycles 
Initial denaturation 98 1 1 
Denaturation 98 0.25 35 
Annealing Depending on 
TM of primers 
0.5 35 
Elongation 72 0.5/kb 35 
Final Elongation 72 10 1 
Hold 4 ∞ 1 
 
The annealing temperature (TA) depended on the melting temperatures of the 
primers used (TM) for the PCR and was ideally calculated according to the 
formula: 
𝑇𝐴 =  
 𝑇𝑀  (𝑃𝑟𝑖𝑚𝑒𝑟 𝑓𝑤𝑑) + 𝑇𝑀  (𝑃𝑟𝑖𝑚𝑒𝑟 𝑟𝑒𝑣)
2
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A no template-control was employed to ensure that all components used were 
free of contaminating DNA. For this, the volume of the template DNA was 
replaced by an equal volume of dH2O. 
 
 
 
Agarose gel electrophoresis 
 
Agarose gels were prepared using 1xTAE buffer. The agarose was dissolved in 
1xTAE buffer by heating in a microwave oven oven for ca. 5 min at maximum 
power. Once prepared, agarose solutions in 1xTAE were stored at 60 to 65 °C 
in an incubator. To prepare the gel, the agarose solution was poured into 
horizontal gel chambers supplied with a comb. After the gel had solidified, it 
was placed in a running chamber filled with 1xTAE. The comb was removed, 
and the samples were loaded into the wells. As a size standard, Gene Ruler 
DNA Ladder Mix 0.5 µg/µl (Thermo Scientific) was used. The DNA was 
separated in an electric field applying a constant voltage of 120 to 130 V. 
Afterwards, the gel was stained in an ethidium bromide bath (0.1 %(w/v) 
ethidium bromide in dH2O) and destained in a water bath. Finally, the bands 
were visualized under ultraviolet (UV) light (260 nm for documentation and 
366 nm for gel extractions) and a picture taken using an Intas gel 
documentation system. 
 
 
1xTAE buffer 
 
Component Concentration 
TRIS pH 8.4 to 8.5 0.8 M 
Acetic acid 2.28 %(v/v) 
Na2-EDTA 20 mM 
 
The pH was adjusted using HCl. 
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Purification of DNA from reaction mixtures or from 
agarose gels 
 
The DNA of a PCR or a restriction digest was purified from the reaction mix 
or from an agarose gel using the kit „NucleoSpin Gel and PCR clean-up“ 
(Macherey & Nagel), according to the instructions described in the manual. The 
DNA was eluted in an appropriate volume of dH2O. 
 
 
Determination of nucleic acid concentrations 
 
The concentration of RNA or DNA was determined photometrically using 
NanoDrop 2000 Spectrophotometer (Peqlab). Purity was checked considering 
the absorption ratios at 260 nm and 280 nm or at 260 nm and 230 nm. 
Alternatively, DNA concentrations could be determined by separating a known 
volume of the DNA fragment in an agarose gel and estimating the amount of 
DNA in the respective band by comparing its intensity to the band intensities 
of the size standard (Gene Ruler DNA Ladder Mix 0.5 µg/µl (Thermo 
Scientific)). 
 
 
Cloning using restriction enzymes and ligation 
 
Restriction digests 
Restriction digests were performed using enzymes purchased from Thermo 
Scientific, New England Biolabs, MBI Fermentas, Boehringer Mannheim 
GmbH, GIBCO BR, or Promega. The reaction composition and the reaction 
conditions were chosen according to the manufacturer’s instructions. To 
estimate the amount of enzyme necessary for the digest of a DNA, the 
following formula was used: 
𝑈𝑛𝑖𝑡𝑠 (𝐸𝑛𝑧𝑦𝑚𝑒) = 2 ×  
%𝑀𝑎𝑥 (𝐸𝑛𝑧𝑦𝑚𝑒) × 𝑆(𝑃𝑙𝑎𝑠𝑚𝑖𝑑) × 𝑚(𝑃𝑙𝑎𝑠𝑚𝑖𝑑) × 𝑙(𝜆)
𝑡(𝐷𝑖𝑔𝑒𝑠𝑡) × %𝐵𝑢𝑓(𝐸𝑛𝑧𝑦𝑚𝑒) × 𝑆(𝜆) × 𝑚(𝜆) × 𝑙(𝑃𝑙𝑎𝑠𝑚𝑖𝑑)
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Variables 
%Max(Enzyme) – maximal activity of the enzyme [%]; %Max(Enzyme) = 100 % 
%Buf(Enzyme) – activity of the enzyme in the buffer used [%] 
S(Plasmid), S(λ) – number of restriction sites of the enzyme in the plasmid or in the λ-DNA, 
respectively 
m(Plasmid), m(λ) – amount of plasmid used or amount of λ-DNA [µg]; m(λ) = 1 µg 
l(Plasmid), l(λ) – length of plasmid or λ-DNA [bp]; l(λ) = 48500 bp 
t(Digest) – duration of the digest [h] 
 
 
Ligation 
Ligations were performed using T4 DNA Ligase 5 Weiss U/µl and 10x T4 
DNA Ligase Buffer provided by Thermo Scientific. Usually, the amount of 
vector DNA used for a ligation depended on the size of the fragment: per 
1000 bp length, 10 ng of DNA were used. For the insert, a threefold molar 
excess of insert DNA over vector DNA was used. The reaction mixture was 
incubated for at least 20 min at room temperature and half of the prepared 
volume used for the transformation of E. coli. Multiple fragment ligations were 
performed in the same way, using all DNA fragments considered as inserts in 
a threefold molar excess over the single backbone fragment (vector). After 
selection of succsessfully transformed E. coli clones, positive clones were 
identified by test restriction digests. 
 
 
Cloning using the Gateway® system 
 
The Gateway® cloning system was obtained from LifeTechnologies. Cloning 
was performed as recommended in the manual. In short, entry clones were 
created in BP reactions. For this, an insert containing attB sites was prepared 
by PCR. 100 to 250 ng of the insert and of the desired donor plasmid were 
prepared in a total volume of 8 µl and added to 2 µl BP enzyme mixture, 
vortexed, and incubated for 1 h at RT. Then, a part or the entire reaction 
mixture was used for an E. coli transformation. Positive clones were identified 
by Mini Plasmid Preparation and subsequent test restriction digests of the 
isolated plasmids. To transfer the insert from an entry vector to a destination 
vector, 100 to 250 ng of each, the destination vector and the entry vector, were 
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combined with 1 to 2 µl of LR clonase mix in a total volume of 5 to 10 µl, 
vortexed and incubated for 1 h at RT. Finally, the reaction mixture was 
transformed in E. coli, as for a BP reaction. Again, positive clones were 
identified using restriction digest of isolated plasmids. 
 
 
 
Ligation-independent cloning (LIC) 
 
The ligation-independent cloning (LIC) was developed by QB3 MacroLab at 
the University of California, Berkeley. This cloning strategy uses the 
3’-exonuclease activity of T4 polymerase to degrade one strand at the end of a 
linear DNA fragment, thereby creating 5’-overhangs. The overhangs of the 
vector and the insert are complementary. When annealed, the overlap is long 
enough to allow ligation of the nicks in E. coli, therefore circumventing a 
ligation step. 
For ligation-independent cloning, the LIC vector was linearized using an 
appropriate restriction site. The vector was purified from an agarose gel to 
ensure that only fully linearized plasmid was used for the following steps. PCR 
was used to generate the LIC insert, fusing the gene of interest to LIC sites. 
Afterwards, 5‘-overhangs were created in LIC reactions with the help of T4 
polymerase for both, the LIC vector and LIC insert. A LIC reaction contained: 
 
Component Volume Final concentration 
PCR product or vector DNA 50 to 150 ng 
in 10 µl dH2O 
25 to 75 ng 
dNTP (25 mM)* 2 µl 2.5 mM 
5x Buffer for T4 DNA 
Polymerase 
4 µl 1x 
T4 DNA Polymerase (5 u/µl) 0.4 µl 0.1 u/µl 
DTT (100 mM) 1 µl 5 mM 
Total volume 20 µl  
*dNTP binding to the last nucleotide of the overhang to be created 
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The LIC reaction was prepared in a PCR tube and incubated at 22°C for 30 min 
in a thermal cycler. The reaction was heat-inactivated by incubating at 75°C for 
20 min. 
Next, 2 µl of LICed vector and 2 µl LICed PCR product were mixed with 6 µl 
dH2O and allowed to anneal for 10 min at RT. After incubation, this mixture 
was transformed in E. coli. Plasmids were isolated from selected E. coli clones 
and checked in restriction digests. 
 
 
 
Mini plasmid preparation from E. coli 
 
For extraction of small amounts of plasmid DNA, an E. coli clone transformed 
with the desired plasmid was inoculated in LB or dYT media mixed with the 
correct antibiotic in sterile test tubes or flasks and incubated over night at 37°C 
at 220 rpm. The plasmid DNA was isolated from the cells using the 
„NucleoSpin Plasmid“ kit (Macherey & Nagel), following the manual 
instructions. The plasmid DNA bound to the column was eluted with dH2O. 
 
 
 
Midi plasmid preparation from E. coli 
 
For preparation of large amounts of plasmid DNA, an E. coli clone containing 
the plasmid of interest was inoculated in ca. 4 ml dYT media containing the 
appropriate antibiotic in a sterile test tube and cultivated over day at 37°C, 
shaking at 220 rpm. Ca. 300 µl of this pre-culture were used to inoculate 300 ml 
dYT supplied with the required antibiotic in a 2 l flask. This main culture was 
incubated over night at 220 rpm at 37°C. The next day, the E. coli cells were 
harvested by centrifugation at 6000 rpm for 15 min at RT (SLA-3000 rotor, 
Sorvall RC6+ centrifuge). The supernatant was discarded. Plasmid DNA was 
extracted using the kit „NucleoBond XtraMidi“ (Macherey & Nagel), following 
the instructions of the manufacturer. 
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Plasmid isolation from A. tumefaciens 
 
Plasmids were isolated from A. tumefaciens with the help of the NucleoBond 
Plasmid kit (Macherey & Nagel). The protocol recommended by the 
manufacturer was modified as follows: 
Cultures were prepared by inoculating a single A. tumefaciens clone harboring 
the desired plasmid in ca. 10 ml YEB supplied with the appropriate antibiotics. 
The cultures were incubated for 1 or 2 days at 29°C at 220 rpm. 6 to 10 ml of 
the cultures were harvested for plasmid isolation by centrifugation (20 min, 
4000 rpm, RT or 4°C; Rotina 380R centrifuge equipped with 1798 4000rpm 4 
x 300 g rotor). The supernatant was removed, and the pellet resuspended in 
300 µl buffer A1 containing RNase A. Additional 10 µl of a 10 µg/µl RNase A 
stock were added to the sample. Then, 300 µl buffer A2 were added and the 
sample mixed by inversion. Subsequently, the sample was incubated for 5 min 
at room temperature. Lysis was stopped by adding 350 µl neutralization buffer 
(A3). The sample was centrifuged for 20 min at 13000 rpm at RT. After 
centrifugation, the procedure corresponded exactly to the protocol described 
in the manual until elution. The bound plasmid DNA was eluted in 18 to 20 µl 
dH2O. 
 
 
 
Extraction of total DNA from A. thaliana 
 
Total DNA was extracted from A. thaliana using the DNeasy Plant Mini Kit 
(Qiagen) following the instrucitons of the manufacturer. As starting material, 
approximately 500 µg of rosette leaf powder were used and resuspended in 
500 µl buffer AP1. 100 µl of this mixture were diluted with 300 µl AP1. This 
dilution was supplied with 4 µl RNase A. After that, the extraction procedure 
followed the instructions in the manual. 
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DNA sequencing 
 
Purified DNA such as plasmids or PCR products were sent to Microsynth 
(SeqLab) in Göttingen or to Eurofins GATC (Konstanz) for sequencing 
according to the chain termination method by Sanger et al. (1977) [235] using 
specific primers. The DNA template and the primer were mixed according to 
the instructions of the sequencing company. The sequences retrieved were 
analyzed using the program Geneious Pro 5.3.6. (Biomatters Ltd; [236]). 
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Work with RNA 
_____________________________________________________________________ 
 
 
RNA extraction from A. thaliana 
 
For RNA extraction, leaf material was frozen in N2(l) and grinded in a mortar 
to obtain a fine powder. Approximately 200 to 500 µg of leaf powder were 
transferred to 2 ml reaction tubes precooled in liquid nitrogen. The tubes were 
frozen in N2(l) and stored at -70°C until RNA isolation. 
To extract the RNA, the phenol-chloroform method was applied. First, the 
still-frozen leaf powder was mixed with 1.4 ml Trizol buffer and vortexed for 
at least 5 to 10 min. Then, 300 µl chloroform were added and again vortexed 
for 5 to 10 min. The samples were centrifuged at 13000 rpm for 30 to 60 min 
in a table top centrifuge at 4°C. After centrifugation, 920 to 950 µl supernatant 
were mixed 400 µl HSP precipitation buffer and 400 µl isopropanol in fresh 
2 ml reaction tubes. The tubes were inverted several times, incubated for 5 min 
at room temperature and centrifuged again for 30 to 60 min at 13000 rpm at 
4°C to precipitate the RNA. After centrifugation, the supernatant was 
decanted. 500 µl 70 % ethanol were added to the pellet and the samples 
inverted. Then, the samples were spun for 2 to 3 min (no longer than 5 min) at 
13000 rpm at 4°C. Afterwards, the ethanol was removed as fast as possible 
using a pipette. Another 500 µl 70 % ethanol were added to the pellet and both, 
ethanol and pellet, transferred to a fresh 1.5 ml reaction tube. The 
centrifugation step for 2 to 3 min was repeated and the supernatant taken off 
using a pipette. The samples were spun for another minute to collect and 
remove the remaining supernatant. The whitish pellets were dried for ca. 
30 min at room temperature under the hood until they became transparent. 
Finally, the pellets were dissolved in 30 to 100 µl autoclaved dH2O by 
incubating for 10 min at 65°C, vortexing in between. The dissolved RNA was 
stored at -20°C. 
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HSP buffer 
 
Component Concentration 
NaCl 1.2 M 
Na3-citrate × 2 H2O 0.8 M 
 
 
Trizol buffer 
 
Component Concentration 
Phenol containing 0.1 M citrate buffer 38 %(v/v) 
Guanidinium thiocyanate 0.8 M 
Ammoniumthiocyanate 0.4 M 
3 M Na-Acetat pH 5.2 3.3 %(v/v) 
100 % Glycerol 5 %(v/v) 
 
 
 
 
cDNA synthesis 
 
The concentration of the RNA was determined using a NanoDrop 2000 
spectrophotometer. To prepare the cDNA, 1 µg of RNA in a volume of 8 µl 
dH2O was prepared in PCR stripes. An additional control was prepared 
consisting of 8 µl dH2O only. This sample served as a no-template control 
during quantitative Realtime PCR later. 
First, the remaining DNA was digested using DNase I. For this, the following 
master mix was prepared and 2 µl added to each sample. 
 
Component Volume for 1 reaction 
10x Reaction buffer with MgCl2 for 
DNase I 
1 µl 
DNase I, RNase-free, 1 U/µl 1 µl 
 
The stripes were incubated in a PCR cycler for 30 min at 37°C. 
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Then, 1 µl 25 mM EDTA (1:2 dilution of 50 mM EDTA solution provided 
together with DNase I) were added and the samples incubated at 65°C for 
10 min to stop the DNase I digest. 
Secondly, cDNA synthesis was primed using an oligo dT-primer. For this, the 
following master mix was prepared and 1.2 µl added to each sample: 
 
Component Volume for 1 reaction 
Oligo dT-primer (100 µM) 0.2 µl 
dH2O 1 µl 
 
The samples were heated at 70°C for 10 min. 
Finally, a third master mix containing the remaining components necessary for 
cDNA synthesis was prepared and 7.8 µl added to each sample. The master 
mix contained: 
 
Component Volume for 1 reaction 
dH2O 1.5 µl 
5x Reaction Buffer for RT 4 µl 
dNTPs (10 mM) 2 µl 
Revert Aid H Minus Reverse 
Transcriptase 200 U/µl 
0.3 µl 
 
cDNA elongation took place at 42°C for 70 min and the reaction was heat-
inactivated by incubating at 70°C for 10 min. The cDNA was stored at –20°C. 
 
 
Quantitative realtime PCR 
 
For quantitative realtime PCR (qRT-PCR), the cDNA was diluted 10-fold in 
dH2O and 1 µl of this dilution used as a template during the PCR. In addition, 
a primer mix was prepared containing both, forward and reverse primer, at a 
concentration of 4 µM. Using this primer mix and the remaining components, 
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a master mix was prepared. 49 µl of the master mix were added to 1 µl of the 
template cDNA. All in all, a single qRT-PCR reaction contained: 
 
Component Volume Final concentration 
dH2O 17.2 µl  
10xNH4 Reaction Buffer (No 
MgCl2)  
2.5 µl 1x 
50 mM MgCl2 Stock Solution 
(provided together with 
BIOTAQ polymerase) 
1 µl 2 mM 
dNTPs (10 mM) 0.25 µl 100 µM 
Primer mix (4 µM] 2.5 µl 0.4 µM 
SybrGreen (1:1000) 0.25 µl 1:100000 
Fluorscein (1 µM) 0.25 µl 10 nM 
BIOTAQ DNA Polymerase 
5 u/µl  
0.05 µl 0.25 u 
cDNA (1:10 dilution) 1 µl  
 
The reactions were incubated in a thermal cycler according to the following 
protocol: 
 
Step Temperature 
[°C] 
Duration [min] Number of 
cycles 
Initial denaturation 95 1.5 1 
Denaturation 95 0.33 39 
Annealing 55 0.33 39 
Elongation 72 0.66 39 
Final Elongation 72 4 1 
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Preparation of protein extracts from A. thaliana in urea 
buffer 
 
Protein extracts for sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) were prepared by freezing leaf material in liquid nitrogen and 
grinding it in a tissue lyser (Retsch® MM301) for 1 min at 20 Hz using acid-
washed stainless-steel beads (diameter: 5 mm). Afterwards, the bead was 
removed and approximately 100 mg powder were mixed with 200 µl urea 
buffer and heated for 10 min at 65°C. The samples were centrifuged for 15 min 
at 17000 g in a table top centrifuge at RT. The supernatant corresponding to 
the protein extract was transferred to a new tube and stored at -20°C. Protein 
concentration in the extracts was determined in a Pierce 660 assay using the 
ionic detergent compatability reagent (IDCR). For SDS-PAGE, the samples 
prepared in urea buffer were boiled at 65°C for 10 min and loaded on the gel. 
 
Urea buffer 
 
Component Concentration 
Urea 4 M 
Glycerol 16.7 %(v/v) 
SDS 5 %(w/v) 
Bromophenolblue 0.06 g/l 
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TCA precipitation of proteins 
 
An equal volume of ice-cold 20 %(w/v) TCA was added to the protein sample. 
The sample vortexed and then incubated at -20°C for 10 min, followed by 
centrifugation at 17000 g at 4°C for 10 min. The supernatant was removed and 
the pellet washed twice with ice-cold 100 % acetone. For this, 1 ml acetone was 
added to the pellet, the sample was inverted and then centrifuged at 17000 g at 
4°C for 5 min. The supernatant was decanted. In the second washing step, the 
sample was spun again briefly to collect any residual acetone at the bottom of 
the tube. This residual volume was removed using a pipette tip. The pellet was 
dried briefly on ice. 
 
 
 
Determination of protein concentration according to 
Bradford 
 
To measure protein amounts in the range of 1 to 6 µg, the Bradford method 
[237] was applied. Quantification was done with the help of a BSA standard 
curve. For the standard curve, bovine serum albumin (BSA) dilutions of 0, 0.1, 
0.2, 0.3, 0.45, and 0.6 µg/µl in dH2O were prepared and 10 µl added to the wells 
of a microtiter plate. Since the protein samples to be measured were dissolved 
in a buffer but BSA in dH2O, the respective amount of buffer was added to all 
wells of the BSA standard, while 10 µl dH2O were added to the “Unknown” 
samples. Finally, all samples were mixed with 200 µl Roti®-Quant Bradford 
solution diluted 1:5 in dH2O, and incubated at RT for 5 min. Then, the 
absorption at 595 nm was measured in a plate reader (Synergy HT). The 
standard curve was calculated by plotting the values obtained for A595nm against 
the mass of BSA in the sample. Linear regression was performed, and the 
equation retrieved was used to calculate the protein amount in the test samples. 
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Determination of protein concentration using Pierce 660 
reagent 
 
To quantify protein amounts in the range of 1 to 9 µg, Pierce® 660 reagent was 
used. In case the buffer of the protein samples contained detergent, IDCR was 
dissolved in the Pierce® 660 solution according to the manufacturer’s 
instructions. A BSA standard consisting of 1, 3, 6, and 9 µg samples and a blank 
control consisting of dH2O only were prepared. For this, 10 µl of 0, 0.1, 0.3, 
0.6, and 0.9 µg/µl BSA solution in dH2O were added to the wells of a microtiter 
plate. In addition, 10 µl dH2O were added to all the wells in which the protein 
sample to be measured should be prepared. Then, a known volume of the 
protein samples of interest was mixed with dH2O aliquots. To the blank and 
the BSA standard samples, the same volume of buffer was added. Finally, 
150 µl Pierce® 660 (optionally supplied with IDCR) were distributed to the 
wells. The plate was incubated for 5 min at RT. Then, A660nm was measured in 
a plate reader (Synergy HT). A standard curve was obtained by plotting the 
absorbtion intensity against the BSA amount and by performing a linear 
regression. This yielded a formula used to calculate the protein amount in the 
test samples.  
 
 
Denaturing discontinouus polyacrylamide gel 
electrophoresis (reducing and non-reducing) 
 
Discontinouus polyacrylamide gels were casted in home-made gel chambers 
(7 cm × 18.4 cm) or in chambers of the Mini-PROTEAN® Tetra Cell System 
(0.75 or 1.5 mm thickness). First, the gel solutions were prepared omitting only 
ammonium peroxodisulfate (APS), tetramethylethylenediamine (TEMED) and 
acrylamide. These three components were added immediately before pouring 
the gels. First, the resolving gel solution was completed and poured into the 
assembled gel chamber. To obtain an even surface, the resolving gel was 
covered with 100 % isopropanol. After the resolving gel had solidified, 
isopropanol was washed off with dH2O and the stacking gel solution was 
poured on top of the resolving gel. A comb was pressed between the glass 
plates to create the wells. After solidifying, the gels were used immediately for 
electrophoresis or wrapped in wet tissues and foil to store them in the fridge. 
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Gel solutions for denaturing polyacrylamide gels 
Resolving gels (6 %, 8 %, 12 %, 15 %) 
Percentage of acrylamide 8 % 10 % 12 % 15 % 
Component Volume [ml] 
dH2O 4.6 4.0 3.3 2.3 
30 % Acrylamide solution 
(37.5:1) 
2.7 3.3 4.0 5.0 
1.5 M TRIS pH 8.8 2.5 2.5 2.5 2.5 
20 %(w/v) SDS 0.05 0.05 0.05 0.05 
10 %(w/v) APS 0.1 0.1 0.1 0.1 
TEMED 0.006 0.004 0.004 0.004 
Total volume 10 ml 
 
 
Stacking gel (5 %) 
Percentage of acrylamide 5 % 
Component Volume [ml] 
dH2O 6.8 
30 % Acrylamide solution 1.7 
1.5 M TRIS pH 6.8 1.25 
20 %(w/v) SDS  0.05 
10 %(w/v) APS 0.1 
TEMED 0.01 
Total volume 10 
 
 
As an alternative to running self-made gels, Mini-PROTEAN® Precast TGX 
Gels 4-20 % (BioRad) were used. 
For electrophoresis, the gel was assembled in the running chamber filled with 
1x SDS running buffer. The comb was removed. To prepare the samples for 
SDS-PAGE, the protein was mixed with 2x RPB. Samples for reducing PAGE 
were mixed with reducing 2x RPB. In case a non-reducing PAGE was 
performed, the samples were mixed with non-reducing 2x RPB lacking 
dithiothreitol (DTT). The samples were boiled for 5 to 20 min at 95°C, spun 
down briefly and loaded into the wells of the gel. As a size standard, Page 
RulerTM Prestained Protein Ladder (Thermo Scientific) was applied to the gel. 
The gels were run at 80 to 160 V. 
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Reducing and non-reducing 2x RPB 
 
Component Concentration 
TRIS pH 6.8 100 mM 
SDS 4 %(w/v) 
Glycerol 20%(w/v) 
Bromophenol blue A spatula 
 
To prepare reducing RPB, 200 mM DTT were included in the mixture. For 
non-reducing RPB, the DTT was omitted. Reducing and non-reducing RPB 
was stored at -20°C. 
 
 
10x SDS running buffer 
 
Component Concentration 
TRIS 250 mM 
Glycine 1.9 M 
SDS 1 %(w/v) 
 
 
 
Native PAGE 
 
For native PAGE, Mini-PROTEAN® Precast TGX Gels 4-20 % (BioRad) 
were assembled in running chambers containing 1x Native running buffer. The 
running chamber was placed on ice to prevent heating of the gel during the 
run. Samples were mixed with native loading buffer and immediately loaded on 
the gel without boiling them. NativeMarkTM Unstained Protein Standard 
(Invitrogen) was used as a size standard. The gel was run strictly at 80 V. 
 
15x Native loading dye 
 
Component Concentration 
TRIS-HCl pH 6.8 187.5 mM 
Glycerol 7.5 % (v/v) 
 
The solution was prepared using a stock solution of TRIS-HCl buffer 
pH 6.8. The final mixture was supplied with bromophenol blue until the 
solution turned light blue.  
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10x Native running buffer 
 
Component Concentration 
TRIS-base 250 mM 
Glycine 1.92 M 
 
The buffer was diluted 10x prior to use. 
 
 
 
Coomassie staining of polyacrylamide gels 
 
To stain native or denaturing SDS gels with Coomassie, the gel was incubated 
in different solutions on a shaker at room temperature. The gel was exposed to 
Coomassie fixing solution for at least 10 min. Then, the gel was incubated in 
Coomassie staining solution until it became dark blue. The staining solution 
was exchanged for Coomassie destaining solution, in which the gel was 
incubated until the bands were clearly visible. Optionally, gels were destained 
with Coomassie fixation solution. Gels were digitalized using an Epson 
Perfection V700 Photoscanner with the SilverFast-SE v6.6.1r2b software 
(LaserSoft Imaging). 
 
Coomassie fixing solution 
 
Component Concentration 
Acetic acid 10 %(v/v) 
Isopropanol 20 %(v/v) 
 
 
Coomassie staining solution 
 
Component Concentration 
Acetic acid 10 %(v/v) 
Coomassie Brilliant Blue G250 Added until solution 
was dark blue 
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Coomassie destaining solution 
 
Component Concentration 
Acetic acid 10 %(v/v) 
 
 
 
 
Colloidal Coomassie staining of polyacrylamide gels 
 
Colloidal Coomassie staining was used in the course of sample preparation for 
mass spectrometry and performed using a protocol obtained from Dr. Oliver 
Valerius and Dr. Kerstin Schmitt (Service Unit LCMS Protein Analytics, Georg 
August University Göttingen). The protocol represented a modified version of 
the protocol described by Kang et al. (2002) [238]. 
After the run, the SDS gel was incubated for ca. 1 h in Colloidal Coomassie 
fixing solution. This incubation step, as well as all following steps, were done 
at room temperature on a shaker. Afterwards, the gel was washed 2x for ca. 
10 min with dH2O. Then, the gel was stained for some time (not over night) in 
Colloidal Coomassie staining solution. When the bands of interest were visible, 
the gel was washed 3x for ca. 10 min with dH2O. The gel was scanned using an 
Epson Perfection V700 Photoscanner via the SilverFast-SE v6.6.1r2b software 
(LaserSoft Imaging). 
 
 
Colloidal Coomassie fixing solution 
 
Component Concentration 
Ethanol (EtOH) 40 %(v/v) 
Acetic acid 10 %(v/v) 
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Colloidal Coomassie staining solution  
 
Component Concentration 
Aluminium sulfate hexadeca hydrate 5 %(w/v) 
Methanol 10 %(v/v) 
Coomassie Brilliant Blue G250 0.1 %(w/v) 
o-Phosphoric acid 2 %(v/v) 
 
The order of preparation is desicive for the sensitivity of the solution: First, 
aluminium sulfate was dissolved in water, then methanol was added while 
stirring. After mixing, Coomassie was added. When Coomassie appeared to 
be dissolved, phosphoric acid was mixed into the solution creating the 
Coomassie colloidal particels. Eventually, the solution was filled up to the 
final volume using dH2O. 
 
 
 
 
 
Western Blot 
 
Western Blots were used to specifically detect a protein via an antibody after 
SDS-PAGE and subsequent transfer to a polyvinyldiflouride (PVDF) 
membrane. First, the protein samples were separated by SDS-PAGE. 6 pieces 
of Blotting paper and a PVDF membrane, all cut to the size of the resolving 
gel, were prepared. Three layers of Blotting paper were soaked with transfer 
buffer and placed on the cathode of the blotting chamber. The membrane was 
activated in methanol, then incubated in transfer buffer and placed on top of 
the Blotting paper layers. Now, the SDS gel was stacked on top of the 
membrane. Finally, three more layers of Blotting paper were wetted in transfer 
buffer and placed on top of the SDS gel. Bubbles were removed by sliding a 
roller over the stack. The blotting chamber was closed, placing the anode on 
top of the stack. A constant amperage was applied. The blotting time depended 
on the amperage used, the size of the gel and the protein to be detected. 
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Protein Blotting conditions 
Biorad MiniProtean 
Gels (0.75 or 1.5 mm 
thickness) 
Self-made gels 
3xHA-ROXY9 - 125 mA, 60 min 
GFP-TGA1 135 mA, 45 min - 
Strep-MBP-ROXY9 135 mA, 45 min - 
Strep-MBP 135 mA, 45 min - 
His-MBP-JAZ9 135 mA, 45 min - 
 
After disassembly of the blot, the membrane was optionally rinsed with 
methanol. Then, the membrane was incubated with different solutions on a 
shaker. First, it was blocked with blocking solution for at least 1 h at room 
temperature or over night in the cold room. The blocking solution was 
decanted, and the membrane incubated with the primary antibody for 2 h at 
RT or over night in the cold room. Next, the membrane was washed three 
times with 1x TBS-T for 10 min at RT and incubated with a horseradish 
peroxidase (HRP)-coupled secondary antibody for 2 h at RT. The membrane 
was washed five times for 5 min at RT with 1x TBS. Finally, HRP activity was 
detected using either LuminataTM Forte Western HRP Substrate (Millipore) or 
SuperSignalTM West Femto Maximum Sensitivity Substrate (Thermo Scientific) 
and a luminescence imager (Intas ChemoStar Imager, ChemoStarProfessional 
software). 
tag Blocking solution Primary antibody Secondary antibody 
HA 5 %(w/v) skimmed 
milk powder in1x 
TBS or 1xTBS-T 
α-HA (1:2000 to 
4000 in 5 %(w/v) 
skimmed milk 
powder in 1xTBS-T) 
 
α-rabbit (1:8000 in 
5 %(w/v) skimmed 
milk powder in 
1xTBS-T) 
Strep 30 µg/ml BSA in 
1xPBS supplied with 
0.5 %(v/v) Tween- 
20 
 
α-strep (1:10000 in 
2 µg/ml BSA in 
1xPBS-T) 
α-mouse (1:8000 in 
2 µg/ml BSA in 
1xPBS-T) 
GFP 5 %(w/v) skimmed 
milk powder in 
1xTBS or 1xTBS-T 
α-GFP (1:1000 in 
5 %(w/v) skimmed 
milk powder in 
1xTBS-T) 
 
α-mouse (1:8000 in 
5 %(w/v) skimmed 
milk powder in 
1xTBS-T) 
His 5 %(w/v) skimmed 
milk powder in 
1xTBS or 1xTBS-T 
α-His (1:500 in 
5 %(w/v) skimmed 
milk powder in 
1xTBS-T) 
α-mouse (1:8000 in 
5 %(w/v) skimmed 
milk powder in 
1xTBS-T) 
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Transfer buffer 
 
Component Concentration 
TRIS 48 mM 
Glycin 39 mM 
Methanol 20 %(v/v) 
SDS 0.04 %(w/v) 
 
 
10x TBS, 1x TBS and 1x TBS-T 
 
Component Concentration 
TRIS-base 200 mM 
NaCl 1.37 M 
 
To prepare 1x TBS, 10x TBS was diluted 1:10 in dH2O. To prepare 1x PBS-
T, 10x PBS was diluted 1:10 in dH2O and the solution mixed with 0.1 %(v/v) 
Tween-20. 
 
10x PBS, 1x PBS and 1x PBS-T 
 
Component Concentration 
KH2PO4 pH 7.4 40 mM 
Na2HPO4 × 2H2O 160 mM 
NaCl 1.150 M 
 
The pH of 10x PBS was adjusted to 7.4 using KOH and H3PO4 before filling 
up to the final volume. To prepare 1x PBS, 10x PBS was diluted 1:10 in 
dH2O and the pH readjusted to 7.4. To prepare 1x PBS-T, 10x PBS was 
diluted 1:10 in dH2O, the pH readjusted to 7.4 and the solution mixed with 
0.1 %(v/v) Tween-20. 
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Production and analysis of recombinant 
proteins 
_____________________________________________________________________ 
 
 
Expression of recombinant protein in E. coli 
 
To express recombinant proteins in E. coli BL21(DE3), the bacterium was 
transformed with an expression plasmid harboring the gene of interest under 
control of the T7 promoter and terminator. One or more clones were used to 
inocculate a flask containing an adequate volume of LB medium (10 to 20 ml 
per main culture) supplemented with the correct antibiotic. This culture was 
grown over night at 37°C, shaking at 220 rpm. The next day, the optical desity 
at 600 nm was measured in a 1:10 dilution using a Libra S11 
spectrophotometer. Then, a main culture was prepared. For this, 400 ml LB 
medium filled in 2 l flasks without baffles were mixed with the selective 
antibiotic and inocculated to an OD600nm of 0.1 using the pre-culture. The main 
culture was incubated at 37°C at 220 rpm until it reached the OD600nm of 
induction. This density varied for each protein. A culture aliquot corresponding 
to an OD600nm of 2 was taken as a pre-induction sample for SDS-PAGE. The 
sample was stored on ice until processing it further. Expression of the main 
culture was induced by addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG). The culture was incubated at those growth conditions allowing the 
expression of the recombinant protein. The expression conditions, the IPTG 
concentration, and the growth conditions after induction varied depending on 
the recombinant protein. The table below summarizes the expression 
conditions for each protein:
 
Protein OD600nm(Induction) 
[A.U.] 
c(IPTG) 
[mM] 
Incubation 
Strep-SUMO-ROXY9 ≥ 0.5 0.75 30°C, 3 h, 
220 rpm 
Strep-SUMO-Grx1 ≥ 0.5 1 27°C, ON, 
220 rpm 
Production and analysis of recombinant proteins 
84 
 
Protein OD600nm(Induction) 
[A.U.] 
c(IPTG) 
[mM] 
Incubation 
Strep-MBP-GRXC2 ≥ 0.5 0.5 20°C, ON, 
220 rpm 
GFP-TGA1 ≥ 0.5 1 16°C, ON, 
220 rpm 
His-MBP-JAZ9 ≥ 1 0.5 20°C, 2 d, 
220 rpm 
Strep-MBP ≥ 0.7 0.5 37°C, 2.5 h, 
220 rpm 
 
After expression, the optical density of the cultures was determined and a 
sample corresponding to an OD600nm of 2 was taken as a post-induction sample 
for SDS-PAGE. The sample was kept on ice until later processing. The 
remaining cells from the expression culture were harvested by centrifugation at 
5000 rpm at 4°C to RT for 15 to 20 min (Sorvall RC6+ centrifuge, rotor SLA-
3000). The supernatant was discarded, and the pellet resuspended in 10 to 
20 ml of harvesting buffer. The buffer depended on the type of the 
recombinant protein and is listed in the table below. The cell suspension was 
transferred to a 50 ml falcon tube, which was centrifuged at 4000 rpm for at 
least 20 min. The supernatant was removed as completely as possible and the 
pellet frozen at -20°C. 
Finally, the pre- and post-induction samples were spun down, and the 
supernatants were removed. The pellets were resuspended in 100 µl 2x RPB. 
20 µl of these samples were loaded on an SDS gel to check expression of the 
recombinant protein. 
 
 
Protein Harvesting buffer Buffer recipe 
Strep-SUMO-
ROXY9 
50 mM Na phosphate buffer pH 8.0 Page 88 
Strep-SUMO-
Grx1 
1x Grx1 buffer Pages 89, 90 
Strep-MBP-
GRXC2 
1x Grx1 buffer Pages 89, 90 
GFP-TGA1 50 mM Na phosphate buffer pH 8.0 or 1x 
Grx1 buffer w/o DTT 
Pages 88 to 
90  
His-MBP-
JAZ9 
1x MBP lysis buffer with 50 mM NaCl Page 95 
Strep-MBP 1x MBP lysis buffer Page 93 
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Expression of tobacco etch virus protease in E. coli using 
autoinduction media 
 
Tobacco etch virus (TEV) protease was expressed from the plasmid pMA/CL-
TEV-A in BL21(DE2) growing the cells in autoinduction media. This method 
was described by Sturdier et al. (2014) [239]. For expression of TEV protease, 
a simpler protocol published by the Lindstrom group of the imperial college 
(London) on www.openwetware.org was used. This expression method does 
not rely on IPTG for induction of the T7 polymerase gene placed under control 
of the lac promoter, but on the change in the use of carbon sources by E. coli. 
For this, the cells are grown in medium containing a mixture of glucose, 
glycerol and lactose. The cells first grow by consuming their preferred carbon 
source glucose, which represses the lac promoter. Once glucose becomes 
limiting, E. coli switches to the use of lactose for growth, which induces 
transcription from the lac promoter and, thereby, expression of the 
recombinant protein. 
To express the TEV protease via this method, several of the transformed BL21 
clones were inoculated in a small volume of autoinduction media and then 
distributed to 2 l flasks without baffels which contained 400 ml autoinduction 
media supplied with the correct antibiotic. These cultures were incubated for 
6 h at 37°C, shaking them at 220 rpm. Then, the cultures were transferred to 
29°C and 220 rpm and expression was continued over night. 
The cells were harvested by centrifugation at 4°C and 5000 rpm for 20 min in 
an SLA-3000 rotor (Sorvall RC6+ centrifuge). The pellets were resuspended in 
1x Strep buffer and transferred to 50 ml falcon tubes. The cells were pelleted 
again by centrifugation at 4000 rpm at 4°C for 40 min. The supernatant was 
decanted, and the pellets frozen in liquid nitrogen to store them at -70°C. 
 
Stock solutions of carbon sources 
 
Component Concentration 
Glycerol 60 %(v/v) 
Glucose 10 %(w/v) 
Lactose 8 %(w/v) 
 
The solutions were prepared in dH2O and sterilized by filtration through a 
0.2 µm filter. 
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Autoinduction media 
 
Component Concentration 
Na2HPO4 (water-free) 0.6 %(w/v) 
KH2PO4 (water-free) 0.3 %(w/v) 
Tryptone/peptone from caseine 2 %(w/v) 
Yeast extract 0.5 %(w/v) 
NaCl 0.5 %(w/v) 
Glycerol 0.6 %(v/v) 
Glucose 0.05 %(w/v) 
Lactose 0.2 %(w/v) 
 
The autoinduction media was prepared by dissolving Na2HPO4, KH2PO4, 
tryptone/peptone, yeast extract and NaCl in dH2O and adjusting the pH to 
7.2 using NaOH. The solution was filled up to 96 % of the final volume and 
autoclaved. Before use, the medium was completed by adding the carbon 
sources using the stock solutions listed above. 
 
 
1x Strep buffer 
 
Component Concentration 
TRIS pH 8.0 10 mM 
NaCl 150 mM 
Na2-EDTA 0.5 mM 
 
The buffer was prepared as a 10x stock solution, the pH was titrated to 8.0 
at RT using HCl. The stock solution was diluted adequately before use. 
 
 
 
Expression of recombinant protein in insect cells 
 
Strep-MBP-ROXY9 was produced via the bacculovirus system in Trichoplusia 
ni (T. ni) by Isaac Fianu from the Department of Molecular Biology (Prof. Dr. 
Patrick Cramer) at the MPI of Biohphysical Chemistry (Göttingen). The 
expression vector encoding strep-MBP-ROXY9 (438C_strep-ROXY9) was 
ligated into a bacmid with the help of DH10 Multibac cells. The isolated bacmid 
was used to transfect High Five insect cells. Expression cultures of 600 ml were 
grown and harvested in this department, as well. The cells harvested after 
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expression were frozen in liquid nitrogen, stored at -70°C, and transported on 
dry ice. 
 
 
 
Purification of strep-SUMO-ROXY9 from BL21(DE3)-
star using gravity flow columns 
 
Strep-SUMO-ROXY9 was purified from a cell pellet resulting from a 400 ml 
expression culture. The pellet was resuspended in 20 ml Na phosphate buffer 
pH 8.0. To this suspension, DTT and lysozyme were added to a final 
concentration of 1 mM and 25 µg/ml, respectively. The sample was incubated 
for ca. 1 h at 15 rpm end-over-end in the cold room or for up to 2 h on ice 
without agitation. Next, the cells were lysed by sonication (Sonopuls sonifier, 
MS73 sonotrode: 15 min, 1 sec pulse on, 2 sec pulse off, 50 % amplitude), 
under aerobic conditions or in a nitrogen atmosphere created in an atmosbag 
glove bag (Sigma-Aldrich) by evaporating liquid nitrogen. The lysate was 
centrifuged at 20000 rpm in a SS-34 rotor (Sorvall RC6+ centrifuge) at RT to 
4°C for 45 min. The supernatant was kept as the crude extract for purification. 
20 µl of the crude extract were taken as a sample for SDS-PAGE and mixed 
with 20 µl reducing RPB. 
To purify the recombinant protein from the crude extract, 750 µl 50 % 
StrepTactin slurry were added to a gravity flow column and equilibrated by 
washing the beads twice with 9 ml Na phosphate buffer pH 8.0 + 1 mM DTT. 
The crude extract was loaded and the flowthrough collected. A 20 µl sample of 
the flowthrough was mixed with an equal volume of non-reducing RPB for 
SDS-PAGE. The column was washed four times with 2.5 ml Na phosphate 
buffer pH 8.0 + 1 mM DTT. Again, a 20 µl sample of the last wash step was 
taken for SDS-PAGE and mixed with non-reducing RPB. Finally, the protein 
was eluted in four steps, using 375 µl Na phosphate buffer pH 8.0 + 1 mM 
DTT + 2.5 mM D-desthiobiotin. 10 µl of each fraction were taken as a sample 
for SDS-PAGE and supplied with an equal volume of reducing RPB. 
The SDS-PAGE samples were stored at -20°C. The protein was stored at 4°C 
or at – 20°C. 
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50 mM Na phosphate buffer pH 8.0 
 
Component Concentration 
Na2HPO4/NaH2PO4 pH 8.0 50 mM 
NaCl 200 mM 
 
This buffer was prepared by mixing 0.5 M Na2HPO4 and 0.5 M NaH2PO4 in 
the ratio 95:5 to achieve pH 8.0 at a final concentration of 50 mM. After 
NaCl was added, the pH of the buffer was checked and readjusted using 
NaOH or H3PO4, if necessary. 
 
 
 
 
Purification of strep-SUMO-Grx1 from BL21(DE3)-star 
using gravity flow columns 
 
Strep-SUMO-Grx1 was purified from three to four E. coli pellets (BL21 or 
BL21-star), each resulting from a 400 ml expression culture. Each pellet was 
resuspended in 15 ml Grx1 lysis buffer; alternatively, two pellets were pooled 
in 15 ml of this buffer. DTT and lysozyme were added to a final concentration 
of 1 mM and 40 to 80 µg/ml, respectively. Following incubation for 1 h at 
15 rpm in the cold room, the DTT concentration was increased to 5 – 10 mM 
in total. Then, the cell suspensions were lysed on ice using a Sonopuls sonifier 
equipped with an MS73 sonotrode (15 min, 1 sec pulse on, 2 sec pulse off, 
50 % amplitude). Afterwards, the cell suspension was transferred to a 
centrifugation tube and spun at 20000 rpm for 45 min at 20°C (Sorvall RC6+ 
centrifuge, rotor SS-34). Finally, the supernatants were pooled in a fresh tube 
to obtain the crude extract for purification. A sample of the crude extract was 
taken for SDS-PAGE, mixed with 2x reducing RPB and 20 µl of this sample 
were loaded on SDS gels. 
Strep-SUMO-Grx1 was purified via StrepTactin beads. The amount of the 
column material and the buffer volumes used for the purification depended on 
the number of pellets lysed. Thus, the amounts and volumes are summarized 
in the table below. To prepare the column, 50 % StrepTactin slurry were loaded 
in a gravity flow column and the liquid was allowed to drain off. The 
StrepTactin beads were equilibrated by applying Grx1 wash buffer twice. Next, 
the crude extract was loaded. The flowthrough was collected in a fresh tube. 
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An aliquot of the flowthrough was mixed with 2x RPB and 20 µl of this mixture 
were analyzed by SDS-PAGE. The column was washed four times with Grx1 
wash buffer. A 20 µl sample of the last wash step was taken, supplied with 2x 
RPB and checked by SDS-PAGE. Ultimately, strep-SUMO-Grx1 was eluted in 
three steps using Grx1 elution buffer. A 10 µl sample of each elution fraction 
was mixed with an equal volume of 2x reducing RPB and analyzed by SDS-
PAGE. 
The amounts of StrepTactin slurry and the buffer volumes were: 
Number of pellets 3 4 
Number of gavity flow columns 1 2 
V(50 % strepTactin slurry) per column 750 µl 1 ml 
V(Wash buffer) for equilibration per column 9 ml 12 ml 
V(Wash buffer) for washing per column 2 ml 2.5 ml 
V(Elution buffer) for elution per column 375 µl 500 µl 
 
Elution fractions, as well as the samples for SDS-PAGE were stored at -20°C. 
 
 
1x Grx1 lysis buffer 
 
Component Concentration 
TRIS-HCl pH 7.5 50 mM 
Na2-EDTA 1 mM 
 
This buffer was prepared as a 10x stock solution, adjusting the pH at RT to 
7.5 using HCl. The stock solution was autoclaved. To obtain 1x buffer, the 
10x stock was diluted adequately and the pH readjusted to 7.5 using NaOH 
or HCl. 1x Grx1 lysis buffer was then used to prepare all other Grx1 
purification buffers. 
 
1x Grx1 wash buffer 
 
Component Concentration 
TRIS-HCl pH 7.5 50 mM 
Na2-EDTA 1 mM 
DTT 10 mM 
 
To prepare this buffer, 1 mM DTT was added to 1x Grx1 lysis buffer. 
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1x Grx1 elution buffer 
 
Component Concentration 
TRIS-HCl pH 7.5 ~ 50 mM 
Na2-EDTA ~ 1 mM 
Glycerol 10 %(w/v) 
DTT 5 – 10 mM 
D-Desthiobiotin 2.5 mM 
 
To prepare this buffer, 10 g 100% glycerol were filled up to 100 ml using 1x 
Grx1 lysis buffer and supplied freshly with DTT and D-Desthiobiotin. 
 
 
 
 
Test purification of strep-MBP-ROXY9 from insect cells 
using amylose resin 
 
For the small-scale purification of strep-MBP-ROXY9 from insect cells, the 
cells from 25 ml culture were concentrated in 1 ml and stored at -70 °C. Prior 
to purification, a 1 ml aliquot was thawed on ice or at RT and mixed with 0.2 g 
acid-washed glass beads with a diameter of 400 to 650 µm. 100 µl 1x MBP lysis 
buffer supplied with 1 mM DTT (page 93) an 1x Protease Inhibitor Cocktail 
were added. Then, the cells were lysed in a bead beater, shaking them three 
times for 30 sec at 30 Hz. In between, the cells were placed on ice. Afterwards, 
the lysate was spun for 15 min at 17000 g at 4°C. The supernatant (crude 
extract) was used for the purification via amylose-coated beads. A 10 µl sample 
of the crude extract was taken for SDS-PAGE and mixed with reducing RPB. 
For the purification, amylose resin in 20 % EtOH (Biolabs) was used. The 
beads were centrifuged at RT at 12000 g throughout the entire procedure. 
300 µl resin were transferred into a 1.5 ml reaction tube and centrifuged for 
30 sec. The ethanol was removed. For equilibration, the beads were 
resuspended in 300 µl 1x MBP lysis buffer wit 1 mM DTT and 1x Protease 
Inhibitor Cocktail, centrifuged again for 10 sec. After removal of the 
supernatant, 600 µl fresh lysis buffer were added, the beads resuspended and 
spun down at for 10 sec. The supernatant was removed and the washing with 
another fresh 600 µl aliquot of the buffer repeated. In this last step, the beads 
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were sedimented by centrifugation for 30 sec and the supernatant was 
removed. 
The equilibrated beads were mixed with the insect cell crude extract and 
incubated overnight in the cold room attached to a rotor, turning them at 
10 rpm end-over-end. The next day, the sample was centrifuged for 1 min and 
the supernatant corresponding to the flowthrough transferred to a new reaction 
tube. A 10 µl sample of the flowthrough was taken for SDS-PAGE and mixed 
with reducing RPB. The beads were washed twice with 1 ml 1x MBP lysis 
buffer with 1 mM DTT and 1x Protease Inhibitor Cocktail, centrifuging them 
for 10 sec and discarding the supernatant. In the third washing step, the beads 
were pelleted for 1 min and the supernatant was collected in a fresh tube. A 
20 µl sample of this wash step was taken for SDS-PAGE, mixing it with 
reducing RPB. The protein bound to the amylose beads was eluted in three 
steps. For each elution step, the beads were resuspended in 300 µl 1x MBP 
elution buffer containing 1 mM DTT (page 93) and 1x Protease Inhibitor, 
incubated for 5 min on ice and finally centrifuged for 1 min. The supernatant 
was transferred to a new reaction tube. Finally, a 20 µl sample from each elution 
step was taken for SDS-PAGE analysis and mixed with reducing RPB. 
 
 
 
Purification of strep-MBP from BL21 using an ÄKTA 
purifier 
 
Strep-MBP was purified from E. coli BL21 cell pellets resulting from four 
400 ml expression cultures. Each pellet was thawed and resuspended in 10 ml 
1xMBP lysis buffer with 50 mM NaCl (page 95). Two suspensions were pooled 
and mixed with 2 – 3 spatulas lysozyme. Lysozyme-mediated degradation of 
the bacterial cell wall took place in the cold room for 15 min, rotating the 
samples at 15 rpm end-over-end. Each suspension was lysed by sonication on 
ice for 15 min at 50 % amplitude using 1 sec-pulses followed by 2 sec-breaks. 
Afterwards, the suspensions were centrifuged at 20000 rpm at 4°C for 45 min 
(Sorvall RC6+, SS-34). The supernatants were pooled and filtered through a 
0.45 µm sterile filter. A 20 µl sample of the resulting crude extract was taken 
for SDS-PAGE and mixed with an equal volume of reducing RPB. The rest of 
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the crude extract was used for purification. For purification, two 5 ml 
MBPTrap columns were connected to an ÄKTA prime plus device and 
equilibrated with 1xMBP lysis buffer with 50 mM NaCl. The crude extract was 
loaded with the help of a 50 ml superloop at a flow rate of 1 ml/min, collecting 
10 ml fractions. The column was washed with 1x MBP lysis buffer with 50 mM 
NaCl at a flow rate of 1 ml/min, collecting again 10 ml fractions, until the 
A280nm reached the baseline level. For elution, 100 % of 1x MBP elution buffer 
containing 50 mM NaCl (page 95) were passed at a flow rate of 1 ml/min over 
the column, fractionating the eluate in 2 ml steps. 20 µl of each flowthrough 
and wash fraction and 30 µl of each elution fraction were mixed with an equal 
volume of non-reducing RPB and separated by SDS-PAGE. 
 
 
 
ÄKTA-based purification of strep-MBP-ROXY9 (insect 
cells) 
 
High Five insect cells expressing strep-MBP-ROXY9 from a 600 ml culture 
were pelleted and resuspended in 30 to 50 ml Buffer L at the department for 
Molecular Biology (Prof. Dr. Patrick Cramer, MPI for Biophysical Chemistry, 
Göttingen). Prior to lysis, the cells were briefly thawed by placing the tubes in 
a beaker containing water. Sonication was performed on ice employing a 
Sonopuls sonifier with an M73 sonotrode at an amplitude of 30 % and 
alternating a 0.4 sec-pulse and a 0.6 sec-break over 5 min. The resulting cell 
lysate was transferred to a centrifugation tube and centrifuged at 20000 rpm for 
45 min at RT to 4°C (Sorvall centrifuge RC6+, rotor SS-34). The supernatant 
was filtered through a 0.45 µm sterile filter. A small aliquot was mixed with 2x 
RPB. 20 µl of this mixture were subjected to SDS-PAGE. 
To purifiy strep-MBP-ROXY9, an ÄKTA prime plus purifier (GE Healthcare) 
placed at 10 to 20°C was connected to two 5 ml MBPTrap columns (GE 
Healthcare). The columns were equilibrated with 1x MBP lysis buffer. Then, 
the filtered crude extract was loaded at a flow rate of 1 ml/min using a 50 ml 
superloop (GE Healthcare). The flowthrough was collected in 5 ml fractions. 
After loading, the column was washed until the absorption at 280 nm returned 
to the baseline absorption of the 1x MBP lysis buffer. The flow rate during 
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washing was 1 ml/min and the fraction size was 5 ml. Bound protein was eluted 
using 1x MBP elution buffer at a flow rate of 1 ml/min, fractionating 2 ml. 
Protein-containing fractions were stored at 4°C in a fridge. To analyze the 
success of protein purification, 10 µl of each fraction of interest were mixed 
with 2x RPB and separated by SDS-PAGE. 
 
 
 
1x Buffer L 
 
Component Concentration 
HEPES pH 7.5 20 mM 
NaCl 300 mM 
Na2-EDTA 1 mM 
Imidazol 30 mM 
DTT 1 mM 
Protease Inhibitor Cocktail 1x 
 
 
 
 
1x MBP lysis buffer 
 
Component Concentration 
HEPES pH 7.5 20 mM 
NaCl 300 mM 
Na2-EDTA 2 mM 
Glycerol 5 %(w/v) 
DTT 1 mM 
 
A 5x stock solution of this buffer was prepared omitting DTT and glycerol. 
The pH was adjusted at RT using NaOH and the stock solution was 
autoclaved. Prior to purification, the 5x buffer was diluted adequately mixing 
it with glycerol and DTT to the final concentrations. The pH of the final 
1x buffer was not readjusted. For ÄKTA-based purification, the buffer was 
filtered through a Nylon membrane (pore size 0.2 µM) and degassed. 
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1x MBP elution buffer 
 
Component Concentration 
HEPES pH 7.5 20 mM 
NaCl 300 mM 
Na2-EDTA 2 mM 
Glycerol 5 %(w/v) 
D-Maltose 100 mM 
DTT 1 mM 
 
To prepare this buffer, 5x MBP lysis buffer was diluted adequately, dissolving 
maltose, glycerol and DTT. The pH of the elution buffer was not readjusted. 
As for the 1x MBP lysis buffer, the buffer was filtered through a Nylon 
membrane (pore size 0.2 µM) and degassed. 
 
 
 
strep-MBP-GRXC2 from E. coli using an ÄKTA purifier 
 
Strep-MBP-GRXC2 was purified from four E. coli BL21-star pellets obtained 
by expression of 400 ml cultures. The pellets were thawed by placing the tubes 
briefly in a beaker containing water. Two pellets were pooled by resuspending 
them in a total volume of 20 ml 1x MBP lysis buffer containing 50 mM NaCl. 
With the tip of a spatula, lysozyme was added to the cell suspension and the 
mixture incubated for ca. 30 min in the cold room, rotating the samples at 
15 rpm. The cells were lysed by sonication on ice (Sonifier Sonopuls, sonotrode 
MS73; Programm: 15 min, 1 sec pulse on, 2 sec pulse off, 50 % amplitude). The 
lysate was centrifuged at 10 to 4°C for 45 min at 20000 rpm in a SS-34 rotor 
(Sorvall RC6+ centrifuge). After centrifugation, the supernatants were pooled 
and filtered through a 0.45 µm sterile filter prior to purification via an ÄKTA 
prime plus purifier equipped with two 5 ml MBPTrap columns. The columns 
were equilibrated with 1x MBP lysis buffer containing 50 mM NaCl. After 
taking a small sample for SDS-PAGE, the crude extract was loaded using a 
50 ml superloop at a flow rate of 1 ml/min, collecting 5 ml fractions. The 
column was washed with 1x MBP lysis buffer containing 50 mM NaCl until the 
baseline absorption at 280 nm of the buffer was reached. Elution took place at 
1 ml/min, fractionating 2 ml, and using 1x MBP elution buffer containing 
50 mM NaCl. To analyze the purification, 20 µl of each fraction of interest were 
mixed with 2x RPB and loaded on an SDS gel. 
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1x MBP lysis buffer containing 50 mM NaCl 
 
Component Concentration 
HEPES pH 7.5 20 mM 
NaCl 50 mM 
Na2-EDTA 2 mM 
Glycerol 5 %(w/v) 
DTT 1 – 2 mM 
 
A 5x stock solution and 1x dilutions of this stock were prepared as described 
for the MBP lysis buffer used for purification of strep-MBP-ROXY9 (page 
93). 
 
 
1x MBP elution buffer containing 50 mM NaCl 
 
Component Concentration 
HEPES pH 7.5 20 mM 
NaCl 50 mM 
Na2-EDTA 2 mM 
Glycerol 5 %(w/v) 
D-Maltose 100 mM 
DTT 1 – 2 mM 
 
This buffer was prepared as described for the MBP lysis buffer used for 
purification of strep-MBP-ROXY9 (page 93). 
 
 
 
Purification of TEV protease from E. coli cells using an 
ÄKTA purification system 
 
His-tagged TEV protease was purified from E. coli pellets derived from a 
400 ml expression culture. The pellets were thawed in water. Each pellet was 
resuspended in 20 ml 1x TEV wash buffer. With the tip of a spatula, lyszyme 
was added and the cell suspensions incubated for approximately 30 min in the 
cold room at 15 rpm. Then, each pellet was lysed by sonication on ice for 
15 min using a Sonopuls sonifier and an MS73 sonotrode. Over these 15 min, 
the suspension was pulsed with 50 % amplitude for 1 sec, followed by a break 
Production and analysis of recombinant proteins 
96 
 
of 2 sec. The cell lysate was centrifuged for 45 min at 4°C in an SS-34 rotor 
(Sorval RC6+ centrifuge) at 20000 rpm. The supernatants were pooled and 
filtrered through an 0.45 µm sterile filter. 
Purification was performed using one 5 ml HisTrap column per pellet. The 
column(s) were connected to an ÄKTA prime plus device (GE healthcare). 
The crude extract was loaded using a Superloop at a flow rate of 1 ml/ml 
collecting 5 ml fractions. Then, the column was washed using 1x TEV wash 
buffer. Once the baseline of A280nm was reached, a gradient ranging from 0 to 
100 % 1xTEV elution buffer over 25 ml per pellet was applied. Finally, TEV 
protease was eluted using 100 % 1x TEV elution bufffer. During elution, 2.5 ml 
fractions per pellet were collected. Those fractions containing TEV protease 
were pooled and concentrated. To remove the imidazol, the protein was 
dialysed in the cold room for 3 h against a 1000-fold volume of 1x TEV wash 
buffer using a MEMBRA-CEL dialysis tubing (3 kDa Molecular weight cut-off 
(MWCO)). After that, the buffer was exchanged, and dialysis continued over 
night against the ca. 1000-fold volume of fresh 1x TEV wash buffer. 
Alternatively, TEV protease was dialysed four times (three times for 45 min 
and once over night) against the 700-fold buffer volume. 
 
 
1x TEV wash buffer 
 
Component Concentration 
TRIS pH 8.0 50 mM 
NaCl 150 mM 
Glycerol 5 %(w/v) 
 
The pH of the buffer was adjusted at RT using HCl. 
 
1x TEV elution buffer 
 
Component Concentration 
TRIS pH 8.0 50 mM 
NaCl 150 mM 
Glycerol 5 %(w/v) 
Imidazol 250 mM 
 
The pH of the buffer was adjusted at RT with HCl. 
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TEV digest of strep-MBP-ROXY9 
 
To cleave off the tag from strep-MBP-ROXY9, His-TEV, freshly purified from 
E. coli, was used. Strep-MBP-ROXY9 was present in 1x MBP elution buffer 
(page 93), whereas TEV protease was present in TEV wash buffer (page 96). 
The protein concentrations were determined according to Bradford. 4.8 mg 
strep-MBP-ROXY9 were mixed with 3.48 mg His-TEV and filled up to 15 ml 
with TEV wash buffer. A sample of 20 µl was removed from the mixture and 
supplied with 20 µl reducing RPB for analysis by SDS-PAGE. To initiate the 
cleavage reaction, 30 µl 1 M DTT were added to the remaining digest. Then, 
the digest was incubated over night at 4°C. Afterwards, the digest was 
centrifuged at 4000 rpm at 4°C for ca. 30 min to remove precipitated protein. 
A 20 µl sample of the supernatant was taken for SDS-PAGE and mixed with 
reducing RPB. Subsequently, uncut protein, TEV protease and the strep-MBP 
tag were tried to be removed by several purification steps: First, a 5 ml 
MBPTrap and a 5 ml HisTrap column were connected to an ÄKTA purifier 
and equilibrated with TEV wash buffer. The digest was passed over the column 
using TEV wash buffer at a flow rate of 1 ml/min, collecting 2 ml fractions. 
All protein-containing fractions were pooled and a 30 µl sample taken for SDS-
PAGE. To the remaining mixture, DTT was added in a final concentration of 
1 mM. The digest was further purified via StrepTactin resin placed in a gravity 
flow column. For this, 2 ml of the 50 % StrepTactin slurry were added to a 
12 ml-gravity flow column and equilibrated by filling up the column twice with 
TEV wash buffer. The pooled fractions were passed over the resin and the 
flowthrough was collected. Again, 30 µl were removed as a sample for SDS-
PAGE and mixed with an equal volume of reducing RPB. Finally, the 
flowthrough was concentrated about 20-fold at 4°C using a VivaSpin 
concentrator with an MWCO of 3 kDa. After dialysis against the desired buffer, 
this preparation was used for experiments. Of the samples taken during the 
preparation of ROXY9, 40 µl were separated by 15 % SDS-PAGE. 
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Dialysis 
 
Dialysis was either performed using ZelluTrans dialysis tubing (MWCO: 12 – 
14 kDa, Roth) or MEMBRA-CEL (Serva) dialysis tubing (MWCO: 3 kDa). The 
tubings were prepared for use according to the manufacturer’s instructions: 
While ZelluTrans tubings were soaked in and rinsed with dH2O, MEMBRA-
CEL tubings were boiled for 2 to 3 times in dH2O for at least 20 min. On 
account of the rather small enzyme volumes used for dialysis, dialysis was 
usually performed in reaction tubes, the lid of which was scooped out with a 
hot needle. The protein was added to these tubes, fixing a single layer of dialysis 
tubing under the hole in the lid. The tubes were placed upside-down in dialysis 
buffer. Dialysis took place in the cold room, stirring the buffer constantly. 
Buffer composition, buffer volume and duration of dialysis and dialysis tubing 
depended on the type of experiment. At the end of dialysis, 50 to 100 ml of 
dialysis buffer were kept as a buffer control for experiments and protein 
concentration measurements. 
 
Experiment Tubing Buffer Volume Duration/Steps 
HEDS, 
Insulin, and 
GAPDH 
assay 
MembraCel Na/K phosphate 
pH 7.5 
3333x 1 h + ON 
 MembraCel Na/K phosphate 
pH 7.5 
2500x 3x 1h + 1x ON 
 Zellutrans Na/K phosphate 
pH 7.5 + GSH 
1500x 2x 2h + 1x 1h, 
1x ON 
 MembraCel Na/K phosphate 
pH 7.5 + GSH 
2333x, 
then 
3333x 
1x 4 h + for 
2 d 
Ellman’s 
assay 
Zellutrans Na/K phosphate 1000x 2x 2h + 1x 1h, 
1x ON 
 
 
5xNa/K phosphate buffer  
 
This buffer was prepared as described by Starke et al. (2003) [87]; however, 
0.5 M stock solutions of Na2HPO4 and KH2PO4 were used. A given volume 
of 0.5 M Na2HPO4 was mixed with KH2PO4 until a pH of 7.5 was reached. 
Before use, this 5x stock solution was diluted adequately. 
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Analytical gel filtration of strep-MBP-ROXY9 
 
Analytical gel filtration was performed in cooperation with the department for 
Molecular Enzymology (Prof. Dr. Kai Tittmann, University Göttingen). For 
this, a SuperdexTM 200 10/300 GL column connected to an ÄKTApure device 
equipped with a Fraction Collector F9-R was equilibrated with 1x MBP lysis 
buffer containing 1 mM DTT (page 93). Strep-MBP-ROXY9 was concentrated 
to approximately 7 µg/µl. After centrifugation at 17000 g and 4°C to remove 
precipitated protein, ca. 150 µl were injected into a 100 µl loop and loaded on 
the column. For separation, the column was washed with 1x MBP lysis buffer 
at a flow rate of 0.5 ml/min, fractionating 0.5 ml. Additionally, a gel filtration 
standard (BioRad #1511901) was passed over the column in three replicates 
under the same conditions used for strep-MBP-ROXY9. The elution volume 
of all peaks observed during the separation of strep-MBP-ROXY9 and the gel 
filtration standard was determined using the software Unicorn 7.1 (GE 
Healthcare). For the size standard, the mean of the elution volume of each 
standard molecule was calculated. Then, the partition coefficient (Kav) for each 
peak was determined using the following formula: 
𝐾𝑎𝑣 =  
𝑉𝑒 − 𝑉0
𝑉𝑐 − 𝑉0
 
Ve corresponds to the volume after which the protein elutes. V0 is the void 
volume, corresponding to those proteins which are too big for separation and, 
thus, elute first from the column. Vc can be approximated by the total volume 
of the column (24 ml for SuperdexTM 200 10/300 GL). 
The Kav values for the size standard were plotted against log(Molecular weigth 
(MW)). Using the Kav value for strep-MBP-ROXY9, its log(MW) was calculated 
and converted into the value of its molecular weight. 
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Concentrating proteins 
 
Proteins were concentrated using concentrator tubes with a polyether sulfone 
membrane and an adequate MWCO (obtained from Corning or GE 
Healthcare). The concentrators loaded with the protein were spun at 4°C and 
4000 rpm in a Rotina 380 R centrifuge, in which a 1798 4000rpm 4 x 300 g 
rotor was fastened. 
The following table lists the concentrators used for certain proteins: 
Protein Concentrator 
Strep-MBP-ROXY9 Spin-X® UF 6; 
30 or 50 kDa MWCO 
(Corning) 
ROXY9 after TEV cleavage Vivaspin 20; 
3 kDa MWCO 
(GE Healthcare) 
His-TEV Vivaspin 20; 
3 kDa MWCO 
(GE Healthcare) 
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Characterization of glutaredoxins 
_____________________________________________________________________ 
 
The catalytic activity of glutaredoxins was measured towards the substrates 
HEDS, insulin, and glutathionylated GAPDH (GAPDH-SG). For all those 
experiments, the glutaredoxins were dialyzed against 1xNa/K phosphate 
buffer (page 98). Buffer without 1 mM glutathione served to remove DTT 
from the purification process. Buffer supplemented with 1 mM glutathione 
served to remove DTT while keeping the proteins reduced through the action 
of glutathione. The proteins were dialyzed over night, using ZelluTrans (Roth) 
or MEMBRA-CEL (Serva) tubings. The buffer was at least exchanged once. 
Buffer volumes were used such that the total purification buffer volume was 
diluted at least by a factor of 7777000 during the entire dialysis process. When 
removing only DTT, the glutaredoxin activity experiments were conducted 
within the next two days after dialysis. When exchanging DTT for GSH, the 
proteins were stored for a longer time. The protein concentration for the assays 
was determined according to Bradford. A 100 mM stock of L-glutathione was 
always prepared freshly before the experiments. 
 
 
 
Bis(2-hydroxyethyl)disulfide (HEDS) assay 
 
During the HEDS assay, the artificial compound HEDS is reduced by the 
glutaredoxin, leading to the formation of GSSG. Coupling the reduction of 
HEDS to the reduction of GSSG by GSSG reductase allows photometric 
measurement of the reaction progress, since GSSG reductase requires electrons 
from NADPH for its catalysis. In contrast to NADPH, oxidized nicotinamide 
adenine dinucleotide phosphate (NADP+) does not absorb at 340 nm. Thus, a 
decline in absorption at this wavelength indicates proceeding reduction of 
HEDS. However, the first steps of HEDS reduction by glutaredoxins are not 
fully clarified. HEDS might first react with GSH to GSSEtOH. Subsequent 
deglutathionylation of GSSEtOH by the glutaredoxin leads to formation of 
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GSSG. In parallel, glutaredoxins might reduce HEDS directly and are recycled 
by glutathione, producing GSSG [56,75,101,107,240,241]. 
The protocol of the HEDS assay was adapted from Gallogly et al. (2008) [242] 
and modified. A single reaction of the HEDS assay contained: 
Component Volume Concentration 
Na/K phosphate buffer (5x) 40 µl 1x 
HEDS (8.75 M) 0.02 µl 0.875 mM 
NADPH (20 mM) 2 µl 0.2 mM 
GSSG reductase (1.5 mg/ml) 0.25 µl 2 µg/ml 
GSH (100 mM) 2 µl 1 mM 
Glutaredoxin (0.1 – 20 µM)/Dialysis 
buffer  
10 µl 0.005 – 2 µM 
 Ad 200 µl 
dH2O 
 
 
10 µl of the enyzme or the dialysis buffer in case of the no-enzyme control were 
pipetted into the wells of a microtiter plate. Then, a master mix containing all 
other components of the reaction was prepared and 190 µl of it quickly 
distributed to each well. The absorption at 340 nm was measured imeadiately 
every 20 sec over 20 min. 
 
 
 
Insulin assay 
 
In the insulin assay, the reduction of insulin by glutaredoxins is measured. 
Insulin consists of two chains, A and B, which are linked by disulfide bridges. 
Glutaredoxins can reduce these disulfide bridges, thereby resolving the linkage 
between chain A and chain B. Chain B, however, is insoluble, when not bound 
to chain A and precipitates. Thus, ongoing insulin reduction can be monitored 
by measuring the turbidity of the solution at 650 nm [78,243]. 
The insulin assay was performed as described in Zaffagnini et al. (2008) [78]. A 
single reaction of the insulin assay contained: 
 
Methods 
103 
 
Component Volume/Amount Concentration 
K phosphate buffer pH 7.0 (0.5 M) 40 µl 0.1 M 
Na2-EDTA pH 8.0 (0.5 M) 0.8 µl 2 mM 
Insulin 0.015 mg 0.075 µg/µl 
GSH (100 mM) 2 µl 1 mM 
Glutaredoxin (0.1 – 20 µM)/Dialysis 
buffer  
10 µl 0.005 – 2 µM 
 Ad 200 µl dH2O  
 
First, a master mix containing K phosphate buffer, EDTA and dH2O was 
prepared. The required amount of insulin was weighed and dissolved in this 
mix, rotating it at 15 rpm at room temperature. In the meantime, 10 µl of the 
enzyme or dialysis buffer for the “No enzyme” control were pipetted into the 
wells of a microtiter plate. When dissolved, 188 µl of the master mix were added 
to the wells. Finally, 2 µl 100 mM glutathione were added and the reactions 
mixed. The microtiter plate was incubated for 10 h at room temperature in a 
plate reader, shaking the plate before measuring A650nm every 10 min. 
 
0.5 M K phosphate buffer pH 7.0 
 
To prepare this buffer, 0.5 M K2HPO4 were mixed with 0.5 M KH2PO4 until 
a pH of 7.0 at RT was reached. 
 
 
 
GAPDH assay 
 
The GAPDH assay is based on the inactivation of GAPDH by 
glutathionylation and its reactivation by glutathione. GAPDH catalyzes the 
conversion of glyceraldehyde-3- phosphate (GAP) to 1,3-bisphosphoglycerate 
(BPGA), thereby consuming inorganic phosphate and generating NADH. The 
reaction is reversible. The GAPDH assay makes use of the reverse reaction: 
First, GAPDH forms a covalent intermediate with BPGA via a catalytic 
cysteine residue. Then, electrons are transferred from NADH to this 
intermediate yielding the final reaction product GAP and releasing oxidized 
nicotinamide adenine dinucleotide (NAD+). The catalytic cysteine residue of 
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GAPDH has been shown to be glutathionylated, leading to the inactivation of 
the enzyme [37,78]. 
The GAPDH assay was adapted from Zaffagnini et al. (2008) [78]. 
For this experiment, several solutions were prepared freshly: 
• 250 µM rabbit muscle GAPDH in Na phosphate buffer pH 8.0 (page 
88) 
• 100 mM GSH in dH2O 
• 150 mM 3-phosphoglycerate in dH2O (protected from light) 
• 100 mM ATP in dH2O 
• 700 mM H2O2 in dH2O (protected from light) 
 
First, glutathionylated GAPDH was prepared. For this, the following reaction 
mix was pipetted: 
Component Volume/Amount Concentration 
Na phosphate buffer pH = 8.0 4513 µl  
250 µM GAPDH 333 µl 15 µM 
100 mM GSH  150µl 3 mM 
700 mM H2O2  10 µl 1.4 mM 
 ∑ 5 ml  
 
The reaction was incubated for at least 15 min at RT, protecting it from light. 
In the mean time, two PD-10 desalting columns (GE Healthcare) were 
equilibrated by filling them up with Na phosphate buffer pH 8.0 twice. Then, 
2.5 ml GAPDH mixture were loaded per column and the flowthrough 
discarded. GAPDH-SG was eluted with 3.5 ml Na phosphate buffer pH 8.0 
and both eluates were pooled. This step served to remove residual GSH and 
H2O2 from the reaction. 
An additional control to address the maximal GAPDH activity was prepared 
by mixing 166.5 µl 250 µM GAPDH with 3.333 ml Na phosphate buffer 
pH 8.0. This yielded a 12 µM dilution of GAPDH which corresponds to the 
maximal possible GAPDH concentration that can be obtained after desalting. 
In the second step of the experiment, the substrate of GAPDH during the first 
step of its reaction, BPGA, was prepared. For this, a mastermix consisting of 
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the following components was prepared and incubated for at least 10 min at 
room temperature, protected from light: 
Component Volume/Amount 
for a single reaction 
Concentration 
Na phosphate buffer pH = 8.0 41.71 µl  
150 mM 3-phosphoglycerate 4.5 µl 13.5 mM 
100 mM ATP  3 µl 6 mM 
1M MgCl2  0.75 µl 15 mM 
15 u/µl 3-phosphoglyceric acid 
phosphokinase 
0.04 µl 0.012 u/µl 
 ∑ 50 µl  
 
50 µl aliquots of this master mix were distributed to the wells of a 96-well 
microtiter plate. They served to stop the deglutathionylation of GAPDH. 
Then, the actual deglutathionylation reactions were prepared. The following 
samples were included into the assay: 
GAPDH GAPDH-SG GAPDH-SG + 
DTT 
GAPDH-SG + 
GSH 
GAPDH-SG + 
Glutaredoxin 
500 µl GAPDH 
12 µM 
 
500 µl 
GAPDH-SG 
500 µl 
GAPDH-SG 
500 µl 
GAPDH-SG 
500 µl 
GAPDH-SG 
100 µl Dialysis 
buffer 
 
100 µl Dialysis 
buffer 
100 µl Dialysis 
buffer 
100 µl Dialysis 
buffer 
100 µl Enyzme 
(2 – 20 µM) 
25 µl dH2O 25 µl dH2O 25 µl 1 M DTT 25 µl 100 mM 
GSH 
25 µl 100 mM 
GSH 
 
These reactions were incubated at RT and 50 µl aliquots were removed and 
stopped by mixing them with 50 µl BPGA mix in the microtiter plate at 
different time points. Once, all samples were taken and stopped, a third master 
mix was prepared by mixing the following components: 
Component Volume/Amount 
for a single reaction 
Concentration 
Na phosphate buffer pH = 8.0 48.2 µl  
0.5 M Na2-EDTA pH = 8.0 0.3 µl 3 mM 
20 mM NADH  1.5 µl 0.6 mM 
 ∑ 50 µl  
 
This mastermix was also protected from light, until 50 µl of it were distributed 
to each well fo the 96-well plate containing a stopped sample of the reactions. 
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Then, the absorption at 340 nm was measured every minute over 1 h to 
determine the activity of deglutathionylated GAPDH. For data evaluation, the 
absorption intensity was plotted over time and the slope of the linear range of 
the curve determined via linear regression in Excel. This yielded the velocity of 
GAPDH. The velocity of GAPDH was then plotted against the time points at 
which the aliquots for the final measurement were withdrawn. This yielded the 
glutaredoxin activity. 
 
 
 
RoGFP assay to determine deglutathionylation activity of 
glutaredoxins 
 
RoGFP is an oxidation-sensitive GFP variant. Reduced roGFP absorbs more 
strongly at ca. 480 nm whereas oxidized roGFP absorbs more strongly at 
400 nm. Independent of the wavelength used for excitation, roGFP emits 
fluorescence light at 510 nm. The intensity of emission depends on the intensity 
of excitation. Thus, reduced roGFP will emit more strongly after excitation at 
480 nm than after excitation at 400 nm, whereas oxidized roGFP will emit less 
after excitation at 480 nm than after excitation at 400 nm. Hence, the ratio of 
emission after excitation at the different wavelength reflects the oxidation state 
of roGFP [244]. 
RoGFP assays were carried out in coopreration with the department for 
Chemical Signalling (Prof. Dr. Andreas Meyer) at the Institut für 
Nutzpflanzenwissenschaft und Ressourcenschutz (INRES). Strep-MBP-
ROXY9 was dialyzed against K phosphate buffer pH 8.0 (dilution factor ca. 
2700000) and send on ice to Lara Ostermann, who perfomed the experiment 
described below: 
100 mM DTT and 10 mM NADPH, as well as 10 U glutathione reductase were 
prepared in 100 mM K phosphate buffer. In addition, a 25 mM GSH solution 
in potassium phosphate buffer was prepared. Importantly, the pH was 
readjusted to pH 8.0. 100 µM stock solutions of the glutaredoxins to be tested 
and 10 µM N-terminally His-tagged roGFP2 were prepared in the same buffer. 
The roGFP sample was splitted into two parts and one of them was treated 
with 10 mM DTT for 20 min (roGFPred), whereas the other part was left 
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untreated (roGFPox). The roGFP sample containing DTT was not desalted as 
it should stay reduced throughout the experiment. The glutaredoxins (GRXs) 
were used in the oxidized state in which they were purified. 
Using these proteins, the reactions listed in the table below were prepared: 
 
Sample Blank NADPH roGFP2red roGFP2ox GRX 
 
Prepared in wells 
        
 
V(100 mM K 
phosphate buffer pH 
8.0) [µl] 
 
92 82 82 82 62 61 59 52 
V (10 mM NADPH) 
[µl] 
 
- 10 - - 10 10 10 10 
V(10 µM roGFP2red) 
[µl] 
 
- - 10 - - - - - 
V(10 µM roGFP2ox) 
[µl] 
 
- - - 10 10 10 10 10 
V(10 U GR) [µl] 
 
- - - 10 10 10 10 10 
V(100 µM GRX) [µl] 
 
- - - - - 1 2 5 
Added via injector         
 
V(25 mM GSH) [µl] 
 
- - - - 8 8 8 8 
V(100 mM K 
phosphate buffer pH 
8.0) [µl] 
 
8 8 8 8 - - - - 
 
With exception of the 8 µl GSH or K phosphate buffer, the reactions were 
prepared in at least three replicates in a 96-well microtiter plate. The injection 
pumps of the plate reader were filled with K phosphate buffer or GSH 
solution. The measurement of the fluorescence emission at 510 nm after 
excitation at 400 nm and 482 nm, respectively, was initiated and continued for 
10 min to allow equilibration. Then, 8 µl of GSH or buffer were injected to 
start the reactions. Fluorescence changes of the reactions were monitored over 
at least 60 min. For data evaluation, the ratio of the emission after excitation at 
400 nm and after excitation at 482 nm was computed and plotted against the 
time. 
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K phosphate buffer pH 8.0 
 
Component Volume 
0.5 M KH2PO4 5 % (v/v) 
0.5 M K2HPO4 95 % (v/v) 
 
The pH of the buffer was adjusted at RT with concentrated o-phosphoric 
acid or with KOH. 
 
 
 
RoGFP assay to determine glutathionylation activity of 
glutaredoxins 
 
This assay was performed in analogy to the deglutathionylation assay with 
roGFP. The glutaredoxins were reduced prior to the experiment by treatment 
wit 10 mM DTT for 45 min, followed by desalting via ZebaSpin columns. 
Oxidized roGFP2 was added to the enyzeme reactions instead of reduced 
roGFP2. Moreover, instead of GSH, GSSG was injected to a final 
concentration of 5 mM. 
 
 
 
Analysis of glutathione and iron-sulfur cluster binding 
 
Thermophoresis and BioLayer Interferometry to determine the dissociation 
constant (Kd) of strep-MBP-ROXY9 towards glutathione, were carried out by 
Dr. Sven-Andreas Freibert at the institute for Cytobiology and Cytopathology 
(Prof. Dr. Roland Lill, Institute for Cytobiology and Cytopathology, Philipps-
University Marburg). For this, DTT was removed via a ZebaSpin or a PD-10 
column. 
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Chemical reconstitution of a potential iron-sulfur cluster in strep-MBP-
ROXY9 in the presence of glutathione and the subsequent determination of 
bound iron and sulfide ions via the ferene-based approach [245] and the 
methylene blue method [246] were performed by Dr. Freibert. Purified strep-
MBP-ROXY9 was dialyzed to remove EDTA and sent on wet ice to this 
institute. 
 
 
 
Differential labeling of reduced and oxidized cysteine 
residues in purified strep-MBP-ROXY9 
 
The experiment was carried out as described by Vollheyde (2014) [247]. In this 
experiment, the reduced thiol groups of strep-MBP-ROXY9 were labeled with 
iodoacetamide (IAM) while the modified thiol groups were labeled with an 
iodoacetyl Tandem Mass TagTM (iodoTMT0-126, Thermo Scientific). To 
prevent loss of or changes in the cysteine modifications, the light was kept low 
during the experiment and incubation periods were carried out in the dark. 
Iodoacetamide, Tris(2-carboxyethyl)phosphine (TCEP), ascorbate and 
iodoTMT solutions were prepared freshly before starting the experiment. 
First, about 90 µg of purified protein were subjected to a TCA precipitation to 
remove all oxidizing or reducing agents from the buffer solution. The resulting 
pellet was resuspended in 500 µl Urea buffer containing 100 mM 
iodoacetamide. The mixture was incubated at 25°C for 15 min, shaking it at 
600 rpm, and precipitated again using TCA. This time, the pellet was dissolved 
in 300 µl reduction buffer (either with 1 mM ascorbate to prepare the labeling 
of nitrosylated cysteine residues only or with 20 mM TCEP to allow labeling 
of all modified cysteine residues) and incubated at 30°C for 30 min, shaking the 
sample at 600 rpm. After a third TCA precipitation, the pellet was resuspended 
in 20 µl HENS buffer (Thermo Scientific). Then, 1 µl iodoTMT solution was 
added and the samples incubated at 37°C, shaking them for about 1 h. 
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Urea buffer 
 
Component Concentration 
TRIS-HCl pH 8.5 200 mM 
Urea 6 M 
Na2-EDTA 5 mM 
SDS 0.005 %(w/v) 
 
 
Reduction buffer with TCEP 
 
Component Concentration 
Urea buffer 90 %(v/v) 
200 mM TCEP 10 %(v/v) 
 
Reduction buffer with ascorbate 
 
Component Concentration 
Urea buffer 90 %(v/v) 
20 mM L(+)-ascorbic acid 5 %(v/v) 
dH2O 5 %(v/v) 
 
 
Stock solutions to be prepared freshly 
 
Component Concentration 
TCEP in dH2O 200 mM 
L(+)-ascorbic acid in dH2O 20 mM 
Iodoacetamide in urea buffer 100 mM 
iodoTMT0-126 in DMSO 10 µg/µl 
 
 
 
 
Treatment of strep-MBP-ROXY9 for Ellman’s assay and 
redox titration 
 
To prepare strep-MBP-ROXY9 in different oxidation states, protein purified 
in the presence of DTT was concentrated to 95 µM and subjected to the 
following treatments: 
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Oxidation by removal of DTT via dialysis 
A sample of ca. 400 µl strep-MBP-ROXY9 was dialyzed against 100 mM 
HEPES pH 7.0 to remove DTT from the purification process. The dilution 
factor was ca. 1000000-fold. Dialysis took place in the cold room over night. 
 
Oxidation by removal of DTT via a ZepaSpin column and oxidation with H2O2 
200 µl strep-MBP-ROXY9 purified in the presence of DTT were dialysed over 
night in the cold room against K phosphate buffer pH 8.0 (as used for roGFP 
assays, page 108). The dilution factor during dialysis was ca. 4000000-fold. 
Then, the sample was splitted into two aliquots of 70 µl. One aliquot was 
treated for 20 min with 10 mM DTT at RT, whereas the other aliquot was 
incubated with 10 mM H2O2 for the same time. Both samples were desalted via 
ZebaSpin columns equilibrated with Ellman’s assay buffer (page 113). 
 
 
Determination of free thiol groups using 5,5-dithio-bis-2-
nitrobenzoic acid (Ellman’s assay [248]) 
 
5,5-dithio-bis-2-nitrobenzoic acid (DTNB) was obtained from Thermo 
Scientific and the assay was conducted according to the manufacturer’s 
instructions with some modifications. The final protocol was: 
Strep-MBP-ROXY9 was subjected to the following treatments: Removal of 
DTT by dialysis or ZebaSpin column or oxidation with H2O2. The treatments 
are described in the section before. After the treatment, the protein 
concentration of all samples was determined according to Bradford and 
different dilutions of the protein within the detection range of the L-cysteine 
standard curve were made in 1xNa/K phosphate buffer (page 98). The entire 
L-cysteine standard curve ranged from 0.025 mM to 1.5 mM. For this standard, 
L-cysteine was dissolved freshly in DTNB assay buffer to a concentration of 
1.5 mM. The standard samples were prepared by diluting the 1.5 mM L-
cysteine solution according to the following table: 
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Sample V(Assay buffer) 
[µl] 
V(1.5 mM L-cysteine) 
[µl] 
c(L-cysteine) 
[mM] 
A - 300 (A) 1.5 
B 50 250 (A) 1.25 
C 100 200 (A) 1 
D 150 150 (A) 0.75 
E 200 100 (A) 0.5 
F 250 50 (A) 0.25 
G 150 150 (F) 0.125 
H 240 60 (E) 0.1 
I 150 150 (H) 0.05 
J 150 150 (I) 0.025 
K 300 - 0 
 
Since L-cysteine is light-sensitive, all these samples were protected from light. 
A 4 mg/ml DTNB stock solution was made freshly using assay buffer. A 
mastermix consisting of 2.5 µl DTNB solution and 125 µl DTNB assay buffer 
per sample was prepared. 125 µl of this master mix were distributed to the wells 
of a microtiter plate. To the wells of the L-cysteine standard samples, 12.5 µl 
1xNa/K phosphate buffer were added, whereas to the wells of the protein 
samples, 12.5 µl DTNB assay buffer were added. Then, 12.5 µl of the L-
cysteine standard samples were distributed to their wells and 12.5 µl of the 
different strep-MBP-ROXY9 dilutions. Each standard and each protein sample 
was prepared in triplicate. After the samples were mixed thoroughly, the plate 
was incubated for 15 min at room temperature. Eventually, the absorption at 
420 nm was measured in a Synergy HT plate reader. 
To determine the concentration of free thiols in the protein samples, a standard 
curve was obtained by plotting A420nm against the concentration of free thiols 
of the standard samples (one free thiol per cysteine molecule) and by 
performing a linear regression. The resulting equation was used to calculate the 
concentration of free thiols in the protein samples. By dividing the 
concentration of free thiols by the protein concentration in each sample, the 
number of reduced cysteines in strep-MBP-ROXY9 was determined. 
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Ellman’s assay buffer 
 
Component Volume 
50 mM Na phosphate buffer pH 8.0 200 ml 
0.5 M Na2-EDTA pH 8.0 400 µl 
 
 
 
 
Redox titration using monobromobimane 
 
To determine the mid-point redox potential of strep-MBP-ROXY9, the 
method described by Couturier et al. (2013) [77] was employed. In this method, 
oxidized protein is incubated in the presence of different ambient redox 
potentials (Eh) set by mixing DTT and dithiane (oxidized DTT) in defined 
ratios. The relation between the redox potential and the concentration of 
oxidized and reduced compounds is specified by the Nernst equation: 
𝐸ℎ =  𝐸
0 + 
𝑅 × 𝑇
𝑛 × 𝐹
× ln (
𝑐(𝑂𝑥)
𝑐(𝑅𝑒𝑑)
) 
R = 8.314 J/(mol×K); 
T = 298 K (25 °C); 
n = 2 (for DTT/dithiane; n is the number of electrons exchanged between the oxidized and 
the reduced compound); 
F = 96485.336 C/mol 
Thus, the entire measurement depends on the DTT standard redox potential 
(E0), which is -0.33 V at pH 7.0 at 25°C [77]. Therefore, the pH of the 100 mM 
HEPES buffer used throughout the experiment was adjusted to 7.0 at 25°C. 
The experiment was carried out as close to 25°C, as possible. 
The protein oxidation state adjusts over time to the ambient redox potential 
created by the different DTT/dithiane concentrations. Finally, reduced cysteine 
residues are labeled with the fluorescing dye monobromobimane (mBBr). 
Using the fluorescence intensity, the extent of reduction and oxidation of the 
protein in each sample is determined [77,249]. 
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Oxidized strep-MBP-ROXY9 was prepared according to the protocol for 
removal of DTT by dialysis. After dialysis, the concentration of the sample was 
determined according to Bradford and dilutions of ca. 15 µM in 100 mM 
HEPES pH 7.0 were prepared. 
To set the ambient redox potential, fresh stock solutions of DTT and dithiane 
were made by dissolving the compounds to a concentration of 4 mM in 
100 mM HEPES pH 7.0. Using these stock solutions, different dilutions were 
pipetted to obtain the indicated ambient redox potential: 
Eh [V] c(Dithiane)/ 
c(DTT) 
V(Dithiane 
4 mM) 
V(DTT 4 mM) 
-0,3 10,3 3647 353 
-0,29 22,5 3829 171 
-0,28 49 3920 80 
-0,27 106,7 3962 38 
-0,26 232,5 3982 18 
-0,25 506,3 3992 8 
-0,24 1102,8 3996 4 
-0,23 2401,8 900 100 µl of sample "-0.26" 
-0,22 5231,1 900 100 µl of sample "-0.25" 
-0,21 11393,2 900 100 µl of sample "-0.24" 
-0,2 24814,1 900 100 µl of sample "-0.23" 
-0,19 54044,6 900 100 µl of sample "-0.22" 
-0,18 117708,1 900 100 µl of sample "-0.21" 
-0,17 256365,9 900 100 µl of sample "-0.20" 
 
Finally, 100 µl of the DTT/dithiane mixtures were added to 100 µl aliquots of 
the 15 µM protein dilution. The samples were incubated for approximately 2 h 
at ca. 25°C. Then, 10 µl of a 40 mM mBBr stock solution in 100 % DMSO 
were added. After the addition of the light-sensitive mBBr, further processing 
took place in the dark. The samples were incubated with mBBr for another 
20 min at 25°C. The reaction was stopped by adding 210 µl 20 % ice-cold TCA. 
The protein was precipitated on ice for 30 min, followed by a centrifugation at 
17000 g at 4°C for 10 min. The supernatant was removed with a pipette tip and 
1 ml of 100 % ice-cold acetone was added to each pellet. To wash the pellet 
thoroughly, the tubes were inverted several times and then centrifuged for 
another 5 min at 4°C at 17000 g. The supernatant was removed completely, 
and the pellets dried briefly at RT. Finally, the pellets were dissolved by adding 
400 µl 100 mM TRIS pH 8.0 containing 1 %(w/v) SDS vortexing them for ca. 
5 min. 100 µl of the solution were added to the wells of a 96-well plate. As a 
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blank, 100 µl TRIS-SDS buffer were added to one well. Then, fluorescence was 
excited using a 360/40 filter in a Synergy HT plate reader and measured with a 
528/40 filter. 
To analyze the data, the blank value was substracted from the sample values. 
Following the protocol described by Couturier et al. (2013) [77], the highest 
value measured was set to 100 % reduced protein, whereas the lowest value 
measured was set to 0 % reduced protein. All other values were assigned values 
for the percentage of reduced protein accordingly. The percentage of the 
reduced protein was plotted against the ambient redox potential and the 
inflection point of the resulting curve estimated to determine roughly the 
standard redox potential of the protein [77]. However, it should be noted that 
this way of data evaluation leads to errors when the protein used is not fully 
reduced or oxidized under the ambient redox potential chosen. Employing 
additional controls, namely fully reduced and fully oxidized protein, might be 
advisable. Still, since the experiment performed in this study was a first try to 
establish the method, it was performed exactly according to Couturier et al. 
(2013). 
 
 
 
Analysis of the cysteine redox state by mass spectrometry 
 
Sample preparation 
Strep-SUMO-ROXY9 was dialyzed against 1xNa/K phosphate buffer pH 7.5 
(page 98), optionally containing the reducing reagents of interest. Of these 
preparations, a sample containing ca. 90 µg of the protein was taken and 
immediately precipitated with TCA. Then, the reduced and oxidized cysteines 
of strep-MBP-ROXY9 were labeled with IAM or iodoTMT0-126, respectively. 
After incubation in HENS buffer (Thermo Scientific) containing the iodoTMT 
reagent, the samples were mixed with non-reducing RPB and stored at -20°C 
until further processing. 
The following table summarizes the preparation procedure for each sample 
analyzed in this work: 
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Sample 
ID 
Sample name 
Dialysis 
Buffer additive and 
concentration 
Dilution factor 
KT11 
Strep-MBP-ROXY9 
+ DTT 
 
None 
(used as purified) 
None 
(used as purified) 
KT07 
Strep-MBP-ROXY9 
- DTT 
 
none 4.8 × 1011 
KT09 
Strep-MBP-ROXY9 
+ GSH 
 
1 mM GSH 1.3 × 1013 
 
In addition to these samples, another sample was prepared to test how fast 
oxidized strep-MBP-ROXY9 can be reduced by GSH (KT17). For this, about 
90 µg strep-MBP-ROXY9 were mixed with GSH to a final concentration of 
1 mM, incubated for 10 min and instantly subjected to TCA precipitation. 
Reduced and oxidized cysteine residues were labeled with IAM and 
iodoTMT0-126, respectively. 
Finally, all samples were loaded on 10 % SDS gels (the samples were not boiled 
to protect the modifications) and separated at 80 V in fresh 1x SDS running 
buffer. Subsequently, the gels were stained with Colloidal Coomassie. After 
documentation using an Epson Perfection V700 Photo scanner, all bands of 
interest were cut out from the gel with a clean scalpel blade and transferred to 
fresh 2 ml reaction tubes. The gel slices were destained with Colloidal 
Coomassie fixing solution, applying about 2 ml of this solution to the gel slice 
and rotating it at 30 rpm at room temperature for short time or overnight in 
the cold room. To destain the gel slices as completely as possible, destaining 
was performed over a duration of three days, exchanging the fixing solution 
every day. 
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Sample preparation for liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) 
 
In-gel trypsin digest 
The destained gel pieces were cut into 2 mm pieces using a clean scalpel. The 
gel pieces were transferred to a 2 ml reaction tube, covered with acetonitrile 
and vortexed for 10 min at RT to dehydrate them. To rehydrate the gel pieces, 
acetonitrile was removed, and the gel pieces covered with 150 µl 100 mM 
NH4HCO3, shaking them again at RT for 10 min. After removing NH4HCO3, 
150 µl acetonitrile were added, the gel pieces vortexed again for 10 min at RT, 
and the acetonitrile removed. This washing with NH4HCO3 and acetonitrile 
was repeated once. Finally, the gel pieces were dried in a speedvac at 50°C for 
ca. 10 min. The gel pieces were covered with trypsin digestion buffer and 
incubated for 45 min on ice. After removing the trypsin digestion buffer, the 
gel pieces were covered with 25 mM NH4HCO3 pH 8.0 and incubated over 
night at 37°C. 
The sample was centrifuged at 13000 rpm for 1 min at RT (table top centrifuge) 
and the supernatant transferred to a fresh LoBind Eppendorf tube (“collection 
tube”). To extract the acidic peptides, the gel pieces were overlain with 20 mM 
NH4HCO3 and vortexed for 10 min at RT. The tube was spun at 13000 rpm 
for 1 min at RT and the supernatant transferred to the collection tube. Next, 
basic peptides were extracted by repeating the following step three times: The 
gel pieces were covered with 50 % acetonitrile/5 % formic acid and vortexted 
for 20 min at RT. Then, the gel pieces were spun down by centrifugation at 
13000 rpm for 1 min at RT and the supernatant transferred to the collection 
tube. Finally, the liquid in the collection tube was completely evaporated in a 
speedvac at 50°C, leaving only the peptides in the pellet. This pellet could be 
stored -20°C. 
 
C18 stage tip purification 
Stage tips were prepared by placing two 0.5 mm plugs of C18 material in a 
200 µl tip. The stage tips were placed in an adaptor in a 2 ml reaction tube 
without lid. To equilibrate the C18 material, 100 µl methanol/0.1 % formic acid 
was loaded on the stage tip. The stage tip was spun down for 2 min at 17000 g 
at RT and the flow through discarded. Next, 100 µl 70 % acetonitrile/0.1 % 
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formic acid were added to the C18 material and centrifugation repeated. The 
flowthrough was discarded. Finally, 100 µl 0.1 % formic acid were pipetted into 
the stage tip, centrifuged and the flow through discarded. This step was 
repeated once. 
The pellet obtained after trypsin digestion was resuspended in an appropriate 
volume of fresh sample buffer by pipetting and by sonication in an ultrasonic 
bath for 3 min at maximum power. The samples were spun down briefly to 
sediment any residual non-dissolved pellet pieces and the supernatant was 
loaded on the equilibrated stage tip placed in a fresh tube, followed by 
incubation for 3 to 5 min at RT. The stage tip was centrifuged for 5 min at 
4000 rpm and the flowthrough reloaded, repeating incubation and 
centrifugation. The stage tip was washed twice by adding 100 µl 0.1 % formic 
acid, centrifuging for 2 min at 10000 rpm. Finally, the stage tip was transferred 
to a fresh LoBind Eppendorf tube and 60 µl 70 % acetonitrile/0.1 % formic 
acid were pipetted onto the C18 material. The sample was centrifuged for 5 min 
at 4000 rpm at RT. The eluate was dried in a speedvac at 50°C and the pellet 
was stored until LC-MS/MS analysis. Prior to LC-MS/MS analysis, the pellet 
was dissolved in 20 µl fresh sample buffer by pipetting and sonification in an 
ultrasonic bath (3 min, maximum power). The sample was transferred into LC-
MS vials, making sure that there were no air bubbles or undissolved pellet 
pieces in the solution. 
 
Trypsin solution 
25 µg Trypsin were dissolved in 25 µl resuspension buffer and mixed with 
475 µl 25 mM NH4HCO3 pH 8.0 (Trypsin solution). 750 µl 25 mM NH4HCO3 
pH 8.0 were added before use to 500 µl Trypsin solution. 
 
 
Sample buffer 
 
Component Concentration 
H2O 98 %(v/v) 
Acetonitrile 2 %(v/v) 
Formic acid 0.1 %(v/v) 
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LC-MS/MS measurement and data analysis 
 
LC-MS/MS was performed by Dr. Kerstin Schmitt at the Service Unit LCMS 
Protein Analytics (Georg August University Göttingen) on a Q Exactive HF 
mass spectrometer using electron spray ionization. LC-MS/MS data was 
analyzed using the software Proteome Discoverer 2.2.0. (Thermo Scientific). 
To achieve a rough quantification, the number of different peptide spectrum 
matches (PSMs) observed for each modified peptide was divided by the 
number of (different) PSMs for a non-modified peptide resulting from the 
MBP tag of ROXY9. Two sets of normalized PSMs were produced, using two 
different non-modified MBP peptides. This data analysis allowed comparisons 
of the amount of the same peptide in different samples, but not between 
different peptides. 
 
 
 
Pulldown of recombinant GFP-TGA1 and His-MBP-JAZ9 
using strep-MBP-ROXY9 from insect cells 
 
To analyze co-purification of GFP-TGA1 and His-MBP-JAZ9 with strep-
MBP-ROXY9 and strep-MBP as a control, recombinant proteins were used. 
Strep-MBP-ROXY9 was purified from insect cells whereas strep-MBP was 
purified from E. coli, as described in the sections before. Maltose was removed 
by dialyzing against 1x MBP lysis buffer with 50 mM NaCl (dilution factor ca. 
5000000, buffer recipe page 95). The protein concentrations were determined 
according to Bradford. GFP-TGA1 and His-MBP-JAZ9 were expressed in E. 
coli. A single 400 ml pellet of E. coli cells expressing GFP-TGA1 and His-MBP-
JAZ9 was thawed and resuspended in 20 ml 1x MBP lysis buffer containing 
50 mM NaCl. Two tablets EDTA-free protease inhibitor cocktail (Biomake) 
and a spatula of lysozyme were added. The samples were incubated for 20 min 
in the cold room, agitating them end-over-end at 15 rpm. Then, the cells were 
lysed by sonication (15 min, 1 sec pulse on, 2 sec pulse off, 50 % amplitude). 
The samples were centrifuged at 4°C at 4000 rpm for 30 min and the 
supernatants used for the pulldown experiment. 
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To prepare a pulldown sample, 500 µl GFP-TGA1 crude extract or His-MBP-
JAZ9 crude extract were mixed with a final concentration of 1 µM strep-MBP-
ROXY9 or strep-MBP and filled up to 1.480 µl using 1x MBP lysis buffer with 
50 mM NaCl. 20 µl TEV dialysis buffer (page 96) were added. The samples 
were incubated in the cold room, rotating them end-over-end at 15 rpm over 
night. 
The next day, 500 µl aliquots of 50 % StrepTactin slurry in 2 ml reaction tubes 
were prepared. The beads were spun down at 17000 g at RT for 10 sec and the 
supernatant was removed. Then, the beads were equilibrated by adding 1 ml 1x 
MBP lysis buffer with 50 mM NaCl, inverting, and centrifuging again at 
17000 g at RT for 10 sec and removing the supernatant. This step was repeated 
twice. Finally, each bead aliquot was resuspended in 250 µl 1x MBP lysis buffer 
with 50 mM NaCl and all aliquots were pooled. 300 µl of the equilibrated slurry 
were distributed to fresh 2 ml tubes. After taking a 20 µl sample (“Input”) of 
the pulldown mixture and supplying it with non-reducing RPB, the beads were 
mixed with the residual pulldown mixture and incubated for ca. 30 min at RT, 
rotating them end-over-end at 15 rpm. After incubation, the mixture was 
transferred in 800 µl-steps on a BioRad Spin column and centrifuged at 1000 g 
at RT for 1 min. The flowthrough was pooled in a tube and a 22 µl sample 
taken for SDS-PAGE, mixing it with 22 µl non-reducing RPB (“Unbound”). 
The beads were washed five times with 800 µl 1x MBP lysis buffer with 50 mM 
NaCl, centrifuging at 1000 g for 1 min at RT. The flowthrough was discarded. 
After the last wash step, residual liquid in the spin column was removed by a 
blank spin for 1 min at 1000 g at RT. Finally, the bound protein was eluted by 
adding 400 µl of a 1:1 mixture of non-reducing RPB and 1x MBP lysis buffer 
with 50 mM NaCl. The samples were incubated at RT for 5 min and 
centrifuged at 1000 g for 1 min at RT. 20 µl of the elution were separated 
together with 20 µl of the input and 22 µl of the unbound samples on precast 
SDS gels (4 – 20 % gradient) and blotted in a semi-dry Western blot on a PVDF 
membrane. For each pulldown, two gels were prepared, one to perform a 
Western blot with the anti-strep antibody, and the other one to perform a 
Western blot with the anti-His or anti-GFP antibody. 
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Amino acids required for ROXY9 in vivo 
activity 
_____________________________________________________________________ 
 
 
Construction and selection of stable ROXY9 
overexpression plants 
 
ROXY9 (At2g47880, CEPD2) belongs to the glutaredoxins with a peculiar CC 
motif in their active site [145,154]. The ROXY9 active site is 21CCLC24. The 
active site of the CC-type glutaredoxins is immediately followed by another, 
conserved residue: Either a histidine, or – as for ROXY9 – a tyrosine [133,145]. 
In a previous study, it was shown that ROXY9 can repress hyponastic growth 
when overexpressed in A. thaliana. Overexpression of mutated ROXY9 
variants was used to investigate which of the three active site cysteines in 
ROXY9 are necessary for repression of hyponasty. To act as a repressor, 
ROXY9 requires the CC motif, but not the most C-terminal cysteine residue 
of the active site [155,156]. 
In this work, the dissection of the active site in ROXY9 was continued by 
examining the function of the conserved tyrosine residue (Tyr25) after the active 
site motif. To this end, a ROXY9 mutant construct was cloned in which the 
Tyr25 codon was exchanged for an alanine codon (ROXY9 CCLCA). In 
addition, it was tested whether the CC-type active site is indispensable for 
ROXY9 activity. Thus, the active site coding sequence of ROXY9 was 
exchanged for the coding sequence of an active site of a class I glutaredoxin 
(ROXY9 CPYC). Both mutant variants were placed under control of the 
CaMV35S promoter and the constructs were stably transformed in A. thaliana 
Col-0. As a control, a plant overexpressing wildtype ROXY9 from the same 
promoter was generated. For each transformation, several homozygous plants 
were isolated and analyzed by Western Blot for the expression of their 
transgene in petioles under different light regimes: Control light, low light 
treatment, and backshift to control light after low light treatment. As controls, 
petioles from Col-0, a former ROXY9 overexpression line (#7-18, [155,156])  
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were included in the analysis. Col-0 + HA-ROXY9 #17-4 had lost the transgene 
during segregation and thus served as an internal control. 
As can be seen in Figure R1, this internal control did not express HA-tagged 
ROXY9, as expected. The same observation was made for the wildtype. Col-0 
+ HA-ROXY9 #7-18, in contrast, expressed the transgene. The newly 
generated line Col-0 + HA-ROXY9 #5-18 expressed the transgene to similar 
levels, whereas Col-0 + HA-ROXY9 #4-40 and #7-25 showed an even higher 
expression. All other ROXY9 lines (#2-22, #17-3, #29-1, #30-7) displayed 
poor or no expression of HA-tagged ROXY9. In contrast to this, most of the 
ROXY9 CCLCA (lines #1-3, #9-10, and #18-10) or ROXY9 CPYC (lines #13-
8, #18-1, #29-3, and #31-4) overexpression lines showed an equal or a stronger 
expression than Col-0 + HA-ROXY9 #7-18. Only lines Col-0 + HA-ROXY9 
CCLCA #29-2 and Col-0 + HA-ROXY9 CPYC #19-10 had a weaker 
expression. Lines Col-0 + HA-ROXY9 CCLCA #37-5, as well as Col-0 + HA-
ROXY9 CPYC #27-3 and #38-5 could not be evaluated since Coomassie 
Brilliant Blue staining of the membrane indicated lower protein amounts in 
general. Regarding the different light regimes, the overall expression seemed 
not to depend on the light treatment; the variations observed might have been 
caused by uneven blotting (e.g. Figure R1, part II, central blot Col-0 + HA-
ROXY9 #7-18). 
Based on this result, the following plant lines were selected to analyze the 
activity of the different ROXY9 mutant variants in comparison to plants 
overexpressing wildtype ROXY9: 
Col-0 + HA-ROXY9 #2-22, #4-40, #5-18, and #7-25 
Col-0 + HA-ROXY9 CCLCA #1-3, #9-10, and #18-10 
Col-0 + HA-ROXY9 CPYC #18-1, #29-3, and #31-4 
As controls, the following plant lines were chosen: 
Col-0 
Col-0 + HA-ROXY9 #7-18 
Col-0 + HA-ROXY9 #17-4 (corresponding to Col-0) 
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Figure R1, part I. Characterization of A. thaliana overexpressing HA-ROXY9 and 
mutant versions of ROXY9 by Western Blot. Col-0 was transformed stably with 
pB2GW7HA-ROXY9, pB2GW7HA-ROXY9 CCLCA, or pB2GW7HA-ROXY9 CPYC. 
Homozygous plants were isolated and grown for 4 weeks in a 12 h light regime. Afterwards, 
the plants were subjected to different light treatments (control light (CL), low light (LL), low 
light followed by control light (LL to CL)) as described in Methods (page 59). Finally, the 
petioles of one or two plants per line were harvested to prepare urea extracts. 10 µg of the 
protein extracts were separated by 15 % SDS-PAGE and analyzed by Western Blot using an 
HA antibody. Afterwards, the membrane was stained with Coomassie Brilliant Blue (CBB) to 
control loading. ROXY9 – Col-0 + HA-ROXY9, CCLCA – Col-0 + HA-ROXY9 CCLCA, 
CPYC – Col-0 + HA-ROXY9 CPYC; 1 – plant 1, 2 – plant 2. The asterisk indicates a rupture in the 
gel. 
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Figure R1, part II. Characterization of A. thaliana overexpressing HA-ROXY9 and 
mutant versions of ROXY9 by Western Blot. Col-0 was transformed stably with 
pB2GW7HA-ROXY9, pB2GW7HA-ROXY9 CCLCA, or pB2GW7HA-ROXY9 CPYC. 
Homozygous plants were isolated and grown for 4 weeks in a 12  h light regime. Afterwards, 
the plants were subjected to different light treatments (control light (CL), low light (LL), low 
light followed by control light (LL to CL)) as described in Methods (page 59). Finally, the 
petioles of one or two plants per line were harvested to prepare urea extracts. 10 µg of the 
protein extracts were separated by 15 % SDS-PAGE and analyzed by Western Blot using an 
HA antibody. Afterwards, the membrane was stained with Coomassie Brilliant Blue (CBB) to 
control loading. ROXY9 – Col-0 + HA-ROXY9, CCLCA – Col-0 + HA-ROXY9 CCLCA, 
CPYC – Col-0 + HA-ROXY9 CPYC; 1 – plant 1, 2 – plant 2. 
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The peculiar active site and Tyr25 of ROXY9 are 
indispensable to repress hyponasty 
 
To examine whether ROXY9 is active when its active site is mutated to CPYC 
or when Tyr25 is mutated into an alanine, three of the Arabidopsis lines 
overexpressing wildtype ROXY9, ROXY9 CCLCA or ROXY9 CPYC were 
examined for their ability to initiate and terminate low light-induced hyponastic 
growth. Col-0 + HA-ROXY9 #17-4 (i.e. Col-0) served as a negative control, 
whereas Col-0 + HA-ROXY9 #7-18 served as a positive control for the 
repressive effect of functional ROXY9 on hyponasty. 
Figure R2 and Supplementary Figures SR1, part I to III summarize the results 
from three independent experiments: 
The leaf angles of wildtype Arabidopsis ranged from 5 to 10°. The plants 
initiated hyponasty when placed in low light conditions leading to an increased 
leaf angle of 15 to 30°. With exception of one experiment (Figure R2C; Figure 
SR1, part III), they also terminated hyponasty when shifted to control light 
conditions after low light treatment. In contrast, Col-0 + HA-ROXY9 #7-18 
showed no or a reduced hyponastic growth, as reported earlier [155,156]. The 
newly generated plants overexpressing HA-ROXY9 showed a similar 
behaviour. In several cases, even negative angles could be observed. 
Interestingly, both, Col-0 + HA-ROXY9 CCLCA and CPYC plant lines were 
able to perform hyponastic growth, reflecting the wildtype behaviour in two 
out of three experiments. In the experiment shown in Figure R2C (Figure SR1, 
part III), both plant lines lowered their leaves upon backshift to control light, 
while the wildtype did not. 
Thus, ROXY9 seems to require its active site and Tyr25 for its repressive activity 
on hyponasty in vivo. 
In consequence of the repressed circadian hyponastic growth, ROXY9 
overexpressing plants exhibit a reduced petiole length [155]. To further support 
the results from the hyponastic growth experiments described before, the 
petiole length of the different overexpression lines in comparison to wildtype 
plants, Col-0 + HA-ROXY9 #17-4 (i.e. Col-0) and Col-0 + HA-ROXY9 #7-18 
was studied. Since in this work, the leaves between the different plant lines 
varied in size, the petiole length relative to the entire leaf length was determined 
(Figure R3). The petioles of wildtype plants were about 45 % of the entire leaf   
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Figure R2. Analysis of hyponastic growth of plants overexpressing HA-ROXY9, HA-
ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, HA-ROXY9 
CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 weeks in 12 h 
light/12 h dark rhythm and then transferred to different light conditions as described in 
Methods (page 59). After the differential light treatments, pictures of the plants in the side view 
were taken with a Canon PowerShot G11 camera and angles of leaf 7 or 8 measured using 
Image J. Bars represent mean ± standard error of the mean (SEM) from at least 4 replicates. 
A, B, and C show three independend experiments. CL – control light, LL – low light, LL to CL – 
shift from low light to control light; Col-0 corresponds to Col-0 + HA-ROXY9 #17-4. 
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Figure R3. Determination of relative petiole length of plants overexpressing HA-
ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 
weeks in 12 h day. Either leaf 7 or 8 from at least 6 different plants was detached and 
photographed from the top with a Canon PowerShot G11 camera. The petiole length and the 
blade length were measured using Image J and the petiole length relative to the entire leaf length 
computed. Bars represent mean ± SEM. Statistical analysis (One-way-ANOVA and Tukey test) 
was performed using GraphPad Prism 8.0.1 assuming normally distributed data. Adjusted p-
values in comparison to Col-0 are indicated above the bars: ns – non-significant, p>0.05, * - p 
≤ 0.05, ** - p-value ≤ 0.01, *** - p-value ≤ 0.001, **** - p-value ≤ 0.0001. 
 
 
length. A similar observation was made for Col-0 + HA-ROXY9 CPYC lines 
and two out of three Col-0 + HA-ROXY9 CCLCA lines. Col-0 + HA-ROXY9 
CCLCA #1-3 petioles were slightly, but significantly shorter. This pattern 
remained the same when analysing additional ROXY9 or ROXY9 mutant 
overexpression lines (Figure SR2). In addition to Col-0 + HA-ROXY9 CCLCA 
#1-3, another plant line (#29-2) exhibited a significantly reduced relative petiole 
length. Since expression of HA-ROXY9 CCLCA in this plant was 
comparatively low, whereas expression of HA-ROXY9 CCLCA in plant line 
#1-3 was strong, the insertion site of the transgene in the genome could lead 
to this effect, since petiole growth is influenced by many factors [250–253]. 
Alternatively, ROXY9 CCLCA might be partially functional regarding certain 
processes or under certain conditions. 
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ROXY9 requires its peculiar active site and Tyr25 to delay 
flowering 
 
Aside from repressing hyponasty, overexpression of ROXY9 was found to 
delay flowering [157]. Thus, the number of days plants overexpressing HA-
ROXY9, HA-ROXY9 CCLCA, or HA-ROXY9 CPYC needed to initiate a 
floral stem of ca. 1 cm length was determined. On this day, the number of 
leaves of each plant was counted to check whether the plant is generally 
retarded in development or whether it exhibits a specific delay in flowering. As 
controls, Col-0, Col-0 + HA-ROXY9 #17-4 and Col-0 + HA-ROXY9 #7-18 
were used. The data is depicted in Figure R4 and Figures SR3. 
Wildtype plants flowered after ca. 27 to 28 days, whereas plants overexpressing 
ROXY9 formed floral stems after ca. 35 days, a significant delay (Figure R4A). 
HA-ROXY9 CCLCA- or HA-ROXY9 CPYC-overexpressing plants flowered 
about the same time as wildtype plants. This suggests, that ROXY9 is inactive 
in delaying flowering when Tyr25 is mutated or when the active site is exchanged 
for CPYC. 
While wildtype plants and HA-ROXY9 CCLCA or CPYC-overexpressing 
plants had at maximum 15 leaves on average at the onset of flowering, Col-0 + 
HA-ROXY9 #7-18, #2-22, #4-40, #5-18, and #7-25 showed at least 16 leaves 
at this time point (Figure R4B). However, with exception of a single plant line 
(#2-22), this difference was statistically not significant. Still, ROXY9 
overexpressing plants formed additional, smaller leaves in between the ≥16 
leaves. This feature was also observed for two out of six plants of Col-0 + HA-
ROXY9 CCLCA #1-3 though this plant exhibited 14.7 leaves at flowering. 
Despite the lack of a significant difference between the numbers of the counted 
leaves, the occurrence of these additional, smaller leaves might suggest that the 
delay in flowering is accompanied by an increase in the leaf number. This hints 
that ROXY9 delays flowering, but not development. Analysis of additional 
transgenic plant lines (Figure SR3) confirmed the observations and showed that 
the phenotype required a strong expression of the transgene in case of HA-
ROXY9 transformants (Figures R1 and SR3): Whereas weakly expressing 
plants (#17-3, #29-1 and #30-7) flowered like wild type plants, plants 
expressing the transgene strongly showed the retardation (e.g. #2-22 and #4-
40). 
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Figure R4. Flowering time point and leave number at flowering of plants 
overexpressing HA-ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants 
overexpressing HA-ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S 
promoter were grown under long day conditions. The number of days were counted until a 
1 cm floral stem could be observed (A). At this time point, the number of leaves was 
determined (B). Bars represent mean ± SEM from at least 5 replicates. Statistical analysis (One-
way-ANOVA and Tukey test) was performed using GraphPad Prism 8.0.1 assuming normally 
distributed data. Adjusted p-values in comparison to Col-0 are indicated above the bars: ns – 
non-significant, p>0.05, * - p ≤ 0.05, ** - p-value ≤ 0.01, *** - p-value ≤ 0.001, **** - p-value 
≤ 0.0001. a - smaller leaves in between counted leaves for all replicates, b - smaller leaves in between counted 
leaves for all except for 1 replicate, c – smaller leaves in between counted leaves for 2 replicates out of 6 
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In vitro characterization of ROXY9 
_____________________________________________________________________ 
 
The composition of the active site in ROXY9 and Tyr25 are important for the 
activity of the protein in vivo. Since CC-type glutaredoxins are poorly 
understood at the biochemical level [176], it cannot be deduced why these 
residues are indispensable for ROXY9 function. To approach the importance 
of these amino acids, a biochemical study of ROXY9 was initiated. For this, 
ROXY9 should be produced recombinantly and analyzed for typical 
glutaredoxin activities, such as reductase and oxidase activity, glutathione 
binding and the association with iron-sulfur clusters [1]. 
 
 
Recombinant ROXY9 is aggregated when produced in 
E. coli, but can be purified from insect cells 
 
CC-type glutaredoxins are difficult to express and/or purify. The only 
biochemical study about CC-type glutaredoxins to date analyzed a chimeric 
protein composed of a CPYC glutaredoxin in which a CC-type active site was 
inserted and a CC-type glutaredoxin deleted for the ALWL motif at its C-
terminus. Both proteins were produced in E. coli and purified via a His tag 
[176]. Having the expression difficulties in mind, ROXY9 was decided to be 
expressed as a SUMO fusion protein to support expression and solubility [254]. 
Thus, ROXY9 was cloned via the Gateway system in the expression vector 
pGP172-SUMO-GW, placing the gene in frame to an N-terminal strep-SUMO 
tag under control of the T7 promoter and terminator. The expression vector 
was transformed in E. coli BL21 or BL21-star, expressed at 30°C for 3 to 4 h 
and purified via its strep tag. As shown in Figure R5, the 27 kDa fusion protein 
could be purified successfully. It migrated at 35 kDa during SDS-PAGE, 
However, due to its low isoelectric point (pI) of 6.01 which is expected to 
accelerate the migration during SDS-PAGE, the reasons for this migration 
behaviour are unclear (Figure R5A). When separating strep-SUMO-ROXY9 by 
native PAGE (Figure R5B), two bands, one at 720 kDa and one slightly below 
appeared. Moreover, a smear ranging from the band at 720 kDa to the bottom   
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Figure R5. Purification of strep-SUMO-ROXY9 from E. coli. Strep-SUMO-ROXY9 was 
expressed from pGP172-SUMO-ROXY9 in BL21-star. The protein was purified via a 
StrepTactin gravity flow column as described in Methods (page 87) and 10 µl of CE, FT, and 
E1 to E4 and 20 µl of W4 were separated by 12 % SDS-PAGE (A). The gel was stained with 
Coomassie Brilliant Blue. Prestained PageRuler was used as a size standard. The arrow points 
at the band of strep-SUMO-ROXY9. The asterisk marks a contamination from StrepTactin-
based purification. To determine the oligomerization state of purified strep-SUMO-ROXY9, 
50 µl of fraction E2 were analyzed by native PAGE using a a 4 to 20 % gradient gel (B). 
NativeMark Protein Standard Unstained (Fermentas) was used as a size standard. The gel 
underwent Coomassie staining. M – Marker, CE – crude extract, FT – flowthrough, W4 – wash 4, 
E1 to E4 – eluate 1 to 4, R9 – strep-SUMO-ROXY9. 
 
 
of the well was observed. Altogether, this indicates that strep-SUMO-ROXY9 
forms high-molecular weight aggregates. 
Despite a multitude of attempts to optimize the purification of strep-SUMO-
ROXY9 (such as different buffer conditions or renaturation, data not shown), 
it was impossible to obtain lower molecular weight species of strep-SUMO-
ROXY9 from E. coli. Finally, the expression host was changed to insect cells 
(Trichoplusia ni). Thus, ROXY9 was cloned via the LIC method in the 
expression vector 438C_strep, fusing it N-terminally to a strep-MBP tag, and 
expressed in insect cells by Isaac Fianu (Department for Molecular Biology, 
Prof. Dr. Patrick Cramer, MPI for Biophysical Chemistry, Göttingen). The 
protein was purified via its MBP tag using an ÄKTA purifier. The 
chromatogram from the purification (Figure R6A) showed a broad absorption 
plateau for fractions 1 to 7, corresponding to the flowthrough (Figure R6B). 
After switching to 100 % Buffer B for elution, a large peak with a maximum of   
Results 
133 
 
 
 
Figure R6. Purification of strep-MBP-ROXY9 from insect cells. Strep-MBP-ROXY9 was 
expressed in T. ni Hi5 cells and purified via an MBPTrap column using an ÄKTA system. (A) 
shows the chromatogram of the purification procedure. Buffer B corresponds to 1x MBP 
elution buffer. 10 µl of each fraction were analyzed by 10 % SDS-PAGE. The gels were stained 
with Coomassie Brilliant Blue (B). The arrow indicates the migration height of strep-MBP-
ROXY9. Prestained PageRuler (Thermo Scientific) was used as a molecular weight standard. 
mAU – milli absorption units, M – Marker, CE – crude extract, 1 to 35 – fraction number. 
 
ca. 2000 mAU in fractions 20 to 21 was observed (Figure R6A). As revealed by 
SDS-PAGE (Figure R6B), this peak corresponded to strep-MBP-ROXY9 (ca. 
59 kDa). Concentration measurements according to Bradford indicated that ca. 
20 mg strep-MBP-ROXY9 could be obtained from a 600 ml insect cell culture 
with a concentration of ca. 5 mg/ml (80 µM) in the most highly concentrated 
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fractions (data not shown). Importantly, when separating strep-MBP-ROXY9 
purified from insect cells by native PAGE (Figure R7), a band at ca. 242 kDa 
could be detected. Excluding anomalous migration in native PAGE, this band 
could correspond to a tetramer of strep-MBP-ROXY9. The distinct aggregates 
observed for strep-SUMO-ROXY9 purified from E. coli could not be detected 
anymore for strep-MBP- ROXY9. Only a faint smear could be observed above 
the band at 242 kDa. 
To further confirm, that strep-MBP-ROXY9 is not present in aggregates, 
analytical gel filtration was performed in cooperation with the group of Prof. 
Dr. Kai Tittmann (Georg-August-University, Göttingen). The chromatogram 
of strep-MBP-ROXY9 (Figure R8A) showed two peaks, a smaller one with a 
maximum at 8.08 ml and a larger one with a maximum at 14.71 ml. The first 
peak likely corresponds to aggregated protein and its maximum was thus used 
as the void volume for the calculation of the molecular weight. The second 
peak (fraction 31) corresponded to a species of strep-MBP-ROXY9 the size of 
which was within the range of the standard (Figure R8B). From this peak, a 
molecular weight of 61 kDa could be calculated for strep-MBP-ROXY9, which 
is close to its theoretical molecular weigth of 59 kDa (Figure R8C and D). 
Consequently, analytical gel filtration indicated that strep-MBP-ROXY9 might 
form a monomer, which contrasts with the results from native PAGE (Figure 
R7). Despite the contrasting results from native PAGE and analytical gel 
filtration, it is evident that strep-MBP-ROXY9 purified from insect cells is 
largely soluble and non-aggregated. 
 
 
Figure R7. Analysis of the oligomerization state of 
strep-SUMO-ROXY9 and strep-MBP-ROXY9. Strep-
SUMO-ROXY9 was expressed in E. coli and purified via 
StrepTactin resin. Strep-MBP-ROXY9 was purified from 
insect cells via an amylose resin. 50 µl of strep-SUMO-
ROXY9 E2 and ca. 4.5 µg of strep-MBP-ROXY9 were 
separated by native PAGE (4 – 20 % gradient). 
NativeMark Protein Standard Unstained (Fermentas) was 
loaded as a size standard. The gel was stained with 
Coomassie. The arrow point shows strep-MBP-ROXY9. 
M – marker.  
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Figure R8. Analytical gel filtration of strep-MBP-ROXY9. At least 700 µg of strep-MBP-
ROXY9 purified from insect cells were passed over a SuperdexTM 200 10/300 GL gel filtration 
column in 1x MBP lysis buffer with DTT. The column was calibrated by performing three runs 
of the BioRad gel filtration standard in the same buffer. (A) shows the overlay of the 
chromatograms for the single strep-MBP-ROXY9 run and one of the calibration runs. Black 
numbers above the peaks indicate the molecular weigths of the proteins in the standard. The 
asterisk marks the peak of vitamin B12 in the standard. Because this peak did not continue the 
linear correlation between Kav and log(MW), it was not taken into account for linear regression. 
(C) shows the linear correlation between Kav and log(MW). The equation obtained after linear 
regression and its R2 value are shown in the diagram. The data points of the standard are shown 
in yellow, the data point for strep-MBP-ROXY9 is shown in blue. Table (D) summarizes the 
calculation of the molecular weigth of strep-MBP-ROXY9 from the volume at its peak 
maximum. (B) shows a 12 % SDS-PAGE gel on which a sample before gel filtration (Before) 
and the indicated gel filtration fractions were separated. The gel was stained with Coomassie. 
Prestained PageRuler was used as a size standard. The arrow points at strep-MBP-ROXY9. M 
– marker, MW – molecular weigth.  
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Strep-MBP-ROXY9 purified from insect cells can interact 
with GFP-TGA1 
 
ROXY9 was shown previously to interact with the transcription factor TGA1 
(At5g65210) in yeast-two-hybrid experiments and in pulldown experiments 
with proteins expressed in Arabidopsis leaf protoplasts [156,157]. Moreover, it 
interacts with the transcriptional repressor JAZ9 (At1g70700) in a yeast-two-
hybrid experiment [178]. This information was exploited to test whether 
purified strep-MBP-ROXY9 is expressed in a functional conformation. To this 
end, the purified protein should be tested for its interaction with recombinant 
TGA1 and JAZ9 via a pulldown experiment in vitro. 
As a negative control for the pulldown experiment, strep-MBP should be used. 
Thus, strep-MBP was expressed from the plasmid pGP172-MBP in E. coli and 
purified via an amylose column using an ÄKTA purification system. The 
purification was checked by SDS-PAGE (Figure R9). The protein preparation 
was pure with exception of an equally strong band right below strep-MBP. The 
identiy of this protein is unknown. Still, the preparation was used for the 
pulldown experiment (Figure R10). 
 
 
 
Figure R9. Purification of strep-MBP from E. coli. Strep-MBP was expressed from the 
plasmid pGP172-MBP in E. coli and purified using an ÄKTA purification system supplied with 
an MBPTrap column. The success of the purification was analyzed by loading 20 µl of CE, 
20 µl of fractions 3 to 9, and 30 µl of fractions 10 to 19 on a gradient SDS gel (4 – 20 %). 
Prestained PageRuler (Thermo Scientific) was used as a molecular weight standard. After the 
run, the gels were stained with Coomassie. The arrow marks the band most likely 
corresponding to strep-MBP while the asterisk marks a band belonging to an unknown protein 
which was co-purified. M – Marker, CE – crude extract, FT – flowthrough, W – wash, E – elution, 1 
to 19 – fraction number.  
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Figure R10. Co-purification of GFP-TGA1 and His-MBP-JAZ9 using strep-MBP or 
strep-MBP-ROXY9. 1 µM purified strep-MBP and strep-MBP-ROXY9 was incubated with 
His-MBP-JAZ9 and GFP-TGA1 crude extracts prepared after expression of these proteins in 
E. coli. Strep-MBP and strep-MBP-ROXY9 were purified from the mixture using StrepTactin 
beads and co-purifucation of His-MBP-JAZ9 and GFP-TGA1 was analyzed. For this, 10 µl of 
the Input (I) and Elution (E) fractions, and 11 µl of the Unbound (U) fraction were separated 
by non-reducing SDS-PAGE using precast gradient gels (4-20 %). Western Blots of the gels 
were made. His-MBP-JAZ9 and GFP-TGA1 were detected using a His antibody (B) and a 
GFP antibody (D), respectively. To control even amounts of strep-MBP and strep-MBP-
ROXY9 in the different samples, Western Blots were detected with a strep antibody (A and 
C). M – Marker. 
 
For the pulldown, strep-MBP and strep-MBP-ROXY9 were coupled to 
StrepTactin sepharose and crude extracts from E. coli cells expressing either 
GFP-TGA1 or His-MBP-JAZ9 were passed over the columns. Input, 
Unbound and Elution fractions were analyzed by Western Blot. Strep-MBP 
and strep-MBP-ROXY9 were detected to ensure equal loading (Figure R10A 
and C). Similar amounts of both proteins were present in the different fractions, 
showing that they could be successfully purified. In contrast, His-MBP-JAZ9 
could only be detected in the Input and in the Unbound fraction, but neither 
in the elution of the strep-MBP- or the strep-MBP-ROXY9-coupled beads 
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(Figure R10B). Likewise, GFP-TGA1 was present in Input and Unbound 
samples of strep-MBP and strep-MBP-ROXY9-covered beads (Figure R10D). 
However, GFP-TGA1 could be co-purified with strep-MBP-ROXY9, but not 
with strep-MBP. This result suggests that strep-MBP-ROXY9 can interact with 
GFP-TGA1, but not with His-MBP-JAZ9. The lack of the co-purification of 
His-MBP-JAZ9 could have several reasons, ranging from compromised 
binding e.g. due to the large MBP tags fused to both proteins to a truly missing 
interaction. The interaction between ROXY9 and JAZ9 is not as well 
supported by experiments as the interaction between ROXY9 and TGA1. 
Since this well-known interaction could be reproduced, strep-MBP-ROXY9 
was considered to be in a functional state when purified from insect cells and 
was thus used for further analyses. 
 
 
Strep-MBP-ROXY9 is partly oxidized after removal of 
DTT 
 
Strep-MBP-ROXY9 is a glutaredoxin containing five cysteines, three of which 
are in the active site. Since this type of protein depends on reduced cysteine 
residues for activity, strep-MBP-ROXY9 was purified in the presence of at least 
1 mM DTT. However, DTT as a strong reductant interferes with assays to test 
glutaredoxin activity. Thus, DTT was removed by dialysis before the 
experiments to address the catalytic activity of strep-MBP-ROXY9. After 
removal of DTT by dialysis, Ellman’s reagent [248] was used to determine the 
number of reduced cysteines per molecule of strep-MBP-ROXY9 using an L-
cysteine standard curve (Figure R11, sample A). A sample of 74 µM strep-
MBP-ROXY9 contained 138 µM free thiol groups, corresponding to 
approximately two out of five reduced cysteines per protein molecule. Thus, 
strep-MBP-ROXY9 was only partly reduced after purification and DTT 
removal. Preincubation of such a protein preparation with DTT for 20 min and 
removal of DTT immediately before the Ellman’s assay also caused two 
reduced cysteines per strep-MBP-ROXY9 (Figure R11, sample B). However, 
treatment with H2O2 for 20 min and removing it by a desalting column 
increased the oxidation of strep-MBP-ROXY9 to one reduced cysteine per 
protein (Figure R11, sample C), suggesting that strep-MBP-ROXY9 after DTT 
removal is not in its maximally oxidized state. 
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Figure R11. Number of reduced cysteines in strep-MBP-ROXY9 under different 
oxidative and reductive conditions. Strep-MBP-ROXY9 was exposed to the three different 
treatments described in A. Afterwards, the number of reduced cysteines was determined using 
Ellman’s reagent. A calibration curve with L-cysteine was prepared in triplicate (mean ± 
standard deviation (SD) was plotted) (B) and used to calculate the number of reduced cysteines 
per protein (C). The samples were measured in triplicate and the protein concentration was 
determined with Bradford solution.  
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Strep-MBP-ROXY9 does neither reduce HEDS, insulin 
nor glutathionylated GAPDH after removal of DTT 
 
Despite strep-MBP-ROXY9 being partially oxidized, the protein was tested for 
its catalytic activity in vitro: The reduction capacity towards the artificial 
substrate HEDS and the deglutathionylation activity towards the protein 
substrate GAPDH, as well as the protein disulphide reduction activity towards 
insulin were assayed. As positive controls, the well characterized human 
glutaredoxin Grx1 [242,255–257] and the plant glutaredoxin GRXC2 from 
A. thaliana were chosen. The GRXC2 homolog in poplar was already 
characterized regarding its catalytic properties [77] and also for A. thaliana 
GRXC2, a catalytic activity was recently described [88]. 
Grx1 was expressed as a strep-SUMO fusion in E. coli and purified via its strep-
tag (Figure R12). The 27 kDa protein showed the same anomalous migration 
as already observed for strep-SUMO-ROXY9 during SDS-PAGE (Figure 
R5A). Since the purification necessitated the use of low-salt buffer, some 
contaminations with E. coli proteins remained in elution fractions 2 and 3 of 
strep-SUMO-Grx1. GRXC2 was fused to a strep-MBP-tag and expressed in 
E. coli, as well. The protein was purified via its MBP tag using an ÄKTA purifier 
(Figure R13). After switching to the elution buffer B, only two small peaks 
could be detected by measuring A280nm (Figure R13A). SDS-PAGE showed, 
 
 
Figure R12. Purification of strep-
SUMO-Grx1 from E. coli. Strep-MBP-
Grx1 was expressed in E. coli BL21-star 
and purified using a StrepTactin gravitiy 
flow column. 12 % SDS-PAGE and 
Coomassie staining visualized the course 
of the purification. 10 µl of CE, FT, and 
E1 to E3, and 20 µl of W4 were loaded. 
Prestained PageRuler (Thermo Scientific) 
was employed as a size standard. The 
arrow shows the band of strep-SUMO-
Grx1. M – Marker, CE – crude extract, FT – 
flowthrough, W4 – wash 4, E1 to E3 – eluate 1 
to 3 
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Figure R13. Purification of strep-MBP-GRXC2 from E. coli. Strep-MBP-GRXC2 was 
expressed in E. coli BL21-star and purified via its MBP tag using an ÄKTA purification system. 
Purification was monitiored by following A280nm (A). Buffer B represents 1x MBP elution buffer 
with 50 mM NaCl. 20 µl of each fraction were separated by 10 % SDS-PAGE. The gels were 
stained with Coomassie (B). The arrow points at strep-MBP-GRXC2, whereas the asterisk 
marks the strep-MBP tag. Prestained PageRuler (Thermo Scientific) was used as a size standard. 
mAU – milli absorption units, M – Marker, CE – crude extract, 1 to 33 – fraction number. 
 
 
that the first peak (fraction 28) corresponded to almost pure strep-MBP-
GRXC2 in very low amounts. The second peak belonged to a mixture of strep-
MBP-GRXC2 with strep-MBP tag (Figure R13B, fractions 29 and 30). For this 
reason, the concentration of strep-SUMO-Grx1 fraction E1 and strep-MBP-
GRXC2 Fraction 28 was determined using Bradford solution. When other 
elution fractions were used, the concentration was estimated by loading a 
known volume of the protein preparation on an SDS gel together with 
different, defined amounts of BSA. Both proteins were dialysed to remove 
DTT from the purification and tested along with strep-MBP-ROXY9 for 
catalytic activity. 
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First, the deglutathionylation and/or disulphide reduction activity of all three 
proteins towards HEDS was addressed (Figure R14A and B). For both, strep-
SUMO-Grx1 and strep-MBP-GRXC2, 5, 25 and 50 nM protein were tested. 
For strep-MBP-ROXY9, the ten-fold concentrations were used. As a negative 
control, a reaction without enzyme, but with glutathione was used. Reduction 
activity was visualized by coupling the glutaredoxin reaction to the NADPH-
consuming reaction of GSSG reductase. As shown in Figure R14B, GSH alone 
led to a slow decline in the absorption at A340nm. Strep-SUMO-Grx1 and strep-
MBP-GRXC2 did not differ from the no-enzyme control when they were used 
at concentrations of 5 nM. At 25 and 50 nM, however, a deglutathionylation 
activity could be detected by the stronger decrease in A340nm. Strep-MBP-
ROXY9 was not different from the no-enzyme control even though it was used 
in higher concentrations than the two control proteins, suggesting that it is 
unable to reduce HEDS. 
Next, the capacity of all three proteins to reduce the intermolecular disulfides 
in insulin was addressed (Figure R14A, C and D). The concentrations of the 
proteins used were the same as for the HEDS assay. As a control served a 
sample containing GSH but lacking a glutaredoxin. Precipitation of the 
insoluble B chain of bovine insulin was followed by the increase in A650nm. The 
negative control led to an increase in the absorption after 1.5 h, indicating that 
GSH alone caused reduction of insulin to a small extent (Figure R14D). Strep-
SUMO-Grx1 and strep-MBP-GRXC2 were active at a concentration of 25 and 
50 nM, but not or only weakly at a concentration of 5 nM (Figure R14C and 
D). Similarly, strep-MBP-ROXY9 used at a concentration of 50 nM did not 
reduce insulin to a higher extent than observed for the no-enzyme control. 
However, at 250 and 500 nM, strep-MBP-ROXY9 even seemed to slow down 
the reduction rate observed for glutathione alone (Figure R14D). 
Because we could only observe this so far unexplainable effect of strep-MBP-
ROXY9 towards insulin and no activity towards HEDS, we decided to use a 
protein substrate to test deglutathionylation. For this reason, strep-SUMO-
Grx1 and strep-MBP-ROXY9 were tested for their deglutathionylation 
capacity towards glutathionylated GAPDH. As outlined in Methods (page 103), 
this assay relies on the inactivation of GAPDH by glutathionylation of its 
catalytic cysteine residue (GAPDH-SG) and reactivation by deglutathionylation 
through glutaredoxins [37]. Deglutathionylation is indirectly determined via the 
activity of GAPDH, the reaction of which needs reduced nicotinamid adenine 
dinucleotide (NADH) [37,78]. Figure R14E displays the initial velocity of 
GAPDH and GAPDH-SG after different time points of incubation with or 
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without glutaredoxin. As controls, non-glutathionylated GAPDH, 
glutathionylated GAPDH and GAPDH-SG treated with DTT were used. The 
deglutathionylation of GAPDH-SG caused by GSH alone was determined by 
omitting the enzyme in the reaction mix. Whereas non-glutathionylated 
GAPDH was active, GAPDH-SG was completely inactive in this assay. 
Reactivation of GAPDH-SG with an excess of DTT restored GAPDH activity, 
though not to the same levels as observed for GAPDH. This might be 
explained by partial reduction or by protein losses caused by the preparation 
procedure of GAPDH-SG, as the GAPDH activity measured for the non-
glutathionylated control is caused by the maximum possible GAPDH 
concentration within the experiment. Glutathione treatment led to a much 
smaller enhancement of GAPDH activity over time, indicating that it restored 
GAPDH activity though not as efficiently as DTT. Strep-SUMO-Grx1 at a 
concentration of 40 nM reactivated approximately twice as much GAPDH as 
glutathione. After removal of DTT by dialysis, strep-MBP-ROXY9, although 
used again at almost ten-fold higher concentrations than strep-SUMO-Grx1, 
exhibited a weak to no activity compared to glutathione. 
Assuming that ROXY9 might only act on a subset of proteins, redox-sensitive 
GFP (roGFP) was selected as another target to test for deglutathionylation 
activity of strep-MBP-ROXY9. This experiment was performed by Lara 
Ostermann (INRES, Prof. Dr. Markus Schwarzländer, Bonn). During this 
experiment, roGFP is first oxidized (roGFPox) and then incubated with GSH 
or GSH and glutaredoxin. The redox state of roGFP determines its 
fluorescence emission intensity at 510 nm after excitation at 400 nm and 
482 nm. Oxidation of the protein leads to an increase of its fluorescence 
emission after excitation at 400 nm, whereas reduction causes an increase in 
the fluorescence emission after excitation at 482 nm [244]. Thus, redox 
reactions can be followed by monitoring the ratio of F400nm/F482nm. Samples 
containing roGFPox showed a high fluorescence ratio, while samples containing 
roGFPred showed a low fluorescence ratio (Figure SR4). In this experiment, 
GRXC1 from Arabidopsis purified by the department for Chemical Signalling 
(INRES) in Bonn was used as a positive control. Strep-MBP-ROXY9 was 
dialysed against the reaction buffer, thereby removing DTT. This treatment 
leads to an oxidation of the protein (Figure R11, sample A). The control 
protein, GRXC1, was used in the oxidized state in which it was purified. 
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Figure R14, part I. In vitro reductase activity of strep-MBP-ROXY9 when DTT is 
removed by dialysis. Different concentrations of strep-SUMO-Grx1, strep-MBP-GRXC2 
and strep-MBP-ROXY9 (A) were analyzed in the HEDS (B) and the insulin assay (C and D) 
for reductase activity. The diagrams show the change in the absorption at 340 nm (HEDS) and 
650 nm (insulin) over time. In case of the insulin assay, the measurement was continued after 
a break at 4.5 h (C) for another 4.5 h (D). Each reaction was prepared only once. 
 
  
Results 
145 
 
 
 
Figure R14, part II. In vitro reductase activity of strep-MBP-ROXY9 when DTT is 
removed by dialysis. (E) Strep-SUMO-Grx1 and strep-MBP-ROXY9 were compared in the 
GAPDH assay. For this, ca. 40 nM of strep-SUMO-Grx1 and ca.300 nM strep-MBP-ROXY9 
were added together with GSH to the reaction mixtures containing maximally 9.6 µM 
glutathionylated GAPDH (GAPDH-SG). The GAPDH activity was assessed by withdrawing 
aliquots during the reaction and measuring the velocity of GAPDH (v(GAPDH)) in these 
samples. The initial velocity of GAPDH was plotted over the timepoints at which a sample 
was taken. Treatment of GAPDH-SG with DTT or GSH alone served as controls. 
Additionally, a sample of untreated GAPDH-SG and 9.6 µM GAPDH were analyzed. All 
samples in the GAPDH assay were prepared only once. (F and G) strep-MBP-ROXY9 and N-
terminally His-tagged GRXC1 were compared regarding the reduction of oxidized roGFP2. 
Strep-MBP-ROXY9 and GRXC1 were used in an oxidized state. The indicated amounts of 
GRXC1 (F) and strep-MBP-ROXY9 (G) were incubated with or without GSH and oxidized 
roGFP. The reactions were started after 10 min of preincubation. The initial velocity of these 
reactions measured in the linear reaction phase between minutes 13 and 15 was plotted in the 
bar charts. Values represent mean ± SD.  
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Figures R14F and G display the slope of the increasing reduction of roGFP for 
samples containing 0, 1, 2, or 5 µM of glutaredoxin, either with or without 
glutathione. The fluorescence changes over the entire experiments are shown 
in Figure SR4. GRXC1 (Figure R14F) led to a significant increase in the amount 
of reduced roGFP compared to the controls without glutathione and without 
enzyme, or with glutathione alone. However, the reduction of roGFP by 
GRXC1 depended on glutathione, as no activity was observed for samples 
containing enzyme, but lacking glutathione. In contrast, for strep-MBP-
ROXY9, only the background activity caused by glutathione could be observed, 
even when protein was added to the reaction mixture (Figure R14G). Thus, 
while GRXC1 reduced roGFPox, strep-MBP-ROXY9 did not. 
 
 
Strep-MBP-ROXY9 oxidizes quickly after removal of DTT 
 
The lack of a reductase activity for strep-MBP-ROXY9 could be caused by the 
partial oxidation of the protein. Because glutathione is a reductant and is 
present in the reaction mixtures of all glutaredoxin activity assays, strep-MBP-
ROXY9 purified in the presence of DTT should be dialyzed against buffer 
containing glutathione in order to prevent oxidation of the protein. Because 
glutathione interferes with the Ellman’s method, a first attempt to determine 
the oxidation state of strep-MBP-ROXY9 when dialyzed against glutathione by 
mass spectrometry was made. In addition, protein purified with DTT and 
protein from which DTT was removed by dialysis, as well as protein incubated 
for only 10 min with glutathione, was analyzed. At the end of the respective 
treatment, all samples were immediately precipitated with TCA and then 
labelled with IAM and iodoTMT: For this, first, all reduced cysteines were 
blocked with IAM. Subsequently, all oxidized cysteines were reduced with 
TCEP. Finally, all cysteine residues reduced by TCEP were labelled with 
iodoTMT. Thus, all originally reduced cysteine residues are marked by IAM 
whereas all originally oxidized cysteine residues are labelled with iodoTMT. For 
analysis of the MS data (Supplementary table SR1, part I to IV; Figures R15 
and SR5), the number of independent identifications (PSMs) was normalized 
to the number of independent identifications of two different, unmodified 
peptides from the MBP tag. For normalization, only those peptides which were 
fully labelled and completely cleaved by trypsin were chosen, because they were 
Results 
147 
 
present in all samples and corresponded to the most abundant peptides. This 
normalization allowed a comparison between different treatments for the same 
peptide. All other peptides, which were sometimes not found in all samples, 
were considered qualitatively. 
Data analysis showed that protein containing DTT was the most strongly 
reduced preparation of all regarding the active site (Figure R15A to D and 
SR5A to D). Still, oxidized peptides were discovered in this sample, but their 
amount cannot be deduced. Removal of DTT, as well as introducing GSH by 
dialysis while removing DTT resulted in an increase of strep-MBP-ROXY9 
with one or none reduced cysteine residues within the active site compared to 
the DTT-treated sample (Figure R15C and D and SR5C and D). The sample 
treated for 10 min with GSH after removal of DTT showed constantly low 
amounts of the different peptides (Figure R15A to D and SR5A to D). Cys49 
was partially oxidized and partially reduced. The extent of reduction or 
oxidation did not vary much between the different treatments (Figure R15E 
and F and SR5E and F). Similar observations were made for Cys61 with 
exception of the sample which was treated for 10 min with glutathione (Figure 
R15G and H and SR5G and H). As for the active site peptides, this 10 min 
glutathione treatment led to the lowest normalized PSMs for all oxidation states 
analyzed. However, the effect was less pronounced compared to the active site 
peptides. Because the initial PSM values are normalized to the amount of 
protein analyzed by MS, these low numbers of peptides cannot result from 
lower protein amounts in general. Additionally, the peptides could be detected 
in other samples excluding difficulties with separation and detection of these 
peptides during MS. Instead, the low normalized PSM values might result from 
incomplete labelling and/or incomplete cleavage. Several not fully labelled or 
cleaved peptides were detected in the four samples (Supplementary table SR1). 
Importantly, as not each of these peptides was detected throughout all samples, 
their number cannot be estimated. Thus, they represent an unknown variable 
in this analysis. Similarly, this analysis did not include a search for peptides 
linked by or containing disulphide bridges or cysteine residues oxidized to 
sulfonic acids. Whereas disulphide bridges can in principle be detected 
indirectly via reduction with TCEP and iodoTMT labelling, sulfonic acids 
cannot be reduced by TCEP and therefore escape labelling with iodoTMT 
[258]. However, enhanced sulfonic acid formation after 10 min treatment with 
the reducing agent glutathione seems unlikely. 
Considering the whole dataset, the contribution of sulfonic acid formation to 
the number of oxidized peptides and of those modifications which cannot be  
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Figure R15. Analysis of the strep-MBP-ROXY9 redox state by LC-MS/MS. Strep-MBP-
ROXY9 was purified from insect cells in the presence of DTT and subjected to different 
oxidizing and reducing treatments: (1) Dialysis to remove DTT; (2) Dialysis to remove DTT 
and then incubation for 10 min with GSH; (3) Dialysis against buffer containing GSH, to 
remove DTT while simultaneously applying GSH. All samples were labeled with IAM (reduced 
cysteines) and iodoTMT (oxidized cysteines), separated in a 10 % non-reducing SDS-PAGE 
and analyzed by LC-MS/MS as described in Methods (pages 109-110 and 115-119). To allow 
quantification, the number of different PSMs for each peptide and modification was 
normalized to the number of PSMs of an unmodified peptide resulting from the MBP tag 
(LYPFTWDAVR [1267,64698 Da]). As this allows only comparison of the abundance of 
specific peptides between treatments, the values for the normalized PSMs were plotted 
accordingly: active site-containing peptides with none (A), one (B), two (C) or three (D) 
oxidized cysteines; peptides containing Cys49 in a reduced (E) or oxidized (F) state; peptides 
containing Cys61 in a reduced (G) or oxidized state (H). Please note that the diagrams show 
only the properly cleaved and fully labelled peptides of each sample. They are the most 
abundant peptides in each sample. All other peptides are listed in Supplementary table SR1.  
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quantified is impossible to estimate. For these reasons, the entire the mass 
spectrometry analysis must be considered with caution. Despite these 
limitations, the data from the fully labelled and fully cleaved peptides suggested 
that strep-MBP-ROXY9 is only partially reduced, even in presence of DTT, 
and oxidizes more strongly in the active site, when DTT is removed or 
exchanged for glutathione. However, the nature of these redox modifications 
and the precise proportion of oxidized protein in all samples except for that 
from which DTT was removed by dialysis (Figure R11, sample A) remain 
elusive. 
 
 
Strep-MBP-ROXY9 can weakly deglutathionylate 
GAPDH-SG when dialyzed prior to the experiment against 
glutathione and when used in higher concentrations 
 
Assuming that the increased oxidation observed for the active site in case of 
dialysis against GSH was caused by glutathionylation and disulphide bond 
formation which play a role during catalysis [74,101], strep-MBP-ROXY9 and 
the control proteins, strep-MBP-Grx1 and strep-MBP-GRXC2, were dialysed 
against glutathione before the reductase assays. To avoid an influence of the 
low glutathione amounts in the protein preparation after dialysis, all reactions 
without enzyme contained the same amount of dialysis buffer instead of 
glutaredoxin. 
When analysing 1 µM strep-MBP-ROXY9 along with 20 nM strep-SUMO-
Grx1 and 30 nM strep-MBP-GRXC2 in the HEDS (Figure R16A and C) and 
in the insulin assay (Figure R16B and C), strep-SUMO-Grx1 and strep-MBP-
GRXC2 showed a reductase activity. This reductase activity, however, was not 
evident for strep-MBP-ROXY9. As before when dialysed to remove DTT, 
strep-MBP-ROXY9 showed apparently an inhibition of reduction in the insulin 
assay. 
When the GAPDH assay was repeated under the new conditions (Figure 
R16D), again, strep-SUMO-Grx1 (70 nM) and strep-MBP-GRXC2 (100 nM) 
were able to reactivate glutathionylated GAPDH. Different amounts of strep- 
MBP-ROXY9 ranging from ca. 3 µM down to 300 nM were analysed in   
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Figure R16. In vitro reductase activity of strep-MBP-ROXY9 when the protein is 
dialyzed against GSH. Strep-SUMO-Grx1, strep-MBP-GRXC2, and strep-MBP-ROXY9 
were dialyzed against buffer containing GSH to remove DTT and concomittantly introducing 
GSH into the sample. Then, their activity was compared using the indicated protein 
concentrations (C) in the HEDS (A) and the insulin assay (B). In (A) and (B), the absorption 
values represent the mean of three technical replicates ± SD, except for the no enzyme control 
for which only one reaction was prepared. The three proteins were also analyzed in the 
GAPDH assay (D). The concentrations used in the GAPDH assay are shown in the legend 
below the corresponding diagram. As described before, the reductase activty was measured by 
the decline in absorption at 340 nm for the HEDS assay and by the increase in absoprtion at 
650 nm for the insulin assay. For the GAPDH assay, the initial velocity (v) of GAPDH in 
aliquots taken after the indicated timepoints was determined to assess the deglutathionylation 
activity. Note that dialysis buffer was added to those samples without enzyme to compensate 
for the glutathione amounts introduced by the dialysis buffer for all experiments shown above. 
All samples in the GAPDH assay were prepared only once. 
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comparison. At 300 nM, the activity of ROXY9 was similar to the activity 
observed after removal of DTT without introducing glutathione in the protein 
sample during dialysis (Figure R14E). Surprisingly, strep-MBP-ROXY9 was 
able to deglutathionylate GAPDH-SG at concentrations of 0.75, 1.5, and 3 µM. 
Only at 1.5 to 3 µM, strep-MBP-ROXY9 reached an activity comparable to the 
control proteins. Thus, strep-MBP-ROXY9 can deglutathionylate GAPDH-
SG albeit at a ca. 15 to 30-fold less efficiency in comparison to strep-SUMO-
Grx1 and strep-MBP-GRXC2. However, it is impossible to conclude whether 
this activity of strep-MBP-ROXY9 only results from the higher protein 
concentrations used in this experiment or whether it comes from the dialysis 
against glutathione or both, since the concentration of strep-MBP-ROXY9 was 
only titrated in this experiment (Figure R16D), but not after removal of DTT 
using dialysis buffer without glutathione (Figure R14E). 
 
 
The strep-MBP tag does not interfere with the catalytic 
activity of strep-MBP-ROXY9 
 
Aside from the redox state, the weak activity observed for strep-MBP-ROXY9 
might result from inhibition of catalysis by the large strep-MBP tag. Because 
cloning of ROXY9 into 438C_strep introduced a TEV site between ROXY9 
and the strep-MBP tag, TEV protease was expressed in E. coli and purified to 
homogeneity via its His tag (Figure SR6). The SDS gel in Figure R17 shows 
His-TEV and strep-MBP-ROXY9 alone, as well as the mixture of both 
proteins before overnight incubation at 4°C. After incubation, a complete 
cleavage of the tag from ROXY9 was observed, as evidenced by the 
disappearing band of strep-MBP-ROXY9. Instead, a band of the strep-MBP 
tag at ca. 40 kDa and ROXY9 at ca. 12 kDa became visible. Despite several 
purification steps to remove the strep-MBP tag and His-TEV from the reaction 
mixture, only His-TEV could be removed successfully, whereas approximately 
half of the strep-MBP tag remained in the solution. Still, this protein mixture 
should suffice for activity measurements and was thus used in the HEDS, the 
insulin and in the GAPDH assay. The concentration of ROXY9 was estimated 
from an SDS gel by comparing the band intensities resulting from separation 
of a defined volume of the ROXY9 preparation to the band intensities of 
various defined amounts of BSA. 
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Again, strep-SUMO-Grx1 and strep-MBP-GRXC2 were able to reduce HEDS 
and insulin, while strep-MBP-ROXY9 was not (Figure R18A, B, and C). As for 
strep-MBP-ROXY9, ROXY9 was not active in these assays, suggesting that the 
tag did not interfere with its catalytic activity. Interestingly, ROXY9 did not 
inhibit the reduction of insulin as did strep-MBP-ROXY9 (Figure R18B and 
C). When testing the glutaredoxins in the GAPDH assay, strep-SUMO-Grx1 
and strep-MBP-GRXC2 deglutathionylated GAPDH-SG (Figure R18D). 
Strep-MBP-ROXY9 reactivated GAPDH-SG, although again with a weaker 
efficiency. After dialyzing both proteins against GSH, both, ROXY9 and strep-
MBP-ROXY9 exhibited a similar activity, showing that the tag does not inhibit 
ROXY9 deglutathionylation activity. 
 
 
 
 
Figure R17. TEV digest of strep-MBP-ROXY9. Purified strep-MBP-ROXY9 was 
incubated with purified His-TEV protease over night at 4°C. Subsequently, the strep-MBP tag, 
as well as uncleaved strep-MBP-ROXY9 and His-TEV were tried to be removed by several 
purification steps (MPBTrap + HisTrap, StrepTactin). The final mixture was concentrated. The 
proteins before mixing, the digestion mixture before and after incubation, and the purification 
steps were analyzed by running 4.4 µg His-TEV, 6 µg strep-MBP-ROXY9, and 20 µl of the 
remaining fractions on a 15 % SDS gel. The gel was stained with Coomassie. Prestained 
PageRuler (Thermo Scientific) was employed as a size standard. M – Marker. 
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Figure R18. In vitro reductase activity of strep-MBP-ROXY9 and ROXY9. Strep-SUMO-
Grx1, strep-MBP-GRXC2, strep-MBP-ROXY9, and ROXY9 were dialyzed against buffer 
containing GSH, this way removing DTT, but including GSH. The reductase activity of all 
proteins was compared using the indicated protein concentrations (C) in the HEDS (A) and 
the insulin assay (B). For the GAPDH assay (D), 70 nM strep-SUMO-Grx1, 100 nM strep-
MBP-GRXC2, and 400 nM strep-MBP-ROXY9 or ROXY9 were used. For the HEDS assay, 
the mean absorption at 340 nm ± SD of technical triplicates is shown for strep-SUMO-Grx1, 
strep-MBP-GRXC2, and strep-MBP-ROXY9. For ROXY9, the mean of two technical 
replicates is plotted; for the no enzyme control, only a single reaction was prepared. For the 
insulin assay, the mean absorption at 650 nm ± SD from technical triplicates is depicted, except 
for the no enzyme control for which only one reaction was measured. In case of the GAPDH 
assay, the initial velocity of the GAPDH over 60 min of reactivation by deglutathionylation is 
plotted in a bar chart. In all experiments, dialysis buffer was added to those samples without 
enzyme to compensate for the glutathione amounts introduced by the dialysis buffer. All 
samples in the GAPDH assay were prepared only once. 
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Strep-MBP-ROXY9 and ROXY9 need glutathione to 
reactivate GAPDH-SG 
 
Strep-MBP-ROXY9 did only deglutathionylate GAPDH-SG but reduced 
neither HEDS nor roGFPox. This might be explained by target specificity. 
Alternatively, ROXY9 might not be recycled by glutathione during catalysis. If 
this is the case, ROXY9 would only be active for one reaction cycle, and the 
amounts of GAPDH reduced by ROXY9 would correspond to the amounts 
of ROXY9 added to the reaction. To investigate whether ROXY9 is recycled 
by glutathione, strep-MBP-ROXY9 and ROXY9 were dialysed against 
glutathione and then subjected to the GAPDH assay. The activity of both 
proteins was addressed either with or without glutathione. To compensate for 
the glutathione present in the protein preparations, dialysis buffer was added in 
adequate amounts to all reactions without glutaredoxin. 
As described before, a weak activity could be measured for both, strep-MBP-
ROXY9 and ROXY9 (Figure R19A). Importantly, this activity depended on 
glutathione suggesting that ROXY9 deglutathionylates GAPDH-SG and is 
recycled by glutathione. 
To further investigate the requirement of glutathione in the reaction mix, the 
redox potential of strep-MBP-ROXY9 against the DTT/dithiane redox system 
was determined with the help of monobromobimane (mBBr, Figure R19B). 
For this, strep-MBP-ROXY9 was dialyzed to remove DTT from the 
purification buffer. Unfortunately, the Eh range chosen for this first experiment 
did not extend far enough into the low voltages. Thus, the saturation of the 
fluorescence observed in this region for other glutaredoxins [77] was not 
identified in this experiment. Considering that analysis of such a dataset would 
lead to an overestimation of the redox potential, the data was still evaluated. 
The curve showed an inflection point at roughly -0.27 V. Thus, the redox 
potential of strep-MBP-ROXY9 was -0.27 V. As listed in Figure R19C, this 
value is in the range of the redox potentials measured for catalytically active 
CPYC glutaredoxins which are recycled by glutathione [77]. Thioredoxins 
which are not recycled by glutathione, exhibit lower redox potentials [76]. 
Taking the overestimation of the redox potential of strep-MBP-ROXY9 into 
account, its true redox potential might be closer to that of thioredoxins. 
However, since this type of analysis determines the average redox potential of 
all five cysteine residues in strep-MBP-ROXY9, it might be that the five 
cysteines in ROXY9 show different redox potentials. Consistent with this, MS  
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Figure R19. Strep-MBP-ROXY9 and ROXY9 require GSH to reduce GAPDH-SG. (A) 
Strep-MBP-ROXY9 and ROXY9 were dialyzed against buffer containing glutathione to 
remove DTT from the purification but to simultaneously include GSH to the protein sample. 
These protein preparations were tested for their activity in the GAPDH assay, either with or 
without glutathione as a cofactor. Approximately 400 nM strep-MBP-ROXY9 or ROXY9 were 
used. Importantly, dialysis buffer was added to all samples without enzyme to compensate for 
the glutathione amounts introduced by this buffer. The initial GAPDH activity was plotted 
over the different time points, at which samples from the deglutathionylation reaction were 
taken. All samples in the GAPDH assay were prepared only once. (B) Strep-MBP-ROXY9 was 
purified in the presence of DTT. Prior to the redox titration experiment, DTT was removed 
by dialysis. Then, 7.5 µM strep-MBP-ROXY9 were incubated in the presence of different 
ambient redox potentials (Eh) set by mixing defined ratios of DTT and dithiane in 100 mM 
HEPES pH 7.0. Finally, the percentage of reduced protein was determined using 
monobromobimane and plotted against the ambient redox potential to estimate the redox 
potential of strep-MBP-ROXY9. All values represent single measurements. The table in (C) 
summarizes the redox potentials of different glutaredoxins studied elsewhere and compares 
them to strep-MBP-ROXY9. 
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data showed that even in the presence of 1 mM DTT, strep-MBP-ROXY9 was 
not fully reduced (Figure R15), suggesting that some residues might have rather 
low redox potentials. Consequently, other ROXY9 cysteine residues must have 
higher redox potentials and could thus be reduced by glutathione.  
 
 
Strep-MBP-ROXY9 oxidizes reduced roGFP 
 
Though strep-MBP-ROXY9 acted as a reductase towards glutathionylated 
GAPDH with glutathione as a reducing agent, its activity was much weaker 
than for control CPYC-type glutaredoxins. According to findings by Moseler 
et al. (2015) and Begas et al. (2017), the CGFS-type glutaredoxin GRXS15 does 
not catalyze reduction reactions but rather the reverse reaction, acting as an 
oxidase towards reduced roGFP. For this, it requires GSSG as a cosubstrate 
[75,97,116,117,259,260]. Similarly, the CPYC-type glutaredoxin GRXC1 acts as 
an oxidase for roGFPred in the presence of GSSG [75,97]. 
For this reason, the oxidase activity of strep-MBP-ROXY9 was tested in the 
roGFP assay using GRXC1 as a positive control. The assay was set up as 
described before for the reduction of oxidized roGFP, but reduced roGFP was 
replaced by oxidized roGFP and GSH was replaced by GSSG. Strep-MBP-
ROXY9 was dialyzed against the assay buffer to remove DTT and received a 
DTT treatment right before the experiment. Thus, it contained two reduced 
cysteines per protein (Figure R11, sample B). GRXC1 was treated in the same 
way. Again, oxidized roGFP showed a weak fluorescence ratio, whereas 
reduced roGFP exhibited a high fluorescence ratio (Figure SR7). The slope of 
the oxidation of roGFPred caused by GSSG and/or the glutaredoxins is shown 
in Figures R20A and B. GSSG increased the oxidation of roGFPred. Both, 
GRXC1 and strep-MBP-ROXY9 doubled the oxidation speed, but only in the 
presence of GSSG. Thus, strep-MBP-ROXY9 acted as an oxidase towards 
roGFPred using GSSG. Consequently, GSSG might transfer a glutathione to 
strep-MBP-ROXY9, which subsequently transfers this glutathione moiety on 
roGFPred. 
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Figure R20. Strep-MBP-ROXY9 oxidizes reduced roGFP2. Strep-MBP-ROXY9 (B) was 
dialyzed against buffer without DTT and tested for its ability to oxidize reduced roGFP2 in 
comparison with N-terminally His-tagged GRXC1. Both proteins received a DTT-treatment 
and were desalted immediately before the experiment via a column. (A). Different protein 
concentrations from 0 to 5 µM were used. After 10 min of preincubation, GSSG was added to 
start the reactions, while buffer was added to the control samples without cofactor. The initial 
velocity was determined by measuring the change in the fluorescence ratio of roGFP2 between 
minutes 13 and 15 of the reaction and plotted in a bar chart. Values represent mean ± SD. For 
1 µM GRXC1 – GSSG and 5 µM GRXC1 + GSSG only two replicates were prepared. Thus, 
no SD could be calculated.  
 
 
Strep-MBP-ROXY9 binds glutathione probably via altered 
glutathione interaction sites 
 
A recent publication [75] suggested that the glutathione binding site of 
glutaredoxins consists of two functionally distinct regions: (1) an activation site 
stabilizing the thiolate of bound glutathione and of the N-terminal cysteine of 
the active site and (2) a scaffold site interacting with the glutathione moiety 
from the substrate to be deglutathionylated. Differences in the amino acid 
composition of these two sites were proposed to account for the diverging 
activities observed for CPYC and CGFS glutaredoxins: Whereas in CPYC 
glutaredoxins both sites are functional, CGFS glutaredoxins have a non-
functional activation site. Since strep-MBP-ROXY9 showed an activity pattern 
resembling that of CGFS-type glutaredoxins, its interaction with glutathione 
was examined. 
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First, the dissociation constant of strep-MBP-ROXY9 and glutathione was 
quantified by Dr. Sven-Andreas Freibert (Prof. Dr. Roland Lill, Phillips-
Universität Marburg) using microscale thermophoresis (MST) and BioLayer 
Interferometry (Figure R21A and B). For this, DTT from the purification 
process of strep-MBP-ROXY9 was removed via a desalting column. Thus, the 
experiments were conducted with oxidized protein. Although both 
measurements represent initial experiments, they suggested that the Kd of 
strep-MBP-ROXY9 for glutathione is around 146 µM (Figure R21C). This 
value is ca. 10-fold higher than measured for the CPYC glutaredoxin strep-
MBP-GRXC2 (12.6 ± 3.6 µM) and about 30-fold higher than determined for 
the CC-type glutaredoxin strep-MBP-ROXY19 (4.6 ± 1 µM) [174]. Both values 
were obtained by MST. Wang et al. (2014) calculated the Kd value for the 
plastidial CGFS glutaredoxin GRXS14 based on NMR data, yielding a value of 
ca. 5 mM [95]. Thus, the Kd value of strep-MBP-ROXY9 is in between that of 
a catalytically active CPYC glutaredoxin and a catalytically largely inactive 
CGFS glutaredoxin [88,174,259]. 
The higher dissociation constant of strep-MBP-ROXY9 compared to strep-
MBP-ROXY19 and strep-MBP-GRXC2 might be caused by the partial 
conservation of the glutathione binding site in CC-type glutaredoxins [80]. The 
analysis of the conservation of glutathione binding residues in CC-type 
glutaredoxins carried out by Gutsche et al. (2015) focussed on five sites in 
glutaredoxins required for glutathione binding [80]. At that time, it was still 
unknown that the glutathione binding site is divided into a glutathione 
activation site and a glutathione scaffold site (Figure I4C). However, Begas et 
al. (2017) did not include CC-type glutaredoxins when analysing the activation 
and scaffold site [75]. 
To examine the extent of conservation of the glutathione binding site ROXY9 
identified by Gutsche et al. (2015) in the light of the study by Begas et al. (2017), 
the protein sequence of ROXY9 was aligned with all glutaredoxins used in this 
work and known to catalyse reductase reactions or for which the Kd was 
determined. These glutaredoxins were Arabidopsis GrxC1, GrxC2 (GRX370), 
GRXS14, ROXY19, and human Grx1. In addition, S. cerevisiae Grx7 and 
Plasmodium falciparum (P. falciparum) Grx1 were included in the alignment, as 
these two glutaredoxins were dissected regarding their interaction with 
glutathione by Begas et al. (2017). Since they also analysed AtGRXS15, its 
sequence was added to the alignment [75]. Finally, S. cerevisiae Grx6 was chosen, 
since its crystal structure was solved [108] and compared to ScGrx7 by Begas et 
al. (2017) (Figure I4D) [75]. 
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Figure R21. strep-MBP-ROXY9 binds glutathione. Strep-MBP-ROXY9 purified in the 
presence of DTT was dialyzed to remove EDTA from the purification buffer and then purified 
via desalting columns to remove DTT. It was subsequently tested by BioLayer Interferometry 
(BLI, A) and microscale thermophoresis (MST, B) for its binding to glutathione. (A) shows the 
raw data from a single BioLayer Interferometry measurement. The dark red, green, light and 
dark blue curves correspond to the recorded interference shifts in nm for different GSH 
concentrations, wherease the light red lines show their fit. The diagram in (B) displays the mean 
of the normalized fluorescence of 200 nM NHS-labeled ROXY9 ± SD (dark blue points) of 
three technical replicates and the corresponding fit (light blue curve) including its residual plot 
(green). From both datasets, Kd for strep-MBP-ROXY9 and GSH was computed and 
compared to published values for other glutaredoxins (C). 
 
 
M 
In vitro characterization of ROXY9 
160 
 
The alignment is shown in Figure R22. Only those residues for which a 
function in glutathione binding has been suggested based on experimental data 
[75,79,80,92,94] are highlighted (Figures I3A and B, I6A, B, and C, SI1C). The 
activation site for binding of the recycling glutathione and the scaffold site for 
binding of the glutathionylated substrate are indicated in red and blue, 
respectively (for comparison see Figure I4C and D). 
In comparison to CPYC- and CGFS-type glutaredoxins, a major difference of 
CC-type glutaredoxins found within the active site [80]. With respect to the 
active site, the tyrosine from the CPYC motif (A2) has been suggested as an 
activation site residue, though based on initial data. In CGFS-type 
glutaredoxins, this residue is replaced by a phenylalanine [75] and a leucine in 
ROXY9 or methionine in ROXY19, respectively [80]. Tyrosine harbors a 
hydroxyl group and can therefore form hydrogen bonds. Both, phenylalanine 
and tyrosine harbor a benzol ring allowing π-stacking interactions. In contrast, 
the side chains of leucine and methionine are stretched and can only form Van-
der-Waals interactions. Thus, the residue in CC-type glutaredoxins deviates 
regarding its properties compared to CPYC- and CGFS-type glutaredoxins. 
The lysine residue (A1) characterized with respect to its function in the 
activation site [75] is conserved in ROXY9 and ROXY19.  
The major differences of ROXY9 and ROXY19 and glutaredoxins from the 
CPYC and CGFS class are restricted to the scaffold site, in particular the TVP 
(S3 to S5) and the GG motif (S6 and S7). In ROXY9, the TVP motif is replaced 
by 64AVP66 and the GG motif by 76GS77, whereas a KLP motif and the usual 
GG motif are found in ROXY19 [80]. The K of the KLP motif and the 
methionine found in the active site of ROXY19 appear to block the glutathione 
binding groove in the homology model of this protein (Figure I3F to H) [80]; 
however, the smaller alanine found in ROXY9 at this site might narrow the 
groove less than the lysine in ROXY19. The negatively charged residue at the 
second or third position after the GG motif (S9 or S10) was characterized 
regarding its function in the scaffold site [75]. Because at position S9, a negative 
residue is found in ROXY19 [80] and at positions S10 in ROXY9, this site 
seems to be conserved in both CC-type glutaredoxins. Residues S2 and S8 are 
difficult to evaluate with respect to conservation because they are variable even 
in CPYC-glutaredoxins. 
Similarly, residues S1 and A3 cannot be evaluated regarding their conservation. 
The present alignment suggests that residue A3 is positively charged in CGFS- 
and CC-type glutaredoxins but shows variable properties in CPYC-type  
Results 
161 
 
 
 
Figure R22. Potential glutathione-binding residues are substituted in ROXY9. The 
protein sequences of CC-type glutaredoxins ROXY9 and ROXY19, the CPYC-type 
glutaredoxins GRXC1, GRXC2, human Grx1 and the CGFS-type glutaredoxins GRXS14 and 
GRXS15, as well as Grx6 and Grx7 from baker’s yeast and Grx1 from P. falciparum were aligned 
using CLUSTAL O (1.2.4) via the UniProt database (A). The degree of conservation of the 
different amino acids is highlighted by different gray values in the following order: dark grey 
(*, conserved) > grey (:) > light grey (.) > white (not conserved). The glutathione-binding 
residues are marked by arrows: Red arrows point to those residues proposed to participate in 
the activation site (A1 to A3). Those residues belonging to the putative scaffold site are 
indicated by blue arrows (S1 to S10). A black arrow shows the active site cysteine. Residues 
which deviate from the residues observed for catalytically active glutaredoxins are shown in 
yellow. The figure was prepared according to Gutsche et al. (2015) [80] and Begas et al. (2015) 
[75]. 
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glutaredoxins. Residue S1 is negatively charged in CC-type glutaredoxins and 
positively charged in all other glutaredoxins. However, the gaps found in front 
of this region might allow a different way of aligning these residues depending 
on the algorithms and/or the protein sequences used. Gutsche et al. (2015) and 
Begas et al. (2017) presented alignments deviating from the one shown here 
[75,80]. Thus, it is unclear whether S1 and A3 are conserved in CC-type 
glutaredoxins. 
All in all, major differences in the glutathione binding site are restricted to the 
active site, which is part of the activation site, and the TVP and GG motif, 
forming in parts the scaffold site. 
 
 
 
Strep-MBP-ROXY9 could bind a [4Fe-4S] cluster 
 
Strep-MBP-ROXY9 was only weakly active as a reductase but catalyzed the 
oxidation of reduced roGFP efficiently. This observation is reminiscent of the 
CGFS-type glutaredoxin GRXS15. CGFS-type glutaredoxins are known to 
bind iron-sulfur clusters [95,97,114,116,129,139]. To test, whether strep-MBP-
ROXY9 might bind an iron-sulfur cluster, as well, the protein was reconstituted 
non-enzymatically by Dr. Sven-Andreas Freibert and analyzed for iron-sulfur 
cluster binding. For this, strep-MBP-ROXY9 was dialyzed to remove EDTA 
from the purification buffer. During reconstitution, the protein was incubated 
in the presence of iron ions derived from ammonium iron (III) citrate, FeCl2, 
or FeCl3, lithium sulphide, glutathione and DTT. After incubation, the protein 
was purified from the reaction mix via a desalting column. Reconstitution took 
place under anaerobic conditions [261]. 
The reconstituted protein had a brownish colour and lost this colour quickly 
when exposed to air (S. Freibert, personal communication). Ultraviolet/Visible 
(UV/Vis)-spectral measurements (Figure R23A and B) showed a large peak at 
280 nm caused by strep-MBP-ROXY9, which has an extinction coefficient of 
ca. 80000 M-1cm-1. Around 320, 420 and 590 nm shoulders indicative of iron-
sulfur cluster binding could be observed. The absorption at 420 nm was ca. 
0.14 A.U. (Figure R23B) while it was 1.8 A.U. at 280 nm (Figure R23A), and 
therefore, 13-fold higher. Considering a single cluster bound per protein, a 
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cluster with an extinction coefficient around 6000 M-1cm-1 at 420 nm would fit 
to this absorption ratio. Alternatively, an extinction coefficient of ca. 
12000 M-1cm-1 would argue for one cluster bound by two proteins. These values 
are within the range observed usually for [4Fe-4S] clusters (3000 to 
15 000 M-1 cm-1 [261]). 
To determine the stoichiometry of the occupancy, the amount of iron ions and 
the number of sulphide ions bound per molecule of strep-MBP-ROXY9 was 
quantified using a feren-based method [245] or the methylene-blue method 
[246], respectively (Figure R23C). Approximately 5 iron ions and 3.4 sulphide 
ions could be determined per protein. Considering some non-specifically 
bound iron and slightly lower cysteine concentrations in the methylene blue 
standard, these data indicate that strep-MBP-ROXY9 might associate with a 
[4Fe-4S] cluster. However, the unclear oxidation state of the protein sample 
even in presence of reducing agents questions this calculation unless the 
number of oxidized proteins is much smaller than that of reduced proteins.  
 
 
 
Figure R23. Strep-MBP-ROXY9 probably binds an iron-sulfur cluster after 
reconstitution. Strep-MBP-ROXY9 was dialyzed to remove EDTA from the purification 
buffer and then reconstituted non-enzymatically and anaerobically in the presence of 
glutathione. To test iron-sulfur cluster incorporation, a UV/Vis spectrum of the reconstituted 
protein was recorded (A). (B) shows an enlargement of this spectrum. Shoulders around 
320 nm, 420 nm, and 590 nm are indicated by arrows. In addition, the amount of iron ions and 
sulfide ions bound to reconstituted strep-MBP-ROXY9 was quantified (C)
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Towards a mechanism of regulation of TGA1 
by ROXY9 
_____________________________________________________________________ 
 
 
Complementation of the tga1 tga4 mutant with genomic 
TGA1 (TGA1g) constructs 
 
ROXY9 was shown to repress the activity of TGA1 regarding hyponastic 
growth [155,156]. A repressive function has also been published for several 
other CC-type glutaredoxins [145–147,151,162,164,168,169]. Redox 
modification of TGA transcription factors by CC-type glutaredoxins to change 
TGA factor activity has been frequently discussed [145–
149,151,153,155,163,164,166,168–171]. Especially, TGA1 has been reported as 
a redox-regulated transcription factor [32,224]. 
During in vitro characterization of strep-MBP-ROXY9, only a weak 
deglutathionylation activity of ROXY9 towards GAPDH-SG was observed but 
a stronger oxidase activity. To test whether ROXY9 can redox-modify TGA1 
during hyponastic growth [155], the requirement of the cysteine residues of 
TGA1 for the regulation of hyponastic growth was addressed. 
For this, complementation of the tga1 tga4 mutant with three different 
constructs was tested. The complementation constructs are shown in Figure 
R24A. Since the cDNA sequence of TGA1 under control of the 35S promoter 
does not complement [32,157], the genomic coding sequence of TGA1 and 
approximately 2000 bp upstream of the 5’-untranslated region (5’UTR) as well 
as ca. 300 bp downstream of the TGA1 stop codon were cloned into the 
pB vector, as described previously [223,262]. In the course of cloning, a 1xHA 
tag was introduced right before the start codon of TGA1 leading to an N-
terminal tag. This construct represented the wildtype complementation 
construct [223,262]. To test the requirement of the cysteine residues of TGA1, 
a cysteine mutant complementation construct was generated. For this, all four 
cysteine codons in the genomic coding sequence of TGA1 were mutated. In 
analogy to Despres et al., 2003, the cysteines were mutated such that they  
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Figure R24. Complementation of the tga1 tga4 mutant with genomic TGA1. (A) 
Complementation constructs used for stable transformation of the A. thaliana tga1 tga4 mutant. 
Introns are shown in grey; exons are depicted in blue. Mutations are shown as yellow lightnings. 
(B) Clustal O (1.2.4)-based alignment of the stretch in the TGA1 protein sequence containing 
the cysteine residues (yellow) with the corresponding sequences of TGA2 to TGA10. The 
alignment was done via UniProt. 
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mimicked the reduced state of the protein but allowed integrity of the protein 
fold. Based on the amino acids found in other TGA factors from Arabidopsis 
at the sites of the cysteines in TGA1 (Figure R24B), the first two cysteine 
codons (C172N and C260N) were converted into asparagine codons, whereas 
the second two cysteine codons were exchanged for serine codons (C266S and 
C287S) [224]. Again, this mutant construct was fused N-terminally to a single 
HA-tag. As a control construct, the single HA-tag was placed between the 
genomic TGA1 control regions. Unfortunately, later, a mutation of A192 in the 
3’-untranslated region (3’UTR) in the control construct was found to be 
mutated to a guanine. The 3’UTR of the other two complementation constructs 
was intact (Figure SR8). 
The three complementation constructs were subsequently transformed into the 
tga1 tga4 mutant via the flower dip method and homozygous transformants 
were isolated. Three lines for each construct were selected for 
complementation analysis. The selected lines were: 
tga1 tga4 + pB1xHA-TGA1g #5-6, #15-3, #21-9 
tga1 tga4 + pB1xHA-TGA1g C172N C260N C266S C287S #5-3, #15-15, #22-
2 
tga1 tga4 + pB1xHA #10-3, #11-2, #21-9 
As an internal control, line tga1 tga4 + pB1xHA-TGA1g #22-7 was used. 
During segregation, it had lost its transgene and, thus, corresponded to a 
tga1 tga4 mutant. Further controls were Col-0 and the original tga1 tga4 mutant. 
 
 
TGA1g complements the tga1 tga4 mutant when all four 
cysteines are mutated 
 
The above-mentioned complementation lines were tested sequentially in three 
independent hyponastic growth experiments (Figure R25 and SR9, part I to 
III). While wildtype plants initiated hyponastic growth under low light 
conditions, and lowered their leaves when shifted back to control light 
conditions, tga1 tga4 mutants were compromised in this response. Similar 
effects were observed for the control complementation lines tga1 tga4 +  
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Figure R25. Analysis of hyponastic growth of the TGA1 complementation lines. Selected 
complementation lines of the tga1 tga4 mutant were grown together with the tga1 tga4 mutant 
and Col-0 wildtype plants for 4 weeks in 12 h day and then treated with CL, LL or first with LL 
followed by CL, as described in Methods (page 59). Pictures of the plants were taken with a 
Canon PowerShot G11 camera. Angles of leaf 7 or 8 were measured using ImageJ. Bars are 
mean ± SEM from at least 6 replicates. (A), (B), and (C) represent three independet 
experiments. CL – control light, LL – low light, LL to CL – shift from low light to control light. tga1 tga4 
corresponds to tga1 tga4 + pB1xHA-TGA1g #22-7, which lost its transgene during segregation as a 
heterozygous plant. 
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pB1xHA #10-3, #11-2, and #21-9. In contrast, tga1 tga4 mutants 
complemented with 1xHA-TGA1g or 1xHA-TGA1g C172N C260N C266S 
C287S showed a hyponastic response similar to the wildtype. 
Complementation seemed sometimes partial (Figure R25B and C), which could 
be attributed to a reduced functionality of the resulting proteins or to 
differences in expression. In summary, it seemed that both, 1xHA-TGA1g and 
1xHA-TGA1g C172N C260N C266S C287S-complemented the hyponastic 
growth deficit of the tga1 tga4 mutant, suggesting that the cysteine residues in 
TGA1 do not play a role during regulation of hyponasty. 
To further substantiate these findings, the petiole length relative to the entire 
leaf length was determined. As shown in Figure R26 and SR10, Col-0 plants had 
petioles almost half as long as the entire leaf (ca. 49 %). The petioles of tga1 tga4 
mutants and the internal control plant (tga1 tga4 + pB1xHA-TGA1g #22-7) 
were only 40 % as long as the whole leaf. This was also observed for the control 
complementation lines expressing only the 1xHA tag. When 1xHA-TGA1g or  
 
 
 
Figure R26. Measurement of the relative petiole length of the TGA1 complementation 
lines. Col-0, tga1 tga4, a complementation line (TGA1g) from the Department of Botany (Prof. 
Dr. Yuelin Zhang, UBC Vancouver [222,223,262]) and selected complementation lines 
constructed during this work were grown for 4 weeks in 12 h day. Either leaf 7 or 8 from at 
least 6 different plants was detached and photographed from the top with a Canon PowerShot 
G11 camera. The petiole length and the blade length were measured using Image J and the 
petiole length relative to the entire leaf length computed. Bars represent mean ± SEM. 
Statistical analysis (One-way-ANOVA and Tukey test) was performed using GraphPad Prism 
8.0.1 assuming normally distributed data. Adjusted p-values in comparison to Col-0 are 
indicated above the bars: ns – non-significant, p>0.05, * - p ≤ 0.05, ** - p-value ≤ 0.01, *** - 
p-value ≤ 0.001, **** - p-value ≤ 0.0001. 
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1xHA-TGA1g C172N C260N C266S C287S were expressed in tga1 tga4, the 
resulting relative petiole length was in between that of the tga1 tga4 mutant and 
that of Col-0. However, this appeared to be only significant for two out of three 
1xHA-TGA1g C172N C260N C266S C287S complementation lines. Including 
additional plants into the analysis revealed that both, 1xHA-TGA1g and TGA1 
cysteine mutant transformants, varied in their capacitiy to complement the 
reduced petiole length of the tga1 tga4 mutant (Figure SR10). However, for the 
cysteine mutant complementation construct, more plants with a significantly 
reduced petiole length were observed than for the 1xHA-TGA1g 
complementation construct. Still, the differences in the petiole length between 
both types of complementation lines were not strong. Altogether, this might 
suggest only a partial complementation by both constructs. Thus, the 
complementation constructs might either not result in fully functional proteins 
or TGA1 might be redundant with TGA4 in controlling the petiole length. All 
in all, TGA1g seems to complement the phenotype independent of its cysteine 
residues at least partially. 
In addition to controlling hyponasty and petiole length, the tga1 tga4 mutant 
was described to flower late [223]. Since this phenotype resembles the delay in 
flowering observed for ROXY9 overexpressing plants, it seems possible that 
ROXY9 represses TGA1 also during the induction of flowering [157]. Thus, 
the number of days, wildtype plants, tga1 tga4 mutants, and the internal control 
line TGA1g needed to start flowering was quantified along with those of the 
complementation lines generated for this study. Additionally, the number of 
leaves on the day of flowering was counted. The data is depicted in figures R27 
and SR11, part I and II. 
Col-0 flowered after ca. 35 days in this experiment and had ca. 19 leaves on the 
day of flowering. The tga1 tga4 mutant flowered three days later and had more 
leaves than the wildtype. As for the ROXY9 overexpressing plants, the 
formation of numerous smaller leaves among the counted leaves were 
observed. This indicates, that the late flowering phenotype of the tga1 tga4 
mutant is not a result of a generally delayed development. However, the internal 
control line (#22-7) neither flowered significantly later than wildtype plants nor 
showed an increased leaf number. Similarly, only two out of three plants 
expressing the 1xHA tag showed a delay in flowering, and only one of them 
formed significantly more leaves. Consequently, flowering might be influenced 
by additional effects resulting e.g. from the construction process of these 
transgenic lines. Alternatively, the sample size used in this experiment might 
not have been high enough to clearly distinguish the small differences in the 
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time point of flowering and leaf number between wildtype-like plants and 
tga1 tga4 mutant-like plants. This is supported by the observation of tendencies 
even in case of statistically insignificant differences, and the formation of 
additional, smaller leaves by tga1 tga4 + pB1xHA-TGA1g #22-7, and those 
plants expressing 1xHA. Despite these discrepancies for some control plants, 
the TGA1g complementation construct seemed to successfully restore the 
initiation of flowering after ca. 35 days. Interestingly, this was only observed 
for two of the three cysteine mutant complementation lines tested. The other 
transformant flowered significantly earlier than the wildtype. However, the leaf 
number did not differ from wildtype leaves for TGA1g- and TGA1g C172N 
C260N C266S C287S-complementation lines. Analysis of additional plant lines 
confirmed these results (Figure SR11, part I and II). 
Considering the influence of additional factors and the small sample size, it 
seems that the tga1 tga4 mutant flowers later than Col-0 but is not generally 
delayed in development. Moreover, the 1xHA-TGA1g seems to complement 
the phenotype of the tga1 tga4 mutant. Similarly, the TGA1g complementation 
construct carrying the cysteine mutations complements the phenotype, and 
sometimes even causes an earlier flowering. However, because neither the 
TGA1 protein levels nor the influence of the tag and the effect of the cysteine 
mutations on the stability of TGA1 were analyzed in planta, the cause of this 
observation cannot be evaluated. 
All in all, the results from analyzing hyponastic growth contrast with a redox 
regulation of TGA1 regarding hyponasty [155] whereas for the flowering 
timepoint, a minor influence of the cysteines cannot be ruled out. 
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Figure R27. Flowering time point and leave number at flowering of TGA1g 
complementation lines. Col-0, tga1 tga4, TGA1g [222,223,262] and tga1 tga4 mutants 
complemented with the constructs shown in Figure 24A were grown in a long day climate 
chamber. The number of days was determined until a floral stem of 1 cm lenght was visible 
(A). At this time point, the number of leaves was counted, as well (B). Bars are mean ± SEM 
from at least 5 replicates. Statistical analysis (One-way-ANOVA and Tukey test) was performed 
using GraphPad Prism 8.0.1 assuming normally distributed data. Adjusted p-values in 
comparison to Col-0 are indicated above the bars: ns – non-significant, p>0.05, * - p ≤ 0.05, ** 
- p-value ≤ 0.01, *** - p-value ≤ 0.001, **** - p-value ≤ 0.0001. a - smaller leaves in between counted 
leaves for all replicates. 
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The CC-type glutaredoxin ROXY9 as an iron-
sulfur cluster binding oxidase 
_____________________________________________________________________ 
 
CC-type glutaredoxins are a land plant-specific group of glutaredoxins which 
have been associated with the regulation of different stress responses and 
developmental processes [80,176]. In these pathways, they mediate the 
repression of TGA transcription factors [80], but their precise function has 
remained enigmatic. 
Because glutaredoxins are known to redox-modify proteins to regulate their 
activity, CC-type glutaredoxins have frequently been speculated to change the 
oxidation state of TGA transcription factors [145–
149,151,153,155,160,163,164,166,168–173]. Especially, the cellular pool of 
TGA1 was found to change its redox state after treatment with salicylic acid 
[224]. Thus, the regulation of TGA1 activity after hyponastic growth by 
ROXY9 was proposed to occur via redox regulation [155,156]. However, 
evidence for a catalytic activity of CC-type glutaredoxins is scarce [174,176]. 
 
Purified strep-MBP-ROXY9 is sensitive to oxidation 
This study was set up to characterize ROXY9 biochemically. This required the 
production of recombinant protein. First, a strep-SUMO-fusion of ROXY9 
was expressed in E.coli. However, the protein turned out to be aggregated 
(Figure R5), and this condition could not be changed by optimizing the 
expression and purification procedure. This is similar to the published 
unsuccessfull attempts to express and purifiy CC-type glutaredoxins from 
E. coli [174,176]. Strikingly, switching the expression host for strep-MBP tagged 
ROXY9 from E.coli to insect cells resulted in large amounts of soluble, 
monomeric protein (Figure R6 to 8). Importantly, the well-known interaction 
between TGA1 and ROXY9 was reproduced in a pulldown experiment using 
strep-MBP-ROXY9 and recombinant GFP-TGA1 (Figure R10C and D) 
[156,157]. Because this pulldown experiment was not quantitative, it cannot be 
concluded whether the entire strep-MPB-ROXY9 preparation has led to the 
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co-purification of GFP-TGA1. Thus, at least, a fraction of recombinant 
ROXY9 is functional. 
Because glutaredoxins rely on their cysteine residues for catalysis and iron-
sulfur cluster binding [1,9], strep-MBP-ROXY9 was purified in the presence of 
the reducing agent DTT. Mass spectrometry revealed that even in the presence 
of DTT, strep-MBP-ROXY9 is partly oxidized, although the extent of this 
oxidation was not determined (Figure R15). Consequently, strep-MBP-ROXY9 
was either present in an oxidized state in insect cells or oxidized after cell lysis 
during purification despite the presence of DTT. After removal of DTT by a 
desalting column or by dialysis, the thiol content of the protein preparation was 
oxidized to ca. 60 % as suggested by performing Ellman’s assay (Figure R11). 
Importantly, treatment with glutathione during dialysis did not lead to a 
reduction of the protein (Figure R15). Thus, glutathione in the dialysis buffer 
might not protect strep-MBP-ROXY9 entirely from oxidation, since 
glutathione is oxidized to GSSG in the absence of a recycling system [1,9]. 
Alternatively, it could modify strep-MBP-ROXY9 by glutathionylation [1,9]. 
Rapid oxidation after purification was also observed for the CGFS-type 
glutaredoxin AtGRXS16, which oxidized during non-reducing gel 
electrophoresis and was also not reduced by glutathione [263]. The rapid 
oxidation of AtGRXS16 possibly depends on its N-terminal active site cysteine 
residue with a low pKa value [263]. Thus, it can be speculated that at least some 
cysteines of strep-MBP-ROXY9 have low pKa values, as well, making them 
reactive to oxidants. In the future, determination of the pKa values together 
with redox titration experiments and detailed quantitative mass spectrometric 
analyses of wild type strep-MBP-ROXY9 and strep-MBP-ROXY9 versions in 
which the cysteine residues are mutated might reveal the reason for the fast 
oxidation of strep-MBP-ROXY9. A physiological function of this sensitivity of 
strep-MBP-ROXY9 towards oxidation remains to be investigated. Prelimiary 
experiments with plants overexpressing HA-tagged ROXY9 showed that 
ROXY9 is present in a reduced state even when the plant is treated with 
hydrogen peroxide [N. Li, unpublished]. However, hydrogen peroxide is readily 
scavenged by antioxidant systems [264,265]. Therefore, further studies using 
high light [264,265], menadione, paraquat or diamide to induce oxidative stress 
have to be conducted. 
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Strep-MBP-ROXY9 potentially acts as a weak reductase 
Strep-MBP-ROXY9 was inactive in using glutathione to reduce different 
glutaredoxin substrates after removing DTT from the protein preparation by 
desalting columns or dialysis (Figure R14). Based on the above-mentioned 
results regarding the oxidation of strep-MBP-ROXY9, it could be speculated 
that glutathione from the assay mixtures is not able to reduce the CC-type 
glutaredoxin. 
Introducing glutathione into the protein preparation while removing DTT by 
dialysis and testing higher amounts of the CC-type glutaredoxin resulted in a 
weak reactivation of GAPDH, which is most likely caused by a ROXY9-
mediated deglutathionylation of GAPDH-SG (Figure R16D). However, it is 
unclear whether the antioxidant glutathione [1,9] preserved the catalytic activity 
of strep-MBP-ROXY9 or whether the higher protein concentrations used led 
to this effect. A weak reductase activity of strep-MBP-ROXY9 would be 
consistent with previous data showing that chimeric CPYC-type glutaredoxins 
carrying a CC-type active site slowly reduce glutaredoxin substrates [176]. 
However, in contrast to the chimeric glutaredoxins, strep-MBP-ROXY9 was 
not active towards the disulphide bridge-containing substrates HEDS and 
insulin [56,75,101,107,240,241,243,266] (Figure R16A to D), indicating that 
strep-MBP-ROXY9 might not reduce disulphide bridges. Recently, GAPDH 
was found to easily form disulphide bridges after glutathionylation of the active 
site [267]. If strep-MBP-ROXY9 only catalyzes deglutathionylation but not the 
reduction of other disulphides, only a part of the GAPDH pool serves as a 
substrate for strep-MBP-ROXY9. In addition, it might not use the artificial 
compound HEDS in its glutathionylated form as a substrate 
[56,75,101,107,240,241,266]. Thus, a selectivity of strep-MBP-ROXY9 for the 
substrate and/or the type of disulphide bond on the substrate could account 
for its weak activity in the GAPDH assay. 
However, the sensitivity of strep-MBP-ROXY9 to oxidation most likely lowers 
the amounts of active protein in the preparation used. Hence, the oxidation 
state of strep-MBP-ROXY9 after purification with increased DTT 
concentrations, different reducing agents, or anaerobic conditions has to be 
tested. Once conditions under which strep-MBP-ROXY9 can be purified and 
analysed in a reduced state have been established, the catalytic activity of strep-
MBP-ROXY9 towards HEDS, insulin, GAPDH, and roGFP can be re-
assessed. This would allow a more precise analysis of the catalytic properties of 
ROXY9 and will support the evaluation of the observed catalytic activity 
towards glutathionylated GAPDH. 
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Strep-MBP-ROXY9 acts as an oxidase in vitro 
Aside from reductase reactions, glutaredoxins can catalyse the oxidation of 
certain proteins, such as roGFP, by glutathionylation [1,9,75,87,88,263]. During 
the oxidation of roGFP, the glutaredoxin first glutathionylates itself via GSSG 
(Figure D1, step A) and then transfers the glutathione moiety to roGFP (Figure 
D1, step B and C). Glutathionylated roGFP forms a disulphide bridge, thereby 
releasing glutathione (Figure D1, step D) [268]. 
In contrast to the weak activity towards glutathionylated GAPDH, strep-MBP-
ROXY9 oxidized reduced roGFP2 as strongly as the control glutaredoxin 
GRXC1 from the CPYC class (Figure R20). Strep-MBP-ROXY9 after removal 
of DTT was used. Although strep-MBP-ROXY9 is partially oxidized under 
these conditions, the oxidation of roGFP2red by strep-MBP-ROXY9 depended 
on GSSG, suggesting that strep-MBP-ROXY9 was first glutathionylated by 
GSSG and then transferred the glutathione moiety to roGFP2red. 
A glutathionylation activity has initially been described for the CPYC-type 
glutaredoxin Grx1 from humans [87]. On the one hand, this glutathionylation 
activity might play a role in the quenching of reactive oxygen species: Reaction 
with ROS leads to the formation of glutathionyl radicals, which might be 
glutathionylated by glutaredoxins, forming GSSG. On the other hand, 
glutaredoxins can glutathionylate other proteins, thereby regulating their 
activity [87]. In A. thaliana, GRXC2 was found by pulldown experiments and 
yeast-two-hybrid studies to interact with the receptor-like kinase BAK1. In vitro 
experiments showed that the glutaredoxin glutathionylates BAK1, which 
results in an inhibition of the BAK1 kinase activity [88]. However, in vivo 
evidence for the redox regulation of BAK1 is still missing. In contrast, the TGA 
transcription factor TGA1 has already been described as a redox-controlled 
protein in vivo and in vitro [32,224]. Because ROXY9 interacts with TGA1 in 
pulldown and yeast-two-hybrid experiments [155–157] and showed an oxidase 
activity towards roGFP2red, it is tempting to speculate that it might regulate 
TGA1 by glutathionylation. Thus, future experiments using TGA1 as a 
substrate could be conducted to test this hypothesis. TGA1 can be purified 
from E. coli or translated in vitro as described by Després et al. (2003) [224] and 
Lindermayr et al. (2010) [32]. Labelling of the oxidized and reduced residues via 
iodoTMT and IAM could be used to detect changes in the redox state of TGA1 
via Western Blots using iodoTMT and TGA1 antibodies. Alternatively, 
labelling of reduced cysteines via mBBr would allow to measure changes in the 
TGA1 redox state photometrically [249]. Finally, mass spectrometry could be  
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Figure D1. Oxidation of roGFP by glutaredoxins. In step A, the glutaredoxin (GRX, grey) 
binds GSSG via its scaffold site (blue) and then glutathionylates itself on its N-terminal active 
site cysteine (step B). The weak activation site (red) in CGFS-type glutaredoxins prevents 
deglutathionylation of the glutaredoxin via another molecule of glutathione or additional 
cysteines from the glutaredoxin. RoGFP (green) than takes over the glutathione moiety (step C) 
which results in the formation of an intramolecular disulphide in the protein (step D). The figure 
was prepared according to Meyer & Dick (2010) [268], Begas et al. (2017) [75], and Zannini et 
al. (2019) [263]. 
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used to identify the redox modifications occurring in TGA1 after incubation 
with strep-MBP-ROXY9 and GSSG. 
 
The weak reductase/strong oxidase activity of ROXY9 might be determined by the 
glutathione binding site 
As described above, strep-MBP-ROXY9 exhibited probably a weak reductase 
activity but a significant oxidase activity (Figures R16D and R20). It is 
interesting to note that such a differential activity has previously been described 
for the CGFS-type glutaredoxins GRXS15 and GRXS16 [75,97,116,117]. This 
differential activity was recently attributed to the composition of the 
glutathione binding site in GRXS15 and GRXS16: 
The weak reductase activity of GRXS15 and GRXS16 might result from a 
weakened glutathione activation site (Figure I4C and D) [75,263]. This site 
binds and activates the recycling glutathione molecule during glutaredoxin 
catalysis [75]. Whereas both CGFS-type glutaredoxins might still be able to 
attack the substrate, forming a disulfide bridge via their N-terminal acitve site 
cysteine to glutathione or the target itself, they inefficiently bind and activate 
the recycling glutathione molecule to resolve this linkage (Figure I4A and B). 
Thus, the slow recycling of the glutaredoxin becomes limiting regarding the 
overall reaction velocity [75,263]. 
In CGFS-type glutaredoxins, binding and activation of glutathione is hampered 
by amino acid exchanges and an extended loop region before the active site 
motif [75,263]. Comparing the amino acid sequence of ROXY9 and other CC-
type glutaredoxins to those of CPYC- and CGFS-type glutaredoxins (Figure 
R22; [80]) shows that the disturbing loop region is missing in ROXY9. 
Moreover, the conserved lysine residue of the activation site is present in 
ROXY9 [80]. However, in CPYC-type glutaredoxins, the tyrosine of the active 
site might contribute to the binding and activation of glutathione, as indicated 
by initial results [75]. This residue is replaced in both, CGFS-type glutaredoxins 
[75] and CC-type glutaredoxins [80]. Consequently, the leucine found at this 
site in ROXY9 might weaken the acitvation site in this protein, thereby 
lowering its reductase activity. 
In contrast to the weak activation site, the scaffold site of CGFS-type 
gluaredoxins might still enable an interaction with GSSG and glutathionylation 
of the glutaredoxin N-terminal active site cysteine residue (Figure D1, steps A 
and B) [75]. Because the altered activation site prevents an efficient attack of 
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recycling cysteine or a recycling glutathione molecule on the glutathione-mixed 
disulphide in the glutaredoxin active site, the protein remains glutathionylated 
[75,263]. This enables the transfer of the glutathione moiety to a target protein 
such as roGFP, resulting in its oxidation (Figure D1, step B and C) [75,263,269]. 
The scaffold site of glutaredoxins includes the TVP and the GG motif and a 
rather conserved glutamate residue after the GG motif (Figure I4D) [75]. The 
scaffold site glutamate appears to be conserved in ROXY9, but not the TVP 
and the GG motif (Figure R22) [80]. Thus, as for GRXS15 and GRXS16, the 
rather strong oxidase activity might result from the amino acid exchanges 
observed in the TVP and the GG motif in ROXY9. Because the oxidation of 
roGFP by ROXY9 is comparable to that of GRXC1 (Figure R20), but CGFS-
type glutaredoxins are weaker oxidases than GRXC1 [75,97,263], one could 
speculate that the differences in the ROXY9 glutathione binding site allow a 
more efficient association with GSSG and/or a less efficient recycling than the 
CGFS-glutaredoxin scaffold site. In addition to this, a reactive N-terminal 
active site cysteine residue could be rapidly glutathionylated, as described for 
AtGRXS16 [263], and the weakened activation site might prevent that ROXY9 
deglutathionylates itself [75,263]. 
Because the activities of ROXY9 described in this work resemble those of the 
CGFS-type glutaredoxins GRXS15 and GRXS16, it might be interesting to test 
mutant ROXY9 variants for their kinetic parameters regarding glutathione and 
the glutathionylated substrate during catalysis, as described by Begas et al. 
(2017) [75]. Such studies would address the influence of certain glutathione 
binding site residues on the efficiency of the association of ROXY9 with the 
substrate, as well as the binding and activation of the recycling glutathione [75]. 
Once designed and purified, the ROXY9 mutants could be tested for their 
activity in plate reader-based roGFP or GAPDH assays. However, because of 
the oxidation sensitivity of ROXY9, such experiments might require anaerobic 
conditions. By crystallization and NMR, the structure of the glutathione 
binding groove in ROXY9 could be examined. However, these structural 
studies will require optimization of the TEV cleavage of ROXY9 (Figure R17) 
regarding the purification of the cleaved protein. Both, mutant analysis and 
structural studies could reveal differences and similarities in the binding mode 
of glutathione between glutaredoxins from the CC class and the other classes 
and might therefore help to understand the deviations observed in the catalytic 
activity of strep-MBP-ROXY9 and the control glutaredoxins from the CPYC 
class. 
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Purified strep-MBP-ROXY9 might bind an iron-sulfur cluster 
Aside from catalytic activity, several glutaredoxins were found to incorporate 
[2Fe-2S] or [3Fe-4S]+ clusters as dimers [1,81,90,95,112–117,124]. Similarly, a 
CC-type glutaredoxin from poplar associated with an iron-sulfur cluster. Using 
chimeric CPYC-glutaredoxins with a CC-type active site, Couturier et al. (2010) 
showed that CC-type glutaredoxins possibly bind [2Fe-2S] clusters [176]. In 
this study, strep-MBP-ROXY9 was reconstituted in the presence of DTT and 
glutathione under anaerobic conditions in vitro. As indicated by UV/Vis 
spectroscopy and determination of the iron and sulfur amount bound per 
protein, strep-MBP-ROXY9 incorporated probably a [4Fe-4S] cluster per 
monomer (Figure R23). With exception of zebrafish Grx2, all glutaredoxins 
analyzed so far for cluster incorporation bind iron-sulfur clusters as dimers. 
Moreover, they use their active site and glutathione to coordinate these 
cofactors via the thiolate of cysteines [1,81,90,95,112–117,124,126]. Therefore, 
the active site represents a potential iron-sulfur cluster binding site in ROXY9. 
ROXY9 carries a CCLC active site extended by a tyrosine residue (CCLCY) 
(Figure SI2) [133,145]. In addition, it harbours two more cysteine residues, 
which are conserved in its most closely related orthologues, ROXY6, 7, and 8. 
As inferred from an alignment with ROXY19 and the ROXY19 homology 
model, one of them, Cys49, is probably located at the end of helix α2 placed 
rectangular to the helix containing parts of the active site (α1) (Figures R22, SI2, 
and D2A). Thus, it might be situated close to the active site. Consequently, four 
cysteine residues in proximity to each other can be identified in ROXY9. Since 
both, [2Fe-2S] and [4Fe-4S] cluster require four ligands for coordination 
(Figure I5B and C) [118,119], they represent potential residues to test for cluster 
coordination, once cluster binding can be confirmed for ROXY9. Finally, since 
the cluster was reconstituted in the presence of glutathione, glutathione might 
represent an additional ligand, as observed for other glutaredoxins 
[1,81,90,95,112–117,124,126]. However, as can be seen in Figure D2A, the 
coordination of an iron-sulfur cluster by ROXY9 would require a partially 
altered orientation of the cysteine residues in the region of the active site motif 
and a different orientation of the cysteine of glutathione. Structural 
rearrangements within the active site and the glutathione binding mode upon 
cluster binding occur for both, CPYC- and CGFS-type glutaredoxins (Figure 
I6E and F) [92,94,124] and are therefore not unlikely to occur in ROXY9. 
Cluster association of strep-MBP-ROXY9 turned out to be unstable under 
aerobic conditions (S. Freibert, personal communication). Consequently, the 
cluster itself might be labile under these conditions [270], but the lability could  
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Figure D2, part I. Localization of the CCMCH motif in ROXY19 and residues 
homologous to the ROXY9 external cysteines and speculation about potential iron-
sulfur cluster binding modes for ROXY9. Due to the lack of a ROXY9 structural model, 
the figures were created from the ROXY19 homology model [80] using Chimera. Size and 
properties of most amino acids highlighted in the figure are similar in ROXY9 and ROXY19, 
allowing speculations about iron-sulfur cluster binding mode in ROXY9 based on the 
ROXY19 structure. (A) illustrates a potential coordination by the CC motif, Cys49, and the 
cysteine of glutathione. The amino acid one letter code and numbering are shown in black for 
ROXY19 and in grey for ROXY9. The active site cysteines of ROXY19 are shown in yellow, 
whereas the methionine and the histidine of the extended active site are shown in pink. 
Glutathione is depicted as a stick model in orange. The residues homologous to the external 
cysteines in ROXY9 are coloured in cyan. The precise alignment of strand β1 (partly hidden by 
helix α1), helix α2 and the loop in between is impossible because the residues and the length of 
this region are not well conserved. In ROXY9, the loop might be shorter.  
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Figure D2, part II. Localization of the CCMCH motif in ROXY19 and residues 
homologous to the ROXY9 external cysteines and speculation about potential iron-
sulfur cluster binding modes for ROXY9. Due to the lack of a ROXY9 structural model, 
the figures were created from the ROXY19 homology model [80] using Chimera. Size and 
properties of most amino acids highlighted in the figure are similar in ROXY9 and ROXY19, 
allowing speculations about iron-sulfur cluster binding mode in ROXY9 based on the 
ROXY19 structure. (B) depicts a cluster binding mode via the CC motif, the tyrosine of the 
extended active site and Cys49. Colouring and labelling are the same es in Figure D2, part I. 
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also be caused by the rapid oxidation of ROXY9 under aerobic conditions. The 
latter possibility questions the observed stoichiometry of the iron and sulphide 
ions bound to strep-MBP-ROXY9. However, because the DTT concentrations 
used during reconstitution are higher than those used for the purification, the 
possibility exists that that strep-MBP-ROXY9 is fully reduced during the 
reconstitution. Thus, the oxidation state of strep-MBP-ROXY9 under 
reconstitution conditions has to be determined, before the experiment is 
reproduced. In case the binding of a [4Fe-4S] cluster by strep-MBP-ROXY9 
can be confirmed, EPR and Mössbauer spectroscopy will have to be used to 
reasonably show the incorporation of an iron-sulfur cluster. Once, cluster 
incorporation has been demonstrated and the type of cluster has been 
determined, structural studies and mutant analysis could be used to find out 
how ROXY9 coordinates this cluster. 
 
Comparisons of ALWL- and non-ALWL CC-type glutaredoxins 
To clarify the function of CC-type glutaredoxins in planta, the requirement of 
the active site cysteine residues of ROXY9 and other CC-type glutaredoxins 
for their repressive activity has been studied before (Table D1) 
[146,152,155,174,175]. Lacking a corresponding knock-out mutant, ROXY9 
and mutant constructs of ROXY9 were ectopically expressed in wildtype plants 
and their influence on hyponastic growth was examined. These experiments 
showed that ROXY9 requires its CC-motif for repression, but not the last 
active site cysteine residue. [155]. Similarly, in this study, two further ROXY9 
mutants, ROXY9 CPYC and ROXY CCLCA were tested for their repressive 
activity regarding hyponastic growth and flowering.  
Although the flowering and petiole length experiments might have suffered 
from a small sample size, the ROXY9 CPYC mutant protein appeared to be 
inactive in repressing both, hyponasty and flowering (Figure R1 to R4, SR1 to 
SR3). Since the CPYC motif lacks the second cysteine residue of the active site 
motif, the apparent inactivity of ROXY9 CPYC is consistent with previous data 
showing that this cysteine is essential for ROXY9 activity [155]. These findings 
contrast with the observations made for other CC-type glutaredoxins: 
Overexpression of the CC-type glutaredoxin ROXY19 and a CPYC mutant of 
ROXY19 in wild type plants showed that both proteins are active (Table D1) 
[152]. The same type of experiment revealed that the second cysteine of the CC 
motif in ROXY19 might be dispensable for its function [174]. When 
complementing the roxy1 mutant with ROXY1 and ROXY1 SSMS under the 
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control of the ROXY1 promoter, Ziemann (2010) noticed that both proteins 
were functional (Table D1) [175]. Thus, whereas ROXY9 might require the CC 
motif for its activity, ROXY1 and ROXY19 do not. Aside from the active site 
requirements, ROXY1, ROXY19, and ROXY9 differ in their C-terminus. 
Whereas ROXY1 and ROXY19 carry an ALWL motif at this site, ROXY9 
lacks this motif [145,155,168,170]. Interestingly, there are findings pointing to 
differences between the repressive mechanisms used by ALWL- and non-
ALWL CC-type glutaredoxins: Whereas ROXY19 interacts with TPL in 
transient protoplast assays via its ALWL motif and represses TGA2 during 
these assays, it is unable to repress TGA1-mediated hyponasty when 
overexpressed. ROXY9 shows exactly the opposite behaviour [155,168,177]. 
Thus, the difference between the requirement of the CC motif for repression 
might represent another difference between these two subgroups of CC-type 
glutaredoxins. Still, this questions the strict conservation of this motif within 
CC-type glutaredoxin [133,134,136]. One could speculate, that, whereas this 
cysteine is necessary for repression in non-ALWL CC-type glutaredoxins, it 
might fulfill an alternative function in ALWL-containing CC-type 
glutaredoxins. Thus, additional experiments involving more CC-type 
glutaredoxins from these two subgroups are necessary to uncover the role of 
the CC motif in both groups of CC-type glutaredoxins. 
Aside from its CC motif, ROXY9 required the tyrosine extending the active 
site to repress both, flowering and hyponasty (Figure R1 to R4, SR1 toSR3). 
Measuring the shortening of petiole length caused by ROXY9 overexpression 
suggested that the CCLCA mutant protein might be partially functional 
regarding this phenotype (Figure SR2). Still, statistical effects resulting from the 
small sample size might have influenced the outcome of the petiole length and 
flowering experiments. Therefore, repetition of these experiments is necessary 
to confirm these results. Currently, the tyrosine residue appears to be important 
for repression, although perhaps not in general. This importance of the 
extended active site motif for ROXY9 contrasts with the findings for ROXY19: 
Mutation of the histidine extending the active site in ROXY19 does not disturb 
its repressive activity (Table D1) [174]. Interestingly, all ALWL-containing CC-
type glutaredoxins in A. thaliana harbour a histidine after their active site motif, 
while a tyrosine is found in most non-ALWL glutaredoxins (Figure SI2) [133]. 
Thus, regarding ROXY9 and its most closely related proteins ROXY6, 7, and 
8 [145], this tyrosine residue could constitute a further difference in the 
repressive mechanisms of ALWL- and non-ALWL CC-type glutaredoxins. 
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Structural modelling of ROXY19 suggests that the side chain of the histidine 
residue of the extended active site is protruding from the protein surface [80]. 
The homologous residues from other glutaredoxins stick out from the surface, 
as well (Figures SI1A to C and D2) [94,110]. Thus, in ROXY9, the tyrosine of 
the CCLCY motif might also be situated on the surface of the protein. 
Regarding this surface localization, one could speculate that this residue might 
be modified or interact with other molecules. Interestingly, a tyrosine 
contributes to the binding of a mononuclear cluster in the iron-sulfur cluster 
assembly protein IscA [118,271]. Hence, this protruding tyrosine residue might 
represent an additional candidate for iron-sulfur cluster ligation in ROXY9 
aside from the active site cysteines and the external C49. 
All in all, the results presented here substantiate the view that the repressive 
mechansims of the non-ALWL CC-type glutaredoxin ROXY9 and the ALWL 
CC-type glutaredoxin ROXY19 differ [155,168,177]. However, this assumption 
is based on the overexpression of wildtype-like or mutant ROXY9 and 
ROXY19 in wildtype Arabidopsis plants [152,155,174]. Overexpression can 
lead to artificial effects. In contrast, the complementation of mutant plants of 
both CC-type glutaredoxins might provide more reliable results. Thus, in the 
future, knock-out plants for ROXY9 and ROXY19 and their redundant genes 
[145,152,155,168] should be obtained and transformed with wildtype-like and 
mutant ROXY9 or ROXY19 variants. 
 
 
Table D1. Summary of the active site requirements of ALWL and non-ALWL CC-type 
glutaredoxins. The table shows the extended active site motif, the presence of an ALWL 
motif and the requirements of the 1st, 2nd, and 3rd active site cysteine, as well as the histidine or 
tyrosine of the extended active site. The outcome of mutating the active site to CPYC is shown, 
as well. 1 – Lemaire (2004) [133], 2 – Ziemann (2010) [175], 3 – Xing et al. (2005) [146], 4 – Oberdiek 
(2017) [174], 5 – Huang et al. (2016) [152], 6 – Oberdiek, unpublished, 7– Li (2017) [155], 8 – this 
work. 
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Potential regulatory mechanisms of TGA1 by 
ROXY9 
_____________________________________________________________________ 
 
The TGA transcription factor TGA1 was found to change its redox state after 
treatment with salicylic acid in planta [224]. Since the tga1 tga4 mutant 
phenocopies ROXY9 overexpression plants with respect to hyponasty and 
because ROXY9 is a glutaredoxin, TGA1 was speculated to be redox-regulated 
by ROXY9 [155]. In an initial experiment to address this idea, an HA-tagged 
TGA1 version with mutations in all four cysteine residues mimicking the 
reduced state of the protein was expressed in tga1 tga4 plants and compared to 
plant lines expressing either a tagged non-mutated TGA1 version or the tag 
only. As for the ROXY9 overexpression lines, the phenotype of the different 
lines with respect to hyponastic growth and flowering was examined (Figure 
R25 to 27, SR9 to 11). 
As discussed for the phenotypic analysis of ROXY9 overexpression plants, the 
measurement of the petiole length and flowering might have been influenced 
by a small sample size, and, therefore, requires repetition with a larger sample 
size (Figures R26, R27, SR10, and SR11). In addition, a partial 
complementation – resulting either from the HA tag fused to the expressed 
TGA1 protein or from a contribution of TGA4 [155–157,194,223,229,230,272] 
–  must be taken into account regarding the measurement of the petiole length 
(Figures R26 and SR10). Still, the overall result suggested that the cysteine 
mutant of TGA1 mimicking the reduced state of the protein is at least as active 
as non-mutated TGA1 in planta regarding hyponasty and flowering. With 
respect to flowering (Figures R27 and SR11), the cysteine mutant of TGA1 
appeared to complement the phenotype slightly stronger than the wild type-
like TGA1 version. However, the earlier flowering might be caused by an 
increased stability of the protein. Therefore, this observation will have to be 
proven by analysing the abundance of the transgenic protein in the plant cells. 
Altogether, these findings are in accordance with the observation that a TGA1 
version carrying mutations in only two of the four cysteine residues is active in 
planta [155]. 
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Redox-regulation of TGA1 by ROXY9 
At a first glance, the functionality of the TGA1 cysteine mutant might indicate 
that TGA1 is not redox-regulated during flowering and hyponasty. However, 
if ROXY-mediated repression of these processes via redox changes represents 
only an accessory mechanism, the redox state of the TGA1 cysteines might not 
contribute significantly to the overall termination process. 
Regarding hyponastic growth, the experiments performed so far represent only 
end-point measurements; therefore, altered kinetics of the inititation and/or 
termination of hyponastic growth of the complementation line expressing the 
TGA1 cysteine mutant plants might have been missed. Experiments analysing 
the kinetics of initiation and termination of hyponastic growth [273] in the 
different complementation lines will help to clarify whether TGA1 indeed does 
not require its cysteines during the regulation of hyponastic growth or whether 
a potential fine-tuning of hyponastic growth via redox regulation of TGA1 
occurs. Similar to the TGA1 cysteine mutant plant, roxy8 roxy9 and roxy6 roxy7 
roxy9 mutant plants have been analysed and were found to perform a wild type-
like hyponasty [155] [J. Budimir, unpublished]. Thus, these mutants should also 
be tested for the kinetics of hyponastic growth. Moreover, if these mutants 
show wildtype-like hyponastic growth kinetics, roxy6 roxy7 roxy8 roxy9 and even 
roxy6 roxy7 roxy8 roxy9 roxy20 knockout plants could be included in the analysis 
[145,155,168]. This will clarify the extent of the contribution of ROXY9 and 
its relatives to the regulation of this process. In contrast to roxy8 roxy9 and roxy6 
roxy7 roxy9 mutants, ROXY9 overexpression plants show a clear repression of 
hyponastic growth. To further test, whether this repression is mediated by 
oxidation of TGA1, ROXY9 could be overexpressed in the different tga1 tga4 
complementation lines to test whether the CC-type glutaredoxin still mediates 
repression when the cysteine residues in TGA1 are mutated. Finally, analysing 
the oxidation state of TGA1 in these plants via iodoTMT and IAM labelling 
and subsequent Western blotting will help to understand whether ROXY9 
mediates redox-regulation of TGA1. Aside from examining hyponastic growth, 
the latter two experiments could be performed to test whether TGA1 is 
repressed by ROXY9 via redox regulation during flowering. 
All in all, it is still possible to speculate about a redox regulation of TGA1 by 
ROXY9 during both, hyponastic growth and flowering. Because recombinant 
ROXY9 was found to oxidize roGFP efficiently and because TGA1 is active 
in its reduced state, it seems possible that ROXY9 might oxidize TGA1 to 
inhibit hyponastic growth and induction of flowering (Figure D3A). 
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Repression of TGA1 by ROXY9 via complex formation involving co-repressors and an iron-
sulfur cluster 
Although a minor or pathway-specific redox-regulation of TGA1 by ROXY9 
might exist, the ability of the TGA1 cysteine mutant to complement the 
tga1 tga4 mutant raises the question of alternative mechanisms for ROXY9 to 
repress TGA1 regarding hyponasty and flowering. As discussed before, 
ROXY9 might incorporate an iron-sulfur cluster (Figure R23). Iron-sulfur 
cluster binding would open new possibilities for a repressive mechanism 
regarding TGA1, such as complex formation with TGA1 and perhaps 
additional proteins. Repression by ROXY19 is mediated by recruitment of the 
corepressor TPL [177]. ROXY9 does not bind to TPL directly [177], but JAZ 
proteins, which interact themselves or via the bridging protein NINJA with 
TPL [181], also associate with ROXY9 in yeast-two-hybrid experiments (Figure 
D3B) [178]. In this study, ROXY9 and JAZ9 did not interact in a pulldown 
experiment using recombinant proteins (Figure R10) but this interaction could 
have been disturbed by the large MBP tags fused to both proteins or could 
require specific conditions. However, treatment of plants with methyl 
jasmonate represses hyponastic growth [274]. Since JAZ proteins are degraded 
in the presence of jasmonic acid, these findings contradict with a role of JAZ 
proteins in repression of hyponasty [179]. Still, non-JAZ TIFY proteins, such 
as TIFY8, which also interact with NINJA and ROXY9 [178,181,275] might 
represent candidates for a potential repressive complex. Since ROXY9 and 
ROXY19 differ in the amino acids required for repression [152,155,168,174], 
potential repressive complexes formed by these two proteins might differ, as 
well. In conclusion, other repressive complexes with respect to hyponastic 
growth, with or without TPL, should be considered (Figure D3C). Because the 
data presented in this study suggests that ROXY9 is sensitive to oxidation and 
might associate with an iron-sulfur cluster, one could speculate that the 
regulation of such a complex might be mediated via redox sensitivity of 
ROXY9 and/or cluster incorporation [270]. Regarding iron-sulfur cluster 
binding, it is interesting to note, that sensing of oxidative stress by 
glutaredoxins via labile iron-sulfur clusters has been proposed before 
[94,112,138]. Thus, after excluding a redox-regulation of TGA1 by ROXY9, 
one could attempt the co-purification of complexes involving ROXY9 and 
TGA1 from plant cells to confirm whether TIFY proteins and TPL associate 
with these transcriptional regulators. In addition, simultaneous co-purification 
of enzymes mediating the assembly and transfer of iron-sulfur clusters to target 
proteins would represent a first indication, whether ROXY9 associates with an 
iron-sulfur cluster in planta [S. Freibert, personal communication].  
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Figure D3. Examples for potential regulatory mechanisms of ROXY9 during 
hyponastic growth. (A) TGA1 might become reduced under low light conditions, thereby 
activating hyponastic growth. Upon backshift to control light conditions, ROXY9 is expressed 
[155,156] and might oxidize TGA1, thereby inactivating the protein. (B) TGA1 might be 
repressed by ROXY9 via iron-sulfur cluster binding which induces the association of ROXY9 
with corepressors such as the TIFY protein-NINJA-TPL complex [177,178,181]. ROS/RNS 
might interfere with cluster binding by ROXY9 and therefore release the repression. (C) 
Instead of recruiting the TIFY protein-NINJA-TPL complex, ROXY9 could repress 
hyponasty by e.g. interacting with still unidentified corepressors. Derepression might occur as 
described in (B). Mechanisms similar to those shown in (A), (B), and (C) could contribute to 
the regulation of flowering. However, the stimuli inducing these mechanisms are unknown.
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Figure SI1, part I. Different oxidation states of glutaredoxins occuring during catalysis. 
(A) The crystal structure of S. cerevisiae (Grx2) in its reduced form was solved by Li et al. (2010) 
[110] to a resolution of 1.5 Å. The structure pictures were produced from the PDB file 
(accession: 3CTG) using PyMOL. The cysteines of the CPYC active site are presented as thiols 
and shown in yellow; residues important for glutathione binding are shown in red. Residues 
changing their conformation upon oxidation are coloured in light or dark cyan, respectively. 
Residues speculated to contribute to catalysis are shown in dark cyan; residues demonstarted 
to determine the specific activity are shown in orange. 
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Figure SI1, part II. Different oxidation states of glutaredoxins occuring during 
catalysis. (B) The crystal structure of S. cerevisiae Grx2 in its oxidized form was solved by Li et 
al. (2010) [110] to a resolution of 2.1 Å. The structure pictures were produced from the PDB 
file (accession: 3CTF) using PyMOL. The active site cysteines of the CPYC glutaredoxin form 
an intramolecular disulfide and are shown in yellow; residues important for glutathione binding 
are shown in red. Residues changing their conformation upon oxidation are coloured in light 
or dark cyan, respectively. Residues speculated to contribute to catalysis are shown in dark cyan; 
residues demonstarted to determine the specific activity are shown in orange. 
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Figure SI1, part III. Different oxidation states of glutaredoxins occuring during 
catalysis. (C) The crystal structure of the apoform of A. thaliana GRXC5 covalently bound to 
glutathione via its first active site cysteine was solved by Couturier et al. (2011) [94] to a 
resolution of 1.2 Å. The structure pictures were produced from the PDB file (accession: 3RHB) 
using PyMOL. The active site cysteines of the CPYC glutaredoxin are shown in yellow; residues 
important for glutathione binding are shown in red. Residues found in other glutaredoxins to 
contribute to glutathione binding, but not mentioned in the publication about GRXC5, are 
shown in light blue. Q62 is shown in purple because it indirectly contributes to glutathione 
binding via TVP loop stabilization. Residues homologous to those changing their 
conformation in S. cerevisiae Grx2 upon oxidation are depicted in light and dark cyan. 
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Figure SI2. Alignment of CC-type glutaredoxins from A. thaliana. The sequences from 
all CC-type glutaredoxins in A. thaliana were obtained from and aligned with the Clustal O 
(1.2.4) algorithm on the UniProt database. The degree of conservation between the residues 
from weak to strong is indicated by colours and symbols as follows: light grey (.) > grey (:) > 
dark grey (*). The active site motif is shown in red. The conserved residue following the active 
site is coloured in yellow. Glutathione binding residues and the GG motif are shown in orange, 
whereas the TVP motif is depicted in green. Functional ALWL motifs are shown in blue. Please 
note, that the homology towards residue 81 in ROXY1 is not clear for ROXY18 to 21. The 
homology proposed by Gutsche et al. (2015) [80] is indicated in orange; the homology for 
ROXY19 suggested by structural comparisons (Figure I3) are shown in blue.  
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Figure SI3. Alignment of TGA transcription factors from A. thaliana. The sequences 
from all TGA transcription factors in A. thaliana were obtained from and aligned with the 
Clustal O (1.2.4) algorithm on the UniProt database. The degree of conservation between the 
residues from weak to strong is indicated by colours and symbols as follows: light grey (.) > 
grey (:) > dark grey (*). The approximate position of the bZIP domain and the two glutamine-
rich regions (Q1 and Q2) are indicated by grey stripes above the alignment. Cysteine residues 
are shown in red and yellow.  
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Figure SR1, part I. Analysis of hyponastic growth of plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, HA-
ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 weeks 
in 12 h light/12 h dark rhythm and then transferred to different light conditions as described 
in Methods (page 59). Pictures of the plants were taken with a Canon PowerShot G11 camera. 
The images belong to the experiment shown in Figure R2A. CL – control light, LL – low light, 
LL to CL – shift from low light to control light; Col-0 corresponds to Col-0 + HA-ROXY9 #17-4. 
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Figure SR1, part II. Analysis of hyponastic growth of plants overexpressing HA-
ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 
weeks in 12 h light/12 h dark rhythm and then transferred to different light conditions as 
described in Methods (page 59). Pictures of the plants were taken with a Canon PowerShot 
G11 camera. The images belong to the experiment shown in Figure R2B. CL – control light, 
LL – low light, LL to CL – shift from low light to control light; Col-0 corresponds to Col-0 + HA-ROXY9 
#17-4. 
  
Supplementary figures 
200 
 
 
 
Figure SR1, part III. Analysis of hyponastic growth of plants overexpressing HA-
ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 
weeks in 12 h light/12 h dark rhythm and then transferred to different light conditions as 
described in Methods (page 59). Pictures of the plants were taken with a Canon PowerShot 
G11 camera. The images belong to the experiment shown in Figure R2C. CL – control light, 
LL – low light, LL to CL – shift from low light to control light; Col-0 corresponds to Col-0 + HA-ROXY9 
#17-4. 
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Figure SR2. Determination of relative petiole length of plants overexpressing HA-
ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown for 4 
weeks in 12 h day. Either leaf 7 or 8 from at least 6 different plants was detached and 
photographed from the top with a Canon PowerShot G11 camera. The petiole length and the 
blade length were measured using Image J and the petiole length relative to the entire leaf length 
was computed. Bars represent mean ± SEM. Statistical analysis (One-way-ANOVA and Tukey 
test) was performed using GraphPad Prism 8.0.1 assuming normally distributed data. Adjusted 
p-values in comparison to Col-0 are indicated above the bars: ns – non-significant, p>0.05, * - 
p ≤ 0.05, ** - p-value ≤ 0.01, *** - p-value ≤ 0.001, **** - p-value ≤ 0.0001. 
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Figure SR3, part I. Flowering time point and leave number at flowering of plants 
overexpressing HA-ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants 
overexpressing HA-ROXY9, HA-ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S 
promoter were grown under long day conditions. The number of days were counted until a 
1 cm floral stem could be observed (A). At this time point, the number of leaves was 
determined (B). Bars represent mean ± SEM from at least 5 replicates. a - smaller leaves in between 
counted leaves for all replicates, b - smaller leaves in between counted leaves for all except for 1 replicate, c – 
smaller leaves in between counted leaves for 1 or 2 replicates out of 6. 
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Figure SR3, part II. Comparison of floral stems of plants overexpressing HA-ROXY9, 
HA-ROXY9 CCLCA or HA-ROXY9 CPYC. Plants overexpressing HA-ROXY9, HA-
ROXY9 CCLCA or HA-ROXY9 CPYC from the CaMV35S promoter were grown under long 
day conditions. When the last plant had flowered, the plants were photographed in the side 
view using a Canon PowerShot G11 camera. If necessary, large floral stems were tied to sticks. 
The scale bar corresponds to approximately 10 cm. 
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Figure SR4. In vitro reductase activity of strep-MBP-ROXY9 towards roGFP2 when 
DTT is removed. Strep-MBP-ROXY9 was dialyzed against buffer without DTT. N-terminally 
His-tagged GRXC1 purified in an oxidized state was used as a control. Different amounts of 
enzyme were incubated with or without GSH and oxidized roGFP2. Oxidized roGFP2 and 
reduced roGFP2 alone served as controls. The reactions were equilibrated for 10 min. After 
that, GSH or buffer were added to initate the reactions (arrow and dashed line). The change in 
the fluorescence ration was monitored over time. Values represent mean ± SD. 
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Figure SR5. Analysis of the strep-MBP-ROXY9 redox state by LC-MS/MS. Strep-MBP-
ROXY9 was purified from insect cells in the presence of DTT and subjected to different 
oxidizing and reducing treatments: (1) Dialysis to remove DTT; (2) Dialysis to remove DTT 
and then incubated for 10 min with GSH; (3) Dialysis against buffer containing GSH, to 
remove DTT while simultaneously applying GSH. All samples were labeled with IAM (reduced 
cysteins) and iodoTMT (oxidized cysteines), separated by 10 % non-reducing SDS-PAGE and 
analyzed by LC-MS/MS as described in Methods (pages 109-110 and 115-119). To allow 
quantification, the number of different PSMs for each peptide and modification was 
normalized to the number of PSMs of an unmodified peptide resulting from the MBP tag 
(VNYGVTVLPTFK [1337,74636 Da]). As this allows only comparison of the abundance of 
specific peptides between treatments, the values for the normalized PSMs were plotted 
accordingly: active site-containing peptides with three (A), two (B), one (C) or none (D) 
reduced cysteines; peptides containing Cys49 in a reduced (E) or oxidized (F) state; peptides 
containing Cys61 in a reduced (G) or oxidized state (H). ). Please note that the diagrams show 
only the properly cleaved and fully labelled peptides of each sample. They are the most 
abundant peptides in each sample. All other peptides are listed in Supplementary table SR1 
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Figure SR6. Purification of His-TEV. His-TEV was expressed in E. coli BL21. Cells were 
lysed using lysozyme and sonication. The protein was purified via its His tag using an ÄKTA 
purification system. Purification was controlled by following the changes in A280nm (A). Buffer 
B contains 250 mM imidazole. 20 µl of each fraction were separated by 12 % SDS-PAGE (B). 
In additon, a cell suspension aliquot of 20 µl prior to lysis and after lysozyme treatment were 
analyzed. Prestained PageRuler (Thermo Scientific) was used as a size standard. The gels were 
subsequently stained with Coomassie Brilliant Blue. mAU – milli absorption units, M – Marker, 
CE – crude extract, 1 to 38 – fraction number. 
  
Supplementary figures 
207 
 
 
 
Figure SR7. In vitro oxidase activity of strep-MBP-ROXY9 towards roGFP2 when DTT 
is removed. Strep-MBP-ROXY9 was compared to N-terminally His-tagged GRXC1 regarding 
the oxidation of roGFP2. Both proteins received a DTT treatment prior to the experiment. 
After the treatment, DTT was removed via a desalting column. Different amounts of enzyme 
were incubated with or without GSSG and reduced roGFP2. Oxidized roGFP2 and reduced 
roGFP2 alone served as controls. The reactions were equilibrated for 10 min. After that, GSSG 
or buffer were added to initate the reactions (arrow and dashed line). The change in the 
fluorescence ratio was monitored over time. Values represent mean ± SD. For roGFP2red, 
1 µM GRXC1 – GSSG, and 5 µM GRXC1 + GSSG only two replicates were prepared. Thus, 
no SD could be calculated. 
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Figure SR8. Mutation occuring in the 3’UTR of the 1xHA complementation construct. 
The indicated plasmids were sequenced with primer rev23. Sequence analysis was done using 
Geneious. An excerpt of the alignments in the region of the 3’UTR is shown. The arrow points 
at the 192nd bp after the stop codon of TGA1. 
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Figure SR9, part I. Analysis of hyponastic growth of the TGA1 complementation lines. 
Selected complementation lines of the tga1 tga4 mutant were grown together with the tga1 tga4 
mutant and Col-0 wildtype plants for 4 weeks in 12 h day and then treated with CL, LL or first 
with LL followed by CL, as described in Methods (page 59). Pictures of the plants were taken 
with a Canon PowerShot G11 camera. The images above belong to the experiment shown in 
Figure R25A. CL – control light, LL – low light, LL to CL – shift from low light to control light. tga1 tga4 
corresponds to tga1 tga4 + pB1xHA-TGA1g #22-7, which lost its transgene during segregation as a 
heterozygous plant. 
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Figure SR9, part II. Analysis of hyponastic growth of the TGA1 complementation lines. 
Selected complementation lines of the tga1 tga4 mutant were grown together with the tga1 tga4 
mutant and Col-0 wildtype plants for 4 weeks in 12 h day and then treated with CL, LL or first 
with LL followed by CL, as described in Methods (page 59). Pictures of the plants were taken 
with a Canon PowerShot G11 camera. The images above belong to the experiment shown in 
Figure R25B. CL – control light, LL – low light, LL to CL – shift from low light to control light. tga1 tga4 
corresponds to tga1 tga4 + pB1xHA-TGA1g #22-7, which lost its transgene during segregation as a 
heterozygous plant. 
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Figure SR9, part III. Analysis of hyponastic growth of the TGA1 complementation 
lines. Selected complementation lines of the tga1 tga4 mutant were grown together with the 
tga1 tga4 mutant and Col-0 wildtype plants for 4 weeks in 12 h day and then treated with CL, 
LL or first with LL followed by CL, as described in Methods (page 59). Pictures of the plants 
were taken with a Canon PowerShot G11 camera. The images above belong to the experiment 
shown in Figure R25C. CL – control light, LL – low light, LL to CL – shift from low light to control 
light. tga1 tga4 corresponds to tga1 tga4 + pB1xHA-TGA1g #22-7, which lost its transgene during 
segregation as a heterozygous plant. 
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Figure SR10. Measurement of the relative petiole length of the TGA1 complementation 
lines. Col-0, tga1 tga4, a complementation line (TGA1g) from the Department of Botany (Prof. 
Dr. Yuelin Zhang, UBC Vancouver [222,223,262]) and selected complementation lines 
constructed during this work were grown for 4 weeks in 12 h day. Either leaf 7 or 8 from at 
least 6 different plants was detached and photographed from the top with a Canon PowerShot 
G11 camera. The petiole length and the blade length were measured using Image J and the 
petiole length relative to the entire leaf length computed. Bars represent mean ± SEM. 
Statistical analysis (One-way-ANOVA and Tukey test) was performed using GraphPad Prism 
8.0.1 assuming normally distributed data. Adjusted p-values in comparison to Col-0 are 
indicated above the bars: ns – non-significant, p>0.05, * - p ≤ 0.05, ** - p-value ≤ 0.01, *** - 
p-value ≤ 0.001, **** - p-value ≤ 0.0001. 
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Figure SR11, part I. Flowering time point and leave number at flowering of TGA1 
complementation lines. Col-0, tga1 tga4, TGA1g [222,223,262] and tga1 tga4 mutants 
complemented with the constructs shown in Figure 24A were grown in a long day climate 
chamber. The number of days was determined until a floral stem of 1 cm lenght was visible 
(A). At this time point, the number of leaves was counted, as well (B). Bars are mean ± SEM 
from at least 5 replicates. a - smaller leaves in between counted leaves for all replicates, b – smaller leaves in 
between counted leaves for one plant out of six plants, c – smaller leaves in between counted leaves for two or 
three out of six plants 
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Figure SR11, part II. Flowering time point and leave number at flowering of TGA1 
complementation lines. Col-0, tga1 tga4, TGA1g and tga1 tga4 mutants complemented with 
the constructs shown in Figure 24A were grown in a long day climate chamber. As soon as the 
last plant had flowered, pictures of all plants were taken using a Canon PowerShot G11 camera. 
Large floral stems were bound to sticks. The scale bar corresponds to roughly 10 cm. 
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Table SR1. Mass spectrometric analysis of the strep-MBP-ROXY9 oxidation state, part 
I. Strep-MBP-ROXY9 was purified in the presence of ca. 1 mM DTT. The reduced cysteines 
were labeled with iodoacetamide, while the oxidized cysteine residues were labeled with 
iodoTMT0-126 and then separated by 10 % non-reducing SDS-PAGE (KT11). The gels were 
stained with Colloidal Coomassie. Bands at ca. 59 kDa were cut out from the gel and prepared 
for LC-MS/MS analysis as described in Methods (pages 115-119). The dataset was searched 
and analyzed using PeptideDiscoverer 2.2 (Thermo Scientific). The modifications searched for 
were reduced cysteines (Thiol), nitrosylated cysteines (Nitrosyl), glutathionylated cysteines 
(Glutathione), sulfenic acids (Oxidation), sulfinic acids (Dioxidation), IAM-labelled cysteines 
(Carbamidomethyl), iodoTMT-labeled cysteines (iodoTMT), and oxidized methionines 
(Oxidation). The table lists the coverage for each sample, and all identified peptides with their 
modifications on cysteines (C) and methionines (M) and their mass (Theo. MH+[Da]). The 
position of each modified residue in the corresponding peptide is given in brackets (e.g.[C3]). 
If the position of the modification could not be identified, the residue is only indicated by e.g. 
[C]. The frequency in which a given modification occurs within a peptide is written before the 
name of the modification (e.g. 3xCarbamidomethyl). The quality of each identification is given 
by the X corr value. The number of identifications (different PSMs) was normalized to estimate 
the redox state of the protein. For this, the number of different PSMs for each peptide was 
divided by the number of different PSMs of two different peptides resulting from the MBP 
tag. Those peptides plotted in Figure R15 and SR5 are highlighted. 
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Table SR1. Mass spectrometric analysis of the strep-MBP-ROXY9 oxidation state, part 
II. Strep-MBP-ROXY9 purified in the presence of ca. 1 mM DTT was dialyzed to remove 
DTT. The reduced cysteines were labeled with iodoacetamide, while the oxidized cysteine 
residues were labeled with iodoTMT0-126 and then separated by 10 % non-reducing SDS-
PAGE (KT07). The gels were stained with Colloidal Coomassie. Bands at ca. 59 kDa were cut 
out from the gel and prepared for LC-MS/MS analysis as described in Methods (pages 115-
119). The dataset was searched and analyzed using PeptideDiscoverer 2.2 (Thermo Scientific). 
The modifications searched for were reduced cysteines (Thiol), nitrosylated cysteines 
(Nitrosyl), glutathionylated cysteines (Glutathione), sulfenic acids (Oxidation), sulfinic acids 
(Dioxidation), IAM-labelled cysteines (Carbamidomethyl), iodoTMT-labeled cysteines 
(iodoTMT), and oxidized methionines (Oxidation). The table lists the coverage for each 
sample, and all identified peptides with their modifications on cysteines (C) and methionines 
(M) and their mass (Theo. MH+[Da]). The position of each modified residue in the 
corresponding peptide is given in brackets (e.g.[C3]). If the position of the modification could 
not be identified, the residue is only indicated by e.g. [C]. The frequency in which a given 
modification occurs within a peptide is written before the name of the modification (e.g. 
3xCarbamidomethyl). The quality of each identification is given by the X corr value. The 
number of identifications (different PSMs) was normalized to estimate the redox state of the 
protein. For this, the number of different PSMs for each peptide was divided by the number 
of different PSMs of two different peptides resulting from the MBP tag. Those peptides plotted 
in Figure R15 and SR5 are highlighted. 
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Table SR1. Mass spectrometric analysis of the strep-MBP-ROXY9 oxidation state, part 
III. Strep-MBP-ROXY9 was purified in the presence of ca. 1 mM DTT. After DTT had been 
removed by dialysis, the protein was treated with glutathione for 10 min. The reduced cysteines 
were labeled with iodoacetamide, while the oxidized cysteine residues were labeled with 
iodoTMT0-126 and then separated by 10 % non-reducing SDS-PAGE (KT17). The gels were 
stained with Colloidal Coomassie. Bands at ca. 59 kDa were cut out from the gel and prepared 
for LC-MS/MS analysis as described in Methods (pages 115-119). The dataset was searched 
and analyzed using PeptideDiscoverer 2.2 (Thermo Scientific). The modifications searched for 
were reduced cysteines (Thiol), nitrosylated cysteines (Nitrosyl), glutathionylated cysteines 
(Glutathione), sulfenic acids (Oxidation), sulfinic acids (Dioxidation), IAM-labelled cysteines 
(Carbamidomethyl), iodoTMT-labeled cysteines (iodoTMT), and oxidized methionines 
(Oxidation). The table lists the coverage for each sample, and all identified peptides with their 
modifications on cysteines (C) and methionines (M) and their mass (Theo. MH+[Da]). The 
position of each modified residue in the corresponding peptide is given in brackets (e.g.[C3]). 
If the position of the modification could not be identified, the residue is only indicated by e.g. 
[C]. The frequency in which a given modification occurs within a peptide is written before the 
name of the modification (e.g. 3xCarbamidomethyl). The quality of each identification is given 
by the X corr value. The number of identifications (different PSMs) was normalized to estimate 
the redox state of the protein. For this, the number of different PSMs for each peptide was 
divided by the number of different PSMs of two different peptides resulting from the MBP 
tag. Those peptides plotted in Figure R15 and SR5 are highlighted. 
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Table SR1. Mass spectrometric analysis of the strep-MBP-ROXY9 oxidation state, part 
IV. Strep-MBP-ROXY9 was purified in the presence of ca. 1 mM DTT and then dialysed 
against buffer containing glutathione. This way, DTT was removed while glutathione was 
introduced into the sample. The reduced cysteines were labeled with iodoacetamide, while the 
oxidized cysteine residues were labeled with iodoTMT0-126 and then separated by 10 % non-
reducing SDS-PAGE (KT09). The gels were stained with Colloidal Coomassie. Bands at ca. 
59 kDa were cut out from the gel and prepared for LC-MS/MS analysis as described in 
Methods (pages 115-119). The dataset was searched and analyzed using PeptideDiscoverer 2.2 
(Thermo Scientific). The modifications searched for were reduced cysteines (Thiol), 
nitrosylated cysteines (Nitrosyl), glutathionylated cysteines (Glutathione), sulfenic acids 
(Oxidation), sulfinic acids (Dioxidation), IAM-labelled cysteines (Carbamidomethyl), 
iodoTMT-labeled cysteines (iodoTMT), and oxidized methionines (Oxidation). The table lists 
the coverage for each sample, and all identified peptides with their modifications on cysteines 
(C) and methionines (M) and their mass (Theo. MH+[Da]). The position of each modified 
residue in the corresponding peptide is given in brackets (e.g.[C3]). If the position of the 
modification could not be identified, the residue is only indicated by e.g. [C]. The frequency in 
which a given modification occurs within a peptide is written before the name of the 
modification (e.g. 3xCarbamidomethyl). The quality of each identification is given by the X 
corr value. The number of identifications (different PSMs) was normalized to estimate the 
redox state of the protein. For this, the number of different PSMs for each peptide was divided 
by the number of different PSMs of two different peptides resulting from the MBP tag. Those 
peptides plotted in Figure R15 and SR5 are highlighted. 
 
 
 
 
 
  
Supplementary tables 
224 
 
 
 
 
 225 
 
7 
 
 
Material 
 
  
Material 
226 
 
Organisms 
_____________________________________________________________________ 
 
Bacterial strains 
Species Strain Genotype Reference 
Escherichi
a coli 
DH5α fhuA2 lac(del)U169 phoA glnV44 Φ80' 
lacZ(del)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
Woodcock et al. 
(1989) [276] 
Escherichi
a coli 
DB3.1 F– gyrA462 endA1 Δ(sr1-recA) mcrB mrr 
hsdS20(rB–, mB–) supE44 ara-14 galK2 lacY1 
proA2 rpsL20(SmR) xyl-5 λ– leu mtl1 
Thermo Fisher 
Scientific (Bernard et 
al. (1993)) [277] 
Escherichi
a coli 
BL21 
(DE3) 
B dcm ompT hsdS(rB-mB-) gal Studier & Moffatt 
(1986) [278] 
Escherichi
a coli 
BL21 
StarTM 
(DE3) 
F- ompT hsdSB (rB- mB- ) gal dcm rne131 (DE3) Thermo Fisher 
Scientific 
Agrobacte
rium 
tumefacien
s 
GV310
1 
PMP90RK rifr, gmr Koncz & Schell 
(1986) [279] 
 
 
Insect cells 
Insect cells Line Genotype Reference 
Trichoplusia ni  High FiveTM unknown Thermo Fisher Scientific 
 
 
Arabidopsis thaliana lines 
Line Reference 
Col-0 NASC stock no. N1902 
Col-0 + HA-ROXY9 #7-18 Li, 2017 [155,156] 
Organisms 
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Line Reference 
Col-0 + HA-ROXY9 #17-4 (genotype: Col-0) This work 
Col-0 + HA-ROXY9 #2-22, 4-40, 5-18, 7-25, 17-3, 29-1, and 
30-7 
This work 
Col-0 + HA-ROXY9 CCLCA #1-3, 9-10, 18-10, 29-2, and 37-
5 
This work 
Col-0 + HA-ROXY9 CPYC #13-8, 18-1, 19-10, 27-3, 29-3, 31-
4, and 38-5 
This work 
tga1 tga4 Kesarwani et al. (2007) 
[221] 
tga1 tga4 + pB1xHA-TGA1g #22-7 (genotype: tga1 tga4) This work 
tga1 tga4 + pB1xHA #10-3, 11-2, and 21-9 This work 
tga1 tga4 + pB1xHA-TGA1g #5-6, 15-3, 19-3, 21-9, 22-10, and 
27-1 
This work 
tga1 tga4 + pB1xHA-TGA1g C172N C260N C266S C287S 
#1-9, 5-3, 15-15, 20-6, 22-2, 26-8, and 27-4 
This work 
tga1 tga4 + pGREEN II 0229-HA-TGA1g Shearer et al. (2012); 
Wang & Fobert (2013); 
Sun et al. (2017) 
[222,223,262] 
tga1 tga4 + pGREEN II 0229-HA-TGA1g C260N C266S Department of Botany, 
Prof. Dr. Yuelin Zhang, 
UBC Vancouver 
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Oligo nucleotides 
_____________________________________________________________________ 
 
Primers 
All primers were ordered from Invitrogen. None of them contained 5’ or 3’ 
modifications. 
 
Primers designed by others 
Primer name Sequence (5' → 3') Reference 
MBP 572 for CAAGGGTCAACCATCCAAAC Oberdiek, 2018 [174] 
NdeI-GFP-for GAAGCATATGATGGTGAGCAAGG
GCGAG 
Oberdiek, 2018 [174] 
pB2GW7 fwd CACAATCCCACTATCCTTCGCA C. Thurow*, 
unpublished 
pB2GW7 rev CATGAGCGAAACCCTATAAGAACC C. Thurow*, 
unpublished 
rev23 TTCACACAGGAAACAGCTATGAC C. Thurow*, 
unpublished 
SEQ-L1 pDONR TCGCGTTAACGCTAGCATGGATCT
C 
C. Thurow*, 
unpublished 
SEQ-L2 pDONR GTAACATCAGAGATTTTGAGACAC C. Thurow*, 
unpublished 
T7termrev CCTTTCGGGCTTTGTTAGCAG C. Thurow*, 
unpublished 
TGA1 FOR ATGAATTCGACATCGACACATTTT
GTGC 
Li (2017) [155] 
TGA1 For Rev GCACAAAATGTGTCGATGTCGAAT
TCAT 
Li (2017) [155] 
TGA1 Promoter term 
For 
GTGCTCTCCAAGGTCTTAGGGAAT
CTC 
Li (2017) [155] 
TGA1 sequencing 3 
2100 For 
CCACAAACAGATAATTAGTCCGGT
G 
Li (2017) [155] 
Oligo nucleotides 
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Primer name Sequence (5' → 3') Reference 
TGA1 sequencing 4 
3500 For 
TGCTTGTTTGACTTTGTGTGATCT
AAC 
Li (2017) [155] 
TGA1 sequencing 4 
4200 For 
CAAGAACTCGATCGTGCTAGACAA
C 
Li (2017) [155] 
 
*Department for Plant Molecular Biology and Physiology, Prof. Dr. Chrisitane Gatz, Georg-
August-Universität Göttingen 
 
 
Primers designed during this work 
Primer name Sequence (5' → 3') Purpose 
3xHA 3UTR 
fusion fwd 
CCCTATGACGTCCCGGACTAT
GCAGTCGACTAGGTTTGAGT
TATTTTGTAACAACCAAATGA
AGAAAATGG 
Fwd primer to fuse 3xHA tag 
from pUBQ10-GW7-HA to 
3'UTR sequence of TGA1 
3xHA rev TGCATAGTCCGGGACGTCAT
AGGGATAGCCC 
Rev primer to amplify 3xHA tag 
from pUBQ10-GW7-HA 
3xHA TGA1 
fusion fwd 
GTCCCGGACTATGCAGTCGA
CATGAATTCGACATCGACACA
TTTTGTGC 
Fwd primer to fuse 3xHA tag 
from pUBQ10-GW7-HA to 
genomic TGA1 sequence 
3xHA-TGA1 
PmeI fwd 
ATTGTTTAAACAATTTGTTCT
TTGTTTTCAGTTGAGGAAAAC
TCGAGATGGCATACCCATAC
GACGTTCCGGACTACGC 
Fwd cloning primer binding to 
pUBQGW7HA 3xHA tag, for 
insertion in pGREENII0229-
HA-TGA1g/PmeI site 
3xHA-TGA1 SalI 
rev 
CATGTCGACTGCATAGTCCG
GGACGTCATAGGGATAGCCC 
Rev cloning primer binding to 
pUBQGW7HA 3xHA tag, for 
insertion in pGREENII0229-
HA-TGA1g/SalI site 
438 seq rev TGTGGTATGGCTGATTATGA
TCC 
Rev sequencing primer binding 
100 bp before LIC v1 rev site 
CpoI strep tag TCCCGGACCGATGGGTTCTTC
TTGGAGCCACCCGCAGTTCG 
Fwd primer binding upstream of 
strep tag coding sequence in 
pGP172-MBP-GW constructs 
Grx1 GW fwd GGGGACAAGTTTGTACAAAA
AAGCAGGCTCCATGGCTCAA
GAGTTTGTGAACTGCAAAAT
CC 
Fwd primer to amplify human 
GRX1 gene from p415-roGFP2 
for later integration in pGP172-
MBP-GW vector 
Material 
230 
 
Primer name Sequence (5' → 3') Purpose 
Grx1 GW rev GGGGACCACTTTGTACAAGA
AAGCTGGGTTTACTGCAGAG
CTCCAATCTGCTTTAGCC 
Rev primer to amplify human 
GRX1 gene from p415-roGFP2 
for later integration in pGP172-
MBP-GW vector 
MBP 472 seq rev CAGCAATCAGCGGCCAGG Rev sequencing primer binding 
after 472 bp of MBP coding 
sequence 
pBGW Acc65I 
200 fwd 
CTAGCTGATAGTGACCTTAG
GC 
Sequencing of pBGW starting ca. 
200 bp upstream of Acc65I site 
pBGW EcoRV 
300 rev 
GCACTGAACGTCAGAAGCCG Sequencing of pBGW starting ca. 
300 bp downstream of EcoRV site 
pGP172 NdeI 
fwd 
ATACATATGGCTAGCTGGAG
CCACCC 
Fwd primer binding around NdeI 
site in front of strep tag in 
pGP172 
pGP172-SUMO-
attB1 BamHI rev 
TTTGGATCCCTAGGAGCCTGC
TTTTTTGTACAAACTTGTGAT
CTG 
Rev primer binding to attB1 site 
and the basepair right before 
attB1 site in pGP172-SUMO-
ROXY9, contains a stop codon; 
BamHI site 
pGP172-SUMO-
BamHI rev 
TTTGGATCCCTAACCACCAAT
CTGTTCTCTGTGAGCCTC 
Rev primer binding to end of 
SUMO gene in pGP172-SUMO-
GW, adds a stopcodon to SUMO 
gene; BamHI site 
pGTGA1g seq CATACCTCGCTCTGCTAATCC Sequencing of pGREENII0229-
HA-TGA1g, starting at basepair 
1530 
RB fwd GGTAAACTAAGTCGCTGTAT
GTG 
Primer binding to right border 
(RB) of pGREENII0229-HA-
TGA1g 
rev23 reversed GTCATAGCTGTTTCCTGTGTG
AA 
Reverse complement of rev23 
primer for sequencing of 
pGREENII0229-HA-TGA1g 
ROXY19 Lic v1 
For 
TACTTCCAATCCAATGCAATG
CAAGGAACGATTTCTTGTGCA
AG 
Fwd primer for amplification of 
ROXY19 with LIC sites to clone 
it in 438C_strep 
ROXY19 Lic v1 
rev 
TTATCCACTTCCAATGTTATTA
TCACAACCACAGAGCCCCAAC 
Rev primer for amplification of 
ROXY19 with LIC sites to clone 
it in 438C_strep 
ROXY9 CCLCA 
fwd 
GTTGTCTCTGCGCCGCCGTTC
AAATCCTGTTCCGTGAC 
Fwd fusion PCR primer to 
introduce coding sequence for 
CCLCA motif in ROXY9 coding 
sequence 
Oligo nucleotides 
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Primer name Sequence (5' → 3') Purpose 
ROXY9 CCLCA 
rev 
GATTTGAACGGCGGCGCAGA
GACAACATGAGCTCTTCGTGA
AG 
Rev fusion PCR primer to 
introduce coding sequence for 
CCLCA motif in ROXY9 coding 
sequence 
ROXY9 CPYC 
fwd  
GAAGAGCTCATGTCCATATTG
CTACGCCGTTCAAATCCTGTT
CCG 
Fwd fusion PCR primer to 
introduce coding sequence for 
CPYC motif in ROXY9 coding 
sequence 
ROXY9 CPYC 
rev  
GGCGTAGCAATATGGACATG
AGCTCTTCGTGAAGATCACCA
CTCC 
Rev fusion PCR primer to 
introduce coding sequence for 
CPYC motif in ROXY9 coding 
sequence 
ROXY9 Lic v1 
For 
TACTTCCAATCCAATGCAATG
GACAAAGTGATGAGAATGTC
TTC 
Fwd primer for amplification of 
ROXY9 with LIC sites to clone it 
in 438C_strep 
ROXY9 Lic v1 
rev 
TTATCCACTTCCAATGTTATTA
CTAGTAAAGGATGGACTGAT
AGG 
Rev primer for amplification of 
ROXY9 with LIC sites to clone it 
in 438C_strep 
TGA1 1.intron 
seq 2361 
CTTTTAGCCTGTCATTACAAT
ATATG 
Sequencing primer starting at 
2361 bp in 1. intron of TGA1 
TGA1 3UTR SalI 
fwd 
AAAGTCGACTAGGTTTGAGT
TATTTTGTAACAACCAAATGA
AG 
Fwd cloning primer binding to 
TGA1 stop codon and 
3'UTR/SalI site 
TGA1 C172N 
fwd 
GAACAGAACAGACAGATAAA
TGAACTAAGAACAGTTTTACA
C 
Fwd fusion PCR primer to 
exchange Cys172 codon in TGA1 
for Asn codon 
TGA1 C172N rev GTGTAAAACTGTTCTTAGTTC
ATTTATCTGTCTGTTCTGTTC 
Rev fusion PCR primer to 
exchange Cys172 codon in TGA1 
for Asn codon 
TGA1 C287S fwd CCTTGCGGACTCCGTTGCAGC
GGGAC 
Fwd fusion PCR primer to 
exchange Cys287 codon in TGA1 
for Ser codon 
TGA1 C287S rev GTCCCGCTGCAACGGAGTCC
GCAAGG 
Rev fusion PCR primer to 
exchange Cys287 codon in TGA1 
for Ser codon 
TGA1 NcoI fwd TTCCCATGGAACAGCAGGAA
CTCCTCAC 
Fwd cloning primer binding 
around NcoI site within genomic 
TGA1 coding sequence 
TGA1 seq rev 
exon 8 
GCCGTTGAAAATACTCACCAA
GAGC 
Rev primer for sequencing, binds 
in 8. exon of TGA1 
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qRT-PCR primers 
These primers were ordered from Invitrogen. 
Primer name  Sequence (5' → 3')  Reference 
UBQ5 fwd GACGCTTCATCTCGTCC Kesarwani et al. (2007) [194] 
UBQ5 rev GTAAACGTAGGTGAGTCCA Kesarwani et al. (2007) [194] 
TGA1 fwd ACGAACCTGTCCATCAATTCGG Muthreich, 2014 [157] 
TGA1 rev CCATGGGAAGTATCCTCTGACACG Muthreich, 2014 [157] 
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Plasmids 
_____________________________________________________________________ 
 
Plasmids generated by others 
 
Plasmid 
name 
Description Resistance Reference 
438C Expression vector for insect cells 
harboring the coding sequence of 
a His-MBP tag for N-terminal 
fusion 
AmpR Department for 
Molecular Biology, 
Prof. Dr. Patrick 
Cramer, MPI for 
Biophysical 
Chemistry, Göttingen 
p415-roGFP2 Expression of Homo sapiens Grx1 
fused to roGFP 
AmpR (E. coli), 
LEU2 
(S. cerevisiae) 
Morgan et al. (2013) 
[280] 
pBGW Destination vector for T-DNA 
constructs 
SpecR (E. coli), 
bar 
(A. thaliana) 
VIB-UGent Center 
for Plant Systems 
Biology, Ghent 
University 
pBGWL7 Vector encoding T-DNA with 
fLUC gene for fusion to different 
promoter regions via Gateway 
cloning, 35S terminator 
SpecR VIB-UGent Center 
for Plant Systems 
Biology, Ghent 
University 
pDONR201-
TGA1 
pDONR201 harboring TGA1 
cDNA sequence; the plasmid was 
constructed in analogy to the 
plasmid pDONR223-TGA1 
KanR M. Zander, 
Department for Plant 
Molecular Biology 
and Physiology, Prof. 
Dr. C. Gatz, Georg-
August-Universität 
Göttingen, 
unpublished 
pDONR207 pDONOR plasmid with 
gentamicin resistance cassette 
GentR Life Technologies 
pDONR207-
GRX480 
pDONR207 harboring 
ROXY19/GRX480 coding 
sequence 
GentR Ndamukong et al. 
(2007) 
pDONR207-
ROXY9 
pDONR207 harboring ROXY9 
cDNA sequence 
GentR Muthreich, 2014 [157] 
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Plasmid 
name 
Description Resistance Reference 
pDONR223-
TGA1 
pDONR223 harboring TGA1 
cDNA sequence 
SpecR Li et al. (2018) [156] 
pGP172-
GFP-GW 
Destination vector for T7-
dependent expression in E. coli, 
harbors strep-GFP-tag sequence 
for N-terminal fusions 
AmpR Oberdiek, 2018 [174] 
pGP172-
GFP-
GWΔstrep 
Destination vector for T7-
dependent expression of GFP-
tagged proteins in E. coli 
AmpR Oberdiek, 2018 [174] 
pGP172-
MBP-
GRX370 
Vector to express a strep-MBP-
fusion of A. thaliana 
GRXC2/GRX370 in E. coli under 
control of the T7 promoter and 
terminator 
AmpR Oberdiek, 2018 [174] 
pGP172-
SUMO-GW 
Destination vector for T7-
dependent expression of proteins 
fused N-terminally to a strep-
SUMO tag 
AmpR Oberdiek, 2018 [174] 
pGREENII02
29-HA-
TGA1g 
Vector encoding T-DNA for 
insertion of genomic TGA1 fused 
to 1xHA tag coding sequence in A. 
thaliana genome 
KanR (E. coli), 
bar 
(A. thaliana) 
Shearer et al., (2007) 
Wang & Fobert 
(2013) 
Sun et al. (2017) 
[222,223,262] 
pMA/CL-
TEV-A 
Expression of an MBP-His-tagged 
TEV protease under control of the 
T7 promoter, a TEV site is placed 
in between the MBP and the His 
tag 
AmpR Prof. Dr. Roland Lill, 
Institute for 
Cytobiology and 
Cytopathology, 
Philipps-University 
Marburg 
pUBQ10-
GW7-HA 
Destination vector for UBQ10 
promoter-dependent expression 
of proteins fused to a 3xHA tag in 
A. thaliana protoplasts 
SpecR Uhrig et al. (2017) 
[177] 
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Plasmids generated during this work 
 
The following section shows the maps of all plasmids generated during this 
work in alphabetical order. Their cloning strategy is described. The maps were 
prepared in Geneious 5.3.6. 
 
 
List of plasmids 
438C_strep 
438C_strep_ROXY19 
438C_strep_ROXY9 
pB1xHA-TGA1g 
pB1xHA-TGA1g 3’UTR 
pB1xHA-TGA1g C172N C260N C266S C287S 
pB2-ROXY9 CCLCA-7HA 
pB2-ROXY9 CPYC-7HA 
pB3xHA-TGA1g 
pB3xHA-TGA1g 3'UTR 
pB3xHA-TGA1g C172N C260N C266S C287S 
pDONR207-Grx1 
pDONR207-ROXY9 CCLCA 
pDONR207-ROXY9 CPYC 
pDONR207-TGA1 
pGP172-GFPΔstrep-TGA1 
pGP172-MBP-TGA1 
pGP172-SUMO-Grx1 
pGP172-SUMO-ROXY9 
pGREENII0229-HA-TGA1g 3'UTR 
pGREENII0229-3xHA-TGA1g 3'UTR mutated 
pGREENII0229-HA-TGA1g C172N C260N C266S C287S 
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438C_strep. A vector to express a step-MBP fusion protein in insect cells. Strep-MBP-ROXY9 
was amplified in a PCR from pGP172-MBP-ROXY9 with primers CpoI strep tag and T7 term 
rev and digested with CpoI and Pfl23II. The 369 bp-fragment was extracted from an agarose 
gel and ligated with the 6274 bp-fragment of 438C digested with CpoI/Pfl23II. Resistances: 
KanR (E. coli), bar (A. thaliana). 
 
 
 
 
438C_strep_ROXY19. A vector to express a step-MBP fusion of ROXY19 in insect cells. 
ROXY19 was amplified in a PCR from pDONR207-GRX480 using primers ROXY19 Lic v1 
For and ROXY19 Lic v1 rev, and inserted via LIC in 438C_strep using the SspI site. 
Resistances: KanR (E. coli), bar (A. thaliana). 
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438C_strep_ROXY9. A vector to express a step-MBP fusion of ROXY9 in insect cells. 
ROXY9 was amplified in a PCR from pDONR207-ROXY9 using primers ROXY9 Lic v1 For 
and ROXY9 Lic v1 rev, and inserted via LIC in 438C_strep using the SspI site. Resistances: 
KanR (E. coli), bar (A. thaliana). 
 
 
 
pB1xHA-TGA1g. A vector encoding the T-DNA for insertion of the genomic TGA1 
sequence fused to coding sequence for 1xHA tag in the A. thaliana genome. The insert was cut 
out from pGREENII0229-HA-TGA1g via Acc65I/StuI and ligated in pBGW digested with 
Acc65I/EcoRV. Resistances: SpecR (E. coli), bar (A. thaliana). TGA1 exons are shown in dark 
grey, introns in light grey. 
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pB1xHA-TGA1g 3’UTR. A vector encoding the T-DNA for insertion of a 1xHA tag gene 
unter control of the TGA1 promoter (including its 5'UTR) and 3’UTR in the A. thaliana 
genome. The insert was cut out from pGREENII0229-HA-TGA1g 3'UTR via Acc65I/StuI 
and ligated in pBGW digested with Acc65I/EcoRV. Resistances: SpecR (E. coli), bar (A. thaliana). 
  
 
pB1xHA-TGA1g C172N C260N C266S C287S. A vector encoding the T-DNA for insertion 
of the genomic TGA1 sequence fused to coding sequence of a 1xHA tag in the A. thaliana 
genome; All critical cysteine residues are mutated to amino acids found in other TGA factors 
at this site. The insert was cut out from pGREENII0229-HA-TGA1g C172N C260N C266S 
C287S via Acc65I/StuI and ligated in pBGW digested with Acc65I/EcoRV. Resistances: SpecR 
(E. coli), bar (A. thaliana). TGA1 exons are shown in dark grey, introns in light grey. 
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pB2-ROXY9 CCLCA-7HA. A vector encoding the T-DNA for expression of N-terminally 
HA-tagged ROXY9 CCLCA under control of the 35S promoter and terminator. The ROXY9 
CCLCA was generated as follows: The first PCR product was amplified using primers 
SeqL1/ROXY9 CCLCA rev from pDONR207-ROXY9; the second PCR product was 
amplified using primers ROXY9 CCLCA fwd/SeqL2 from pDONR207-ROXY9. Both PCR 
products were fused in a PCR containing primers SeqL1/SeqL2. Finally, the fusion PCR 
product ROXY9 CCLCA was inserted via an LR in pB2GW7HA. Resistances: SpecR (E. coli), 
bar (A. thaliana). 
 
 
pB2-ROXY9 CPYC-7HA. A vector encoding the T-DNA for expression of N-terminally 
HA-tagged ROXY9 CPYC under control of 35S promoter and terminator. The plasmid was 
generated via the LR pDONR207-ROXY9 CPYC × pB2GW7HA. Resistances: SpecR (E. coli), 
bar (A. thaliana). 
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pB3xHA-TGA1g. A vector encoding the T-DNA for the insertion of the genomic TGA1 
sequence fused to the coding sequence of a 3xHA tag in the A. thaliana genome. The plasmid 
was generated in a 3-fragment ligation of pBGW + Acc65I/EcoRV (7.8 kb fragment), 
pGREENII0229-HA-TGA1g + SalI/StuI (2.7 kb fragment) and pGREENII0229-3xHA-
TGA1g 3'UTR mutated + Acc65I/SalI (2.8 kb fragment). Resistances: SpecR (E. coli), bar (A. 
thaliana). 
 
 
pB3xHA-TGA1g 3'UTR. A vector encoding the T-DNA for insertion of a 3xHA tag coding 
sequence unter control of the TGA1 promoter (incl. 5'UTR) and 3’UTR in the A. thaliana 
genome. The plasmid was generated in a 3-fragment ligation of pBGW + Acc65I/EcoRV 
(7.8 kb fragment), pGREENII0229-HA-TGA1g 3'UTR + SalI/StuI (1 kb fragment) and 
pGREENII0229-3xHA-TGA1g 3'UTR mutated + Acc65I/SalI (2.8 kb fragment). Resistances: 
SpecR (E. coli), bar (A. thaliana). 
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pB3xHA-TGA1g C172N C260N C266S C287S. A vector encoding the T-DNA for the 
insertion of a genomic TGA1 sequence with a 3xHA tag coding sequence in the A. thaliana 
genome; All codons for cysteine residues were mutated to codons of amino acids found in 
other TGA factors at this site. The plasmid was generated in a 3-fragment ligation of pBGW 
+ Acc65I/EcoRV (7.8 kb fragment), pGREENII0229-HA-TGA1g C172N C260N C266S 
C287S + SalI/StuI (2.7 kb fragment) and pGREENII0229-3xHA-TGA1g 3'UTR mutated + 
Acc65I/SalI (2.8 kb fragment). Resistances: SpecR (E. coli), bar (A. thaliana). TGA1 exons are 
shown in dark grey, introns in light grey. 
 
 
pDONR207-Grx1. pDONR207 harboring the Homo sapiens GRX1 cDNA sequence. The 
plasmid was generated in a BP reaction of pDONR207 and the PCR product of primers Grx1 
GW fwd/Grx1 GW rev on p415-roGFP2. Resistances: GentR. 
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pDONR207-ROXY9 CCLCA. pDONR207 harboring gene encoding ROXY9 with CCLCA 
active site. The plasmid was generated in a BP reaction using pDONR207 and the fusion PCR 
product ROXY9 CCLCA. The fusion PCR product was prepared as follows: The first PCR 
product was amplified using primers T7/ROXY9 CCLCA rev from pGP172-SUMO-ROXY9 
and the second PCR product using primers ROXY9 CCLCA fwd/T7termrev from pGP172-
SUMO-ROXY9. Both fragments were fused in a PCR using primers T7/T7termrev. 
Resistances: GentR. 
 
 
pDONR207-ROXY9 CPYC. pDONR207 harboring gene encoding ROXY9 with CPYC 
active site. A fusion PCR product resulting from the PCR products ROXY9 CPYC fwd/GB 
Term-primer and pBD2/ROXY9 CPYC rev (both amplified from pDEST-GBKT7-ROXY9) 
was inserted in a BP reaction in pDONR207. Resistances: GentR. 
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pDONR207-TGA1. pDONR207 harboring TGA1 cDNA sequence. The plasmid was 
generated in a BP reaction of pDONR207 and pGP172-MBP-TGA1. Resistances: GentR. 
 
 
 
 
 
pGP172-GFPΔstrep-TGA1. A vector to express eGFP-TGA1 in E. coli under control of T7 
promoter and terminator. The plasmid was generated in an LR of pGP172-GFP-GWΔstrep 
and pDONR207-TGA1. Resistances: AmpR. 
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pGP172-MBP-TGA1. An expression plasmid to produce N-terminally strep-MBP-tagged 
TGA1 in E. coli BL21. The plasmid was generated in an LR using pDONR223-TGA1 and 
pGP172-MBP-GW. Resistances: AmpR. 
 
 
 
 
pGP172-SUMO-Grx1. A vector encoding an N-terminal strep-SUMO-fusion of human Grx1 
for expression in E. coli via the T7 promoter and terminator. The plasmid was generated in an 
LR of pDONR207-Grx1 and pGP172-SUMO-GW. Resistances: AmpR. 
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pGP172-SUMO-ROXY9. A vector encoding an N-terminal strep-SUMO-fusion of ROXY9 
for expression in E. coli via the T7 promoter and terminator. The plasmid was generated in an 
LR reaction using pDONR207-ROXY9 and pGP172-SUMP-GW. Resistances: AmpR. 
 
 
pGREENII0229-HA-TGA1g 3'UTR. A vector encoding the T-DNA for insertion of a 
1xHA tag unter control of TGA1 promoter (incl. 5'UTR) and 3’UTR in the A. thaliana genome. 
The PCR product of primers TGA1 3UTR SalI fwd/rev23 on the vector pGREENII0229-
HA-TGA1g was digested with SalI/BamHI. The ca. 0.5 kb fragment of this digest was then 
ligated with the 4.5 kb-fragment of the digest of pGREENII0229-HA-TGA1g with StuI/NheI 
and the 3.1 kb-fragment of the digest of pGREENII0229-HA-TGA1g with NheI/SalI and the 
0.4 kb-fragment of the digest pGREENII0229-HA-TGA1g with BamHI/StuI. Resistances: 
SpecR (E. coli), bar (A. thaliana). 
Plasmids 
246 
 
pGREENII0229-3xHA-TGA1g 3'UTR mutated. A vector encoding the T-DNA for 
insertion of a 3xHA tag unter control of the TGA1 promoter (incl. 5'UTR) and 3’UTR in the 
A. thaliana genome; the plasmid carries a mutation in the 3'UTR. The PCR products amplified 
with primers 3xHA-TGA1 Pme1 fwd/3xHA rev from pUBQ10-GW7-HA (ca. 0.2 kb) and 
3xHA 3UTR fusion fwd/rev23 from pGREENII0229-HA-TGA1g (ca. 0.7 kb) were linked in 
a fusion PCR and cloned in pGREENII0229-HA-TGA1g via PmeI and BamHI (the ca. 7.5 kb 
fragment of the vector digest was used for ligation). Resistances: SpecR (E. coli), bar (A. thaliana). 
 
 
 
 
pGREENII0229-HA-TGA1g C172N C260N C266S C287S. A vector encoding the T-DNA 
for insertion of the genomic TGA1 sequence with a 1xHA tag coding sequence in the 
A. thaliana genome; All cysteine codons in TGA1 were mutated to codons of  amino acids 
found in other TGA factors at these sites. First, a TGA1 stretch from total DNA from A. 
thaliana tga1 tga4 + pGTGA1g C260N C266S was amplified using TGA1 C172N fwd/rev23 to 
obtain the template for a PCR with TGA1 C172N fwd/TGA1 C287S rev. Then, PCRs using 
primers TGA1 NcoI fwd/TGA1 C172N rev and TGA1 C287S fwd/rev23 on the template 
pGREENII0229-HA-TGA1g were prepared. All three PCR products were fused by PCR and 
the product digested with NcoI/BamHI. The 1.9 kb fragment from this PCR digest was ligated 
with the 7.4 kb fragment of pGREENII0229-HA-TGA1g digested with NcoI/BamHI. 
Resistances: SpecR (E. coli), bar (A. thaliana). TGA1 exons are shown in dark grey, introns in 
white. 
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Chemicals 
_____________________________________________________________________ 
 
Chemical Product name Company 
30 %(w/w) H2O2 Hydrogen peroxide solution 30 % (w/w) 
in H2O, contains stabilizer 
Sigma-Aldrich 
(Madrid, Spain) 
1,4-Dithiotreit (DTT) 1,4-Dithiotreit ≥99 % p.a. Roth (Karlsruhe, 
Germany) 
30 % Acrylamide-
Bisacrylamide solution 
(ratio 37.5:1) 
Rotiphorese® Gel 30 (37.5:1) ready for 
use, gas-stabilized, aqueous, 30 % 
acrylamide stock solution with 0.8 % 
Bisacrylamide in a ratio of 37.5 :1) 
Roth (Karlsruhe, 
Germany) 
32 % HCl  32 % HCl Rotipuran® p.a. Roth (Karlsruhe, 
Germany) 
3-Phosphoglycerate D-(-)-3-Phosphoglyceric acid disodium 
≥93 % 
Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
5,5′-Dithiobis(2-
nitrobenzoic acid) (DTNB) 
Ellman's Reagent Thermo Scientific 
(Rockford, 
Illinois, USA) 
Acetic acid Acetic acid Rotipuran® 100 % p.a. Roth (Karlsruhe, 
Germany) 
Acetone Acetone ≥99.5 % for synthesis Roth (Karlsruhe, 
Germany) 
Adenosine-5'-triphosphate Adenosine-5'-triphosphate (ATP) Roche 
Diagnostics 
(Mannheim, 
Germany) 
Agar for bacteria Agar-Agar, Kobe I, pulv. for microbiology 
density 0.55 
Roth (Karlsruhe, 
Germany) 
Agar for plants Agar-Agar, Plant, genetic engineering 
quality for plants, density 0.55 
Roth (Karlsruhe, 
Germany) 
Agarose Agarose BioReagent for molecular 
biology, low EEO 
Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
Aluminium sulfate 
Hexadecahydrate 
Aluminium sulfate Hexadecahydrate, 
purum p.a. ≥98.0 % 
Fluka (Buchs, 
Switzerland) 
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Chemical Product name Company 
Ammoniumperoxodisulfat
e 
Ammoniumperoxodisulfate ≥ 98 % p.a. Roth (Karlsruhe, 
Germany) 
Ammonium thiocyanate Ammonium thiocyanate ACS reagent, ≥ 
97.5 % 
Sigma-Aldrich 
(Steinheim, 
Germany) 
Ampicillin Ampicilin sodium salt, BioScience Grade 
for molecular biology and biochemistry 
Roth (Karlsruhe, 
Germany) 
Basta Basta Herbicide Bayer 
(Leverkusen, 
Germany) 
Bromophenol blue Bromophenol blue Na salt for 
electrophoresis 
Roth (Karlsruhe, 
Germany) 
CaCl2 × 2 H2O CaCl2 × 2 H2O ≥99 % p.a. Roth (Karlsruhe, 
Germany) 
Chloroform  Trichlormethane/Chloroform 
Rotipuran® ≥99 % p.a. 
Roth (Karlsruhe, 
Germany) 
Citric acid Monohydrate Citric acid Monohydrate Rotipuran® 
≥99.5 % p.a. 
Roth (Karlsruhe, 
Germany) 
Coomassie Brilliant Blue G 
250 
Coomassie Brilliant Blue G250 for 
electrophoresis 
Merck 
(Darmstadt, 
Germany) 
D-Desthiobiotin D-Desthiobiotin IBA (Göttingen, 
Germany) 
Desoxyadenosine 
triphosphate (dATP) 
Desoxyadenosine triphosphate LifeTechnologies 
GmbH 
(Darmstadt, 
Germany) 
Desoxycytosine 
triphosphate (dCTP) 
Desoxycytosine triphosphate LifeTechnologies 
GmbH 
(Darmstadt, 
Germany) 
Desoxyguanosine 
triphosphate (dGTP) 
Desoxyguanosine triphosphate LifeTechnologies 
GmbH 
(Darmstadt, 
Germany) 
Desoxythymidine 
triphosphate (dTTP) 
Desoxythymidine triphosphate LifeTechnologies 
GmbH 
(Darmstadt, 
Germany) 
Dessicator grease Dessicator grease white Roth (Karlsruhe, 
Germany) 
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Chemical Product name Company 
Diamide Diamide Sigma-Aldrich 
(Rehovot, Israel) 
Dimethylsulfoxide 
(DMSO) 
Dimethylsulfoxide ≥99.5 % BioScience-
Grade for molecular biology 
Roth (Karlsruhe, 
Germany) 
Ethanol  Ethanol Nordbrand 
GmbH 
(Nordhausen, 
Germany) 
Ethidium bromide (EtBr) Ethidium bromide ≥ 98 % for DNA 
staining 
Roth (Karlsruhe, 
Germany) 
Gentamicin Gentamycin sulfate non-sterile USP 
Grade 
Amresco (Solon, 
USA) 
Glucose Monohydrate D(+)-Glucose Monohydrate ≥99.5 % p.a. 
Ph. Eur. 
Roth (Karlsruhe, 
Germany) 
Glutathione L-Glutathione reduced Sigma-Aldrich 
(Tokyo, Japan) 
Glutathione disulfide L-Glutathione oxidized Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
Glycerol Glycerol Rotipuran® ≥99.5 % p.a., 
wasserfrei 
Roth (Karlsruhe, 
Germany) 
Glycerol 86 % Glycerol ~ 86 %, Ph. Eur., reinst Roth (Karlsruhe, 
Germany) 
Glycin Glycin Pufferan® ≥99 % p.a. Roth (Karlsruhe, 
Germany) 
GSNO S-Nitrosoglutathione ≥97 %  Sigma-Aldrich 
(Rehovot, Israel) 
Guanidine thiocyanate Guanidine thiocyanate ≥ 99 %, for 
Biochemistry 
Roth (Karlsruhe, 
Germany) 
HEDS 2-Hydroxyethlydisulfide technical grade Sigma-Aldrich 
(Steinheim, 
Germany) 
HEPES HEPES Pufferan® ≥ 99.5 % p.a. for 
tissue culture 
Roth (Karlsruhe, 
Germany) 
Imidazol Imidazol Pufferan® ≥99 % p.a. Roth (Karlsruhe, 
Germany) 
Iodoacetamide Iodoacetamide Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
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Chemical Product name Company 
iodoTMT0-126  IodoTMT0-126TM Label Reagent Set Thermo Scientific 
(Rockford, 
Illinois, USA) 
Isopropanol  2-propanol Rotipuran® ≥99.8 % p.a. Roth (Karlsruhe, 
Germany) 
Isopropyl-β-D-
thiogalactopyranoside 
(IPTG) 
IPTG ≥99 %, BioScience Grade, dioxan-
free, animal-free 
Roth (Karlsruhe, 
Germany) 
K2HPO4 di-potassium hydrogenphosphate ≥ 98 %, 
waterfree 
Roth (Karlsruhe, 
Germany) 
KH2PO4 KH2PO4 (waterfree) ≥99 % p.a. Roth (Karlsruhe, 
Germany) 
KOH KOH ≥85 % p.a., in pellets Roth (Karlsruhe, 
Germany) 
L(+)-Ascorbic acid L(+)-Ascrobic acid p.a. or L(+)-Ascorbic 
acid ≥99 % p.a. 
Roth (Karlsruhe, 
Germany) 
Lactose Monohydrate Lactose Monohydrate Merck 
(Darmstadt, 
Germany) 
L-Cysteine L-Cysteine 97 % Sigma-Aldrich 
(Steinheim, 
Germany) 
Maltose Monohydrate Maltose Monohydrate crystallized Merck 
(Darmstadt, 
Germany) 
Meat extract LAB-LEMCO' POWDER Meat extract Oxoid 
(Basingstoke, 
England) 
Methanol Methanol Merck 
(Darmstadt, 
Germany) 
MgCl2 MgCl2 Roth (Karlsruhe, 
Germany) 
MgSO4 × 7 H2O MgSO4 × 7 H2O ≥ 99 % p.a. Roth (Karlsruhe, 
Germany) 
Monobromobimane 
(mBBr) 
Monobromobimane (mBBr) Invitrogen 
(Eugene, Oregon, 
USA) 
Murashige & Skoog (MS) 
medium 
Murashige & Skoog medium including 
vitamins 
Duchefa 
Biochemie BV 
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Chemical Product name Company 
(Haarlem, The 
Netherlands) 
N2(l) N2(l) Westfalen AG 
(Münster, 
Germany) 
Na3-citrate × 2 H2O Tri-Natriumcitrat Dihydrat p. A. Roth (Karlsruhe, 
Germany) 
Na2-EDTA × 2 H2O EDTA Disodium salt: Dihydrate, Sigma 
grade 
Sigma (Steinheim, 
Germany) 
Na2HPO4  Na2HPO4 (waterfree) ≥ 99 % p.a. Roth (Karlsruhe, 
Germany) 
Na2HPO4 × 2 H2O Na2HPO4 × 2 H2O ≥ 98 % Ph. Eur. Roth (Karlsruhe, 
Germany) 
NaCl NaCl ≥ 99.5 % p.a. Roth (Karlsruhe, 
Germany) 
NADH  NADH disodium salt, grade II, approx. 
98 % 
Roche 
Diagnostics 
(Mannheim, 
Germany) 
NADPH NADPH Sigma-Aldrich 
(Taufkirchen, 
Germany) 
NaH2PO4 × H2O NaH2PO4 × H2O ≥ 98 % p.a. Roth (Karlsruhe, 
Germany) 
NaOH NaOH ≥99 % p.a. in pellets Roth (Karlsruhe, 
Germany) 
o-Phosphoric acid o-Phosphoric acid Rotipuran® ≥ 85 % 
p.a. 
Roth (Karlsruhe, 
Germany) 
Phenol Phenol solution saturated with 0.1 M 
citrate buffer pH = 4.3 ± 0.2 BioReagent 
for molecular biology 
Sigma (Steinheim, 
Germany) 
Phosphinotricine Phosphinotricine Duchefa 
Biochemie BV 
(Haarlem, The 
Netherlands) 
Protease Inhibitor Cocktail Protease Inhibitor Cocktail, EDTA-free, 
Mini Tablet 
Bimake (Munich, 
Germany) 
Rifampicin Rifampicin > 95 % Duchefa 
Biochemie BV 
(Haarlem, The 
Netherlands) 
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Chemical Product name Company 
SDS Sodium lauryl sulfate ≥ 99 % p.a., for 
biochemistry 
Roth (Karlsruhe, 
Germany) 
Silwet L77 Silwet L77 Kurt Obermeier 
GmbH (Bad 
Berleburg, 
Germany) 
Skimmed milk powder  Skimmed milk powder, easily soluble SUCOFIN 
(Zeven, 
Germany) 
Sodium acetate Sodium acetate ≥ 99 % p.a. waterfree Roth (Karlsruhe, 
Germany) 
Sodium hypochlorite 
solution  
Sodium hypochlorite solution 12 % Cl. 
Techn. 
Roth (Karlsruhe, 
Germany) 
Spectinomycin Spectinomycin Dihydrochloride 
Pentahydrate 
Duchefa 
Biochemie BV 
(Haarlem, The 
Netherlands) 
Sucrose  Sucrose crystallized Duchefa 
Biochemie BV 
(Haarlem, The 
Netherlands) 
TCA  Trichloroacetic acid solution 6.1 N Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
TCEP Tris(2-carboxyethyl)phosphine 
hydrochloride 
Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
TEMED 99 % p.a. for electrophoresis Roth (Karlsruhe, 
Germany) 
trans-4,5-Dihydroxy-1,2-
dithiane (dithiane, oxidized 
DTT) 
trans-4,5-Dihydroxy-1,2-dithiane ≥ 99 % Sigma-Aldrich 
(St. Louis, 
Missouri, USA) 
TRIS TRIS Pufferan® ≥99.9 % p.a. Roth (Karlsruhe, 
Germany) 
Tryptone/peptone from 
casein 
Tryptone/peptone from casein 
(pancreatically digested) 
Roth (Karlsruhe, 
Germany) 
Tween-20 Tween-20 Roth (Karlsruhe, 
Germany) 
Urea Urea ≥99.5 % p.a. BioScience-Grade Roth (Karlsruhe, 
Germany) 
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Chemical Product name Company 
Yeast extract Yeast extract, pulv. for bacteriology Roth (Karlsruhe, 
Germany) 
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Commercially available reagents 
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Reagent Product name Company 
DNA size 
standard 
Gene Ruler DNA Ladder Mix 
0.5 µg/µl 
Thermo Scientific (Rockford, 
Illinois, USA) 
HENS Buffer HENS Buffer (100 mM 
HEPES, pH 8.0, 1 mM EDTA, 
0.1 mM Neocuproine, 1 % SDS) 
Thermo Scientific (Rockford, 
Illinois, USA) 
HRP substrates 
for Western Blot 
detection 
LuminataTM Forte Western HRP 
Substrate 
Millipore (Billerica, Massachusets, 
USA) 
SuperSignalTM West Femto 
Maximum Sensitivity Substrate 
Thermo Scientific (Rockford, 
Illinois, USA) 
Protein size 
standard for 
native PAGE 
NativeMarkTM Unstained 
Protein Standard 
Invitrogen by Thermo Fisher 
Scientific/Life Technologies 
Corporation (Carlsbad, California, 
USA) 
Protein size 
standard for SDS-
PAGE 
Page RulerTM Prestained Protein 
Ladder 
Thermo Scientific (Vilnius, 
Lithuania) 
Chemicals for 
protein 
concentrations 
measurments 
Ionic Detergent Compatibility 
Reagent (IDCR) 
Thermo Scientific (Rockford, 
Illinois, USA) 
Pierce® 660 nm Protein Assay 
Reagent, 750 ml 
Thermo Scientific (Rockford, 
Illinois, USA) 
Roti®-Quant 5x Konzentrat Roth (Karlsruhe, Germany) 
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Protein Company 
3-Phosphoglyceric Phosphokinase from baker's yeast 
(S. cerevisiae) 0.9 mg/ml 1787 units/mg protein 
Sigma-Aldrich (St. Louis, Missouri, 
USA) 
AcTEVTM Protease 10 U/µl Invitrogen by Thermo Fisher 
Scientific, Life Technologies 
Corporation (Carlsbad, California, 
USA) 
AmershamTM ECLTM Anti-mouse IgG, Horesradish 
Peroxidase-Linked Whole Antibody (from sheep) 
GE Healthcare (Buckinghamshire, 
UK) 
AmershamTM ECLTM Anti-rabbit IgG, Horseradish 
Peroxidase-Linked Whole Antibody (from donkey) 
GE Healthcare (Buckinghamshire, 
UK) 
Anti-Green Fluorescent Protein stabilized antibody 
preparation (mixture of two monoclonal antibodies, 
clone 7.1 and 13.1, both clones are Mouse IgG1κ) 
Roche (Basel, Switzerland) 
Anti-HA tag antibody from rabbit, ChIP Grade Abcam (Cambridge, USA) 
BIOTAQ DNA Polymerase 5 u/µl with 10x NH4 
Reaction Buffer (No MgCl2) and 50 mM MgCl2 Stock 
Solution 
Bioline (Luckenwalde, Germany) 
Calf Intestinal Alkaline Posphatase 1 U/µl with CIAP 
Dilution Buffer 
Invitrogen (Carlsbad, California, 
USA) 
DNase I, RNase-free, 1 U/µl with 10x Reaction buffer 
with MgCl2 for DNase I and 50 mM EDTA  
Thermo Scientific (Vilnius, 
Lithuania) 
Fluorscein Calibration Dye 1 mM in DMSO BioRad Laboratories (Munich, 
Germany) 
Gateway cloning system LifeTechnologies GmbH 
(Darmstadt, Germany) 
Glutathione Reductase from baker's yeast (S. cerevisiae) 
(ammoniumsulfate suspension) 1.5 mg protein/ml, 
170 units/mg 
Sigma-Aldrich (St. Louis, Missouri, 
USA) 
Glyceraldehyde-3-phosphate Dehydrogenase from 
rabbit muscle ≥75 units/mg protein (97 units/mg 
protein) 
Sigma-Aldrich (St. Louis, Missouri, 
USA) 
Insulin from bovine pancreas Hybri-MaxTM Sigma-Aldrich (St. Louis, Missouri, 
USA) 
Lysozyme AGS GmbH 
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Phusion High-Fidelity DNA Polymerase (2 U/µl) with 
5x Phusion HF Buffer (contains 7.5 mM MgCl2) 
Thermo Scientific (Vilnius, 
Lithuania) 
Restriction enzymes with corresponding buffers Thermo Scientific (Vilnius, 
Lithuania), New England Biolabs 
(Frankfurt am Main, Germany), 
MBI Fermentas (Vilnius, 
Lithuania), Boehringer Mannheim 
GmbH (Mannheim, Germany), 
GIBCO BRL (Eggenstein, 
Germany), Promega (Madison, 
Wisconsin, USA) 
Revert Aid H Minus Reverse Transcriptase 200 U/µl 
with 5x Reaction Buffer for RT 
Thermo Scientific (Vilnius, 
Lithuania) 
Ribonuclease A Roth (Karlsruhe, Germany) 
StrepMAB classic (IgG1, Anti strep-tag II® 
monoclonal antibody, purified) 
IBA (Göttingen, Germany) 
SYBR® Green I Nucleic Acid Gel Stain 10000x 
concentrate in DMSO 
Cambrex BioScience Rockland 
(Rockland, Maine, USA) 
T4 DNA Ligase 5 Weiss U/µl with 10x T4 DNA 
Ligase Buffer 
Thermo Scientific (Vilnius, 
Lithuania) 
T4 DNA Polymerase 5 u/µl with 5x Buffer for T4 
DNA Polymerase 
Fermentas (Waltham, 
Massachusetts, USA) 
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Kit Product name Company 
Detection of redox modifications 
on proteins 
PierceTM S-Nitrosylation 
Western Blot Kit 
Thermo Scientific 
(Rockford, Illinois, 
USA) 
DNA extraction from plants DNeasy Plant Mini Kit  Qiagen (Hilden, 
Germany) 
PCR and gel purification NucleoSpin® Gel and PCR 
clean-up 
Macherey & Nagel 
(Düren, Germany) 
Plasmid Midi Preparation NucleoBond® Xtra Midi Macherey & Nagel 
(Düren, Germany) 
Plasmid Mini Preparation NucleoSpin® Plasmid Macherey & Nagel 
(Düren, Germany) 
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Lab material Product name Company 
ÄKTA tubes Tube 12 ml, PS, 16/100 mm, 
round bottom, clear 
Greiner bio-one 
(Frickenhausen, Germany) 
Aluminium foil Rotilabo® Aluminiumfolie 
Stärke 30 µm 
Roth (Karlsruhe, Germany) 
ARACONs (tube and base) ARACONs Betatech (Gent, Belgium) 
Atmosbag glove bag Atmosbag glove bag Sigma-Aldrich (St. Louis, 
Missouri, USA) 
Bead material for protein 
purification 
Strep-Tactin® Speharose ® 
50 % Suspension 20 ml 
IBA (Göttingen, Germany) 
Amylose Resin 15 ml New England Biolabs 
(Frankfurt am Main, 
Germany) 
ProfinityTM IMAC Ni-
Charged Resin 
BioRad Laboratories 
(Munich, Germany) 
Blotting paper  Blotting-Papier MN218B 58 
× 60 cm 
Macherey & Nagel (Düren, 
Germany) 
Buffer filtration unit incl. 
Filters 
Membrane Filter, Non-
sterile, NYLON, Size 0.2 
micron, 47 mm 
Thermo Fisher Scientific 
(Rochester, New York, USA) 
Reusable Bottle-Top Filter, 
PSF, fits 45 mm neck, size 
47 mm, 500 ml 
Thermo ScientificTM 
NalgeneTM Products 
(Rochester, New York, USA) 
Columns for protein 
purification 
StrepTrapTM HP 5x 1 ml GE Healthcare (Uppsala, 
Sweden) 
MBPTrapTM HP 5 x 5 ml GE Healthcare (Uppsala, 
Sweden) 
HisTrapTM HP 1x 5ml  GE Healthcare (Uppsala, 
Sweden) 
Concentrators Spin-X® UF 6; 30 or 50 
kDa MWCO PES non-
sterile 6 ml 
Corning (Flintshire, England) 
Vivaspin 20; 3 kDa MWCO GE Healthcare 
(Buckinghamshire, UK) 
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Vivaspin 2; 3 kDa MWCO GE Healthcare 
(Buckinghamshire, UK) 
Cuvettes Cuvettes Polystyrene 10 × 4 
× 45 mm 
Sarstedt (Nümbrecht, 
Germany) 
Dialysis tubing ZelluTrans regenerated 
cellulose Nominal MWCO 
12000 - 14000, Flat Width 
25 mm, Length 15 m, Wall 
thickness 20 µm 
Roth (Karlsruhe, Germany) 
Serva 44310.01 MEMBRA-
CEL® dialysis tubing RC 
diameter 16 mm, 5 m 
Serva (Heidelberg, Germany) 
Filter pipette tips 
 
96 Biosphere® Filter Tips 
0.1 - 10 µl (Sterile/DNA-
/DNase/ RNase-/PCR 
inibitor/ATP-/Pyrogen-free) 
Sarstedt (Nümbrecht, 
Germany) 
Filter Tip 20 µl (DNA-
/DNase-/RNase-/PCR 
inhibitor-free)  
Sarstedt (Nümbrecht, 
Germany) 
Filter Tip 100 µl (DNA-
/DNase-/RNase-/PCR 
inhibitor-free)  
Sarstedt (Nümbrecht, 
Germany) 
Filter Tip 1000 µl (DNA-
/DNase-/RNase-/PCR 
inhibitor-free)  
Sarstedt (Nümbrecht, 
Germany) 
Filters Minisart® syringe filters 
NML hydrophilic single use 
filter unit, non-pyrogenic 0.2 
µm diameter 
Sartorius Stedim Biotech 
GmbH (Göttingen, 
Germany) 
Disposable filter, sterile, 
non-pyrogenic, hydrophilic, 
0.45 µm diameter 
Sartorius Stedim Biotech 
GmbH (Göttingen, 
Germany) 
Filtropur BT25 0.2, 250 ml 
Bottle Top Filter 
Sarstedt (Newton, USA) 
Fluorescence 96-well plates Greiner Bio-One 96-well 
(half area) non-sterile 
polystyrene plate, medium 
binding, colour: black with 
transparent bottom 
Greiner bio-one 
(Frickenhausen, Germany) 
Gel filtration columns PD-10 Columns SephadexTM 
G-25M 
GE Healthcare 
(Buckinghamshire, UK) 
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Lab material Product name Company 
ZebaTM Spin Desalting 
Columns 0.5 ml for 30 - 130 
µl sample 
Thermo Fisher Scientific 
(Rochester, New York, USA) 
Glass beads Glass globules Ø 0.1 mm Roth (Karlsruhe, Germany) 
Glass beads, acid-washed 
425-600 µm (30 - 40 U. S. 
sieve) 
Sigma-Aldrich (Steinheim, 
Germany) 
Glass pipettes (0.5, 1, 2, 5, 10 
and 20 ml) 
Glass pipettes (0.5, 1, 2, 5, 
10 and 20 ml) 
Brand (Wertheim, Germany) 
Glass ware (beakers, flasks, 
bottles, dessicator) 
Glass beakers, glass flasks, 
glass bottles, glass dessicator 
Schott AG (Mainz, 
Germany) 
Laboratory film Parafilm® M Laboratory 
Film 4 IN. × 125 FT. Roll 
Bemis (Neenah, Wisconsin, 
USA) 
Leukopor Leukopor 2.5 cm × 9.2 m BSN Medical (Hamburg, 
Germany) 
Microtiter plates Mikrotestplatte 96 Well, F Sarstedt (Nümbrecht, 
Germany) 
Needles Sterican® 1.20 × 40 mm 
18G × 1 1/2" 
B. Braun (Melsungen, 
Germany) 
PCR strips Multiply® -µStrip 0.2 ml 
chain (DNA-/DNase-
/RNase-/PCR inhibitor-
free) with 8-Lid chain, flat 
(DNA-/DNase-/RNase-
/PCR inhibitor-free)  
Sarstedt (Nümbrecht, 
Germany) 
PCR tubes Ultra Thin-Wall Tubes 0.2 
ml (Free of Dnase, Rnase, 
Metal, Pyrogen) 
BIOplastics (Landgraaf, The 
Netherlands) 
Petri dish (round) Petridish 29×16 mm with 
cams 
Sarstedt (Nümbrecht, 
Germany) 
Petri dish (square) Petri dish 100 × 100 × 20 
mm 
Sarstedt Australia pty Ltd 
(Mawson Lakes, South 
Australia) 
Pipette tips Pipette tip 1000 µl Sarstedt (Nümbrecht, 
Germany) 
Pipette tip 200 µl Sarstedt (Nümbrecht, 
Germany) 
Pipette tip 10 µl Sarstedt (Nümbrecht, 
Germany) 
Lab material 
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Gel-Saver II Tip1 - 200 µl 
Bulk, 1000 
Starlab (Hamburg, Germany) 
Plant pot labels Steckettiketten 10 x 1.6 mm, 
unbedruckt, verschiedene 
Farben 
MEYER-Produckte für den 
Gartenbau 
(Rellingen/Westerstede/ 
Willich/Nossen/Langenau, 
Germany) 
Plastic ware (beakers, 
cylinders) 
Plastic beakers, plastic 
cylinders 
Vitlab GmbH 
(Grossostheim, Germany) 
Polypropylene columns for 
protein purification 
Poly-Prep® 
Chromatography Columns 
BioRad (Hercules, California, 
USA) 
MicroBio-SpinTM Columns BioRad (Hercules, California, 
USA) 
Precast PAGE gels Mini-PROTEAN® Precast 
TGX Gels 4-20%, 10-well 
comb, 50 µl 
BioRad Laboratories 
(Munich, Germany) 
PVDF membrane Roti® PVDF, Pore size 0.45 
µm 375× 26.5 cm  
Roth (Karlsruhe, Germany) 
Reaction tubes Microtube 1.5 ml Sarstedt (Nümbrecht, 
Germany) 
Microtube 2 ml Sarstedt (Nümbrecht, 
Germany) 
Tube 13 ml 100 × 16 mm, 
PP 
Sarstedt (Nümbrecht, 
Germany) 
Tube 15 ml 120 × 17 mm, 
PP (DNase-, RNase-free, 
non-pyrogenic, non-
cytotoxic) 
Sarstedt (Nümbrecht, 
Germany) 
Tube 50 ml 114 × 28 mm, 
PP 
Sarstedt (Nümbrecht, 
Germany) 
Scalpel blades Bayha® non-sterile C. Bruno Bayha GmbH 
(Tuttlingen, Germany) 
Serological pipettes Serological Pipette 10 ml in 
1/10 ml (sterile, non-
cytotoxic, non-pyrogenic) 
Sarstedt (Nümbrecht, 
Germany) 
Serological Pipette 25 ml in 
2/10 ml (sterile, non-
cytotoxic, non-pyrogenic) 
Sarstedt (Nümbrecht, 
Germany) 
Stainless Steel beads Stainless Steel beads Ø 5 
mm G40 Nirosta 
Kugel-Rollen UG (Röthlein, 
Germany) 
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Superloop Superloop 10 ml, 50 ml GE Healthcare (Uppsala, 
Sweden) 
Syringes Omnican® 40 1 ml/40 I.U. 
U-40 Insulin 30 Gx 1/2" 
(0.3 mm × 12 mm) 
B. Braun (Melsungen, 
Germany) 
Omnifix® 40 Solo U-40 
Insulin 1 ml 
B. Braun (Melsungen, 
Germany) 
Single-use syringe 2 (3) ml B. Braun (Melsungen, 
Germany) 
Disposable syringes 3-
pieced, LUERLOK-slip, 
sterile 50(60) ml 
Mediware® Servoprax® 
GmbH (Wesel, Germany) 
Disposable syringes 3-
pieced, LUERLOK-slip, 
sterile 30 ml 
Mediware® Servoprax® 
GmbH (Wesel, Germany) 
Disposable syringes 3-
pieced, LUERLOK-slip, 
sterile 10 ml 
Mediware® Servoprax® 
GmbH (Wesel, Germany) 
Disposable syringes 3-
pieced, LUERLOK-slip, 
sterile 5 ml 
Mediware® Servoprax® 
GmbH (Wesel, Germany) 
NORM-JECT® Luer (non-
pyrogenic, non-toxic, sterile) 
5 ml (6 ml) 
Henke Sass Wolf (Tuttlingen, 
Germany) 
Tooth picks PAPSTAR PURE 1000 
Toothpicks made of Wood 8 
cm 
Papstar (Kall, Germany) 
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Technical device Product name Company 
8-Channel pipette FINNPIPETTE® F2 1 - 10 µl Thermo Scientific 
(Vantaa, Finland) 
FINNPIPETTE® F2 30 - 300 µl Thermo Scientific 
(Vantaa, Finland) 
Autoclave 3870 ELV Tuttnauer (Breda, 
Netherlands) 
PSD H. Hölzel ® GmbH 
(Hörlkofen, 
Germany) 
Systec VX-150 Systec GmbH Labor-
Systemtechnik 
(Wettenberg, 
Germany) 
Systec VX-95 Systec GmbH Labor-
Systemtechnik 
(Wettenberg, 
Germany) 
Bead beater/Tissue lyser Retsch® MM301 Schwingmühle Retsch (Haan, 
Germany) 
Blotting chambers 
(Western Blot) 
V20-SDB 20x 20 cm Semidry Blotter 
Unit 
SCIE-PLAS LTD 
(Cambridge, England) 
Camera Canon PowerShot G11 Canon Deutschland 
GmbH (Krefeld, 
Germany) 
Centrifuges/Rotors 
 
Biofuge pico Heraeus Instruments 
GmbH (Hanau, 
Germany) 
Heraeus Fresco 17 Centrifuge Thermo Scientific 
(Dreieich, Germany) 
Heraeus Pico 17 Centrifuge Thermo Scientific 
(Dreieich, Germany) 
MICRO STAR 17R VWR (Darmstadt, 
Germany) 
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MIKRO 200 Hettich Zentrifugen 
(Tuttlingen, 
Germany) 
MIKRO 200R Hettich Zentrifugen 
(Tuttlingen, 
Germany) 
Rotina 380 R equipped with rotors 
1789-L 1500 rpm, 30 x 4 g or 1798 
4000rpm 4 x 300 g, 1789-A 15000 rpm 
30 x 3 g, or 1725 4000 rpm max 4 x 150 
g 
Hettich Zentrifugen 
(Tuttlingen, 
Germany) 
Rotina 38R Hettich Zentrifugen 
(Tuttlingen, 
Germany) 
Sorvall RC6+ Centrifuge equipped with 
rotors Sorvall® Dupont SUPER-
LITETM GS-3 Model SLA-3000, 
Sorvall® SA-600, or Sorvall® SS-34 
(Dupont) 
Thermo Scientific 
(Dreieich, Germany) 
Clean benches Heraguard Thermo Scientific 
(Dreieich, Germany) 
Safe 2020 Thermo Scientific 
(Dreieich, Germany) 
Climate chambers Climate chambers Johnson Controls 
Systems & Service 
GmbH (Essen, 
Germany) 
Cool chamber (cold 
room) 
Cool chamber Johnson Controls 
Systems & Service 
GmbH (Essen, 
Germany) 
Electroporation device BioRad capacitance extender plus BioRad Laboratories 
(Munich, Germany) 
BioRad Gene Pulser® II BioRad Laboratories 
(Munich, Germany) 
BioRad Pulse controller Plus BioRad Laboratories 
(Munich, Germany) 
Freezer Liebherr Medline Liebherr (Bulle, 
Switzerland) 
Liebherr Premium Liebherr (Bulle, 
Switzerland) 
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Liebherr Premium NoFrost Liebherr (Bulle, 
Switzerland) 
Liebherrr Comfort Liebherr (Bulle, 
Switzerland) 
Siemens GS12DA20 Siemens (Munich, 
Germany) 
FB 50 I Electrolux 
Fridges Liebherr Medline Liebherr (Bulle, 
Switzerland) 
Liebherr Drink Refrigerator FK 2642 
Index 20Q/001 
Liebherr (Austria) 
Liebherr Premium  Liebherr (Bulle, 
Switzerland) 
Tritec® Hannover Tritec (Hannover, 
Germany) 
Gel documentation 
system (Agarose gels) 
Gel documentation system (Agarose 
gels) 
Intas (Göttingen, 
Germany) 
Heater Electric cooker Rommelsbacher 
(Dinkelsbühl, 
Germany) 
HLC MHR11 Ditabis (Pforzheim, 
Gemrany) 
HLC TH26 Ditabis (Pforzheim, 
Gemrany) 
MHR13 Hettich Lab 
Technology 
(Geldermalsen, 
Netherlands) 
Pressure cooking pot WMF 
Chromargen® Stainless steel 18/10 8.5 
l 
WMF (Geislingen an 
der Steige, Germany) 
Horizontal shakers CAT ST5  M. Zipper GmbH 
(Staufen, Germany) 
IKA® Vibrax-VXR equipped with 
attachment Typ VX7 
IKA-Werke 
(originally Janke & 
Kunkel) (Staufen, 
Germany) 
Mini Gyro-Rocker SSM3 Stuart (Staffordshire, 
UK) 
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Ice machine S-No. 106094 Ziegra 
Eismaschinenen 
GmbH (Isernhagen, 
Germany) 
Incubator shaker Certomat® BS-1 Sartorius Stedim 
Biotech (Göttingen, 
Germany) 
Ecotron H T Infors AG (Einsbach, 
Germany) 
Incubators Memmert Memmert 
(Schwabach, 
Germany) 
Memmert Modell 100-800 Memmert 
(Schwabach, 
Germany) 
Lab boy Boy110 Rudolf Cramer AG 
(Degersheim, 
Switzerland) 
Luminescence imager INTAS Chemo cam Intas (Göttingen, 
Germany) 
INTAS ChemoStarProfessional Intas (Göttingen, 
Germany) 
Magnetic stirrers IKA® RH basic 2 IKA-Werke (Staufen, 
Germany) 
IKAMAG® REO IKA-Werke (Staufen, 
Germany) 
MR80 Heidolph Instruments 
(Schwabach, 
Germany) 
RCT basic IKA-Werke (Staufen, 
Germany) 
RCT basic IKA-Werke (Staufen, 
Germany) 
RSM-01S Phoenix Instrument 
(Garbsen, Germany) 
Type RMO Serie 76 Gerhardt (Bonn, 
West Germany) 
Microscope Zeiss Microscope equipped with three 
Zeiss objectives (40x Plan 40/0.65 
160/0.17; 10x 10/0.22 160/-; 3.2x 
3.2/0.07 160/-) 
Zeiss (West 
Germany) 
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Microwave MWD 2923G Alaska Elektro 
(Viernheim, 
Germany) 
Mini centrifuges Rotilabo®-mini-centrifuge Roth (Karlsruhe, 
Germany) 
Rotilabo®-mini-centrifuge equipped 
with rotor The ButterflyTM 
Roth (Karlsruhe, 
Germany) 
Sprout HS Heathrow Scientific 
(Vernon Hills, 
Illinois, USA) 
PAGE gel chambers Mini-PROTEAN® Tetra Cell System  BioRad Laboratories 
(Munich, Germany) 
pH meter pH211 Microprocessor pH Meter HANNA instruments 
(Vöhringen, 
Germany) 
Photometer Libra S11 Biochrom (Berlin, 
Germany) 
NanoDrop 2000 Spectrophotometer Peqlab (Erlangen, 
Germany) 
NanoDrop ONE Thermo Scientific 
(Dreieich, Germany) 
Pipettes (P2N, P10N, 
P20N, P200N, P1000N) 
Pipettes (P2N, P10N, P20N, P200N, 
P1000N) 
Gilson (Villiers Le 
Bel, France) 
Plant incubators Intellus Control system AR-22L Percival Scientific 
(Perry, Iowa, USA) 
Intellus Control system AR-66L Percival Scientific 
(Perry, Iowa, USA) 
Plate reader Synergy HT BioTek (Bad 
Friedrichshall, 
Germany) 
Power supply Consort E323 Consort (Turnhout, 
Belgium) 
Consort EV231 Consort (Turnhout, 
Belgium) 
Consort EV243 Consort (Turnhout, 
Belgium) 
EC 105 ECApparatus 
Corporation (St. 
Petersburg, Florida, 
USA) 
Technical devices 
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PowerPacTM HC Biorad Laboratories 
(Munich, Germany) 
Protein purification 
system 
ÄKTAprime plus GE Healthcare 
(Uppsala, Sweden) 
ÄKTApure equipped with Fraction 
Collector F9-R 
GE Healthcare 
(Uppsala, Sweden) 
qRT PCR thermal cycler BioRad CFX ConnectTM Real-Time 
System 
BioRad Laboratories 
(Munich, Germany) 
BioRad iCycler BioRad Laboratories 
(Munich, Germany) 
qRT PCR thermal cycler 
software 
BioRad iQ5 BioRad Laboratories 
(Munich, Germany) 
Quantum Meter Quantum Flux MQ 200 Apogee Electronics 
Corporation (Santa 
Monica, California, 
USA) 
Reaction tube rotor Intelli-Mixer RM-2L Elmi Laboratory 
Equipment (Riga, 
Latvia) 
Intelli-Mixer RM-2L Skyline Elmi Laboratory 
Equipment (Riga, 
Latvia) 
Scales Kern 572 Max. 3010 g d = 0.01 g Kern (Balingen, 
Germany) 
Sartorius Extend Max 120 g d = 0.1 mg 
ED1245 
Sartorius Stedim 
(Göttingen, 
Germany) 
Scaltec SPQ51 Max 310 g d = 0.01 g Scaltec Instruments 
(Göttingen, 
Germany) 
Scanner Epson Perfection V700 Photo Epson (Meerbusch, 
Germany) 
SilverFast LaserSoft Imaging 
AG (Kiel, Germany) 
Sonifier Sonopuls equipped with an MS73 
sonotrode 
Bandelin electronic 
(Berlin, Germany) 
Sterilisator  Modell 100-800 Memmert 
(Schwabach, 
Germany) 
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Thermal cycler iCycler BioRad Laboratories 
(Munich, Germany) 
MyCyclerTM thermal cycler BioRad Laboratories 
(Munich, Germany) 
Tripod ProBlack 2 Dörr GmbH (Neu 
Ulm, Germany) 
Tube rotator Stuart® Rotator SB2 Stuart (Staffordshire, 
UK) 
Ultralow Freezer Herafreeze Top - 75°C Thermo Scientific 
(Dreieich, Germany) 
HeraFreeze HFU T Series Thermo Scientific 
(Dreieich, Germany) 
Minus 85°C Ultralow Freezer Thermo Scientific 
(Dreieich, Germany) 
Minus 85°C Ultralow Freezer U57085 New Brunswick 
Scientific (Nürtingen, 
Germany) 
Vaccum pump Diaphragm Vaccuum Pump MD1C Vacuubrand GMbH 
& Co KG 
(Werthheim, 
Germany) 
Vortexter IKA® Vibrax-VXR basic equipped 
with attachment Typ VX2E 
IKA-Werke (Staufen, 
Germany) 
LABINCO L46 Labinco BV (Breda, 
The Netherlands) 
MS2 Minishaker IKA-Werke (Staufen, 
Germany) 
Vortex-Genie 2 Scientific Industries 
(Bohemia, New York, 
USA) 
Water bath GFL 1083 GFL (Burgwedel, 
Germany) 
GFL® 1092 GFL (Burgwedel, 
Germany) 
Water desalting device Arium® pro DI Sartorius Stedim 
Biotech (Göttingen, 
Germany) 
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Abbreviations 
_____________________________________________________________________
Abbreviation  Extended spelling  
(number)-x (number)-fold 
3'UTR 3'-untranslated region 
5'UTR 5'-untranslated region 
α Anti 
A. thaliana Arabidopsis thaliana 
A. tumefaciens Agrobacterium tumefaciens 
AmpR Ampicilin resistance 
APS Ammonium peroxodisulfate 
At Arabidopsis thaliana 
ATP Adenosinetriphosphate 
BAK1 Brassinosteroid insensitive 1 (BRI1)-associated receptor kinase 
bar Basta resistance 
BPGA 1,3-bisphosphoglycerate 
bp Base pair 
BSA Bovine serum albumin 
bZIP Basic leucine zipper 
CBB Coomassie brilliant blue 
cDNA Complementary desoxyribonucleic acid 
CEPD2 C-terminally encoded peptide downstream 1 
CL Control light 
D Discussion 
dH2O Distilled water 
DHA Dehydroascorbate 
DMSO Dimethyl sulfoxide 
DNA  Desoxyribonucleic acid 
dNTP Desoxyribonucleotid triphosphate 
DTNB 5,5-dithio-bis-2-nitrobenzoic acid 
DTT Dithiothreitol 
E. coli Escherichia coli 
e.g. Example given 
EDTA Ethylenediaminetetraacetic acid 
Eh Abient redox potential 
Escherichia coli E. coli 
ET Ethylene 
et al. et alii 
Abbreviations 
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Abbreviation  Extended spelling  
EtOH Ethanol 
FTR Ferredoxin thioredoxin reductase 
fwd Forward 
GAP Glyceraldehyde 3-phosphate 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase  
GentR Gentamicin resistance 
GRX Glutaredoxin 
GSH Glutathione 
GSNO Nitrosoglutathione 
GSSEtOH Mixed disulfide between glutathione and 
β-mercaptoethanol 
GSSG Glutathione disulfide 
HA Haemagglutinin 
HEDS Bis(2-hydroxyethyl)disulfide 
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HRP Horseradish peroxidase 
I Introduction 
i.e. id est 
IAM Iodoacetamide 
IDCR Ionic detergent compatability reagent  
iodoTMTTM Iodoacetyl Tandem Mass TagTM 
IPTG Isopropyl-β-D-thiogalactopyranoside 
JA Jasmonic acid/jasmonate 
JAZ Jasmonate (Zinc-finger inflorescence meristem) ZIM 
domain 
KanR Kanamycin resistance 
Kav Partition coefficient 
Kd Dissociation constant 
LB medium Luria-Bertani medium 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LEU2 Leucine biosynthesis 2 
LIC Ligation-independent cloning 
LL Low light 
mAU Milli absorbtion units 
mBBr Monobromobimane 
MBP Maltose-binding protein 
MS medium Murashige-Skoog medium 
MS Mass spectrometry 
MST Microscale thermophoresis 
MW Molecular weight 
MWCO Molecular weight cut-off 
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NAD+ Nicotinamide adenine dinucleotide, oxidized form 
NADH Nicotinamide adenine dinucleotide, reduced form 
NADP+ Nicotinamide adenine dinucleotide phosphate, 
oxidized form 
NADPH Nicotinamide adenine dinucleotide phosphate, 
reduced form 
NHS N-hydroxysuccinimide 
NINJA Novel Interactor of JAZ 
NMR Nuclear magnetic resonance 
NPR1 Nonexpressor of pathogenesis-related proteins 1 
NRT2.1 Nitrate transporter 2.1 
NRT2.2 Nitrate transporter 2.2 
ODXXXnm Optical densitiy at XXX nm 
ON Over night 
ox Oxidized 
P. falciparum Plasmodium falciparum 
PAGE Polyacrylamide gel electrophoresis 
PAN PERIANTHIA 
PBS Phosphate-buffered saline 
PBS-T Phosphate-buffered saline-Tween-20 
PCR Polymerase chain reaction 
PDB Protein database 
Pf Plasmodium falciparum 
pI Isoelectric point 
PIPES 1,4-Piperazinediethanesulfonic acid 
pKa value Acid dissociation constant 
PSM Peptide spectrum match 
PTT Phosphinotricine 
PVDF Polyvinyldiflouride 
Q1 Glutamine-rich region 1 (domain of TGA 
transcription factors) 
Q2 Glutamine-rich region 2 (domain of TGA 
transcription factors) 
qRT-PCR Quantitative realtime PCR 
R Results 
red Reduced 
rev Reverse 
RNA Ribonucleic acid 
RNS Reactive nitrogen species 
roGFP Redox-sensitive green fluorescent protein 
ROS Reactive oxygen species 
RT Room temperature 
Abbreviations 
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Abbreviation  Extended spelling  
S Supplementary 
S. cerevisiae Saccharomyces cerevisiae 
SA Salicylic acid/salicylate 
Sc Saccharomyces cerevisiae 
SCL14 Scarecrow-like 14 
SD Standard deviation 
SDS Sodium dodecylsulfate 
SEM Standard error of the mean 
-SG Glutathione moiety 
SpecR Spectinomycin resistance 
SUMO Small ubiquitin-modifier 
T. ni Trichoplusia ni 
TBS TRIS-buffered saline 
TBS-T TRIS-buffered saline-Tween-20 
TCA Trichloroacetic acid 
TCEP Tris(2-carboxyethyl)phosphine 
T-DNA Transfer DNA 
TEMED Tetramethylethylenediamine 
TEV Tobacco etch virus 
TGA transcription 
factor 
TGACG-motif binding transcription factor 
TGA1g Genomic TGA1 
TPL TOPLESS 
TR Thioredoxin reductase 
TRIS 2-Amino-2-(hydroxymethyl)-1,3-propanediol 
TRX Thioredoxin 
UV Ultraviolet 
UV/Vis Ultraviolet/Visible light 
v Velocity 
X corr Cross correlation 
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Unit sign  Extended spelling  
% Percent 
‰ Per mil 
%(v/v) Percent volume per volume 
%(w/v) Percent weight per volume 
° Degree 
°C Degree Celsius 
Å Angström 
A.U., AU Absorption units 
Da Dalton 
F Farrad 
g Gramm 
h Hours 
L, l Litre 
M Molar (mol/l) 
m Metre 
min Minutes 
mol Mol 
rpm Rounds per minute 
s, sec Seconds 
U, u Units 
Ω Ohm 
V Volt 
 
Unit prefix  Extended spelling  Scaling factor  
k kilo 103 
m milli 10-3 
µ micro 10-6 
n nano 10-9 
 
Natural constant  Value and unit  
g 9.81 m/s2 
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Amino acids and bases 
_____________________________________________________________________ 
 
Amino acid  Three letter code  Single letter code  
Alanine Ala A 
Cysteine Cys C 
Aspartate Asp D 
Glutamate Glu E 
Phenylalanine Phe F 
Glycin Gly G 
Histidine His H 
Isoleucine Ile I 
Lysine Lys K 
Leucine Leu L 
Methionine Met M 
Asparagine Asn N 
Proline Pro P 
Glutamine Gln Q 
Arginine Arg R 
Serine Ser S 
Threonine Thr T 
Valine Val V 
Tryptophane Trp W 
Tyrosine Tyr Y 
 
 
 
Base  Code  
Adenine A 
Cytosine C 
Guanine G 
Thymine T 
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